FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Boedhoe, PSW
   van Rooij, D
   Hoogman, M
   Twisk, JWR
   Schmaal, L
   Abe, Y
   Alonso, P
   Ameis, SH
   Anikin, A
   Anticevic, A
   Arango, C
   Arnold, PD
   Asherson, P
   Assogna, F
   Auzias, G
   Banaschewski, T
   Baranov, A
   Batistuzzo, MC
   Baumeister, S
   Baur-Streubel, R
   Behrmann, M
   Bellgrove, MA
   Benedetti, F
   Beucke, JC
   Biederman, J
   Bollettini, I
   Bose, A
   Bralten, J
   Bramati, IE
   Brandeis, D
   Brem, S
   Brennan, BP
   Busatto, GF
   Calderoni, S
   Calvo, A
   Calvo, R
   Castellanos, FX
   Cercignani, M
   Chaim-Avancini, TM
   Chantiluke, KC
   Cheng, YQ
   Cho, KIK
   Christakou, A
   Coghill, D
   Conzelmann, A
   Cubillo, AI
   Dale, AM
   Dallaspezia, S
   Daly, E
   Denys, D
   Deruelle, C
   Di Martino, A
   Dinstein, I
   Doyle, AE
   Durston, S
   Earl, EA
   Ecker, C
   Ehrlich, S
   Ely, BA
   Epstein, JN
   Ethofer, T
   Fair, DA
   Fallgatter, AJ
   Faraone, SV
   Fedor, J
   Feng, X
   Feusner, JD
   Fitzgerald, J
   Fitzgerald, KD
   Fouche, JP
   Freitag, CM
   Fridgeirsson, EA
   Frodl, T
   Gabel, MC
   Gallagher, L
   Gogberashvili, T
   Gori, I
   Gruner, P
   Gursel, DA
   Haar, S
   Haavik, J
   Hall, GB
   Harrison, NA
   Hartman, CA
   Heslenfeld, DJ
   Hirano, Y
   Hoekstra, PJ
   Hoexter, MQ
   Hohmann, S
   Hovik, MF
   Hu, H
   Huyser, C
   Jahanshad, N
   Jalbrzikowski, M
   James, A
   Janssen, J
   Jaspers-Fayer, F
   Jernigan, TL
   Kapilushniy, D
   Kardatzki, B
   Karkashadze, G
   Kathmann, N
   Kaufmann, C
   Kelly, C
   Khadka, S
   King, JA
   Koch, K
   Kohls, G
   Konrad, K
   Kuno, M
   Kuntsi, J
   Kvale, G
   Kwon, JS
   Lazaro, L
   Lera-Miguel, S
   Lesch, KP
   Hoekstra, L
   Liu, YN
   Lochner, C
   Louza, MR
   Luna, B
   Lundervold, AJ
   Malpas, CB
   Marques, P
   Marsh, R
   Martinez-Zalacain, I
   Mataix-Cols, D
   Mattos, P
   McCarthy, H
   McGrath, J
   Mehta, MA
   Menchon, JM
   Mennes, M
   Martinho, MM
   Moreira, PS
   Morer, A
   Morgado, P
   Muratori, F
   Murphy, CM
   Murphy, DGM
   Nakagawa, A
   Nakamae, T
   Nakao, T
   Namazova-Baranova, L
   Narayanaswamy, JC
   Nicolau, R
   Nigg, JT
   Novotny, SE
   Nurmi, EL
   Weiss, EO
   Tuura, RLO
   O'Hearn, K
   O'Neill, J
   Oosterlaan, J
   Oranje, B
   Paloyelis, Y
   Parellada, M
   Pauli, P
   Perriello, C
   Piacentini, J
   Piras, F
   Piras, F
   Plessen, KJ
   Puig, O
   Ramos-Quiroga, JA
   Reddy, YCJ
   Reif, A
   Reneman, L
   Retico, A
   Rosa, PGP
   Rubia, K
   Rus, OG
   Sakai, Y
   Schrantee, A
   Schwarz, L
   Schweren, LJS
   Seitz, J
   Shaw, P
   Shook, D
   Silk, TJ
   Simpson, HB
   Skokauskas, N
   Vila, JCS
   Solovieva, A
   Soreni, N
   Soriano-Mas, C
   Spalletta, G
   Stern, ER
   Stevens, MC
   Stewart, SE
   Sudre, G
   Szeszko, PR
   Tamm, L
   Taylor, MJ
   Tolin, DF
   Tosetti, M
   Tovar-Moll, F
   Tsuchiyagaito, A
   van Erp, TGM
   van Wingen, GA
   Vance, A
   Venkatasubramanian, G
   Vilarroya, O
   Vives-Gilabert, Y
   von Polier, GG
   Walitza, S
   Wallace, GL
   Wang, Z
   Wolfers, T
   Yoncheva, YN
   Yun, JY
   Zanetti, MV
   Zhou, FF
   Ziegler, GC
   Zierhut, KC
   Zwiers, MP
   Thompson, PM
   Stein, DJ
   Buitelaar, J
   Franke, B
   van den Heuvel, OA
AF Boedhoe, Premika S. W.
   van Rooij, Daan
   Hoogman, Martine
   Twisk, Jos W. R.
   Schmaal, Lianne
   Abe, Yoshinari
   Alonso, Pino
   Ameis, Stephanie H.
   Anikin, Anatoly
   Anticevic, Alan
   Arango, Celso
   Arnold, Paul D.
   Asherson, Philip
   Assogna, Francesca
   Auzias, Guillaume
   Banaschewski, Tobias
   Baranov, Alexander
   Batistuzzo, Marcelo C.
   Baumeister, Sarah
   Baur-Streubel, Ramona
   Behrmann, Marlene
   Bellgrove, Mark A.
   Benedetti, Francesco
   Beucke, Jan C.
   Biederman, Joseph
   Bollettini, Irene
   Bose, Anushree
   Bralten, Janita
   Bramati, Ivanei E.
   Brandeis, Daniel
   Brem, Silvia
   Brennan, Brian P.
   Busatto, Geraldo F.
   Calderoni, Sara
   Calvo, Anna
   Calvo, Rosa
   Castellanos, Francisco X.
   Cercignani, Mara
   Chaim-Avancini, Tiffany M.
   Chantiluke, Kaylita C.
   Cheng, Yuqi
   Cho, Kang Ik K.
   Christakou, Anastasia
   Coghill, David
   Conzelmann, Annette
   Cubillo, Ana, I
   Dale, Anders M.
   Dallaspezia, Sara
   Daly, Eileen
   Denys, Damiaan
   Deruelle, Christine
   Di Martino, Adriana
   Dinstein, Ilan
   Doyle, Alysa E.
   Durston, Sarah
   Earl, Eric A.
   Ecker, Christine
   Ehrlich, Stefan
   Ely, Benjamin A.
   Epstein, Jeffrey N.
   Ethofer, Thomas
   Fair, Damien A.
   Fallgatter, Andreas J.
   Faraone, Stephen, V
   Fedor, Jennifer
   Feng, Xin
   Feusner, Jamie D.
   Fitzgerald, Jackie
   Fitzgerald, Kate D.
   Fouche, Jean-Paul
   Freitag, Christine M.
   Fridgeirsson, Egill A.
   Frodl, Thomas
   Gabel, Matt C.
   Gallagher, Louise
   Gogberashvili, Tinatin
   Gori, Ilaria
   Gruner, Patricia
   Gursel, Deniz A.
   Haar, Shlomi
   Haavik, Jan
   Hall, Geoffrey B.
   Harrison, Neil A.
   Hartman, Catharina A.
   Heslenfeld, Dirk J.
   Hirano, Yoshiyuki
   Hoekstra, Pieter J.
   Hoexter, Marcelo Q.
   Hohmann, Sarah
   Hovik, Marie F.
   Hu, Hao
   Huyser, Chaim
   Jahanshad, Neda
   Jalbrzikowski, Maria
   James, Anthony
   Janssen, Joost
   Jaspers-Fayer, Fern
   Jernigan, Terry L.
   Kapilushniy, Dmitry
   Kardatzki, Bernd
   Karkashadze, Georgii
   Kathmann, Norbert
   Kaufmann, Christian
   Kelly, Clare
   Khadka, Sabin
   King, Joseph A.
   Koch, Kathrin
   Kohls, Gregor
   Konrad, Kerstin
   Kuno, Masaru
   Kuntsi, Jonna
   Kvale, Gerd
   Kwon, Jun Soo
   Lazaro, Luisa
   Lera-Miguel, Sara
   Lesch, Klaus-Peter
   Hoekstra, Liesbeth
   Liu, Yanni
   Lochner, Christine
   Louza, Mario R.
   Luna, Beatriz
   Lundervold, Astri J.
   Malpas, Charles B.
   Marques, Paulo
   Marsh, Rachel
   Martinez-Zalacain, Ignacio
   Mataix-Cols, David
   Mattos, Paulo
   McCarthy, Hazel
   McGrath, Jane
   Mehta, Mitul A.
   Menchon, Jose M.
   Mennes, Maarten
   Martinho, Mauricio Moller
   Moreira, Pedro S.
   Morer, Astrid
   Morgado, Pedro
   Muratori, Filippo
   Murphy, Clodagh M.
   Murphy, Declan G. M.
   Nakagawa, Akiko
   Nakamae, Takashi
   Nakao, Tomohiro
   Namazova-Baranova, Leyla
   Narayanaswamy, Janardhanan C.
   Nicolau, Rosa
   Nigg, Joel T.
   Novotny, Stephanie E.
   Nurmi, Erika L.
   Weiss, Eileen Oberwelland
   Tuura, Ruth L. O'Gorman
   O'Hearn, Kirsten
   O'Neill, Joseph
   Oosterlaan, Jaap
   Oranje, Bob
   Paloyelis, Yannis
   Parellada, Mara
   Pauli, Paul
   Perriello, Chris
   Piacentini, John
   Piras, Fabrizio
   Piras, Federica
   Plessen, Kerstin J.
   Puig, Olga
   Ramos-Quiroga, J. Antoni
   Reddy, Y. C. Janardhan
   Reif, Andreas
   Reneman, Liesbeth
   Retico, Alessandra
   Rosa, Pedro G. P.
   Rubia, Katya
   Rus, Oana Georgiana
   Sakai, Yuki
   Schrantee, Anouk
   Schwarz, Lena
   Schweren, Lizanne J. S.
   Seitz, Jochen
   Shaw, Philip
   Shook, Devon
   Silk, Tim J.
   Simpson, H. Blair
   Skokauskas, Norbert
   Vila, Juan Carlos Soliva
   Solovieva, Anastasia
   Soreni, Noam
   Soriano-Mas, Carles
   Spalletta, Gianfranco
   Stern, Emily R.
   Stevens, Michael C.
   Stewart, S. Evelyn
   Sudre, Gustavo
   Szeszko, Philip R.
   Tamm, Leanne
   Taylor, Margot J.
   Tolin, David F.
   Tosetti, Michela
   Tovar-Moll, Fernanda
   Tsuchiyagaito, Aki
   van Erp, Theo G. M.
   van Wingen, Guido A.
   Vance, Alasdair
   Venkatasubramanian, Ganesan
   Vilarroya, Oscar
   Vives-Gilabert, Yolanda
   von Polier, Georg G.
   Walitza, Susanne
   Wallace, Gregory L.
   Wang, Zhen
   Wolfers, Thomas
   Yoncheva, Yuliya N.
   Yun, Je-Yeon
   Zanetti, Marcus, V
   Zhou, Fengfeng
   Ziegler, Georg C.
   Zierhut, Kathrin C.
   Zwiers, Marcel P.
   Thompson, Paul M.
   Stein, Dan J.
   Buitelaar, Jan
   Franke, Barbara
   van den Heuvel, Odile A.
CA ENIGMA ADHD Working Grp
   ENIGMA ASD Working Grp
   ENIGMA OCD Working Grp
TI Subcortical Brain Volume, Regional Cortical Thickness, and Cortical
   Surface Area Across Disorders: Findings From the ENIGMA ADHD, ASD, and
   OCD Working Groups
SO AMERICAN JOURNAL OF PSYCHIATRY
LA English
DT Article
ID AUTISM SPECTRUM DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER;
   DEFICIT HYPERACTIVITY DISORDER; OBSESSIVE-COMPULSIVE DISORDER;
   FIELD-STRENGTH; MEGA-ANALYSIS; ABNORMALITIES; VOXEL; MRI; CORTEX
AB Objective: Attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and obsessive-compulsive disorder (OCD) are common neurodevelopmental disorders that frequently co-occur. The authors sought to directly compare these disorders using structural brain imaging data from ENIGMA consortium data.
   Methods: Structural T-1-weighted whole-brain MRI data from healthy control subjects (N=5,827) and from patients with ADHD (N=2,271), ASD (N=1,777), and OCD (N=2,323) from 151 cohorts worldwide were analyzed using standardized processing protocols. The authors examined subcortical volume, cortical thickness, and cortical surface area differences within a mega-analytical framework, pooling measures extracted from each cohort. Analyses were performed separately for children, adolescents, and adults, using linear mixed-effects models adjusting for age, sex, and site (and intracranial volume for subcortical and surface area measures).
   Results: No shared differences were found among all three disorders, and shared differences between any two disorders did not survive correction for multiple comparisons. Children with ADHD compared with those with OCD had smaller hippocampal volumes, possibly influenced by 10. Children and adolescents with ADHD also had smaller intracranial volume than control subjects and those with OCD or ASD. Adults with ASD showed thicker frontal cortices compared with adult control subjects and other clinical groups. No OCD-specific differences were observed across different age groups and surface area differences among all disorders in childhood and adulthood.
   Conclusions: The study findings suggest robust but subtle differences across different age groups among ADHD, ASD, and OCD. ADHD-specific intracranial volume and hippocampal differences in children and adolescents, and ASD-specific cortical thickness differences in the frontal cortex in adults, support previous work emphasizing structural brain differences in these disorders.
EM d.vanrooij@donders.ru.nl
RI Haar, Shlomi/I-7498-2019; Haavik, Jan/ABE-1535-2020; Ehrlich,
   Stefan/ABB-4650-2020; Coghill, David/ABF-5213-2020; Wolfers,
   Thomas/ABF-1461-2020; Moreira, Pedro Silva/E-4471-2018; Stein, Dan
   J/A-1752-2008; Banaschewski, Tobias/ABE-5985-2020; Alexander,
   Baranov/O-4882-2019; Stevens, Michael/M-7678-2017; Namazova-Baranova,
   Leyla/C-9485-2019; Franke, Barbara/D-4836-2009; Moll, Fernanda
   Tovar/N-3320-2018; HIRANO, YOSHIYUKI/L-1234-2017; Brem,
   Silvia/M-7130-2016; Venkatasubramanian, Ganesan/AAD-9117-2019; Esteves,
   Madalena/T-5171-2018; Huyser, Chaim/N-2345-2015; Christakou,
   Anastasia/B-7838-2008
OI Haar, Shlomi/0000-0003-2213-6585; Ehrlich, Stefan/0000-0003-2132-4445;
   Coghill, David/0000-0003-3017-9737; Moreira, Pedro
   Silva/0000-0002-2800-3903; Stein, Dan J/0000-0001-7218-7810;
   Banaschewski, Tobias/0000-0003-4595-1144; Alexander,
   Baranov/0000-0003-3987-8112; Stevens, Michael/0000-0002-3799-5465;
   Namazova-Baranova, Leyla/0000-0002-2209-7531; Franke,
   Barbara/0000-0003-4375-6572; Moll, Fernanda Tovar/0000-0002-0292-5985;
   HIRANO, YOSHIYUKI/0000-0003-3844-3061; Brem, Silvia/0000-0002-8031-1305;
   Venkatasubramanian, Ganesan/0000-0002-0949-898X; Sakai,
   Yuki/0000-0003-2475-8548; Esteves, Madalena/0000-0001-6674-1256; Huyser,
   Chaim/0000-0001-8757-3124; Christakou, Anastasia/0000-0002-4267-3436;
   Ziegler, Georg C./0000-0001-9411-3169; Silk, Tim/0000-0002-7290-512X;
   Castellanos, Francisco/0000-0001-9192-9437; Yoncheva,
   Yuliya/0000-0001-6495-7504; McGrath, Jane/0000-0002-4894-4823;
   Schrantee, Anouk/0000-0002-4035-4845; Janssen,
   Joost/0000-0001-7613-2067; Wallace, Gregory/0000-0003-0329-5054
CR Amat JA, 2008, BRAIN COGNITION, V66, P105, DOI 10.1016/j.bandc.2007.05.009
   Anholt GE, 2010, J AUTISM DEV DISORD, V40, P580, DOI 10.1007/s10803-009-0922-1
   Antshel KM, 2013, EXPERT REV NEUROTHER, V13, P1117, DOI 10.1586/14737175.2013.840417
   Barnes J, 2010, NEUROIMAGE, V53, P1244, DOI 10.1016/j.neuroimage.2010.06.025
   Boedhoe PSW, 2019, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00102
   Boedhoe PSW, 2018, AM J PSYCHIAT, V175, P453, DOI 10.1176/appi.ajp.2017.17050485
   Boedhoe PSW, 2017, AM J PSYCHIAT, V174, P60, DOI 10.1176/appi.ajp.2016.16020201
   Brieber S, 2007, J CHILD PSYCHOL PSYC, V48, P1251, DOI 10.1111/j.1469-7610.2007.01799.x
   Carlisi CO, 2017, BIOL PSYCHIAT, V82, P83, DOI 10.1016/j.biopsych.2016.10.006
   Clarkson MJ, 2011, NEUROIMAGE, V57, P856, DOI 10.1016/j.neuroimage.2011.05.053
   Cubillo A, 2012, CORTEX, V48, P194, DOI 10.1016/j.cortex.2011.04.007
   Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020
   de Wit SJ, 2014, AM J PSYCHIAT, V171, P340, DOI 10.1176/appi.ajp.2013.13040574
   Dougherty CC, 2016, NEUROPSYCHOL REV, V26, P25, DOI 10.1007/s11065-015-9300-2
   Ecker C, 2013, JAMA PSYCHIAT, V70, P59, DOI 10.1001/jamapsychiatry.2013.265
   Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239
   Faraone SV, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.20
   Fouche JP, 2017, BRIT J PSYCHIAT, V210, P67, DOI 10.1192/bjp.bp.115.164020
   Haar S, 2016, CEREB CORTEX, V26, P1440, DOI 10.1093/cercor/bhu242
   Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051
   Hibar DP, 2016, MOL PSYCHIATR, V21, P1710, DOI 10.1038/mp.2015.227
   Hoogman M, 2019, AM J PSYCHIAT, V176, P531, DOI 10.1176/appi.ajp.2019.18091033
   Hoogman M, 2017, LANCET PSYCHIAT, V4, P310, DOI 10.1016/S2215-0366(17)30049-4
   Im K, 2008, CEREB CORTEX, V18, P2181, DOI 10.1093/cercor/bhm244
   Kassem MS, 2013, MOL NEUROBIOL, V47, P645, DOI 10.1007/s12035-012-8365-7
   Klein M, 2019, AM J PSYCHIAT, V176, P228, DOI 10.1176/appi.ajp.2018.18020149
   Lim L, 2015, PSYCHOL MED, V45, P965, DOI 10.1017/S0033291714001974
   Naaijen J, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1072-6
   Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281
   Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886
   Norman LJ, 2016, JAMA PSYCHIAT, V73, P815, DOI 10.1001/jamapsychiatry.2016.0700
   Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94
   Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104
   Shaw P, 2013, BIOL PSYCHIAT, V74, P599, DOI 10.1016/j.biopsych.2013.04.007
   Tardif CL, 2010, HUM BRAIN MAPP, V31, P943, DOI 10.1002/hbm.20908
   Thompson PM, 2014, BRAIN IMAGING BEHAV, V8, P153, DOI 10.1007/s11682-013-9269-5
   van den Heuvel OA, 2016, EUR NEUROPSYCHOPHARM, V26, P810, DOI 10.1016/j.euroneuro.2015.12.005
   van Erp TGM, 2016, MOL PSYCHIATR, V21, P547, DOI 10.1038/mp.2015.63
   van Rooij D, 2018, AM J PSYCHIAT, V175, P359, DOI 10.1176/appi.ajp.2017.17010100
   Weisberg J, 2014, CEREB CORTEX, V24, P37, DOI 10.1093/cercor/bhs276
   Westlye LT, 2010, NEUROIMAGE, V52, P172, DOI 10.1016/j.neuroimage.2010.03.056
   Zielinski BA, 2014, BRAIN, V137, P1799, DOI 10.1093/brain/awu083
NR 42
TC 4
Z9 5
U1 8
U2 8
PU AMER PSYCHIATRIC PUBLISHING, INC
PI WASHINGTON
PA 800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA
SN 0002-953X
EI 1535-7228
J9 AM J PSYCHIAT
JI Am. J. Psychiat.
PD SEP
PY 2020
VL 177
IS 9
BP 834
EP 843
DI 10.1176/appi.ajp.2020.19030331
PG 10
WC Psychiatry
SC Psychiatry
GA NH8OQ
UT WOS:000564923300012
PM 32539527
DA 2020-12-17
ER

PT J
AU Szczupak, D
   Liu, CR
   Yen, CCC
   Choi, SH
   Meireles, F
   Victorino, C
   Richards, L
   Lent, R
   Silva, AC
   Tovar-Moll, F
AF Szczupak, Diego
   Liu, Cirong
   Yen, Cecil C. C.
   Choi, Sang-Ho
   Meireles, Fernanda
   Victorino, Caroline
   Richards, Linda
   Lent, Roberto
   Silva, Afonso C.
   Tovar-Moll, Fernanda
CA IRC5 Consortium
TI Long-distance aberrant heterotopic connectivity in a mouse strain with a
   high incidence of callosal anomalies
SO NEUROIMAGE
LA English
DT Article
ID CONSTRAINED SPHERICAL DECONVOLUTION; CORPUS-CALLOSUM; STRUCTURAL
   CONNECTOME; LONGITUDINAL BUNDLE; ACALLOSAL MOUSE; AGENESIS; BRAIN;
   FETUSES; MICE
C1 [Szczupak, Diego; Lent, Roberto; Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Postgrad Program Morphol Sci, Rio De Janeiro, Brazil.
   [Szczupak, Diego; Liu, Cirong; Yen, Cecil C. C.; Choi, Sang-Ho; Silva, Afonso C.] NIH, Bldg 10, Bethesda, MD 20892 USA.
   [Szczupak, Diego; Liu, Cirong; Choi, Sang-Ho; Silva, Afonso C.] Univ Pittsburgh, Pittsburgh, PA 15260 USA.
   [Meireles, Fernanda; Victorino, Caroline; Lent, Roberto; Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Meireles, Fernanda; Victorino, Caroline; Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging CENABIO, Rio De Janeiro, Brazil.
   [Richards, Linda] Univ Queensland, Queensland Brain Inst & Sch Biomed Sci, Brisbane, Qld, Australia.
RP Tovar-Moll, F (corresponding author), DOr Inst Res & Educ, Rio De Janeiro, RJ, Brazil.
EM fernanda.tovarmoll@idor.org
RI Moll, Fernanda Tovar/N-3320-2018
OI Moll, Fernanda Tovar/0000-0002-0292-5985; LIU,
   CIRONG/0000-0002-7986-4615
FU Research Support Foundation of the State of Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); National Council for Scientific and
   Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq); D'Or Institute for Research and
   Education (IDOR); Intramural Research Program of the NIH, NINDSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Neurological Disorders &
   Stroke (NINDS); Australian National Health and Medical Research Council
   (NHMRC)National Health and Medical Research Council of Australia
   [GNT1120615]
FX This work is part of the Ph.D. thesis of D.S. and was supported by
   Research Support Foundation of the State of Rio de Janeiro (FAPERJ),
   National Council for Scientific and Technological Development (CNPq), as
   well as by intramural grants from D'Or Institute for Research and
   Education (IDOR). This research was supported (in part) by the
   Intramural Research Program of the NIH, NINDS. LJR is supported by an
   Australian National Health and Medical Research Council (NHMRC)
   Principal Research Fellowship GNT1120615. We are thankful to Lisa Zhang
   for technical support, Ted Usdin and Jonathan Kuo for their microscopy
   expertise, and Jorge Moll for proofreading earlier versions of this
   manuscript. We are equally thankful to Tim Edwards and Ryan Dean for
   useful discussions. We thank the members and affiliates of the
   International Research Consortium for the Corpus Callosum and Cerebral
   Connectivity (IRC5,https://www.irc5.org) for discussions and input. The
   authors have no competing interests.
CR Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019
   Arrigoni F, 2016, EUR RADIOL, V26, P2587, DOI 10.1007/s00330-015-4084-6
   Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025
   Bishop KM, 1996, PSYCHOBIOLOGY, V24, P187
   Brodkin ES, 2007, BEHAV BRAIN RES, V176, P53, DOI 10.1016/j.bbr.2006.06.025
   Chen XJ, 2006, NEUROIMAGE, V29, P99, DOI 10.1016/j.neuroimage.2005.07.008
   Contarino VE, 2014, MAGN RESON IMAGING, V32, P1428, DOI 10.1016/j.mri.2014.07.007
   Edwards TJ, 2014, BRAIN, V137, P1579, DOI 10.1093/brain/awt358
   Fenlon LR, 2015, NEURAL DEV, V10, DOI 10.1186/s13064-015-0033-y
   Gipson CD, 2017, GENES BRAIN BEHAV, V16, P101, DOI 10.1111/gbb.12324
   Gogolla N, 2007, CURR OPIN NEUROBIOL, V17, P516, DOI 10.1016/j.conb.2007.09.002
   Gross KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162755
   Jakab A, 2015, NEUROIMAGE, V111, P277, DOI 10.1016/j.neuroimage.2015.02.038
   Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061
   Lazarev VV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152668
   Liu CR, 2016, NEUROIMAGE, V139, P259, DOI 10.1016/j.neuroimage.2016.06.037
   Livy DJ, 1997, HIPPOCAMPUS, V7, P2, DOI 10.1002/(SICI)1098-1063(1997)7:1<2::AID-HIPO2>3.0.CO;2-R
   Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186
   OLAVARRIA J, 1988, J COMP NEUROL, V270, P575, DOI 10.1002/cne.902700411
   Owen JP, 2013, NEUROIMAGE, V70, P340, DOI 10.1016/j.neuroimage.2012.12.031
   OZAKI HS, 1993, J COMP NEUROL, V336, P595, DOI 10.1002/cne.903360411
   OZAKI HS, 1987, BRAIN RES, V400, P239, DOI 10.1016/0006-8993(87)90623-8
   Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107
   Pavlovic S, 2009, SURG RADIOL ANAT, V31, P501, DOI 10.1007/s00276-009-0471-5
   Probst M, 1901, ARCH PSYCHIAT NERVEN, V34, P709, DOI 10.1007/BF02680175
   Rash BG, 2001, J COMP NEUROL, V434, P147, DOI 10.1002/cne.1170
   Ren T, 2007, J NEUROSCI, V27, P10345, DOI 10.1523/JNEUROSCI.2787-07.2007
   Sforazzini F, 2016, BRAIN STRUCT FUNCT, V221, P941, DOI 10.1007/s00429-014-0948-9
   Stephenson DT, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-7
   Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016
   Tovar-Moll F, 2007, CEREB CORTEX, V17, P531, DOI 10.1093/cercor/bhj178
   Tovar-Moll F, 2014, P NATL ACAD SCI USA, V111, P7843, DOI 10.1073/pnas.1400806111
   Ullmann JFP, 2013, NEUROIMAGE, V78, P196, DOI 10.1016/j.neuroimage.2013.04.008
   Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016
   WAHLSTEN D, 1974, BRAIN RES, V68, P1, DOI 10.1016/0006-8993(74)90530-7
NR 35
TC 0
Z9 0
U1 2
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1053-8119
EI 1095-9572
J9 NEUROIMAGE
JI Neuroimage
PD AUG 15
PY 2020
VL 217
AR 116875
DI 10.1016/j.neuroimage.2020.116875
PG 10
WC Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA MB1MG
UT WOS:000542370300010
PM 32335262
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Melo, A
   Oliveira-Szejnfeld, PS
   Malinger, G
   Tavares, JS
   Melo, FO
   Coutinho, LCQM
   Gama, GL
   Moll, FT
   Aguiar, RS
   Tanuri, A
   Amorim, MM
AF Melo, Adriana
   Oliveira-Szejnfeld, Patricia S.
   Malinger, Gustavo
   Tavares, Jousilene S.
   Melo, Fabiana O.
   Coutinho, Larissa Cristina Q. M.
   Gama, Gabriela L.
   Moll, Fernanda T.
   Aguiar, Renato S.
   Tanuri, Amilcar
   Amorim, Melania M.
TI Outcomes of subsequent pregnancies following Zika virus infection: A
   comparative case series
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Congenital abnormalities; Microcephaly; Pregnancy; Zika; Zika virus
AB Neither microcephaly nor neurological damage was found in children born from pregnancies subsequent to one resulting in an infant with congenital Zika syndrome.
C1 [Melo, Adriana; Tavares, Jousilene S.; Melo, Fabiana O.; Coutinho, Larissa Cristina Q. M.; Gama, Gabriela L.; Amorim, Melania M.] Inst Pesquisa Prof Joaquim Amor Neto, Campina Grande, Paraiba, Brazil.
   [Melo, Adriana; Gama, Gabriela L.] UNIFACISA, Campina Grande, Paraiba, Brazil.
   [Melo, Adriana; Amorim, Melania M.] Fed Univ Campina Grande UFCG, Campina Grande, Paraiba, Brazil.
   [Oliveira-Szejnfeld, Patricia S.] Univ Fed Sao Paulo, UNIFESP, Dept Radiol, Sao Paulo, Brazil.
   [Malinger, Gustavo] Tel Aviv Univ, Lis Matern Hosp, Tel Aviv Med Ctr, Tel Aviv, Israel.
   [Malinger, Gustavo] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.
   [Moll, Fernanda T.] DOr Inst Res, Rio De Janeiro, Brazil.
   [Moll, Fernanda T.] DOr Inst Res, Sao Paulo, Brazil.
   [Aguiar, Renato S.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Amorim, Melania M.] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RP Melo, A (corresponding author), Rua Salvino de Oliveira Neto 87, BR-58402040 Campina Grande, Paraiba, Brazil.
EM asomelo@gmail.com
RI Moll, Fernanda Tovar/N-3320-2018; Amorim, Melania M/C-5807-2013
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Amorim, Melania
   M/0000-0003-1047-2514
FU Improvement of Higher Education Personnel (CAPES)CAPES; Ministry of
   Education (MEC)Spanish Government; National Council for Scientific and
   Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq); Ministry of Science, Technology,
   Innovation and Communication (MCTI); Department of Science and
   Technology (Decit)Department of Science & Technology (India);
   Secretariat of Science, Technology and Strategic Supplies (SCTIE);
   Ministry of HealthMinistry of Health - Turkey
FX Improvement of Higher Education Personnel (CAPES); Ministry of Education
   (MEC); National Council for Scientific and Technological Development
   (CNPq); Ministry of Science, Technology, Innovation and Communication
   (MCTI); Department of Science and Technology (Decit); Secretariat of
   Science, Technology and Strategic Supplies (SCTIE); Ministry of Health
CR Almeida KJ, 2019, REV ASSOC MED BRAS, V65, P1249, DOI 10.1590/1806-9282.65.10.1249
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Melo A, 2020, DEV MED CHILD NEUROL, V62, P221, DOI 10.1111/dmcn.14227
   Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019
NR 4
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD DEC
PY 2020
VL 151
IS 3
BP 470
EP 474
DI 10.1002/ijgo.13288
EA AUG 2020
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA OS1NL
UT WOS:000557424500001
PM 32623712
DA 2020-12-17
ER

PT J
AU da Rocha, JLD
   Coutinho, G
   Bramati, I
   Moll, FT
   Sitaram, R
AF da Rocha, Josue Luiz Dalboni
   Coutinho, Gabriel
   Bramati, Ivanei
   Moll, Fernanda Tovar
   Sitaram, Ranganatha
TI Multilevel diffusion tensor imaging classification technique for
   characterizing neurobehavioral disorders
SO BRAIN IMAGING AND BEHAVIOR
LA English
DT Article
DE Diffusion tensor imaging; Fractional anisotropy; Fiber tracking; Graph
   theory; Machine learning
ID MRI; FEATURES
AB This proposed novel method consists of three levels of analyses of diffusion tensor imaging data: 1) voxel level analysis of fractional anisotropy of white matter tracks, 2) connection level analysis, based on fiber tracks between specific brain regions, and 3) network level analysis, based connections among multiple brain regions. Machine-learning techniques of (Fisher score) feature selection, (Support Vector Machine) pattern classification, and (Leave-one-out) cross-validation are performed, for recognition of the neural connectivity patterns for diagnostic purposes. For validation proposes, this multilevel approach achieved an average classification accuracy of 90% between Alzheimer's disease and healthy controls, 83% between Alzheimer's disease and mild cognitive impairment, and 83% between mild cognitive impairment and healthy controls. The results indicate that the multilevel diffusion tensor imaging approach used in this analysis is a potential diagnostic tool for clinical evaluations of brain disorders. The presented pipeline is now available as a tool for scientifically applications in a broad range of studies from both clinical and behavioral spectrum, which includes studies about autism, dyslexia, schizophrenia, dementia, motor body performance, among others.
C1 [da Rocha, Josue Luiz Dalboni] Univ Geneva, Dept Clin Neurosci, Brain & Language Lab, Geneva, Switzerland.
   [da Rocha, Josue Luiz Dalboni] Univ Florida, Dept Biomed Engn, Gainesville, FL USA.
   [Coutinho, Gabriel; Bramati, Ivanei; Moll, Fernanda Tovar] DOr Inst Res & Educ, Rio De Janeiro, Brazil.
   [Moll, Fernanda Tovar] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Sitaram, Ranganatha] Pontificia Univ Catolica Chile, Sch Engn, Inst Biol & Med Engn, Santiago, Chile.
   [Sitaram, Ranganatha] Pontificia Univ Catolica Chile, Sch Med, Dept Psychiat, Santiago, Chile.
   [Sitaram, Ranganatha] Pontificia Univ Catolica Chile, Sch Med, Sect Neurosci, Santiago, Chile.
   [Sitaram, Ranganatha] Pontificia Univ Catolica Chile, Lab Brain Machine Interfaces & Neuromodulat, Santiago, Chile.
RP Sitaram, R (corresponding author), Pontificia Univ Catolica Chile, Sch Engn, Inst Biol & Med Engn, Santiago, Chile.; Sitaram, R (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Dept Psychiat, Santiago, Chile.; Sitaram, R (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Sect Neurosci, Santiago, Chile.; Sitaram, R (corresponding author), Pontificia Univ Catolica Chile, Lab Brain Machine Interfaces & Neuromodulat, Santiago, Chile.
EM rasitaram@uc.cl
RI Moll, Fernanda Tovar/N-3320-2018
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Dalboni da Rocha, Josue
   Luiz/0000-0001-8939-6395
FU New INDIGO [FKZ 01DQ13004] Funding Source: Medline; Fondo Nacional de
   Desarrollo Cientifico y Tecnologico [1171313, 1171320] Funding Source:
   Medline
CR Ashburner J., 2010, SPM 8 MANUAL
   Barthelemy M, 2004, EUR PHYS J B, V38, P163, DOI 10.1140/epjb/e2004-00111-4
   Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022
   Becker B., 1998, BINARY DECISION DIAG
   Brodmann K., 1909, VERGLEICHENDE LOKALI
   Cumming G., 2017, INTRO NEW STAT
   Demirhan A., 2015, IEEE 12 INT S BIOM I, DOI [10.1109/ISBI.2015.7163832, DOI 10.1109/ISBI.2015.7163832]
   Dyrba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064925
   Ebadi A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00056
   Einstein A., 1956, INVESTIGATIONS THEOR
   Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107
   Foster ED, 2017, J MED LIBR ASSOC, V105, P203, DOI DOI 10.5195/JMLA.2017.88
   Friston Karl J., 1996, P363
   Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102
   Good P. I, 2000, SPRINGER SERIES STAT, V2
   He X., 2005, P ADV NEUR INF PROC, V18, P507, DOI DOI 10.1155/2014/803919
   Hong SJ, 2017, NEUROLOGY, V88, P734, DOI 10.1212/WNL.0000000000003632
   Huettel SA, 2004, FUNCTIONAL MAGNETIC
   Jin B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S9-S15
   Johnson R., 2011, MILLER FREUNDS PROBA
   Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701
   Lawes INC, 2008, NEUROIMAGE, V39, P62, DOI 10.1016/j.neuroimage.2007.06.041
   LEBIHAN D, 1985, CR ACAD SCI II, V301, P1109
   Li MW, 2014, MAGN RESON IMAGING, V32, P1043, DOI 10.1016/j.mri.2014.05.008
   Li Q, 2014, COMPUT METH PROG BIO, V117, P435, DOI 10.1016/j.cmpb.2014.09.002
   Ojala M, 2010, J MACH LEARN RES, V11, P1833
   Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612
   Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592
   ROSEN KH, 2006, DISCRETE MATH ITS AP, P64007
   Sporns O., 2003, NEUROSCIENCE DATABAS, P171, DOI DOI 10.1007/978-1-4615-1079-6_12
   Vapnik V.N., 1963, Avtomatika i Telemekhanika, V24, P774
   Varkuti B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014801
   Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713
   Yeh FC, 2011, NEUROIMAGE, V58, P91, DOI 10.1016/j.neuroimage.2011.06.021
   Zurita M, 2018, NEUROIMAGE-CLIN, V20, P724, DOI 10.1016/j.nicl.2018.09.002
NR 35
TC 2
Z9 2
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1931-7557
EI 1931-7565
J9 BRAIN IMAGING BEHAV
JI Brain Imaging Behav.
PD JUN
PY 2020
VL 14
IS 3
BP 641
EP 652
DI 10.1007/s11682-018-0002-2
PG 12
WC Neuroimaging
SC Neurosciences & Neurology
GA LV2EP
UT WOS:000538253100001
PM 30519999
OA Green Published
DA 2020-12-17
ER

PT J
AU De Felice, FG
   Tovar-Moll, F
   Moll, J
   Munoz, DP
   Ferreira, ST
AF De Felice, Fernanda G.
   Tovar-Moll, Fernanda
   Moll, Jorge
   Munoz, Douglas P.
   Ferreira, Sergio T.
TI Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the
   Central Nervous System
SO TRENDS IN NEUROSCIENCES
LA English
DT Editorial Material
ID CEREBROSPINAL-FLUID; RNA
AB Emerging evidence indicates that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), can cause neurological complications. We provide a brief overview of these recent observations and discuss some of their possible implications. In particular, given the global dimension of the current pandemic, we highlight the need to consider the possible long-term impact of COVID-19, potentially including neurological and neurodegenerative disorders.
C1 [De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernanda G.; Munoz, Douglas P.] Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.
   [De Felice, Fernanda G.] Queens Univ, Dept Psychiat, Kingston, ON K7L 3N6, Canada.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Tovar-Moll, Fernanda; Moll, Jorge] DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.; De Felice, FG (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.; De Felice, FG (corresponding author), Queens Univ, Dept Psychiat, Kingston, ON K7L 3N6, Canada.
EM felice@bioqmed.ufrj.br
RI Ferreira, Sergio/AAZ-1576-2020; Moll, Fernanda Tovar/N-3320-2018
OI Ferreira, Sergio/0000-0001-7160-9866; Moll, Fernanda
   Tovar/0000-0002-0292-5985
FU Alzheimer's Society Canada; Weston Brain Institute; National Institute
   for Translational Neuroscience (INNT/Brazil); Brazilian funding agency
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Brazilian funding agency Fundacao de Amparo a Pesquisa do Estado
   do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Canadian Institutes of
   Health Research (CIHR)Canadian Institutes of Health Research (CIHR);
   Ontario Brain Institute
FX Work in the laboratories of the authors was supported by grants from
   Alzheimer's Society Canada and the Weston Brain Institute (to F.G. D.F),
   the National Institute for Translational Neuroscience (INNT/Brazil) (to
   S. T. F., F.G.D.F, and J. M.), the Brazilian funding agencies Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao
   de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (to S.T. F.,
   F.G.D.F, F.T-M., and J.M.), and from the Canadian Institutes of Health
   Research (CIHR) and Ontario Brain Institute (to D.P.M.).
CR Arabi YM, 2015, INFECTION, V43, P495, DOI 10.1007/s15010-015-0720-y
   CABIRAC GF, 1994, MICROB PATHOGENESIS, V16, P349, DOI 10.1006/mpat.1994.1035
   Cain MD, 2019, NEURON, V103, P771, DOI 10.1016/j.neuron.2019.07.015
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]
   Desforges M, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010014
   FAZZINI E, 1992, MOVEMENT DISORD, V7, P153, DOI 10.1002/mds.870070210
   Gane SB, 2020, RHINOLOGY, V58, P299, DOI 10.4193/Rhin20.114
   Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597
   Hung ECW, 2003, CLIN CHEM, V49, P2108, DOI 10.1373/clinchem.2003.025437
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Morfopoulou S, 2016, NEW ENGL J MED, V375, P497, DOI 10.1056/NEJMc1509458
   MURRAY RS, 1992, ANN NEUROL, V31, P525, DOI 10.1002/ana.410310511
   Nilsson A, 2020, INFECT DIS-NOR, V52, P419, DOI 10.1080/23744235.2020.1729403
   Platt MP, 2020, P NATL ACAD SCI USA, V117, P6708, DOI 10.1073/pnas.1911097117
   Poyiadji N., 2020, RADIOLOGY, V2
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
NR 16
TC 33
Z9 31
U1 3
U2 3
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0166-2236
EI 1878-108X
J9 TRENDS NEUROSCI
JI Trends Neurosci.
PD JUN
PY 2020
VL 43
IS 6
BP 355
EP 357
DI 10.1016/j.tins.2020.04.004
PG 3
WC Neurosciences
SC Neurosciences & Neurology
GA LT0DR
UT WOS:000536748200001
PM 32359765
OA Green Published, Bronze
DA 2020-12-17
ER

PT J
AU Pereira, HVFS
   dos Santos, SP
   Amancio, APRL
   de Oliveira-Szejnfeld, PS
   Flor, EO
   Tavares, JD
   Ferreira, RVB
   Tovar-Moll, F
   de Amorim, MMR
   Melo, A
AF Fernandes Souza Pereira, Heloisa Viscaino
   dos Santos, Stella Pinto
   Rodrigues Lazzari Amancio, Ana Paula
   de Oliveira-Szejnfeld, Patricia Soares
   Flor, Edneusa Oliveira
   Tavares, Jousilene de Sales
   Brandao Ferreira, Rayssa Vieira
   Tovar-Moll, Fernanda
   Ramos de Amorim, Melania Maria
   Melo, Adriana
TI Neurological outcomes of congenital Zika syndrome in toddlers and
   preschoolers: a case series
SO LANCET CHILD & ADOLESCENT HEALTH
LA English
DT Article
ID CLASSIFICATION-SYSTEM; CEREBRAL-PALSY; VIRUS; CHILDREN; INFANTS;
   RELIABILITY; SPECTRUM; EPILEPSY; CLASSIFY; ABILITY
AB Background Congenital Zika syndrome causes a spectrum of neurological symptoms with varying effects on function that require different therapeutic strategies. To date, this spectrum of effects and its clinical implications have not been completely described. We describe the neurological examination findings in toddlers and preschoolers, including predominant symptom complexes and comorbidities.
   Methods This study is a case-series neurological evaluation of 75 children with congenital Zika syndrome in Campina Grande, Brazil. The study is part of a cohort of children with congenital Zika syndrome that started in 2015 and is still ongoing. Children with Zika virus infection detected during pregnancy (mothers exhibited rash and were followed and diagnosed by fetal ultrasound abnormalities or RT-PCR) or through microcephaly screening after birth, using Intergrowth 21 guidelines, were selected by laboratory and radiological criteria. Children were examined during a 10-day period in September, 2018, and underwent neurological interview, examination, and assessment of functional outcomes and comorbidities. Children were divided in groups of predominant corticospinal or neuromuscular clinical signs and the associations between these groups and clinical comorbidities were assessed.
   Findings All of the children recruited to the study from Nov 29, 2015 to Nov 30, 2017 had imaging correlates of congenital Zika syndrome. Children were assigned to groups depending on the signs exhibited, either corticospinal or neuromuscular, with or without dyskinetic signs. 75 children completed the evaluation, 38 (51%) girls and 37 (49%) boys. Median age was 33 months (range 26-40 months; IQR 29-34). Microcephaly was present at birth in 56 (75%) children, and 19 (25%) children were born with normal head circumference, 15 of whom later developed microcephaly. Neurological examination grouped four children as having isolated dyskinetic signs, 48 children were assigned to the corticospinal group and 23 into the neuromuscular group. Dyskinetic findings were present in 30 (40%) children, either alone (four [5%]) or combined with corticospinal (19 [40%] of 48) or neuromuscular (seven [30%] of 23) findings. Comorbidities were highly prevalent, and the neuromuscular group had worse functional outcomes, evaluated by gross motor function (p=0.026), manual abilities (p=0.0013), and communication function (p<0.0005) classification scales, than the corticospinal group, whereas pneumonia (p<0.0005) and urinary tract infections (p<0.0005) were more frequent in the corticospinal group. Cortical hyperexcitability was supported by several clinical correlates, such as early onset epilepsy, persistence of primitive reflexes, and dystonia.
   Interpretation We describe distinct neurological profiles in the congenital Zika syndrome spectrum, with functional outcomes tending to correlate with these groups. The clinical division of children based on the disease signs proposed here is supported by the literature on central and peripheral nervous system pathology in congenital Zika syndrome. The high prevalence of dyskinetic symptoms merits special attention. Copyright (C) 2020 Elsevier Ltd. All rights reserved.
C1 [Fernandes Souza Pereira, Heloisa Viscaino; dos Santos, Stella Pinto; Flor, Edneusa Oliveira] Univ Estado Rio De Janeiro, Pediat Neurol Clin, Dept Pediat, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Fed Univ Rio Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Fed Univ Rio Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.
   [Fernandes Souza Pereira, Heloisa Viscaino; de Oliveira-Szejnfeld, Patricia Soares; Tovar-Moll, Fernanda] DOr Inst Res & Educ, Rio De Janeiro, Brazil.
   [Rodrigues Lazzari Amancio, Ana Paula] Adao Pereira Nunes State Hosp, Rio De Janeiro, Brazil.
   [de Oliveira-Szejnfeld, Patricia Soares] Univ Sao Paulo, Dept Diagnost Imaging, Sao Paulo, Brazil.
   [de Oliveira-Szejnfeld, Patricia Soares] Univ Fed Sao Paulo, Fdn Inst Educ & Res Diagnost Imaging, Sao Paulo, Brazil.
   [Tavares, Jousilene de Sales; Brandao Ferreira, Rayssa Vieira; Ramos de Amorim, Melania Maria; Melo, Adriana] Res Inst Prof Amorim Neto, Campina Grande, Paraiba, Brazil.
   [Ramos de Amorim, Melania Maria; Melo, Adriana] Univ Fed Campina Grande, Campina Grande, Paraiba, Brazil.
RP Pereira, HVFS (corresponding author), Univ Estado Rio De Janeiro, Pediat Neurol Clin, Dept Pediat, Rio De Janeiro, Brazil.
EM heloisa.pereira@hupe.uerj.br
RI Moll, Fernanda Tovar/N-3320-2018; Amorim, Melania M/C-5807-2013
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Amorim, Melania
   M/0000-0003-1047-2514; Soares de Oliveira Szejnfeld,
   Patricia/0000-0002-3780-5182
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq); Coordination for the Improvement of Higher Education Personnel
FX Brazilian National Council for Scientific and Technological Development
   and by the Coordination for the Improvement of Higher Education
   Personnel.
CR Abramov DM, 2018, NEUROLOGY, V90, pE606, DOI 10.1212/WNL.0000000000004974
   Barbeito-Andres J, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006592
   Campbell SK, 2005, TEST INFANT MOTOR PE
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Monteiro LMC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193514
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Einspieler C., 2008, PRECHTLS METHOD QUAL
   Einspieler C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7235
   Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162
   Hadders-Algra M, 2018, DEV MED CHILD NEUROL, V60, P39, DOI 10.1111/dmcn.13540
   Hallett M, 2001, EPILEPSY MOVEMENT DI, P111
   Hidecker MJC, 2011, DEV MED CHILD NEUROL, V53, P704, DOI 10.1111/j.1469-8749.2011.03996.x
   Himmelmann K, 2007, DEV MED CHILD NEUROL, V49, P246, DOI 10.1111/j.1469-8749.2007.00246.x
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Mulkey SB, 2020, JAMA PEDIATR, V174, P269, DOI 10.1001/jamapediatrics.2019.5204
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x
   PediTools, CDC GROWTH CALC 2 20
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Pinato L, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy009
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Sellers D, 2014, DEV MED CHILD NEUROL, V56, P245, DOI 10.1111/dmcn.12352
   Swaiman KF, 2018, SWAIMANS PEDIAT NEUR, P7
   The International Fetal and Newborn Growth Consortium for the 21st Century, INTERGROWTH 21
   van der Linden H, 2018, NEW ENGL J MED, V379, P891, DOI 10.1056/NEJMc1716070
   van der Linden V, 2017, ZIKA IN FOCUS
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
NR 30
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2352-4642
J9 LANCET CHILD ADOLESC
JI Lancet Child. Adolesc. Health
PD MAY
PY 2020
VL 4
IS 5
BP 378
EP 387
DI 10.1016/S2352-4642(20)30041-9
PG 10
WC Pediatrics
SC Pediatrics
GA LS9XC
UT WOS:000536730700016
PM 32199080
OA Bronze
DA 2020-12-17
ER

PT J
AU Pedrosa, CDG
   Souza, LRQ
   Gomes, TA
   de Lima, CVF
   Ledur, PF
   Karmirian, K
   Barbeito-Andres, J
   Costa, MD
   Higa, LM
   Rossi, AD
   Bellio, M
   Tanuri, A
   Prata-Barbosa, A
   Tovar-Moll, F
   Garcez, PP
   Lara, FA
   Molica, RJR
   Rehen, SK
AF Pedrosa, Carolina da S. G.
   Souza, Leticia R. Q.
   Gomes, Tiago A.
   de Lima, Caroline V. F.
   Ledur, Pitia F.
   Karmirian, Karina
   Barbeito-Andres, Jimena
   Costa, Marcelo do N.
   Higa, Luiza M.
   Rossi, Atila D.
   Bellio, Maria
   Tanuri, Amilcar
   Prata-Barbosa, Arnaldo
   Tovar-Moll, Fernanda
   Garcez, Patricia P.
   Lara, Flavio A.
   Molica, Renato J. R.
   Rehen, Stevens K.
TI The cyanobacterial saxitoxin exacerbates neural cell death and brain
   malformations induced by Zika virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID BRAZIL; MICROCYSTINS; SURVEILLANCE; RAPHIDIOPSIS; RESERVOIRS;
   NOSTOCALES; INFECTION; OUTBREAKS; EXPOSURE; SODIUM
AB Author summary
   The uncontrolled spreading of cyanobacteria in drinking water reservoirs has been the cause of serious public health problems worldwide. Toxin-producing cyanobacterial blooms commonly occur during drought periods in the northeast (NE) region of Brazil. During Zika Virus (ZIKV) outbreak in 2015-16, Brazilian NE showed disproportionately higher microcephaly incidence. Here, we test the hypothesis that the cyanotoxin saxitoxin (STX) may act as a co-insult for ZIKV. Water quality surveillance data showed increased cyanobacteria population and higher STX amount in NE region during 2014-2018. In vitro, we observed that neural progenitor cell death was doubled after STX exposure to ZIKV-infected brain organoids. In vivo, chronic ingestion of STX during gestational period potentiated ZIKV-derived brain abnormalities in newborn mice. Our study provides new insights that may explain the discrepancies among Brazilian regions regarding CZS severity. Moreover, the data highlight the importance of cyanobacteria and cyanotoxin freshwater monitoring for future arbovirus outbreaks.
   The northeast (NE) region of Brazil commonly goes through drought periods, which favor cyanobacterial blooms, capable of producing neurotoxins with implications for human and animal health. The most severe dry spell in the history of Brazil occurred between 2012 and 2016. Coincidently, the highest incidence of microcephaly associated with the Zika virus (ZIKV) outbreak took place in the NE region of Brazil during the same years. In this work, we tested the hypothesis that saxitoxin (STX), a neurotoxin produced in South America by the freshwater cyanobacteria Raphidiopsis raciborskii, could have contributed to the most severe Congenital Zika Syndrome (CZS) profile described worldwide. Quality surveillance showed higher cyanobacteria amounts and STX occurrence in human drinking water supplies of NE compared to other regions of Brazil. Experimentally, we described that STX doubled the quantity of ZIKV-induced neural cell death in progenitor areas of human brain organoids, while the chronic ingestion of water contaminated with STX before and during gestation caused brain abnormalities in offspring of ZIKV-infected immunocompetent C57BL/6J mice. Our data indicate that saxitoxin-producing cyanobacteria is overspread in water reservoirs of the NE and might have acted as a co-insult to ZIKV infection in Brazil. These results raise a public health concern regarding the consequences of arbovirus outbreaks happening in areas with droughts and/or frequent freshwater cyanobacterial blooms.
C1 [Pedrosa, Carolina da S. G.; Souza, Leticia R. Q.; de Lima, Caroline V. F.; Ledur, Pitia F.; Karmirian, Karina; Prata-Barbosa, Arnaldo; Tovar-Moll, Fernanda; Rehen, Stevens K.] DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.
   [Gomes, Tiago A.; Karmirian, Karina; Barbeito-Andres, Jimena; Costa, Marcelo do N.; Tovar-Moll, Fernanda; Garcez, Patricia P.; Rehen, Stevens K.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil.
   [Gomes, Tiago A.; Lara, Flavio A.] Fiocruz MS, Oswaldo Cruz Inst, Lab Cellular Microbiol, Rio De Janeiro, RJ, Brazil.
   [Higa, Luiza M.; Rossi, Atila D.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, RJ, Brazil.
   [Bellio, Maria] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, RJ, Brazil.
   [Molica, Renato J. R.] Univ Fed Rural Pernambuco, Acad Unit Garanhuns, Garanhuns, Pe, Brazil.
   [Barbeito-Andres, Jimena] Consejo Nacl Invest Cient & Tecn, ENyS, Inst Studies Neurosci & Complex Syst, Buenos Aires, DF, Argentina.
RP Rehen, SK (corresponding author), DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.; Rehen, SK (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil.
EM srehen@lance-ufrj.org
RI Moll, Fernanda Tovar/N-3320-2018; Higa, Luiza/W-2698-2019;
   Prata-Barbosa, Arnaldo/B-2212-2009; Rehen, Stevens K/J-5874-2012;
   Molica, Renato Jose Reis/Z-3531-2019; Rossi, Atila Duque/AAV-6079-2020
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Prata-Barbosa,
   Arnaldo/0000-0002-4726-9782; Rehen, Stevens K/0000-0003-4216-9501;
   Molica, Renato Jose Reis/0000-0002-6579-6594; Rossi, Atila
   Duque/0000-0001-6235-8807
FU Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/201.340/2016]; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel SuperiorCAPES [88887.116625/2016-01, 440909/2016-3]; Conselho
   Nacional de Desenvolvimento Cientifico e TecnologicoNational Council for
   Scientific and Technological Development (CNPq) [440909/2016-3,
   441096/2016-6]; Financiadora de Estudos e ProjetosCiencia Tecnologia e
   Inovacao (FINEP) [01.08.0657.00, 01.12.0161.00]; Departamento de
   Vigilancia em Saude Ambiental e Saude do Trabalhador - DSAST
   [25380.001612/2017-70]; Banco Nacional de Desenvolvimento Economico e
   Social [10.2.0051.1]
FX This work was funded by Fundacao de Amparo a Pesquisa do Estado do Rio
   de Janeiro (E-26/201.340/2016), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (88887.116625/2016-01 and 440909/2016-3),
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (440909/2016-3 and 441096/2016-6), Banco Nacional de Desenvolvimento
   Economico e Social (10.2.0051.1), Financiadora de Estudos e Projetos
   (01.08.0657.00 and 01.12.0161.00) and Departamento de Vigilancia em
   Saude Ambiental e Saude do Trabalhador - DSAST (25380.001612/2017-70).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aguilera A, 2018, PHYCOLOGIA, V57, P130, DOI 10.2216/17-2.1
   [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953
   [Anonymous], 2018, PLOS ONE, V13, P1, DOI DOI 10.3171/2018.1.JNS172645
   Azevedo SMFO, 2002, TOXICOLOGY, V181, P441, DOI 10.1016/S0300-483X(02)00491-2
   Blaha Ludek, 2009, Interdiscip Toxicol, V2, P36, DOI 10.2478/v10102-009-0006-2
   Bouvy M, 2000, AQUAT MICROB ECOL, V23, P13, DOI 10.3354/ame023013
   Brasil J, 2016, HYDROBIOLOGIA, V770, P145, DOI 10.1007/s10750-015-2578-5
   Burford MA, 2016, HARMFUL ALGAE, V54, P44, DOI 10.1016/j.hal.2015.10.012
   Carmichael WW, 2001, ENVIRON HEALTH PERSP, V109, P663, DOI 10.2307/3454781
   Carneiro RL, 2013, MAR DRUGS, V11, P2949, DOI 10.3390/md11082949
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Chen X, 2018, TOXICOL MECH METHOD, V28, P335, DOI 10.1080/15376516.2017.1411413
   Costa I. A. S., 2006, Braz. J. Biol., V66, P211, DOI 10.1590/S1519-69842006000200005
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0005048
   Fonseca Jessica Roberts, 2015, Acta Limnol. Bras., V27, P78, DOI 10.1590/S2179-975X2814
   Galvao JA, 2009, TOXICON, V54, P891, DOI 10.1016/j.toxicon.2009.06.021
   Hoff-Risseti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074238
   Lancaster M, 2015, EUR PMC FUNDERS GR, V9, P2329, DOI DOI 10.1038/nprot.2014.158
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Marengo JA, 2018, AN ACAD BRAS CIENC, V90, P1973, DOI 10.1590/0001-3765201720170206
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, MON CAS DENG DEBR CH, V48
   Moura AD, 2018, J LIMNOL, V77, P179, DOI 10.4081/jlimnol.2018.1646
   Mowe MAD, 2015, J LIMNOL, V74, P205, DOI 10.4081/jlimnol.2014.1005
   National Comprehensive Cancer Network, 2018, J NATL COMPR CANC NE, V16, P1
   O'Neill K, 2017, BASIC CLIN PHARMACOL, V120, P390, DOI 10.1111/bcpt.12701
   PAHO World Health Organization (WHO), 2017, ZIK SIT REP
   Planells-Cases R, 2000, BIOPHYS J, V78, P2878, DOI 10.1016/S0006-3495(00)76829-9
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rufino R, 2016, CIENC SAUDE COLETIVA, V21, P777, DOI 10.1590/1413-81232015213.17002015
   Soares RM, 2006, ENVIRON TOXICOL, V21, P95, DOI 10.1002/tox.20160
   Soto-Liebe K, 2012, TOXICON, V60, P1324, DOI 10.1016/j.toxicon.2012.09.001
   Teixeira M da G, 1993, Bull Pan Am Health Organ, V27, P244
   VV.AA, 2012, COMPOSITE MAT HDB CM, V3, P1, DOI DOI 10.1515/2152-2812.1105
   Walter JM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00176
   World Health Organization (WHO), 2003, GUID SAF RECR WAT EN, V1, P136
NR 38
TC 2
Z9 2
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2020
VL 14
IS 3
AR e0008060
DI 10.1371/journal.pntd.0008060
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA LH2YY
UT WOS:000528655400033
PM 32163415
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU da Rocha, JLD
   Bramati, I
   Coutinho, G
   Moll, FT
   Sitaram, R
AF da Rocha, Josue Luiz Dalboni
   Bramati, Ivanei
   Coutinho, Gabriel
   Moll, Fernanda Tovar
   Sitaram, Ranganatha
TI Fractional Anisotropy changes in Parahippocampal Cingulum due to
   Alzheimer's Disease
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MILD COGNITIVE IMPAIRMENT; MRI; CLASSIFICATION; FEATURES; BRAIN;
   ASSOCIATION; VALIDATION; FRAMEWORK; DEMENTIA; MCI
AB Current treatments for Alzheimer's disease are only symptomatic and limited to reduce the progression rate of the mental deterioration. Mild Cognitive Impairment, a transitional stage in which the patient is not cognitively normal but do not meet the criteria for specific dementia, is associated with high risk for development of Alzheimer's disease. Thus, non-invasive techniques to predict the individual's risk to develop Alzheimer's disease can be very helpful, considering the possibility of early treatment. Diffusion Tensor Imaging, as an indicator of cerebral white matter integrity, may detect and track earlier evidence of white matter abnormalities in patients developing Alzheimer's disease. Here we performed a voxel-based analysis of fractional anisotropy in three classes of subjects: Alzheimer's disease patients, Mild Cognitive Impairment patients, and healthy controls. We performed Support Vector Machine classification between the three groups, using Fisher Score feature selection and Leave-one-out cross-validation. Bilateral intersection of hippocampal cingulum and parahippocampal gyrus (referred as parahippocampal cingulum) is the region that best discriminates Alzheimer's disease fractional anisotropy values, resulting in an accuracy of 93% for discriminating between Alzheimer's disease and controls, and 90% between Alzheimer's disease and Mild Cognitive Impairment. These results suggest that pattern classification of Diffusion Tensor Imaging can help diagnosis of Alzheimer's disease, specially when focusing on the parahippocampal cingulum.
C1 [da Rocha, Josue Luiz Dalboni] Univ Geneva, Fac Psychol & Sci Educ, Geneva, Switzerland.
   [Bramati, Ivanei; Coutinho, Gabriel; Moll, Fernanda Tovar] DOr Inst Res & Educ, Rio De Janeiro, Brazil.
   [Moll, Fernanda Tovar] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Sitaram, Ranganatha] Pontificia Univ Catolica Chile, Inst Biol & Med Engn, Dept Psychiat, Santiago, Chile.
   [Sitaram, Ranganatha] Pontificia Univ Catolica Chile, Sect Neurosci, Santiago, Chile.
RP da Rocha, JLD (corresponding author), Univ Geneva, Fac Psychol & Sci Educ, Geneva, Switzerland.; Sitaram, R (corresponding author), Pontificia Univ Catolica Chile, Inst Biol & Med Engn, Dept Psychiat, Santiago, Chile.; Sitaram, R (corresponding author), Pontificia Univ Catolica Chile, Sect Neurosci, Santiago, Chile.
EM Josue.Dalboni@unige.ch; rasitaram@uc.cl
RI Moll, Fernanda Tovar/N-3320-2018
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Dalboni da Rocha, Josue
   Luiz/0000-0001-8939-6395
FU Comision Nacional de Investigacion Cientifica y Tecnologica de Chile
   (Conicyt) through Fondo Nacional de Desarrollo Cientifico y Tecnologico,
   FondecytComision Nacional de Investigacion Cientifica y Tecnologica
   (CONICYT)CONICYT FONDECYT [1171320, 1171313]; CONICYT-PIA AnilloComision
   Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT
   PIA/ANILLOS [ACT172121]
FX Author RS was supported by the Comision Nacional de Investigacion
   Cientifica y Tecnologica de Chile (Conicyt) through Fondo Nacional de
   Desarrollo Cientifico y Tecnologico, Fondecyt (project nos. 1171320 and
   1171313), and CONICYT-PIA Anillo ACT172121.
CR Alzheimer's Association, 2017, ALZHEIMERS DEMENT, V12, P459, DOI [DOI 10.1016/J.JALZ.2017.02.001, 10.1016/j.jalz.2017.02.001]
   Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054
   Ashburner J., 2014, SPM12 MANUAL
   Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022
   Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z
   Buchhave P, 2012, ARCH GEN PSYCHIAT, V69, P98, DOI 10.1001/archgenpsychiatry.2011.155
   Crosby E.C., 1962, CORRELATIVE ANATOMY
   da Rocha JLD, 2020, BRAIN IMAGING BEHAV, V14, P641, DOI 10.1007/s11682-018-0002-2
   Davatzikos C., 2010, NEUROBIOL AGING, V32, P2322
   Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008
   Dubois B, 2004, LANCET NEUROL, V3, P246, DOI 10.1016/S1474-4422(04)00710-0
   Dyrba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064925
   Ebadi A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00056
   Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024
   Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402
   Focke NK, 2011, HUM BRAIN MAPP, V32, P1905, DOI 10.1002/hbm.21161
   Friedman J., 2001, ELEMENTS STAT LEARNI
   Fu CHY, 2008, BIOL PSYCHIAT, V63, P656, DOI 10.1016/j.biopsych.2007.08.020
   Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906
   Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797
   Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6
   Hirata Y, 2005, NEUROSCI LETT, V382, P269, DOI 10.1016/j.neulet.2005.03.038
   Huang H, 2008, MAGN RESON IMAGING, V26, P1294, DOI 10.1016/j.mri.2008.03.005
   Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018
   Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015
   Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001
   Jones DK, 2013, NEUROPSYCHOLOGIA, V51, P67, DOI 10.1016/j.neuropsychologia.2012.11.018
   Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8
   Leuzy A, 2014, AMYLOID, V21, P143, DOI 10.3109/13506129.2014.926267
   Li MW, 2014, MAGN RESON IMAGING, V32, P1043, DOI 10.1016/j.mri.2014.05.008
   Liberati G, 2013, INT CONF AFFECT, P838, DOI 10.1109/ACII.2013.157
   Liberati G, 2012, J ALZHEIMERS DIS, V31, pS211, DOI 10.3233/JAD-2012-112129
   Liu YW, 2011, NEUROBIOL AGING, V32, P1558, DOI 10.1016/j.neurobiolaging.2009.10.006
   Mai ST, 2013, IEEE DATA MINING, P508, DOI 10.1109/ICDM.2013.39
   Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466
   McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005
   Menendez-Gonzalez M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00065
   MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479
   Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035
   Nieuwenhuys R, 2008, HUMAN CENTRAL NERVOU
   Nir TM, 2013, NEUROIMAGE-CLIN, V3, P180, DOI 10.1016/j.nicl.2013.07.006
   Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985
   PILLON B, 1986, NEUROLOGY, V36, P1179, DOI 10.1212/WNL.36.9.1179
   Pinto Charles, 2009, Indian J Psychiatry, V51 Suppl 1, pS44
   Rana M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00170
   Rocca M. L., 2018, PHYSL MEASUREMENT, V39
   Rowley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074776
   Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013
   Schmahmann J.D., 2009, FIBER PATHWAYS BRAIN
   Sitaram R, 2017, NAT REV NEUROSCI, V18, P86, DOI 10.1038/nrn.2016.164
   Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027
   Sulzer J, 2013, NEUROIMAGE, V76, P386, DOI 10.1016/j.neuroimage.2013.03.033
   Suppa P, 2016, J ALZHEIMERS DIS, V51, P867, DOI 10.3233/JAD-150804
   Teipel SJ, 2008, EUR J NUCL MED MOL I, V35, pS58, DOI 10.1007/s00259-007-0703-z
   Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791
   van Bruggen T, 2012, PSYCHIAT RES-NEUROIM, V203, P184, DOI 10.1016/j.pscychresns.2011.12.003
   Vapnik V.N., 1963, Avtomatika i Telemekhanika, V24, P774
   Varkuti B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014801
   Victor Maurice, 2000, ADAMS VICTORS PRINCI
   VOGT BA, 1995, J COMP NEUROL, V359, P490, DOI 10.1002/cne.903590310
   Wang Yan, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P754, DOI 10.1109/EMBC.2018.8512372
   Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x
   Wisse LEM, 2015, J ALZHEIMERS DIS, V45, P1247, DOI 10.3233/JAD-142994
   Wu Y, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00041
   Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713
   Zurita M, 2018, NEUROIMAGE-CLIN, V20, P724, DOI 10.1016/j.nicl.2018.09.002
NR 66
TC 2
Z9 2
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 14
PY 2020
VL 10
IS 1
AR 2660
DI 10.1038/s41598-020-59327-2
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA NE9OB
UT WOS:000562932300020
PM 32060334
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Drummond, C
   Coutinho, G
   Monteiro, MC
   Assuncao, N
   Teldeschi, A
   de Souza, AS
   Oliveira, N
   Bramati, I
   Sudo, FK
   Vanderboght, B
   Brandao, CO
   Fonseca, RP
   de Oliveira-Souza, R
   Moll, J
   Mattos, P
   Tovar-Moll, F
AF Drummond, Claudia
   Coutinho, Gabriel
   Monteiro, Marina Carneiro
   Assuncao, Naima
   Teldeschi, Alina
   de Souza, Andrea Silveira
   Oliveira, Natalia
   Bramati, Ivanei
   Sudo, Felipe Kenji
   Vanderboght, Bart
   Brandao, Carlos Otavio
   Fonseca, Rochele Paz
   de Oliveira-Souza, Ricardo
   Moll, Jorge
   Mattos, Paulo
   Tovar-Moll, Fernanda
TI Narrative impairment, white matter damage and CSF biomarkers in the
   Alzheimer's disease spectrum
SO AGING-US
LA English
DT Article
DE language; white matter; mild cognitive impairment; Alzheimer's disease;
   CSF biomarkers
ID MILD COGNITIVE IMPAIRMENT; DISCOURSE COMPREHENSION; VERBAL FLUENCY;
   LANGUAGE; DEMENTIA; MEMORY; BRAIN; FASCICULUS; PATHWAYS; DECLINE
AB Background: Narrative discourse (ND) refers to one's ability to verbally reproduce a sequence of temporally and logically-linked events. Impairments in ND may occur in subjects with Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer's Disease (AD), but correlates across this function, neuroimaging and cerebrospinal fluid (CSF) AD biomarkers remain understudied.
   Objectives: We sought to measure correlates among ND, Diffusion Tensor Imaging (DTI) indexes and AD CSF biomarkers in patients within the AD spectrum.
   Results: Groups differed in narrative production (NProd) and comprehension. aMCI and AD presented poorer inference abilities than controls. AD subjects were more impaired than controls and aMCI regarding WB (p<0.01). ROIs DTI assessment distinguished the three groups. Mean Diffusivity (MD) in the uncinate, bilateral parahippocampal cingulate and left inferior occipitofrontal fasciculi negatively correlated with NProd. Changes in specific tracts correlated with T-tau/A beta 1-42 ratio in CSF.
   Conclusions: AD and aMCI patients presented more ND impairments than controls. Those findings were associated with changes in ventral language-associated and in the inferior parahippocampal pathways. The latest were correlated with biomarkers' levels in the CSF.
   Methods: AD (N=14), aMCI (N=31) and Control (N=39) groups were compared for whole brain (WB) and regions of interest (ROI) DTI parameters, ND and AD CSF biomarkers.
C1 [Drummond, Claudia; Monteiro, Marina Carneiro; Assuncao, Naima; Teldeschi, Alina; de Souza, Andrea Silveira; Oliveira, Natalia; Bramati, Ivanei; Sudo, Felipe Kenji; Vanderboght, Bart; de Oliveira-Souza, Ricardo; Moll, Jorge; Mattos, Paulo; Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Dept Neurosci, Rio De Janeiro, Brazil.
   [Drummond, Claudia] Univ Fed Rio de Janeiro, Dept Speech & Hearing Pathol, Rio De Janeiro, Brazil.
   [Drummond, Claudia; Coutinho, Gabriel; Assuncao, Naima; Mattos, Paulo; Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Grad Program Morphol Sci, Rio De Janeiro, Brazil.
   [Coutinho, Gabriel] Celso Lisboa Univ Ctr, Dept Psychol, Rio De Janeiro, Brazil.
   [Brandao, Carlos Otavio] Neurolife Cerebrospinal Fluid Specialized Lab, Rio De Janeiro, Brazil.
   [Fonseca, Rochele Paz] Pontificial Catholic Univ Rio Grande do Sul, Dept Psychol, Lab Clin & Expt Neuropsychol, Porto Alegre, RS, Brazil.
   [Mattos, Paulo] Univ Fed Rio de Janeiro, Inst Psychiat, Dept Psychiat & Forens Med, Rio De Janeiro, Brazil.
RP Drummond, C; Tovar-Moll, F (corresponding author), DOr Inst Res & Educ IDOR, Dept Neurosci, Rio De Janeiro, Brazil.; Drummond, C (corresponding author), Univ Fed Rio de Janeiro, Dept Speech & Hearing Pathol, Rio De Janeiro, Brazil.; Drummond, C; Tovar-Moll, F (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Grad Program Morphol Sci, Rio De Janeiro, Brazil.
EM cdrummond.ufrj@gmail.com; fernanda.tovarmoll@idor.org
RI Sudo, Felipe Kenji/P-3090-2016; de Mattos, Paulo Eduardo
   Luiz/D-2328-2014; Moll, Fernanda Tovar/N-3320-2018; de Souza, Andrea
   Silveira/AAL-1976-2020
OI Sudo, Felipe Kenji/0000-0003-4738-1368; de Mattos, Paulo Eduardo
   Luiz/0000-0003-0709-3783; Moll, Fernanda Tovar/0000-0002-0292-5985; de
   Souza, Andrea Silveira/0000-0002-1553-2312
FU D'Or Institute for Research and Education; CNPq (Conselho Nacional de
   Pesquisa)National Council for Scientific and Technological Development
   (CNPq); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Ensino
   Superior)CAPES; FAPERJ (Fundacao de Amparo a Pesquisa do Rio de
   janeiro)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Rede D'Or Sao Luiz Hospital Network
FX This research was supported by intramural grants from the D'Or Institute
   for Research and Education and Rede D'Or Sao Luiz Hospital Network, CNPq
   (Conselho Nacional de Pesquisa), CAPES (Coordenacao de Aperfeicoamento
   de Pessoal de Ensino Superior) and FAPERJ (Fundacao de Amparo a Pesquisa
   do Rio de janeiro).
CR Alves GS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/291658
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Aminoff EM, 2013, TRENDS COGN SCI, V17, P379, DOI 10.1016/j.tics.2013.06.009
   Amlien IK, 2014, NEUROSCIENCE, V276, P206, DOI 10.1016/j.neuroscience.2014.02.017
   Ash S, 2007, BRAIN LANG, V103, P181, DOI 10.1016/j.bandl.2007.07.105
   Awad M, 2007, J NEUROSCI, V27, P11455, DOI 10.1523/JNEUROSCI.5257-06.2007
   Baker JE, 2016, ALZHEIMERS DEMENT, V6, P108
   Baldassano C, 2013, NEUROIMAGE, V75, P228, DOI 10.1016/j.neuroimage.2013.02.073
   Barbey AK, 2014, BRAIN, V137, P277, DOI 10.1093/brain/awt312
   Bauer CM, 2018, DIAGNOSTICS, V8, DOI 10.3390/diagnostics8010014
   Beinhoff U, 2005, DEMENT GERIATR COGN, V20, P278, DOI 10.1159/000088249
   Berman JI, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00030
   Bertola L, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00185
   Bertolucci PHF, 2001, ARQ NEURO-PSIQUIAT, V59, P532, DOI 10.1590/S0004-282X2001000400009
   Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z
   Brandao L, 2011, PSICOL-REFLEX CRIT, V24, P161, DOI 10.1590/S0102-79722011000100019
   Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014
   Cannizzaro MS, 2013, J PSYCHOLINGUIST RES, V42, P527, DOI 10.1007/s10936-012-9231-5
   Carlomagno S, 2005, CORTEX, V41, P520, DOI 10.1016/S0010-9452(08)70192-8
   Caselli RJ, 2014, ALZHEIMERS DEMENT, V10, P93, DOI 10.1016/j.jalz.2013.01.003
   Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004
   Chapman SB, 2002, ALZ DIS ASSOC DIS, V16, P177, DOI 10.1097/00002093-200207000-00008
   Charlton RA, 2010, CORTEX, V46, P474, DOI 10.1016/j.cortex.2009.07.005
   Chen TB, 2014, DEMENT GER COGN D EX, V4, P86, DOI [10.1159/000360695, 10.1159/000354359]
   Coutinho G, 2015, INT PSYCHOGERIATR, V27, P1679, DOI 10.1017/S1041610215000307
   Coutinho G, 2013, REV PSIQ CLIN-BRAZIL, V40, P139, DOI 10.1590/S0101-60832013000400003
   De Felice FG, 2002, CELL MOL NEUROBIOL, V22, P545, DOI 10.1023/A:1021832302524
   Lira Juliana Onofre de, 2014, Dement. neuropsychol., V8, P260, DOI 10.1590/S1980-57642014DN83000010
   de Lira JO, 2011, INT PSYCHOGERIATR, V23, P404, DOI 10.1017/S1041610210001092
   de Zubicaray GI, 2011, NEUROIMAGE, V54, P1488, DOI 10.1016/j.neuroimage.2010.08.058
   Dick AS, 2012, BRAIN, V135, P3529, DOI 10.1093/brain/aws222
   Didic M, 2011, J ALZHEIMERS DIS, V27, P11, DOI 10.3233/JAD-2011-110557
   Drummond C, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00096
   Duong A, 2005, BRAIN LANG, V93, P173, DOI 10.1016/j.bandl.2004.10.007
   Engelhardt E, 2008, REV BRASILEIRA NEURO, V44, P19
   Fellgiebel A, 2008, NEUROPSYCHOLOGIA, V46, P1698, DOI 10.1016/j.neuropsychologia.2007.12.010
   Ferris SH, 2013, CLIN INTERV AGING, V8, P1007, DOI 10.2147/CIA.S39959
   Fiandaca MS, 2014, ALZHEIMERS DEMENT, V10, pS196, DOI 10.1016/j.jalz.2014.04.015
   Fleming VB, 2008, APHASIOLOGY, V22, P729, DOI 10.1080/02687030701803762
   Fonseca Rochele Paz, 2008, Pró-Fono R. Atual. Cient., V20, P285, DOI 10.1590/S0104-56872008000400014
   Friederici AD, 2013, CURR OPIN NEUROBIOL, V23, P250, DOI 10.1016/j.conb.2012.10.002
   Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011
   Gaudreau G, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/685613
   GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J
   Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003
   Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011
   Hiyoshi-Taniguchi K, 2015, J NEUROIMAGING, V25, P748, DOI 10.1111/jon.12196
   Ivanova MV, 2016, CORTEX, V85, P165, DOI 10.1016/j.cortex.2016.04.019
   JOANETTE Y, 2004, PROTOCOLE MEC PROTOC
   JOHNSONLAIRD PN, 1983, MENTAL MODELS, P516
   Jones DK, 2013, NEUROPSYCHOLOGIA, V51, P67, DOI 10.1016/j.neuropsychologia.2012.11.018
   Kantarci K, 2011, NEUROLOGY, V77, P26, DOI 10.1212/WNL.0b013e31822313dc
   Kantarci K, 2017, NEUROBIOL AGING, V56, P172, DOI 10.1016/j.neurobiolaging.2017.04.024
   Kim S, 2011, J CLIN NEUROSCI, V18, P916, DOI 10.1016/j.jocn.2010.12.019
   Landau SM, 2010, NEUROLOGY, V75, P230, DOI 10.1212/WNL.0b013e3181e8e8b8
   Lansing AE, 1999, ARCH CLIN NEUROPSYCH, V14, P481, DOI 10.1016/S0887-6177(98)00022-5
   Laske C, 2015, ALZHEIMERS DEMENT, V11, P561, DOI 10.1016/j.jalz.2014.06.004
   Li JP, 2012, NEUROSCI BIOBEHAV R, V36, P757, DOI 10.1016/j.neubiorev.2011.12.001
   Li M, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9860604
   Li Y, 2013, HUM BRAIN MAPP, V34, P3376, DOI 10.1002/hbm.22158
   Lindemer ER, 2015, NEUROBIOL AGING, V36, P2447, DOI 10.1016/j.neurobiolaging.2015.05.011
   Lu DH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22871-z
   Malloy-Diniz LF, 2007, REV BRAS PSIQUIATR, V29, P324, DOI 10.1590/S1516-44462006005000053
   Mar RA, 2004, NEUROPSYCHOLOGIA, V42, P1414, DOI 10.1016/j.neuropsychologia.2003.12.016
   Martin-Loeches M, 2008, NEUROIMAGE, V41, P614, DOI 10.1016/j.neuroimage.2008.02.047
   Maseda A, 2014, AM J ALZHEIMERS DIS, V29, P463, DOI 10.1177/1533317514522540
   Mason R. A., 2006, HDB PSYCHOLINGUISTIC, P765, DOI [10.1016/B978-012369374-7/50020-1, DOI 10.1016/B978-012369374-7/50020-1, 10.1016/b978-012369374-7/50020-1]
   McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005
   Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026
   Metzler-Baddeley C, 2011, J NEUROSCI, V31, P13236, DOI 10.1523/JNEUROSCI.2317-11.2011
   Mills BD, 2013, NEUROPSYCHOLOGIA, V51, P1933, DOI 10.1016/j.neuropsychologia.2013.06.012
   Murphy KI, 2006, J INT NEUROPSYCH SOC, V12, P570, DOI 10.1017/S1355617706060590
   Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217
   Paradela EMP, 2005, REV SAUDE PUBL, V39, P918, DOI 10.1590/s0034-89102005000600008
   Poletti M, 2012, NEUROSCI BIOBEHAV R, V36, P2147, DOI 10.1016/j.neubiorev.2012.07.004
   Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x
   Racine AM, 2019, BRAIN IMAGING BEHAV, V13, P41, DOI 10.1007/s11682-017-9732-9
   Radanovic M, 2009, INT PSYCHOGERIATR, V21, P1081, DOI 10.1017/S1041610209990639
   Rogalsky C, 2011, J COGNITIVE NEUROSCI, V23, P1664, DOI 10.1162/jocn.2010.21530
   Rossini PM, 2007, PROG NEUROBIOL, V83, P375, DOI 10.1016/j.pneurobio.2007.07.010
   Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013
   Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105
   Scherer LC, 2012, ILHA DESTERRO, V63, P129, DOI 10.5007/2175-8026.2012n63p129
   Schmitter-Edgecombe M, 2010, J INT NEUROPSYCH SOC, V16, P661, DOI 10.1017/S1355617710000433
   Selnes Per, 2012, Alzheimers Dement, V8, pS112, DOI 10.1016/j.jalz.2011.07.001
   Sjobeck M, 2006, NEUROBIOL AGING, V27, P673, DOI 10.1016/j.neurobiolaging.2005.03.007
   Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031
   Taler V, 2008, J CLIN EXP NEUROPSYC, V30, P501, DOI 10.1080/13803390701550128
   Testa JA, 2004, J INT NEUROPSYCH SOC, V10, P504, DOI 10.1017/S1355617704104177
   Tifratene K, 2015, NEUROLOGY, V85, P331, DOI 10.1212/WNL.0000000000001788
   Toledo C. M., 2017, ALZHEIMERS DEMENT AM, V19, P31
   Tovar-Moll F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102656
   Tsantali E, 2013, ARCH GERONTOL GERIAT, V57, P263, DOI 10.1016/j.archger.2013.03.011
   van Dijk Teun A., 2008, DISCOURSE CONTEXT SO
   Wakefield SJ, 2014, CURR ALZHEIMER RES, V11, P765, DOI 10.2174/156720501108140910121631
   Weiner MW, 2017, ALZHEIMERS DEMENT, V13, pE1, DOI 10.1016/j.jalz.2016.11.007
   Whitney C, 2009, NEUROIMAGE, V47, P360, DOI 10.1016/j.neuroimage.2009.04.037
   Wilson SM, 2008, CEREB CORTEX, V18, P230, DOI 10.1093/cercor/bhm049
   Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x
   Xu J, 2005, NEUROIMAGE, V25, P1002, DOI 10.1016/j.neuroimage.2004.12.013
   Yang M, 2017, BRAIN TOPOGR, V30, P249, DOI 10.1007/s10548-016-0503-5
   Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008
   Zhuang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058887
NR 103
TC 0
Z9 0
U1 1
U2 1
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD OCT 31
PY 2019
VL 11
IS 20
BP 9188
EP 9208
DI 10.18632/aging.102391
PG 21
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA JK6LI
UT WOS:000494953300034
PM 31682234
OA Green Published
DA 2020-12-17
ER

PT J
AU Sudo, FK
   de Souza, AS
   Drummond, C
   Assuncao, N
   Teldeschi, A
   Oliveira, N
   Rodrigues, F
   Santiago-Bravo, G
   Calil, V
   Lima, G
   Erthal, P
   Bernardes, G
   Monteiro, M
   Tovar-Moll, F
   Mattos, P
AF Sudo, Felipe Kenji
   de Souza, Andrea Silveira
   Drummond, Claudia
   Assuncao, Naima
   Teldeschi, Alina
   Oliveira, Natalia
   Rodrigues, Fernanda
   Santiago-Bravo, Gustavo
   Calil, Victor
   Lima, Gabriel
   Erthal, Pilar
   Bernardes, Gabriel
   Monteiro, Marina
   Tovar-Moll, Fernanda
   Mattos, Paulo
TI Inter-method and anatomical correlates of episodic memory tests in the
   Alzheimer's Disease spectrum
SO PLOS ONE
LA English
DT Article
ID MILD COGNITIVE IMPAIRMENT; ASSOCIATION WORKGROUPS; DIAGNOSTIC
   GUIDELINES; NATIONAL INSTITUTE; HIPPOCAMPAL; RECOMMENDATIONS; DEMENTIA;
   CONSENT; VERSION; ITEM
AB Background
   Episodic memory impairments have been described as initial clinical findings in the Alzheimer's Disease (AD) spectrum, which could be associated with the presence of early hippocampal dysfunction. However, correlates between performances in neuropsychological tests and hippocampal volumes in AD were inconclusive in the literature. Divergent methods to assess episodic memory have been depicted as a major source of heterogeneity across studies.
   Methods
   We examined correlates among performances in three different delayed-recall tasks (Rey-Auditory Verbal-Learning Test-RAVLT, Logical Memory and Visual Reproduction subtests from the Wechsler Memory Scale) and fully-automated volumetric measurements of the hippocampus (estimated using Neuroquant (R)) of 83 older subjects (47 controls, 27 Mild Cognitive Impairment individuals and 9 participants with Dementia due to AD).
   Results
   Inter-method correlations of episodic memory performances were at most moderate. Scores in the RAVLT predicted up to 48% of variance in HOC (Hippocampal Occupancy Score) among subjects in the AD spectrum.
   Discussion
   Tests using different stimuli (verbal or visual) and presenting distinct designs (word list, story or figure learning) may assess divergent aspects in episodic memory, with heterogeneous anatomical correlates.
   Conclusions
   Different episodic memory tests might not assess the same construct and should not be used interchangeably. Scores in RAVLT may correlate with the presence of neurodegeneration in AD.
C1 [Sudo, Felipe Kenji; de Souza, Andrea Silveira; Drummond, Claudia; Assuncao, Naima; Teldeschi, Alina; Oliveira, Natalia; Rodrigues, Fernanda; Santiago-Bravo, Gustavo; Calil, Victor; Lima, Gabriel; Erthal, Pilar; Bernardes, Gabriel; Monteiro, Marina; Tovar-Moll, Fernanda; Mattos, Paulo] DOr Inst Res & Educ, Rio De Janeiro, RJ, Brazil.
   [Drummond, Claudia; Rodrigues, Fernanda] Univ Fed Rio de Janeiro, Dept Speech & Hearing Pathol, Rio De Janeiro, RJ, Brazil.
   [Assuncao, Naima] Univ Fed Rio de Janeiro, Inst Biomed Sci, Morphol Sci Program, Rio De Janeiro, RJ, Brazil.
   [Calil, Victor] Univ Fed Rio de Janeiro, Fac Med, Postgrad Program Clin Med, Rio De Janeiro, RJ, Brazil.
   [Mattos, Paulo] Univ Fed Rio de Janeiro, Inst Psychiat, Rio De Janeiro, RJ, Brazil.
RP Sudo, FK (corresponding author), DOr Inst Res & Educ, Rio De Janeiro, RJ, Brazil.
EM fksudo@gmail.com
RI Moll, Fernanda Tovar/N-3320-2018; Sudo, Felipe Kenji/P-3090-2016
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Sudo, Felipe
   Kenji/0000-0003-4738-1368; Santiago-Bravo, Gustavo/0000-0003-0001-363X;
   SILVEIRA DE SOUZA, ANDREA/0000-0002-1553-2312
FU D'Or Institute for Research and Education; Rede D'Or Sao Luiz Hospital
   Network; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Ensino
   Superior)CAPES; FAPERJ (Fundacao de Amparo a Pesquisa do Rio de
   Janeiro)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPq (Conselho Nacional de Pesquisa)National
   Council for Scientific and Technological Development (CNPq)
FX This research was supported by intramural grants from the D'Or Institute
   for Research and Education and Rede D'Or Sao Luiz Hospital Network, CNPq
   (Conselho Nacional de Pesquisa), CAPES (Coordenacao de Aperfeicoamento
   de Pessoal de Ensino Superior) and FAPERJ (Fundacao de Amparo a Pesquisa
   do Rio de Janeiro). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008
   Allen TA, 2013, P NATL ACAD SCI USA, V110, P10379, DOI 10.1073/pnas.1301199110
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520
   Baek MJ, 2012, J CLIN EXP NEUROPSYC, V34, P396, DOI 10.1080/13803395.2011.645020
   Barker GRI, 2017, NAT NEUROSCI, V20, P242, DOI 10.1038/nn.4472
   Barnes J, 2009, NEUROBIOL AGING, V30, P1711, DOI 10.1016/j.neurobiolaging.2008.01.010
   Bayram Ece, 2018, Alzheimers Dement (N Y), V4, P395, DOI 10.1016/j.trci.2018.04.007
   Brewer JB, 2009, AM J NEURORADIOL, V30, P578, DOI 10.3174/ajnr.A1402
   Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014
   Camozzato AL, 2008, INT PSYCHOGERIATR, V20, P383, DOI 10.1017/S1041610207006254
   Cheke LG, 2013, LEARN MEMORY, V20, P491, DOI 10.1101/lm.030502.113
   Dos Santos RL, 2008, REV BRASILEIRA PROMO, V21, P290, DOI DOI 10.5020/18061230.2008.P290
   DUNNETT CW, 1980, J AM STAT ASSOC, V75, P789, DOI 10.2307/2287160
   Ekstrom AD, 2007, LEARN MEMORY, V14, P645, DOI 10.1101/lm.575107
   Ezzati A, 2016, NEUROPSYCHOLOGIA, V93, P380, DOI 10.1016/j.neuropsychologia.2016.08.016
   Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505
   Gleissner U, 1998, J NEUROL NEUROSUR PS, V65, P665, DOI 10.1136/jnnp.65.5.665
   GLISKY EL, 1995, NEUROPSYCHOLOGY, V9, P229, DOI 10.1037/0894-4105.9.2.229
   Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018
   Labs CorTechs, 2015, HOC PRED DIS PROGR M
   Lee S, 2018, KOREAN J ANESTHESIOL, V71, P353, DOI 10.4097/kja.d.18.00242
   Liu YW, 2010, NEUROBIOL AGING, V31, P1375, DOI 10.1016/j.neurobiolaging.2010.01.022
   Luo W, 2015, NEUROQUANT NORMATIVE
   McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005
   Menendez-Gonzalez M, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/fnagi.2014.00006, DOI 10.3389/FNAGI.2014.00006]
   Min J, 2017, AM J ROENTGENOL, V208, P617, DOI 10.2214/AJR.16.16894
   Miotto EC, 2014, ARQ NEURO-PSIQUIAT, V72, P663, DOI 10.1590/0004-282X20140120
   Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033
   Ochs AL, 2015, J NEUROIMAGING, V25, P721, DOI 10.1111/jon.12229
   Ottoy J, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101771
   Palmer BW, 2017, CLIN GERONTOLOGIST, V40, P24, DOI 10.1080/07317115.2016.1197352
   Papanicolaou AC, 2002, LEARN MEMORY, V9, P99, DOI 10.1101/lm.44302
   Paradela EMP, 2005, REV SAUDE PUBL, V39, P918, DOI 10.1590/s0034-89102005000600008
   Pasquier F, 2001, NEUROCASE, V7, P161, DOI 10.1093/neucas/7.2.161
   PASSARO AD, 2013, FRONT BEHAV NEUROSCI, V7, DOI DOI 10.3389/FNBEH.2013.00007
   Paula Jonas Jardim de, 2012, Arch. Clin. Psychiatry (São Paulo), V39, P19, DOI 10.1590/S0101-60832012000100004
   Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377
   Rugg MD, 2012, NEUROPSYCHOLOGIA, V50, P3070, DOI 10.1016/j.neuropsychologia.2012.06.004
   Schober P, 2018, ANESTH ANALG, V126, P1763, DOI 10.1213/ANE.0000000000002864
   Shing YL, 2008, J EXP PSYCHOL GEN, V137, P495, DOI 10.1037/0096-3445.137.3.495
   Spedo CT, 2012, ADAPTACAO TRANSCULTU
   SPERLING G, 1967, ACTA PSYCHOL, V27, P285, DOI 10.1016/0001-6918(67)90070-4
   Stelmokas J, 2017, J ALZHEIMERS DIS, V60, P1499, DOI 10.3233/JAD-170306
   Thorogood A, 2018, ALZHEIMERS DEMENT, V14, P1334, DOI 10.1016/j.jalz.2018.05.011
   Tomadesso C, 2015, NEUROIMAGE-CLIN, V8, P473, DOI 10.1016/j.nicl.2015.05.010
   Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI 10.1016/j.jalz.2011.09.172
   Weissberger GH, 2017, NEUROPSYCHOL REV, V27, P354, DOI 10.1007/s11065-017-9360-6
   Wolk DA, 2011, NEUROIMAGE, V54, P1530, DOI 10.1016/j.neuroimage.2010.09.005
   Zahodne LB, 2011, CLIN NEUROPSYCHOL, V25, P348, DOI 10.1080/13854046.2011.562869
NR 50
TC 2
Z9 2
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 10
PY 2019
VL 14
IS 10
AR e0223731
DI 10.1371/journal.pone.0223731
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LM7ZE
UT WOS:000532467000122
PM 31600312
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Hoogman, M
   Muetzel, R
   Guimaraes, JP
   Shumskaya, E
   Mennes, M
   Zwiers, MP
   Jahanshad, N
   Sudre, G
   Wolfers, T
   Earl, EA
   Vila, JCS
   Vives-Gilabert, Y
   Khadka, S
   Novotny, SE
   Hartman, CA
   Heslenfeld, DJ
   Schweren, LJS
   Ambrosino, S
   Oranje, B
   de Zeeuw, P
   Chaim-Avancini, TM
   Rosa, PGP
   Zanetti, MV
   Malpas, CB
   Kohls, G
   von Polier, GG
   Seitz, J
   Biederman, J
   Doyle, AE
   Dale, AM
   van Erp, TGM
   Epstein, JN
   Jernigan, TL
   Baur-Streubel, R
   Ziegler, GC
   Zierhut, KC
   Schrantee, A
   Hovik, MF
   Lundervold, AJ
   Kelly, C
   McCarthy, H
   Skokauskas, N
   Tuura, RLO
   Calvo, A
   Lera-Miguel, S
   Nicolau, R
   Chantiluke, KC
   Christakou, A
   Vance, A
   Cercignani, M
   Gabel, MC
   Asherson, P
   Baumeister, S
   Brandeis, D
   Hohmann, S
   Bramati, IE
   Tovar-Moll, F
   Fallgatter, AJ
   Kardatzki, B
   Schwarz, L
   Anikin, A
   Baranov, A
   Gogberashvili, T
   Kapilushniy, D
   Solovieva, A
   El Marroun, H
   White, T
   Karkashadze, G
   Namazova-Baranova, L
   Ethofer, T
   Mattos, P
   Banaschewski, T
   Coghill, D
   Plessen, KJ
   Kuntsi, J
   Mehta, MA
   Paloyelis, Y
   Harrison, NA
   Bellgrove, MA
   Silk, TJ
   Cubillo, AI
   Rubia, K
   Lazaro, L
   Brem, S
   Walitza, S
   Frodl, T
   Zentis, M
   Castellanos, FX
   Yoncheva, YN
   Haavik, J
   Reneman, L
   Conzelmann, A
   Lesch, KP
   Pauli, P
   Reif, A
   Tamm, L
   Konrad, K
   Weiss, EO
   Busatto, GF
   Louza, MR
   Durston, S
   Hoekstra, PJ
   Oosterlaan, J
   Stevens, MC
   Ramos-Quiroga, JA
   Vilarroya, O
   Fair, DA
   Nigg, JT
   Thompson, PM
   Buitelaar, JK
   Faraone, SV
   Shaw, P
   Tiemeier, H
   Bralten, J
   Franke, B
AF Hoogman, Martine
   Muetzel, Ryan
   Guimaraes, Joao P.
   Shumskaya, Elena
   Mennes, Maarten
   Zwiers, Marcel P.
   Jahanshad, Neda
   Sudre, Gustavo
   Wolfers, Thomas
   Earl, Eric A.
   Soliva Vila, Juan Carlos
   Vives-Gilabert, Yolanda
   Khadka, Sabin
   Novotny, Stephanie E.
   Hartman, Catharina A.
   Heslenfeld, Dirk J.
   Schweren, Lizanne J. S.
   Ambrosino, Sara
   Oranje, Bob
   de Zeeuw, Patrick
   Chaim-Avancini, Tiffany M.
   Rosa, Pedro G. P.
   Zanetti, Marcus, V
   Malpas, Charles B.
   Kohls, Gregor
   von Polier, Georg G.
   Seitz, Jochen
   Biederman, Joseph
   Doyle, Alysa E.
   Dale, Anders M.
   van Erp, Theo G. M.
   Epstein, Jeffery N.
   Jernigan, Terry L.
   Baur-Streubel, Ramona
   Ziegler, Georg C.
   Zierhut, Kathrin C.
   Schrantee, Anouk
   Hovik, Marie F.
   Lundervold, Astri J.
   Kelly, Clare
   McCarthy, Hazel
   Skokauskas, Norbert
   Tuura, Ruth L. O'Gorman
   Calvo, Anna
   Lera-Miguel, Sara
   Nicolau, Rosa
   Chantiluke, Kaylita C.
   Christakou, Anastasia
   Vance, Alasdair
   Cercignani, Mara
   Gabel, Matt C.
   Asherson, Philip
   Baumeister, Sarah
   Brandeis, Daniel
   Hohmann, Sarah
   Bramati, Ivanei E.
   Tovar-Moll, Fernanda
   Fallgatter, Andreas J.
   Kardatzki, Bernd
   Schwarz, Lena
   Anikin, Anatoly
   Baranov, Alexandr
   Gogberashvili, Tinatin
   Kapilushniy, Dmitry
   Solovieva, Anastasia
   El Marroun, Hanan
   White, Tonya
   Karkashadze, Georgii
   Namazova-Baranova, Leyla
   Ethofer, Thomas
   Mattos, Paulo
   Banaschewski, Tobias
   Coghill, David
   Plessen, Kerstin J.
   Kuntsi, Jonna
   Mehta, Mitul A.
   Paloyelis, Yannis
   Harrison, Neil A.
   Bellgrove, Mark A.
   Silk, Tim J.
   Cubillo, Ana, I
   Rubia, Katya
   Lazaro, Luisa
   Brem, Silvia
   Walitza, Susanne
   Frodl, Thomas
   Zentis, Mariam
   Castellanos, Francisco X.
   Yoncheva, Yuliya N.
   Haavik, Jan
   Reneman, Liesbeth
   Conzelmann, Annette
   Lesch, Klaus-Peter
   Pauli, Paul
   Reif, Andreas
   Tamm, Leanne
   Konrad, Kerstin
   Weiss, Eileen Oberwelland
   Busatto, Gerald F.
   Louza, Mario R.
   Durston, Sarah
   Hoekstra, Pieter J.
   Oosterlaan, Jaap
   Stevens, Michael C.
   Antoni Ramos-Quiroga, J.
   Vilarroya, Oscar
   Fair, Damien A.
   Nigg, Joel T.
   Thompson, Paul M.
   Buitelaar, Jan K.
   Faraone, Stephen, V
   Shaw, Philip
   Tiemeier, Henning
   Bralten, Janita
   Franke, Barbara
TI Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of
   Large-Scale Clinical and Population-Based Samples
SO AMERICAN JOURNAL OF PSYCHIATRY
LA English
DT Article
ID ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY
   DISORDER; CHILDREN; METAANALYSIS; ADULTS; SIZE; MRI; CONNECTIVITY;
   PARTICIPANTS; SYMPTOMS
AB Objective: Neuroimaging studies show structural alterations of various brain regions in children and adults with attention deficit hyperactivity disorder (ADHD), although nonreplications are frequent. The authors sought to identify cortical characteristics related to ADHD using large-scale studies.
   Methods: Cortical thickness and surface area (based on the Desikan-Killiany atlas) were compared between case subjects with ADHD (N = 2,246) and control subjects (N = 1,934) for children, adolescents, and adults separately in ENIGMA-ADHD, a consortium of 36 centers. To assess familial effects on cortical measures, case subjects, unaffected siblings, and control subjects in the NeuroIMAGE study (N = 506) were compared. Associations of the attention scale from the Child Behavior Checklist with cortical measures were determined in a pediatric population sample (Generation-R, N = 2,707).
   Results: In the ENIGMA-ADHD sample, lower surface area values were found in children with ADHD, mainly in frontal, cingulate, and temporal regions; the largest significant effect was for total surface area (Cohen's d = -0.21). Fusiform gyrus and temporal pole cortical thickness was also lower in children with ADHD. Neither surface area nor thickness differences were found in the adolescent or adult groups. Familial effects were seen for surface area in several regions. In an overlapping set of regions, surface area, but not thickness, was associated with attention problems in the Generation-R sample.
   Conclusions: Subtle differences in cortical surface area are widespread in children but not adolescents and adults with ADHD, confirming involvement of the frontal cortex and highlighting regions deserving further attention. Notably, the alterations behave like endophenotypes in families and are linked to ADHD symptoms in the population, extending evidence that ADHD behaves as a continuous trait in the population. Future longitudinal studies should clarify individual lifespan trajectories that lead to nonsignificant findings in adolescent and adult groups despite the presence of an ADHD diagnosis.
C1 [Hoogman, Martine; Guimaraes, Joao P.; Shumskaya, Elena; Wolfers, Thomas; Bralten, Janita; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands.
   [Hoogman, Martine; Shumskaya, Elena; Mennes, Maarten; Wolfers, Thomas; Buitelaar, Jan K.; Bralten, Janita; Franke, Barbara] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.
   [Muetzel, Ryan; El Marroun, Hanan; White, Tonya; Tiemeier, Henning] Univ Med Ctr Rotterdam, Dept Child & Adolescent Psychiat, Erasmus MC, Rotterdam, Netherlands.
   [Muetzel, Ryan] Univ Med Ctr Rotterdam, Dept Epidemiol, Erasmus MC, Rotterdam, Netherlands.
   [Guimaraes, Joao P.; Zwiers, Marcel P.; Buitelaar, Jan K.] Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Nijmegen, Netherlands.
   [Jahanshad, Neda; Thompson, Paul M.] Keck Sch Med USC, Imaging Genet Ctr, Stevens Neuroimaging & Informat Inst, Marina Del Rey, CA USA.
   [Sudre, Gustavo; Shaw, Philip] NHGRI, Bethesda, MD 20892 USA.
   [Earl, Eric A.; Fair, Damien A.; Nigg, Joel T.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.
   [Soliva Vila, Juan Carlos; Antoni Ramos-Quiroga, J.; Vilarroya, Oscar] Autonomous Univ Barcelona, Dept Psychiat & Forens Med, Cerdanyola Del Valles, Spain.
   [Vives-Gilabert, Yolanda] Univ Politecn Valencia, Inst ITACA, Valencia, Spain.
   [Khadka, Sabin; Novotny, Stephanie E.; Stevens, Michael C.] Hartford Hosp, Olin Neuropsychiat Res Ctr, Hartford, CT 06115 USA.
   [Hartman, Catharina A.; Schweren, Lizanne J. S.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.
   [Heslenfeld, Dirk J.] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Amsterdam, Netherlands.
   [Hoekstra, Pieter J.] Univ Groningen, Dept Child & Adolescent Psychiat, Univ Med Ctr Groningen, Groningen, Netherlands.
   [Ambrosino, Sara; Oranje, Bob; de Zeeuw, Patrick; Durston, Sarah] UMC Utrecht Brain Ctr, NICHE Lab, Dept Psychiat, Utrecht, Netherlands.
   [Chaim-Avancini, Tiffany M.; Rosa, Pedro G. P.; Zanetti, Marcus, V; Busatto, Gerald F.] Univ Sao Paulo, Lab Psychiat Neuroimaging LIM 21, Dept & Inst Psychiat, Fac Med, Sao Paulo, Brazil.
   [Chaim-Avancini, Tiffany M.; Rosa, Pedro G. P.; Zanetti, Marcus, V; Busatto, Gerald F.] Univ Sao Paulo, Ctr Interdisciplinary Res Appl Neurosci NAPNA, Sao Paulo, Brazil.
   [Malpas, Charles B.] Murdoch Childrens Res Inst, Dev Imaging Grp, Melbourne, Vic, Australia.
   [Malpas, Charles B.] Univ Melbourne, Clin Outcomes Res Unit CORe, Dept Med, Royal Melbourne Hosp, Melbourne, Vic, Australia.
   [Malpas, Charles B.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.
   [Kohls, Gregor; Konrad, Kerstin] Univ Hosp RWTH Aachen, Child Neuropsychol Sect, Aachen, Germany.
   [von Polier, Georg G.; Seitz, Jochen] Univ Hosp RWTH Aachen, Child & Adolescent Psychiat, Aachen, Germany.
   [von Polier, Georg G.] Res Ctr Julich, Inst Neurosci & Med Brain & Behav INM7, Julich, Germany.
   [Biederman, Joseph] Massachusetts Gen Hosp, Clin & Res Programs Pediat Psychopharmacol & Adul, Dept Psychiat, Boston, MA 02114 USA.
   [Biederman, Joseph; Doyle, Alysa E.] Harvard Med Sch, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA.
   [Doyle, Alysa E.] Harvard Med Sch, Ctr Genom Med, Massachusetts Gen Hosp, Boston, MA 02115 USA.
   [Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.
   [Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA.
   [Dale, Anders M.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.
   [Dale, Anders M.] Univ Calif San Diego, Ctr Multimodal Imaging & Genet, La Jolla, CA 92093 USA.
   [van Erp, Theo G. M.] Univ Calif Irvine, Dept Psychiat & Human Behav, Clin & Translat Neurosci Lab, Irvine, CA 92717 USA.
   [Epstein, Jeffery N.; Tamm, Leanne] Univ Cincinnati, Coll Med, Div Behav Med & Clin Psychol, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA.
   [Epstein, Jeffery N.; Tamm, Leanne] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA.
   [Jernigan, Terry L.] Univ Calif San Diego, Ctr Human Dev, San Diego, CA 92103 USA.
   [Ziegler, Georg C.; Lesch, Klaus-Peter] Univ Wurzburg, Div Mol Psychiat, Ctr Mental Hlth, Wurzburg, Germany.
   [Schrantee, Anouk; Reneman, Liesbeth] Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands.
   [Hovik, Marie F.] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Hovik, Marie F.; Haavik, Jan] Haukeland Hosp, Div Psychiat, Bergen, Norway.
   [Lundervold, Astri J.] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway.
   [Lundervold, Astri J.; Haavik, Jan] Univ Bergen, KG Jebsen Ctr Neuropsychiat Disorders, Dept Biomed, Bergen, Norway.
   [Kelly, Clare] Trinity Coll Dublin, Sch Med, Sch Psychol, Trinity Coll,Inst Neurosci, Dublin, Ireland.
   [Kelly, Clare] Trinity Coll Dublin, Sch Med, Dept Psychiat, Trinity Coll,Inst Neurosci, Dublin, Ireland.
   [Kelly, Clare; Castellanos, Francisco X.; Yoncheva, Yuliya N.] NYU Langone Med Ctr, Dept Child & Adolescent Psychiat, New York, NY USA.
   [McCarthy, Hazel; Skokauskas, Norbert; Frodl, Thomas] Trinity Coll Dublin, Dept Psychiat, Dublin, Ireland.
   [McCarthy, Hazel] St James Hosp, Ctr Adv Med Imaging, Dublin, Ireland.
   [Skokauskas, Norbert] Norwegian Univ Sci & Technol, Ctr Child & Adolescent Mental Hlth, NTNU, Trondheim, Norway.
   [Tuura, Ruth L. O'Gorman] Univ Childrens Hosp, Ctr MR Res, Zurich, Switzerland.
   [Tuura, Ruth L. O'Gorman] Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.
   [Calvo, Anna; Lazaro, Luisa] August Pi & Sunyer Biomed Res Inst IDIBAPS, Magnet Resonance Image Core Facil, Barcelona, Spain.
   [Lera-Miguel, Sara; Nicolau, Rosa] Hosp Clin Barcelona, Dept Child & Adolescent Psychiat & Psychol, Inst Neurosci, Barcelona, Spain.
   [Chantiluke, Kaylita C.; Christakou, Anastasia; Cubillo, Ana, I; Rubia, Katya] Kings Coll London, Dept Child & Adolescent Psychiat, Inst Psychiat Psychol & Neurosci, London, England.
   [Christakou, Anastasia] Univ Reading, Sch Psychol & Clin Language Sci, Ctr Integrat Neurosci & Neurodynam, Reading, Berks, England.
   [Vance, Alasdair; Coghill, David; Silk, Tim J.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   [Cercignani, Mara; Gabel, Matt C.; Harrison, Neil A.] Brighton & Sussex Med Sch, Dept Neurosci, Brighton, E Sussex, England.
   [Asherson, Philip; Kuntsi, Jonna] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London, England.
   [Baumeister, Sarah; Brandeis, Daniel; Hohmann, Sarah; Banaschewski, Tobias] Heidelberg Univ, Dept Child & Adolescent Psychiat & Psychotherapy, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany.
   [Brandeis, Daniel; Brem, Silvia; Walitza, Susanne] Univ Zurich, Dept Child & Adolescent Psychiat & Psychother, Psychiat Hosp, Zurich, Switzerland.
   [Bramati, Ivanei E.; Brem, Silvia; Walitza, Susanne] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland.
   [Bramati, Ivanei E.; Brem, Silvia; Walitza, Susanne] Swiss Fed Inst Technol, Zurich, Switzerland.
   [Bramati, Ivanei E.; Tovar-Moll, Fernanda; Mattos, Paulo] Dor Inst Res & Educ, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Morphol Sci Program, Rio De Janeiro, Brazil.
   [Fallgatter, Andreas J.; Schwarz, Lena; Ethofer, Thomas] Univ Hosp Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany.
   [Fallgatter, Andreas J.] Univ Tubingen, Lead Grad Sch, Tubingen, Germany.
   [Kardatzki, Bernd; Ethofer, Thomas] Univ Tubingen, Dept Biomed Magnet Resonance, Tubingen, Germany.
   [Anikin, Anatoly] Natl Med Res Ctr Childrens Hlth, Dept Magnet Resonance Imaging & Densitometry, Moscow, Russia.
   [Baranov, Alexandr; Solovieva, Anastasia] Natl Med Res Ctr Childrens Hlth, Moscow, Russia.
   [Namazova-Baranova, Leyla] Russian Natl Res Med Univ, Minist Hlth & Social Dev Russian Federat, Cent Clin Hosp MSHE, Moscow, Russia.
   [Gogberashvili, Tinatin; Karkashadze, Georgii] Natl Med Res Ctr Childrens Hlth, Lab Neurologyand Cognit Hlth, Moscow, Russia.
   [Kapilushniy, Dmitry] Natl Med Res Ctr Childrens Hlth, Dept Informat Technol, Moscow, Russia.
   [El Marroun, Hanan] Erasmus MC Sophia, Dept Pediat, Rotterdam, Netherlands.
   [El Marroun, Hanan] Erasmus Univ, Dept Psychol Educ & Child Studies, Rotterdam, Netherlands.
   [White, Tonya] Univ Med Ctr Rotterdam, Dept Radiol, Erasmus MC, Rotterdam, Netherlands.
   [Mattos, Paulo] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Coghill, David] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia.
   [Coghill, David; Silk, Tim J.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Coghill, David] Univ Dundee, Div Neurosci, Dundee, Scotland.
   [Plessen, Kerstin J.] Child & Adolescent Mental Hlth Ctr, Copenhagen, Denmark.
   [Plessen, Kerstin J.] Univ Hosp Lausanne, Div Child & Adolescent Psychiat, Dept Psychiat, Lausanne, Switzerland.
   [Mehta, Mitul A.; Paloyelis, Yannis] Kings Coll London, Dept Neuroimaging, Inst Psychiat Psychol & Neurosci, London, England.
   [Harrison, Neil A.] Sussex Partnership NHS Fdn Trust, Swandean, E Sussex, England.
   [Bellgrove, Mark A.] Monash Univ, Monash Inst Cognit & Clin Neurosci MICCN, Melbourne, Vic, Australia.
   [Bellgrove, Mark A.] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia.
   [Silk, Tim J.] Deakin Univ, Sch Psychol, Geelong, Vic, Australia.
   [Lazaro, Luisa] Univ Barcelona, Dept Med, Barcelona, Spain.
   [Frodl, Thomas] Otto von Guericke Univ, Dept Psychiat & Psychotherapy, Magdeburg, Germany.
   [Frodl, Thomas] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany.
   [Zentis, Mariam] Bezirksklinikum Regensburg, Regensburg, Germany.
   [Castellanos, Francisco X.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA.
   [Reneman, Liesbeth] Univ Amsterdam, Brain Imaging Ctr, Med Ctr, Amsterdam, Netherlands.
   [Conzelmann, Annette] Dept Child & Adolescent Psychiat Psychosomat & Ps, Tubingen, Germany.
   [Baur-Streubel, Ramona; Zierhut, Kathrin C.; Conzelmann, Annette; Pauli, Paul] Univ Wurzburg, Dept Psychol Biol Psychol, Clin Psychol & Psychotherapy, Wurzburg, Germany.
   [Lesch, Klaus-Peter] IM Sechenov First Moscow State Med Univ, Lab Psychiat Neurobiol, Inst Mol Med, Moscow, Russia.
   [Lesch, Klaus-Peter] Maastricht Univ, Dept Neurosci, Sch Mental Hlth & Neurosci MHeNS, Maastricht, Netherlands.
   [Reif, Andreas] Univ Hosp Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany.
   [Konrad, Kerstin] Res Ctr Julich, JARA Inst Mol Neurosci & Neuroimaging INM 11, Inst Neurosci & Med, Julich, Germany.
   [Weiss, Eileen Oberwelland] Univ Hosp RVVTH Aachen, Translat Neurosci Child & Adolescent Psychiat, Aachen, Germany.
   [Weiss, Eileen Oberwelland] Res Ctr Julich, Cognit Neurosci INM 3, Inst Neurosci & Med, Julich, Germany.
   [Busatto, Gerald F.; Louza, Mario R.] Univ Sao Paulo, Dept Psychiat, Fac Med, Sao Paulo, Brazil.
   [Oosterlaan, Jaap] Vrije Univ Amsterdam, Clin Neuropsychol Sect, Amsterdam, Netherlands.
   [Oosterlaan, Jaap] Emma Childrens Hosp Amsterdam Med Ctr, Amsterdam, Netherlands.
   [Oosterlaan, Jaap] Vrije Univ Amsterdam Med Ctr, Dept Pediat, Amsterdam, Netherlands.
   [Stevens, Michael C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA.
   [Baur-Streubel, Ramona] Vall dHebron Univ Hosp, Dept Psychiat, Barcelona, Spain.
   [Vilarroya, Oscar] Hosp Mar Med Res Inst IMIM, Barcelona, Spain.
   [Fair, Damien A.; Nigg, Joel T.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA.
   [Buitelaar, Jan K.] Karakter Child & Adolescent Psychiat Univ Ctr, Nijmegen, Netherlands.
   [Faraone, Stephen, V] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA.
   [Faraone, Stephen, V] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA.
   [Shaw, Philip] NIHM, Bethesda, MD USA.
   [Tiemeier, Henning] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA.
RP Franke, B (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands.; Franke, B (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.
EM barbara.franke@radboudumc.nl
RI Coghill, David/ABF-5213-2020; Haavik, Jan/ABE-1535-2020; Bellgrove,
   Mark/AAB-3114-2019; Moll, Fernanda Tovar/N-3320-2018; Alexander,
   Baranov/O-4882-2019; Kuntsi, Jonna/AAU-1195-2020; Konrad,
   Kerstin/H-7747-2013; de Mattos, Paulo Eduardo Luiz/D-2328-2014;
   Tiemeier, Henning/H-6534-2019; Wolfers, Thomas/ABF-1461-2020; Brem,
   Silvia/M-7130-2016; Kelly, Clare/H-4629-2016; Castellanos, Francisco
   Xavier/K-1892-2014; Kohls, Gregor/AAH-6429-2020; Mennes,
   Maarten/C-9924-2011; Namazova-Baranova, Leyla/C-9485-2019; Bralten,
   Janita/AAB-9566-2019; Franke, Barbara/D-4836-2009; Zwiers, Marcel
   P/D-2968-2009; Frodl, Thomas/D-8118-2012; Hoogman, Martine/G-8958-2015;
   Stevens, Michael/M-7678-2017; Walitza, Susanne/AAF-5616-2019; Coghill,
   David R/X-6449-2018; Ziegler, Georg C/N-8985-2015; Buitelaar,
   J.K./AAY-7522-2020; Banaschewski, Tobias/ABE-5985-2020; Seitz,
   Jochen/AAE-7363-2019; Faraone, Stephen/AAE-7334-2019; Christakou,
   Anastasia/B-7838-2008; Wolfers, Thomas/G-9575-2015; Rubia,
   Katya/H-7497-2012; Louza, Mario/H-8540-2013
OI Coghill, David/0000-0003-3017-9737; Moll, Fernanda
   Tovar/0000-0002-0292-5985; Alexander, Baranov/0000-0003-3987-8112;
   Kuntsi, Jonna/0000-0002-0113-8162; Konrad, Kerstin/0000-0001-9039-2615;
   de Mattos, Paulo Eduardo Luiz/0000-0003-0709-3783; Tiemeier,
   Henning/0000-0002-4395-1397; Brem, Silvia/0000-0002-8031-1305; Kelly,
   Clare/0000-0001-8253-357X; Castellanos, Francisco
   Xavier/0000-0001-9192-9437; Mennes, Maarten/0000-0002-7279-3439;
   Namazova-Baranova, Leyla/0000-0002-2209-7531; Bralten,
   Janita/0000-0003-1440-8675; Franke, Barbara/0000-0003-4375-6572; Zwiers,
   Marcel P/0000-0001-5483-2935; Hoogman, Martine/0000-0002-1261-7628;
   Stevens, Michael/0000-0002-3799-5465; Walitza,
   Susanne/0000-0002-8161-8683; Coghill, David R/0000-0003-3017-9737;
   Ziegler, Georg C/0000-0001-9411-3169; Banaschewski,
   Tobias/0000-0003-4595-1144; Seitz, Jochen/0000-0002-0110-7980; Faraone,
   Stephen/0000-0002-9217-3982; Christakou, Anastasia/0000-0002-4267-3436;
   Wolfers, Thomas/0000-0002-7693-0621; O'Gorman, Ruth/0000-0001-5932-7786;
   Silk, Tim/0000-0002-7290-512X; Bellgrove, Mark/0000-0003-0186-8349;
   Rubia, Katya/0000-0002-1410-7701; White, Tonya/0000-0003-0271-1896;
   Harrison, Neil/0000-0002-9584-3769; Paloyelis,
   Yannis/0000-0002-4029-3720; Asherson, Philip/0000-0003-2667-2254;
   Vives-Gilabert, Yolanda/0000-0002-3744-5893; Yoncheva,
   Yuliya/0000-0001-6495-7504; Schrantee, Anouk/0000-0002-4035-4845; Louza,
   Mario/0000-0003-1359-4111; Vilarroya, Oscar/0000-0001-8285-5624
FU NCATS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [R21 TR003103] Funding Source: Medline;
   NCRR NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [P41 RR015241, M01 RR000052] Funding Source: Medline;
   NIBIB NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Biomedical
   Imaging & Bioengineering (NIBIB) [U54 EB020403] Funding Source: Medline;
   NICHD NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [P30 HD024061]
   Funding Source: Medline; NIDA NIH HHSUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute on Drug Abuse (NIDA) [HHSN271200800009C] Funding Source:
   Medline; NIMH NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Mental Health (NIMH) [T32 MH067763, K99 MH091238, R01 MH115357, K23
   MH087770, R01 MH099064, R01 MH094639, R01 MH083246, R01 MH086654, U01
   MH099059, R01 MH062873, R01 MH085328, R01 MH078160, R01 MH081803, R00
   MH091238] Funding Source: Medline; NINDS NIH HHSUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Neurological Disorders & Stroke (NINDS) [R01
   NS048527] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Human Genome Research
   Institute (NHGRI) [ZIAHG200378, ZIAHG200378, ZIAHG200378, ZIAHG200378]
   Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING
   AND BIOENGINEERINGUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Biomedical Imaging & Bioengineering (NIBIB) [U54EB020403,
   U54EB020403, U54EB020403, U54EB020403, U54EB020403, U54EB020403,
   U54EB020403, U54EB020403, U54EB020403] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Mental Health (NIMH) [R01MH115357, R01MH099064,
   R01MH085328, R01MH085328, U01MH099059, R01MH078160, R01MH085328,
   R01MH115357, R01MH085328, R01MH115357, R01MH085328, R01MH078160,
   R01MH099064, U01MH099059, R01MH099064, R01MH115357] Funding Source: NIH
   RePORTER
CR Adhikari BM, BRAIN IMAGING BEHAV
   Aoki Y, 2018, J CHILD PSYCHOL PSYC, V59, P193, DOI 10.1111/jcpp.12778
   Barnes J, 2010, NEUROIMAGE, V53, P1244, DOI 10.1016/j.neuroimage.2010.06.025
   Boedhoe PSW, 2018, AM J PSYCHIAT, V175, P453, DOI 10.1176/appi.ajp.2017.17050485
   Bonner MF, 2013, J NEUROSCI, V33, P4213, DOI 10.1523/JNEUROSCI.0041-13.2013
   Bralten J, 2016, J PSYCHIATR NEUROSCI, V41, P272, DOI 10.1503/jpn.140377
   Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475
   Chen LZ, 2016, NEUROSCI BIOBEHAV R, V68, P838, DOI 10.1016/j.neubiorev.2016.07.022
   CHEN WJ, 1994, J CONSULT CLIN PSYCH, V62, P1017, DOI 10.1037/0022-006X.62.5.1017
   Cortese S, 2016, BIOL PSYCHIAT, V80, P896, DOI 10.1016/j.biopsych.2016.06.014
   Ellison-Wright I, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-51
   Faraone SV, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.20
   Franke B, 2016, NAT NEUROSCI, V19, P420, DOI 10.1038/nn.4228
   Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x
   Grasby KL, 2019, BIORXIV, DOI [10.1101/399402, DOI 10.1101/399402]
   Griffiths KR, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.219
   Hart H, 2013, JAMA PSYCHIAT, V70, P185, DOI 10.1001/jamapsychiatry.2013.277
   Hibar DP, 2018, MOL PSYCHIATR, V23, P932, DOI 10.1038/mp.2017.73
   Holme P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056108
   Hoogman M, 2017, LANCET PSYCHIAT, V4, P310, DOI 10.1016/S2215-0366(17)30049-4
   Hutchinson AD, 2008, NEUROPSYCHOLOGY, V22, P341, DOI 10.1037/0894-4105.22.3.341
   Jahanshad N, 2013, NEUROIMAGE, V81, P455, DOI 10.1016/j.neuroimage.2013.04.061
   Klein M, 2019, AM J PSYCHIAT, V176, P228, DOI 10.1176/appi.ajp.2018.18020149
   Le HH, 2014, EUR CHILD ADOLES PSY, V23, P587, DOI 10.1007/s00787-013-0477-8
   Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717
   Luman M, 2005, CLIN PSYCHOL REV, V25, P183, DOI 10.1016/j.cpr.2004.11.001
   Mackey S, 2019, AM J PSYCHIAT, V176, P119, DOI 10.1176/appi.ajp.2018.17040415
   Middeldorp CM, 2016, J AM ACAD CHILD PSY, V55, P896, DOI 10.1016/j.jaac.2016.05.025
   Mostert JC, 2016, PROG NEURO-PSYCHOPH, V67, P82, DOI 10.1016/j.pnpbp.2016.01.011
   Mous SE, 2014, PSYCHOL MED, V44, P3203, DOI 10.1017/S0033291714000877
   Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x
   Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281
   Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005
   Norman LJ, 2016, JAMA PSYCHIAT, V73, P815, DOI 10.1001/jamapsychiatry.2016.0700
   Onnink AMH, 2014, EUR NEUROPSYCHOPHARM, V24, P397, DOI 10.1016/j.euroneuro.2013.11.011
   Plichta MM, 2014, NEUROSCI BIOBEHAV R, V38, P125, DOI 10.1016/j.neubiorev.2013.07.012
   Puiu AA, 2018, NEUROSCI BIOBEHAV R, V90, P231, DOI 10.1016/j.neubiorev.2018.04.016
   Schmaal L, 2017, MOL PSYCHIATR, V22, P900, DOI 10.1038/mp.2016.60
   Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104
   Shaw P, 2014, AM J PSYCHIAT, V171, P276, DOI 10.1176/appi.ajp.2013.13070966
   Shaw P, 2013, BIOL PSYCHIAT, V74, P599, DOI 10.1016/j.biopsych.2013.04.007
   Shaw P, 2012, BIOL PSYCHIAT, V72, P191, DOI 10.1016/j.biopsych.2012.01.031
   Shaw P, 2011, AM J PSYCHIAT, V168, P143, DOI 10.1176/appi.ajp.2010.10030385
   Stevens FL, 2011, J NEUROPSYCH CLIN N, V23, P120, DOI 10.1176/appi.neuropsych.23.2.121
   Taurines R, 2010, ADHD-ATTEND DEFICIT, V2, P267, DOI 10.1007/s12402-010-0040-0
   Thomas R, 2015, PEDIATRICS, V135, pE994, DOI 10.1542/peds.2014-3482
   Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011
   von Rhein D, 2015, EUR CHILD ADOLES PSY, V24, P265, DOI 10.1007/s00787-014-0573-4
   White T, 2018, HUM BRAIN MAPP, V39, P1218, DOI 10.1002/hbm.23911
   White T, 2018, EUR J EPIDEMIOL, V33, P99, DOI 10.1007/s10654-017-0319-y
   Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006
   Yu X, J ATTEN DISORD
NR 52
TC 35
Z9 35
U1 10
U2 38
PU AMER PSYCHIATRIC PUBLISHING, INC
PI WASHINGTON
PA 800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA
SN 0002-953X
EI 1535-7228
J9 AM J PSYCHIAT
JI Am. J. Psychiat.
PD JUL
PY 2019
VL 176
IS 7
BP 531
EP 542
DI 10.1176/appi.ajp.2019.18091033
PG 12
WC Psychiatry
SC Psychiatry
GA IF8ER
UT WOS:000473322200009
PM 31014101
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Marins, T
   Rodrigues, EC
   Bortolini, T
   Melo, B
   Moll, J
   Tovar-Moll, F
AF Marins, T.
   Rodrigues, E. C.
   Bortolini, T.
   Melo, Bruno
   Moll, J.
   Tovar-Moll, F.
TI Structural and functional connectivity changes in response to short-term
   neurofeedback training with motor imagery
SO NEUROIMAGE
LA English
DT Article
DE Brain plasticity; DTI; Functional connectivity; Neurofeedback
ID DEFAULT-MODE NETWORK; OLIGODENDROCYTE PRECURSOR MIGRATION;
   RESTING-STATE; LONGITUDINAL CHANGES; FMRI NEUROFEEDBACK; BRAIN
   ACTIVATION; MENTAL PRACTICE; STROKE; RECOVERY; MYELINATION
AB Recent findings have been challenging current understanding of how fast the human brain change its structural and functional connections in response to training. One powerful way to deepen the inner workings of human brain plasticity is using neurofeedback (NFB) by fMRI, a technique that allows self-induced brain plasticity by means of modulating brain activity in real time. In the present randomized, double-blind and sham-controlled study, we use NFB to train healthy individuals to reinforce brain patterns related to motor execution while performing a motor imagery task, with no overt movement. After 1 h of NFB training, participants displayed increased fractional anisotropy (FA) in the sensorimotor segment of corpus callosum and increased functional connectivity of the sensorimotor resting state network. Increased functional connectivity was also observed in the default mode network. These results were not observed in the control group, which was trained with sham feedback. To our knowledge, this is the first demonstration of white matter FA changes following a very short training schedule (<1 h). Our results suggest that NFB by fMRI can be an interesting tool to explore dynamic aspects of brain plasticity and open new venues for investigating brain plasticity in healthy individuals and in neurological conditions.
C1 [Marins, T.; Rodrigues, E. C.; Bortolini, T.; Melo, Bruno; Moll, J.; Tovar-Moll, F.] Dor Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.
   [Marins, T.; Moll, J.; Tovar-Moll, F.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Post Grad Program Morphol Sci, Rio De Janeiro, RJ, Brazil.
   [Rodrigues, E. C.] Augusto Motta Univ Unisuam, Rio De Janeiro, RJ, Brazil.
RP Tovar-Moll, F (corresponding author), Dor Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.
EM fernanda.tovarmoll@idor.org
RI Moll, Fernanda Tovar/N-3320-2018; de Carvalho Rodrigues,
   Erika/R-6007-2017
OI Moll, Fernanda Tovar/0000-0002-0292-5985; de Carvalho Rodrigues,
   Erika/0000-0001-5464-2963; Marins, Theo/0000-0002-5017-707X
FU Research Support Foundation of the State of Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); National Council for Scientific and
   Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq); D'Or Institute for Research and
   Education
FX This work is part of the Ph.D. thesis of T.M. and was supported by
   Research Support Foundation of the State of Rio de Janeiro (FAPERJ),
   National Council for Scientific and Technological Development (CNPq), as
   well as by intramural grants from D'Or Institute for Research and
   Education. We are thankful to Rodrigo Basilio for the technical support
   and to Isis Ornelas for the useful discussion. The authors have no
   competing interests.
CR Auer T, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00547
   Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634
   Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609
   Butler AJ, 2006, ARCH PHYS MED REHAB, V87, pS2, DOI 10.1016/j.apmr.2006.08.326
   Calautti C, 2003, STROKE, V34, P1553, DOI 10.1161/01.STR.0000071761.36075.A6
   Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905
   Chiew M, 2012, NEUROIMAGE, V61, P21, DOI 10.1016/j.neuroimage.2012.02.053
   Dacosta-Aguayo R, 2015, HUM BRAIN MAPP, V36, P577, DOI 10.1002/hbm.22648
   de Castro F, 2013, CELL MOL LIFE SCI, V70, P4355, DOI 10.1007/s00018-013-1365-6
   de Faria O, 2018, DEV NEUROBIOL, V78, P93, DOI 10.1002/dneu.22539
   deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102
   Decker L, 2000, MOL CELL NEUROSCI, V16, P422, DOI 10.1006/mcne.2000.0885
   Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887
   Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a
   Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669
   Emmert K, 2016, NEUROIMAGE, V124, P806, DOI 10.1016/j.neuroimage.2015.09.042
   Esposito F, 2013, BRAIN, V136, P710, DOI 10.1093/brain/awt007
   Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002
   Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093
   Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304
   Golestani AM, 2013, NEUROREHAB NEURAL RE, V27, P153, DOI 10.1177/1545968312457827
   Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002
   Hardwick RM, 2013, NEUROIMAGE, V67, P283, DOI 10.1016/j.neuroimage.2012.11.020
   HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x
   Hofstetter S, 2013, J NEUROSCI, V33, P12844, DOI 10.1523/JNEUROSCI.4520-12.2013
   Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053
   ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369
   IWASA K, 1980, SCIENCE, V210, P338, DOI 10.1126/science.7423196
   IWASA K, 1980, BIOCHEM BIOPH RES CO, V95, P1328, DOI 10.1016/0006-291X(80)91619-8
   Koizumi A, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0006
   Koush Y, 2017, CEREB CORTEX, V27, P1193, DOI 10.1093/cercor/bhv311
   Koush Y, 2013, NEUROIMAGE, V81, P422, DOI 10.1016/j.neuroimage.2013.05.010
   Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103
   Lassalle-Lagadec S, 2012, RADIOLOGY, V264, P218, DOI 10.1148/radiol.12111718
   Lotze M, 1999, J COGNITIVE NEUROSCI, V11, P491, DOI 10.1162/089892999563553
   Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597
   Malouin Francine, 2007, J Neurol Phys Ther, V31, P20
   Marins TF, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00341
   Neyedli H. F., 2016, NEUROSCIENCE, P1, DOI [10.1016/j.neuroscience.2017.02.0, DOI 10.1016/J.NEUROSCIENCE.2017.02.0]
   Ohno N, 2011, J NEUROSCI, V31, P7249, DOI 10.1523/JNEUROSCI.0095-11.2011
   OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4
   Page SJ, 2007, STROKE, V38, P1293, DOI 10.1161/01.STR.0000260205.67348.2b
   Page SJ, 2009, NEUROREHAB NEURAL RE, V23, P382, DOI 10.1177/1545968308326427
   Park CH, 2011, STROKE, V42, P1357, DOI 10.1161/STROKEAHA.110.596155
   Park JY, 2014, EUR J NEUROSCI, V40, P2715, DOI 10.1111/ejn.12640
   Ruiz S, 2013, HUM BRAIN MAPP, V34, P200, DOI 10.1002/hbm.21427
   Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025
   Sampaio-Baptista C, 2018, ANNU REV NEUROSCI, V41, P25, DOI 10.1146/annurev-neuro-080317-062015
   Sampaio-Baptista C, 2015, NEUROIMAGE, V106, P15, DOI 10.1016/j.neuroimage.2014.11.032
   Sharma N, 2009, STROKE, V40, P1315, DOI 10.1161/STROKEAHA.108.525766
   Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc
   Sitaram R, 2017, NAT REV NEUROSCI, V18, P86, DOI 10.1038/nrn.2016.164
   Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024
   Vargas-Jiménez Carlos Alberto, 2017, Earth Sci. Res. J., V21, P1, DOI 10.1097/01.JAA.0000512234.38679.64
   Stagg CJ, 2014, ELIFE, V3, DOI 10.7554/eLife.01465
   STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373
   Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X
   Stevens B, 1998, J NEUROSCI, V18, P9303
   Tang YY, 2010, P NATL ACAD SCI USA, V107, P15649, DOI 10.1073/pnas.1011043107
   Taubert M, 2010, J NEUROSCI, V30, P11670, DOI 10.1523/JNEUROSCI.2567-10.2010
   Thibault RT, 2018, NEUROIMAGE, V172, P786, DOI 10.1016/j.neuroimage.2017.12.071
   Tovar-Moll F, 2014, P NATL ACAD SCI USA, V111, P7843, DOI 10.1073/pnas.1400806111
   Tuladhar AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066556
   van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010
   Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998
   Ward NS, 2004, CURR OPIN NEUROL, V17, P725, DOI 10.1097/00019052-200412000-00013
   Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245
   WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023
   Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046
   Xiao L, 2016, NAT NEUROSCI, V19, P1210, DOI 10.1038/nn.4351
   Yoo SS, 2008, INT J IMAG SYST TECH, V18, P69, DOI 10.1002/ima.20139
   Zimmermann-Schlatter A, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-8
   Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080
NR 73
TC 6
Z9 6
U1 3
U2 23
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1053-8119
EI 1095-9572
J9 NEUROIMAGE
JI Neuroimage
PD JUL 1
PY 2019
VL 194
BP 283
EP 290
DI 10.1016/j.neuroimage.2019.03.027
PG 8
WC Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA HZ3IX
UT WOS:000468742800023
PM 30898654
DA 2020-12-17
ER

PT J
AU Andrade, JBD
   Ferreira, FM
   Suo, C
   Yucel, M
   Frydman, I
   Monteiro, M
   Vigne, P
   Fontenelle, LF
   Tovar-Moll, F
AF de Salles Andrade, Juliana B.
   Ferreira, Fernanda Meireles
   Suo, Chao
   Yucel, Murat
   Frydman, Ilana
   Monteiro, Marina
   Vigne, Paula
   Fontenelle, Leonardo F.
   Tovar-Moll, Fernanda
TI An MRI Study of the Metabolic and Structural Abnormalities in
   Obsessive-Compulsive Disorder
SO FRONTIERS IN HUMAN NEUROSCIENCE
LA English
DT Article
DE obsessive-compulsive disorder; HMRS; DTI; anterior cingulate cortex;
   cingulate bundle
ID MAGNETIC-RESONANCE-SPECTROSCOPY; WHITE-MATTER ABNORMALITIES; SEROTONIN
   REUPTAKE INHIBITORS; FAMILY-BASED ASSOCIATION; TRANSPORTER GENE SLC1A1;
   MYELIN LIPID-SYNTHESIS; TENSOR IMAGING DTI; FRACTIONAL ANISOTROPY;
   SPATIAL STATISTICS; SYMPTOM DIMENSIONS
AB Obsessive-compulsive disorder (OCD) is a neuropsychiatric illness characterized by obsessions and/or compulsions. Its pathophysiology is still not well understood but it is known that the cortico-striatal-thalamic-cortical (CSTC) circuitry plays an important role. Here, we used a multi-method MRI approach combining proton magnetic resonance spectroscopy (H1-MRS) and diffusion tensor imaging (DTI) techniques to investigate both the metabolic and the microstructural white matter (WM) changes of the anterior cingulate cortex (ACC) in OCD patients as compared to healthy controls. Twenty-three OCD patients and 21 age-, sex-, and education-matched healthy volunteers participated in the study. Our 1H-MRS findings show increased levels of Glx in ACC in OCD. Further, significantly lower fractional anisotropy (FA) values were observed in OCD patients' left cingulate bundle (CB) as compared to healthy controls. Finally, there was a negative correlation between FA in the left CB and level of obsessions, as well as the duration of the illness. Our findings reinforce the involvement of CSTC bundles in pathophysiology of OCD, pointing to a specific role of glutamate (glutamine) and WM integrity.
C1 [de Salles Andrade, Juliana B.; Ferreira, Fernanda Meireles; Frydman, Ilana; Monteiro, Marina; Vigne, Paula; Fontenelle, Leonardo F.; Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [de Salles Andrade, Juliana B.; Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci ICB, Rio De Janeiro, Brazil.
   [Suo, Chao; Yucel, Murat; Fontenelle, Leonardo F.] Monash Univ, Turner Inst Brain & Mental Hlth, Clayton, Vic, Australia.
   [Suo, Chao; Yucel, Murat; Fontenelle, Leonardo F.] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia.
   [Frydman, Ilana; Vigne, Paula; Fontenelle, Leonardo F.] Univ Fed Rio de Janeiro, Inst Psychiat, Obsess Compuls & Anxiety Spectrum Res Program, Rio De Janeiro, Brazil.
RP Fontenelle, LF; Tovar-Moll, F (corresponding author), DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.; Tovar-Moll, F (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci ICB, Rio De Janeiro, Brazil.; Fontenelle, LF (corresponding author), Monash Univ, Turner Inst Brain & Mental Hlth, Clayton, Vic, Australia.; Fontenelle, LF (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia.; Fontenelle, LF (corresponding author), Univ Fed Rio de Janeiro, Inst Psychiat, Obsess Compuls & Anxiety Spectrum Res Program, Rio De Janeiro, Brazil.
EM lfontenelle@gmail.com; fernanda.tovarmoll@idor.org
RI Moll, Fernanda Tovar/N-3320-2018; Yucel, Murat/I-3004-2014
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Yucel,
   Murat/0000-0002-4705-452X
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [302526/2018-8]; Fundacao de Amparo a Pesquisa do Estado do Rio
   de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support
   of the State of Rio de Janeiro (FAPERJ) [CNE E-26/203.052/2017]; DOr
   Institute for Research and Education (IDOR); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)CAPES [001];
   National Health and Medical Research Council (NHMRC)National Health and
   Medical Research Council of Australia [APP1117188]; Australian Research
   Council (ARC)Australian Research Council; Department of Industry,
   Innovation and ScienceAustralian GovernmentDepartment of Industry,
   Innovation and Science; Monash UniversityMonash University; Australian
   GovernmentAustralian GovernmentCGIAR
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq; LF, grant number 302526/2018-8),
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ; LF,
   grant number CNE E-26/203.052/2017), as well as by intramural grants
   from DOr Institute for Research and Education (IDOR). This study was
   financed in part by the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior-Brasil (CAPES)-Finance Code 001. MY has received funding
   from Monash University and Australian Government funding bodies such as
   the National Health and Medical Research Council (NHMRC; including
   Fellowship #APP1117188), the Australian Research Council (ARC), and the
   Department of Industry, Innovation and Science. He has also received
   philanthropic donations from the David Winston Turner Endowment Fund, as
   well as payment from law firms in relation to court and/or expert
   witness reports. The funding sources had no role in study design, data
   analysis, and result interpretation.
CR Admon R, 2012, PSYCHIAT RES-NEUROIM, V203, P207, DOI 10.1016/j.pscychresns.2012.02.002
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Arnold PD, 2009, BRAIN IMAGING BEHAV, V3, P64, DOI 10.1007/s11682-008-9050-3
   Arun P, 2010, J INHERIT METAB DIS, V33, P195, DOI 10.1007/s10545-010-9100-z
   Bhattacharyya S, 2009, NEUROPSYCHOPHARMACOL, V34, P2489, DOI 10.1038/npp.2009.77
   Bora E, 2011, J PSYCHIATR NEUROSCI, V36, P42, DOI 10.1503/jpn.100082
   Brennan BP, 2013, BIOL PSYCHIAT, V73, P24, DOI 10.1016/j.biopsych.2012.06.023
   Carlsson ML, 2001, PROG NEURO-PSYCHOPH, V25, P5, DOI 10.1016/S0278-5846(00)00146-9
   Catheline G, 2010, NEUROBIOL AGING, V31, P1582, DOI 10.1016/j.neurobiolaging.2008.08.012
   Chakrabarty K, 2005, NEUROPSYCHOPHARMACOL, V30, P1735, DOI 10.1038/sj.npp.1300733
   Chakraborty G, 2001, J NEUROCHEM, V78, P736, DOI 10.1046/j.1471-4159.2001.00456.x
   Chamberlain SR, 2005, NEUROSCI BIOBEHAV R, V29, P399, DOI 10.1016/j.neubiorev.2004.11.006
   Chiappelli J, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.43
   Cunha J. A., 2001, MANUAL VERSAO PORTUG
   Del-Ben Cristina Marta, 2001, Revista Brasileira de Psiquiatria, V23, P156, DOI 10.1590/S1516-44462001000300008
   Fineberg NA, 2006, INT CLIN PSYCHOPHARM, V21, P337, DOI 10.1097/01.yic.0000215083.57801.11
   Fontenelle LF, 2011, CNS SPECTRUMS, V16, P101, DOI 10.1017/S1092852912000260
   Garibotto V, 2010, NEUROBIOL DIS, V37, P468, DOI 10.1016/j.nbd.2009.11.003
   Gnanavel S, 2014, MAGN RESON MATER PHY, V27, P407, DOI 10.1007/s10334-013-0427-y
   GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006
   Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.3.CO;2-M
   Grados MA, 2013, EXPERT OPIN DRUG DIS, V8, P1515, DOI 10.1517/17460441.2013.845553
   Ha TH, 2009, NEUROREPORT, V20, P735, DOI 10.1097/WNR.0b013e32832ad3da
   Jansen JFA, 2006, RADIOLOGY, V240, P318, DOI 10.1148/radiol.2402050314
   Jayarajan RN, 2012, DEPRESS ANXIETY, V29, P780, DOI 10.1002/da.21890
   Koch K, 2014, J PSYCHIATR RES, V54, P26, DOI 10.1016/j.jpsychires.2014.03.006
   Kohlrausch FB, 2016, PSYCHIAT RES, V243, P152, DOI 10.1016/j.psychres.2016.06.027
   Lazaro L, 2014, DEPRESS ANXIETY, V31, P1007, DOI 10.1002/da.22330
   Lochner C, 2012, J PSYCHIATR NEUROSCI, V37, P193, DOI 10.1503/jpn.110059
   Luykx JJ, 2012, NEUROSCI BIOBEHAV R, V36, P198, DOI 10.1016/j.neubiorev.2011.05.014
   Madhavarao CN, 2005, P NATL ACAD SCI USA, V102, P5221, DOI 10.1073/pnas.0409184102
   Marinova Z, 2017, CURR NEUROPHARMACOL, V15, P977, DOI 10.2174/1570159X15666170320104237
   McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291
   Meyer JH, 2004, AM J PSYCHIAT, V161, P826, DOI 10.1176/appi.ajp.161.5.826
   Modarresi A, 2018, PHARMACOPSYCHIATRY, V51, P263, DOI 10.1055/s-0043-120268
   Nakamae T, 2011, J PSYCHIATR RES, V45, P687, DOI 10.1016/j.jpsychires.2010.09.016
   Ongur D, 2009, PSYCHIAT RES-NEUROIM, V172, P44, DOI 10.1016/j.pscychresns.2008.06.002
   Ortiz AE, 2015, EUR NEUROPSYCHOPHARM, V25, P60, DOI 10.1016/j.euroneuro.2014.11.007
   Paiva Fernando Fernandes, 2013, Dement. neuropsychol., V7, P216, DOI 10.1590/S1980-57642013DN70200013
   Piras F, 2013, NEUROSCI BIOBEHAV R, V37, P2856, DOI 10.1016/j.neubiorev.2013.10.008
   Pittenger Christopher, 2006, NeuroRx, V3, P69, DOI 10.1016/j.nurx.2005.12.006
   Pittenger C, 2011, PHARMACOL THERAPEUT, V132, P314, DOI 10.1016/j.pharmthera.2011.09.006
   PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604
   Radua J, 2014, NEUROPSYCHOPHARMACOL, V39, P1547, DOI 10.1038/npp.2014.5
   Ramadan S, 2013, NMR BIOMED, V26, P1630, DOI 10.1002/nbm.3045
   Rauch SL, 2003, NEUROSURG CLIN N AM, V14, P213, DOI 10.1016/S1042-3680(02)00114-6
   Reid MA, 2016, SCHIZOPHR RES, V170, P341, DOI 10.1016/j.schres.2015.12.003
   Rodriguez CI, 2013, NEUROPSYCHOPHARMACOL, V38, P2475, DOI 10.1038/npp.2013.150
   Rosenberg DR, 2000, J AM ACAD CHILD PSY, V39, P1096, DOI 10.1097/00004583-200009000-00008
   Rowland LM, 2009, NEUROPSYCHOPHARMACOL, V34, P1514, DOI 10.1038/npp.2008.207
   Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284
   Samuels J, 2011, AM J MED GENET B, V156B, P472, DOI 10.1002/ajmg.b.31184
   Saxena S, 2001, Semin Clin Neuropsychiatry, V6, P82, DOI 10.1053/scnp.2001.21833
   Shepherd Gordon M., 2004, SYNAPTIC ORG BRAIN
   Sheshachala K, 2019, INDIAN J PSYCHIAT, V61, pS58, DOI 10.4103/psychiatry.IndianJPsychiatry_520_18
   Shugart YY, 2009, AM J MED GENET B, V150B, P886, DOI 10.1002/ajmg.b.30914
   Silk T, 2013, PSYCHIAT RES-NEUROIM, V213, P154, DOI 10.1016/j.pscychresns.2013.04.003
   Simonyan K, 2008, BRAIN, V131, P447, DOI 10.1093/brain/awm303
   Simpson HB, 2013, JAMA PSYCHIAT, V70, P1190, DOI 10.1001/jamapsychiatry.2013.1932
   Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062
   Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024
   Sookman D, 2015, PSYCHIAT RES, V227, P74, DOI 10.1016/j.psychres.2014.12.002
   Steel RM, 2001, PSYCHIAT RES-NEUROIM, V106, P161, DOI 10.1016/S0925-4927(01)00080-4
   Sun ZG, 2003, NEUROREPORT, V14, P1833, DOI 10.1097/00001756-200310060-00015
   Szeszko PR, 2005, ARCH GEN PSYCHIAT, V62, P782, DOI 10.1001/archpsyc.62.7.782
   Tang CY, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-25
   Thomason ME, 2011, ANNU REV CLIN PSYCHO, V7, P63, DOI 10.1146/annurev-clinpsy-032210-104507
   Ting Jonathan T, 2008, Curr Chem Genomics, V2, P62
   Wang JF, 2009, NEUROCHEM RES, V34, P138, DOI 10.1007/s11064-008-9726-5
   Wang R, 2017, P ANN INT IEEE EMBS, P3521, DOI 10.1109/EMBC.2017.8037616
   Wang RL, 2018, PSYCHIAT RES-NEUROIM, V277, P39, DOI 10.1016/j.pscychresns.2018.05.004
   Whiteside SP, 2006, PSYCHIAT RES-NEUROIM, V146, P137, DOI 10.1016/j.pscychresns.2005.12.006
   Wijtenburg SA, 2013, NEUROIMAGE, V66, P161, DOI 10.1016/j.neuroimage.2012.10.014
   Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607
   Yucel M, 2008, AUST NZ J PSYCHIAT, V42, P467, DOI 10.1080/00048670802050546
NR 75
TC 4
Z9 4
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1662-5161
J9 FRONT HUM NEUROSCI
JI Front. Hum. Neurosci.
PD JUN 26
PY 2019
VL 13
AR 186
DI 10.3389/fnhum.2019.00186
PG 10
WC Neurosciences; Psychology
SC Neurosciences & Neurology; Psychology
GA IF6CE
UT WOS:000473167900001
PM 31333428
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Vieira, TM
   Lemos, T
   Oliveira, LAS
   Horsczaruk, CHR
   Freitas, GR
   Tovar-Moll, F
   Rodrigues, EC
AF Vieira, Taian M.
   Lemos, Thiago
   Oliveira, Laura A. S.
   Horsczaruk, Carlos H. R.
   Freitas, Gabriel R.
   Tovar-Moll, Fernanda
   Rodrigues, Erika C.
TI Postural Muscle Unit Plasticity in Stroke Survivors: Altered
   Distribution of Gastrocnemius' Action Potentials
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE motor unit; electromyogram; stroke; gastrocnemius; standing
ID MOTOR UNITS; EMG; PERFORMANCE; ATROPHY
AB Neuromuscular adaptations are well-reported in stroke survivors. The death of motor neurons and the reinnervation of residual muscle fibers by surviving motor neurons, for example, seem to explain the increased density of muscle units after stroke. It is, however, unknown whether reinnervation takes place locally or extensively within the muscle. Here we combine intramuscular and surface electromyograms (EMGs) to address this issue for medial gastrocnemius (MG); a key postural muscle. While seven stroke survivors stood upright, two intramuscular and 15 surface EMGs were recorded from the paretic and non-paretic gastrocnemius. Surface EMGs were triggered with the firing instants of motor units identified through the decomposition of both intramuscular and surface EMGs. The standard deviation of Gaussian curves fitting the root mean square amplitude distribution of surface potentials was considered to assess differences in the spatial distribution of motor unit action potentials and, thus, in the distribution of muscle units between limbs. The median number of motor units identified per subject in the paretic and non-paretic sides was, respectively, 2 (range: 1-3) and 3 (1-4). Action potentials in the paretic gastrocnemius were represented at a 33% wider skin region when compared to the non-paretic muscle (Mann-Whitney; P = 0.014). Side differences in the representation of motor unit were not associated with differences in subcutaneous thickness (skipped-Spearman r = -0.53; confidence interval for r: -1.00 to 0.63). Current results suggest stroke may lead to the enlargement of the gastrocnemius muscle units recruited during standing. The enlargement of muscle units, as assessed from the skin surface, may constitute a new marker of neuromuscular plasticity following stroke.
C1 [Vieira, Taian M.] Politecn Torino, Dipartimento Elettron & Telecomunicaz, Lab Ingn Sistema Neuromuscolare LISiN, Turin, Italy.
   [Vieira, Taian M.] Politecn Torino, PoliToBIO Med Lab, Turin, Italy.
   [Lemos, Thiago; Oliveira, Laura A. S.; Horsczaruk, Carlos H. R.; Rodrigues, Erika C.] Ctr Univ Augusto Motta UNISUAM, Programa Posgrad Ciencias Reabilitacao, Rio De Janeiro, Brazil.
   [Oliveira, Laura A. S.] Inst Fed Educ Ciencia & Tecnol IFRJ, Grad Fisioterapia, Rio De Janeiro, Brazil.
   [Freitas, Gabriel R.; Tovar-Moll, Fernanda; Rodrigues, Erika C.] Inst Or Pesquisa & Ensino IDOR, Unidade Conectividade Cerebral, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Posgrad Ciencias Mofol, Rio de Janeiro, Brazil.
RP Rodrigues, EC (corresponding author), Ctr Univ Augusto Motta UNISUAM, Programa Posgrad Ciencias Reabilitacao, Rio De Janeiro, Brazil.; Rodrigues, EC (corresponding author), Inst Or Pesquisa & Ensino IDOR, Unidade Conectividade Cerebral, Rio De Janeiro, Brazil.
EM erikacrodrigues@gmail.com
RI Vieira, Taian M/A-3818-2013; de Carvalho Rodrigues, Erika/AAE-9445-2020;
   Moll, Fernanda Tovar/N-3320-2018; Lemos, Thiago/Q-9518-2017
OI Vieira, Taian M/0000-0002-6239-7301; de Carvalho Rodrigues,
   Erika/0000-0001-5464-2963; Moll, Fernanda Tovar/0000-0002-0292-5985;
   Lemos, Thiago/0000-0002-6657-5689
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES [001]; D'Or
   Institute for Research and Education (IDOR); Italian Bank Foundation,
   Compagnia di San Paolo; CAPESCAPES
FX This study was partially supported by Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, finance code
   001), intramural grants from the D'Or Institute for Research and
   Education (IDOR), and the Italian Bank Foundation, Compagnia di San
   Paolo. CH was recipient of a CAPES fellowship. The funding agencies had
   no role in study design, data collection, and analysis, decision to
   publish, or preparation of the manuscript.
CR Adamson Joy, 2004, J Stroke Cerebrovasc Dis, V13, P171, DOI 10.1016/j.jstrokecerebrovasdis.2004.06.003
   Arasaki K, 2006, J NEUROL SCI, V250, P27, DOI 10.1016/j.jns.2006.06.024
   BENECKE R, 1983, J NEUROL, V230, P143, DOI 10.1007/BF00313625
   BOHANNON RW, 1992, ARCH PHYS MED REHAB, V73, P721
   BURKE RE, 1973, J PHYSIOL-LONDON, V234, P749, DOI 10.1113/jphysiol.1973.sp010370
   Fimland MS, 2011, EUR J APPL PHYSIOL, V111, P3041, DOI 10.1007/s00421-011-1934-z
   Garland SJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00864
   Genthon N, 2008, STROKE, V39, P489, DOI 10.1161/STROKEAHA.107.493478
   Geurts ACH, 2005, GAIT POSTURE, V22, P267, DOI 10.1016/j.gaitpost.2004.10.002
   Heroux ME, 2015, J PHYSIOL-LONDON, V593, P3711, DOI 10.1113/JP270307
   Hodson-Tole EF, 2013, J ELECTROMYOGR KINES, V23, P43, DOI 10.1016/j.jelekin.2012.08.003
   Holobar A, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/1/016008
   Holobar A, 2007, IEEE T SIGNAL PROCES, V55, P4487, DOI 10.1109/TSP.2007.896108
   Holobar A, 2010, IEEE T NEUR SYS REH, V18, P221, DOI 10.1109/TNSRE.2010.2041593
   Lee SSM, 2008, J BIOMECH, V41, P3366, DOI 10.1016/j.jbiomech.2008.09.029
   Lukacs M, 2005, CLIN NEUROPHYSIOL, V116, P1566, DOI 10.1016/j.clinph.2005.04.005
   Lukacs M, 2008, CLIN NEUROPHYSIOL, V119, P2555, DOI 10.1016/j.clinph.2008.08.005
   Lukacs M, 2009, MUSCLE NERVE, V40, P112, DOI 10.1002/mus.21241
   Marigold DS, 2006, EXP BRAIN RES, V171, P459, DOI 10.1007/s00221-005-0293-6
   MARTINEZ AC, 1982, J NEUROL NEUROSUR PS, V45, P756, DOI 10.1136/jnnp.45.8.756
   MCCOMAS AJ, 1973, J NEUROL NEUROSUR PS, V36, P183, DOI 10.1136/jnnp.36.2.183
   McGill KC, 2005, J NEUROSCI METH, V149, P121, DOI 10.1016/j.jneumeth.2005.05.015
   McNulty PA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00518
   Merletti R, 1999, IEEE T BIO-MED ENG, V46, P810, DOI 10.1109/10.771190
   Mesin L, 2011, J BIOMECH, V44, P1096, DOI 10.1016/j.jbiomech.2011.01.031
   Pernet CR, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00606
   Pollock CL, 2015, CLIN NEUROPHYSIOL, V126, P1951, DOI 10.1016/j.clinph.2014.12.015
   Rafuse VF, 1996, J NEUROPHYSIOL, V75, P282
   Roerdink M, 2009, NEUROREHAB NEURAL RE, V23, P267, DOI 10.1177/1545968308323928
   Ryan AS, 2011, NEUROREHAB NEURAL RE, V25, P865, DOI 10.1177/1545968311408920
   SCELSI R, 1982, ACTA NEUROPATHOL, V57, P243, DOI 10.1007/BF00692178
   SEGURA RP, 1981, MUSCLE NERVE, V4, P246, DOI 10.1002/mus.880040312
   STALBERG E, 1991, ELECTROEN CLIN NEURO, V81, P403, DOI 10.1016/0168-5597(91)90048-3
   Tasseel-Ponche S, 2015, NEUROPHYSIOL CLIN, V45, P327, DOI 10.1016/j.neucli.2015.09.003
   VANLEEUWEN JL, 1993, PHILOS T ROY SOC B, V342, P321, DOI 10.1098/rstb.1993.0162
   Vieira TM, 2016, J PHYSIOL-LONDON, V594, P1953, DOI 10.1113/JP271866
   Vieira TMM, 2013, HUM MOVEMENT SCI, V32, P753, DOI 10.1016/j.humov.2013.03.003
   Vieira TMM, 2011, J PHYSIOL-LONDON, V589, P431, DOI 10.1113/jphysiol.2010.201806
   Vieira TMM, 2010, J BIOMECH, V43, P2149, DOI 10.1016/j.jbiomech.2010.03.049
   Vieira TM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13369-1
NR 40
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD JUN 26
PY 2019
VL 10
AR 686
DI 10.3389/fneur.2019.00686
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA IF5IR
UT WOS:000473115000001
PM 31297085
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Bahia, CP
   Vianna-Barbosa, RJ
   Tovar-Moll, F
   Lent, R
AF Bahia, Carlomagno Pacheco
   Vianna-Barbosa, Rodrigo Jorge
   Tovar-Moll, Fernanda
   Lent, Roberto
TI Terminal Arbors of Callosal Axons Undergo Plastic Changes in
   Early-Amputated Rats
SO CEREBRAL CORTEX
LA English
DT Article
DE 3D axon reconstruction; amputation; corpus callosum; morphological
   plasticity; somatosensory cortex
ID PRIMARY SOMATOSENSORY CORTEX; PRIMARY VISUAL AREAS; CORPUS-CALLOSUM;
   SYNAPTIC PLASTICITY; CYTOCHROME-OXIDASE; BARREL CORTEX; LAYER-IV;
   INTERHEMISPHERIC CONNECTIONS; FUNCTIONAL-ORGANIZATION; STRUCTURAL
   ORGANIZATION
AB Sensory information is processed in specific brain regions, and shared between the cerebral hemispheres by axons that cross the midline through the corpus callosum. However, sensory deprivation usually causes sensory losses and/or functional changes. This is the case of people who suffered limb amputation and show changes of body map organization within the somatosensory cortex (S1) of the deafferented cerebral hemisphere (contralateral to the amputated limb), as well as in the afferented hemisphere (ipsilateral to the amputated limb). Although several studies have approached these functional changes, the possible finer morphological alterations, such as those occurring in callosal axons, still remain unknown. The present work combined histochemistry, single-axon tracing and 3D microscopy to analyze the fine morphological changes that occur in callosal axons of the forepaw representation in early amputated rats. We showed that the forepaw representation in S1 was reduced in the deafferented hemisphere and expanded in the afferented side. Accordingly, after amputation, callosal axons originating from the deafferented cortex undergo an expansion of their terminal arbors with increased number of terminal boutons within the homotopic representation at the afferented cerebral hemisphere. Similar microscale structural changes may underpin the macroscale morphological and functional phenomena that characterize limb amputation in humans.
C1 [Bahia, Carlomagno Pacheco; Vianna-Barbosa, Rodrigo Jorge; Tovar-Moll, Fernanda; Lent, Roberto] Univ Fed Rio de Janeiro, Inst Biomed Sci, Av Carlos Chagas 373,Bl F,1st Floor,Rm 31, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Bahia, Carlomagno Pacheco] Fed Univ Para, Inst Hlth Sci, BR-66075110 Belem, Para, Brazil.
   [Tovar-Moll, Fernanda] DOr Inst Res & Educ, BR-22281100 Rio De Janeiro, RJ, Brazil.
RP Lent, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Av Carlos Chagas 373,Bl F,1st Floor,Rm 31, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM rlent@icb.ufrj.br
RI Moll, Fernanda Tovar/N-3320-2018
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Bahia,
   Carlomagno/0000-0003-3794-4710
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [470734/2012-4]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [150959/2014-1, 447835/2014-9];
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [010.002983/2014]; Instituto Nacional de Neurociencia
   Translacional (INNT) [465346/2014-6]
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Grant 470734/2012-4 to R.L.; CNPq, Grant 150959/2014-1 and 447835/2014-9
   to C.P.B.); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ, Grant 010.002983/2014 to R.L.); and Instituto Nacional de
   Neurociencia Translacional (INNT, Grant 465346/2014-6 to R.L.)
CR Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453
   ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C
   ABOITIZ F, 1992, BRAIN RES, V598, P154, DOI 10.1016/0006-8993(92)90179-D
   AggounZouaoui D, 1996, EUR J NEUROSCI, V8, P1132, DOI 10.1111/j.1460-9568.1996.tb01281.x
   Aguiar P, 2013, NEUROINFORMATICS, V11, P393, DOI 10.1007/s12021-013-9188-z
   AKERS RM, 1979, BRAIN RES, V161, P527, DOI 10.1016/0006-8993(79)90682-6
   Akers RM, 1978, J COMP NEUROL, V181, P513, DOI 10.1002/cne.901810305
   Alloway KD, 2008, CEREB CORTEX, V18, P979, DOI 10.1093/cercor/bhm138
   Anderson JC, 2002, J NEUROCYTOL, V31, P211, DOI 10.1023/A:1024113707630
   Anderson JC, 2001, NAT NEUROSCI, V4, P1166, DOI 10.1038/nn772
   Arnold PB, 2001, EXP BRAIN RES, V136, P152, DOI 10.1007/s002210000570
   Barrera K, 2013, DEV NEUROBIOL, V73, P297, DOI 10.1002/dneu.22060
   Beck PD, 1996, J COMP NEUROL, V366, P109
   BERBEL P, 1988, J COMP NEUROL, V276, P132, DOI 10.1002/cne.902760109
   Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552
   BERLUCCHI G, 1972, BRAIN RES, V37, P371, DOI 10.1016/0006-8993(72)90708-1
   Berlucchi G, 2003, PROG BRAIN RES, V144, P79, DOI 10.1016/S0079-6123(03)14400-5
   Berlucchi G, 1999, BRAIN RES BULL, V50, P389, DOI 10.1016/S0361-9230(99)00118-5
   Berlucchi G, 2012, CORTEX, V48, P36, DOI 10.1016/j.cortex.2011.04.008
   Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y
   Bowlus TH, 2003, J COMP NEUROL, V465, P335, DOI 10.1002/cne.10849
   Bozhko G T, 1988, Neurosci Behav Physiol, V18, P323, DOI 10.1007/BF01185526
   Broser P, 2008, CEREB CORTEX, V18, P1588, DOI 10.1093/cercor/bhm189
   Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149
   CAMINITI R, 1979, EXP BRAIN RES, V35, P295
   Catania KC, 2005, CURR BIOL, V15, pR863, DOI 10.1016/j.cub.2005.10.030
   CATANIA KC, 1995, NATURE, V375, P453
   Catania KC, 2006, CURR OPIN NEUROBIOL, V16, P467, DOI 10.1016/j.conb.2006.06.010
   CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0
   Chen LM, 2012, J NEUROSCI, V32, P14649, DOI 10.1523/JNEUROSCI.1841-12.2012
   Chovsepian A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00036
   CONTI F, 1986, SOMATOSENS MOT RES, V3, P273, DOI 10.3109/07367228609144588
   COOGAN TA, 1993, J NEUROSCI, V13, P3749
   DAWSON DR, 1987, J COMP NEUROL, V256, P246, DOI 10.1002/cne.902560205
   De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017
   Doron KW, 2008, CORTEX, V44, P1023, DOI 10.1016/j.cortex.2008.03.007
   Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152
   Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024
   FABRI M, 1991, BRAIN RES, V538, P351, DOI 10.1016/0006-8993(91)90455-5
   Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U
   Fenlon LR, 2015, TRENDS NEUROSCI, V38, P264, DOI 10.1016/j.tins.2015.02.007
   Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007
   Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011
   Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1
   Gogolla N, 2007, CURR OPIN NEUROBIOL, V17, P516, DOI 10.1016/j.conb.2007.09.002
   Hamzei F, 2001, NEUROREPORT, V12, P957, DOI 10.1097/00001756-200104170-00019
   Hayama T, 1997, BRAIN RES BULL, V43, P341, DOI 10.1016/S0361-9230(97)00018-X
   Houzel JC, 2002, BRAZ J MED BIOL RES, V35, P1441, DOI 10.1590/S0100-879X2002001200005
   Hua XY, 2012, BRAIN RES, V1471, P93, DOI 10.1016/j.brainres.2012.06.016
   Inan M, 2007, NEUROSCIENTIST, V13, P49, DOI 10.1177/1073858406296257
   Innocenti GM, 2009, EXP BRAIN RES, V192, P417, DOI 10.1007/s00221-008-1484-8
   INNOCENTI GM, 1977, NEUROSCI LETT, V4, P237, DOI 10.1016/0304-3940(77)90185-9
   INNOCENTI GM, 1995, NEUROPSYCHOLOGIA, V33, P961, DOI 10.1016/0028-3932(95)00033-Y
   IVY GO, 1979, BRAIN RES, V173, P532, DOI 10.1016/0006-8993(79)90247-6
   Iwamura Y, 2002, BEHAV BRAIN RES, V135, P185, DOI 10.1016/S0166-4328(02)00164-X
   Iwamura Y, 2001, NEUROSCIENTIST, V7, P419, DOI 10.1177/107385840100700511
   JONES EG, 1968, J ANAT, V103, P433
   KAAS JH, 1983, ANNU REV NEUROSCI, V6, P325, DOI 10.1146/annurev.ne.06.030183.001545
   KAAS JH, 1983, PHYSIOL REV, V63, P206
   Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001
   Karol E A, 1970, Trans Am Neurol Assoc, V95, P269
   KORALEK KA, 1990, J COMP NEUROL, V299, P133, DOI 10.1002/cne.902990202
   KRUBITZER LA, 1992, J COMP NEUROL, V317, P1, DOI 10.1002/cne.903170102
   KRUBITZER LA, 1986, J COMP NEUROL, V250, P403, DOI 10.1002/cne.902500402
   Krupa DJ, 2004, SCIENCE, V304, P1989, DOI 10.1126/science.1093318
   LAMANTIA AS, 1990, J NEUROSCI, V10, P2156
   LAND PW, 1985, J COMP NEUROL, V238, P225, DOI 10.1002/cne.902380209
   LANE RD, 1995, P NATL ACAD SCI USA, V92, P4264, DOI 10.1073/pnas.92.10.4264
   Lee HK, 2015, CURR OPIN NEUROBIOL, V35, P119, DOI 10.1016/j.conb.2015.08.002
   Lent R, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00208
   Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051
   Luhmann HJ, 2018, NEUROSCIENCE, V368, P256, DOI 10.1016/j.neuroscience.2017.05.025
   Maffei A, 2008, PROG BRAIN RES, V169, P211, DOI 10.1016/S0079-6123(07)00012-X
   Makarov VA, 2008, CEREB CORTEX, V18, P1951, DOI 10.1093/cercor/bhm222
   Maldjian JA, 1999, NEUROIMAGE, V10, P55, DOI 10.1006/nimg.1999.0448
   Maldjian JA, 2014, NEUROIMAGE, V96, P88, DOI 10.1016/j.neuroimage.2014.03.065
   MANZONI T, 1986, J COMP NEUROL, V252, P245, DOI 10.1002/cne.902520208
   MCCANDLISH C, 1989, EXP BRAIN RES, V77, P425, DOI 10.1007/BF00275001
   McCandlish CA, 1996, EXP BRAIN RES, V108, P417
   MCGUIRE BA, 1984, J NEUROSCI, V4, P2920
   Mizuno H, 2007, J NEUROSCI, V27, P6760, DOI 10.1523/JNEUROSCI.1215-07.2007
   Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317
   Oberlaender M, 2011, P NATL ACAD SCI USA, V108, P4188, DOI 10.1073/pnas.1100647108
   PANDYA DN, 1971, BRAIN RES, V32, P31, DOI 10.1016/0006-8993(71)90153-3
   PANDYA DN, 1993, EXP NEUROL, V119, P220, DOI 10.1006/exnr.1993.1024
   PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7
   Paxinos G., 2007, RAT BRAIN STEREOTAXI
   Payne BR, 1996, TRENDS NEUROSCI, V19, P535, DOI 10.1016/S0166-2236(96)10061-8
   Pelled G, 2007, NEUROIMAGE, V37, P262, DOI 10.1016/j.neuroimage.2007.03.069
   Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017
   RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506
   RAMACHANDRAN VS, 1992, SCIENCE, V258, P1159, DOI 10.1126/science.1439826
   Rocha EG, 2007, J COMP NEUROL, V500, P255, DOI 10.1002/cne.21167
   Seelke AMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032322
   SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1
   Simoes EL, 2012, J NEUROSCI, V32, P3211, DOI 10.1523/JNEUROSCI.4592-11.2012
   Singer W, 2013, TRENDS COGN SCI, V17, P616, DOI 10.1016/j.tics.2013.09.006
   Skibinska A, 2000, EXP BRAIN RES, V132, P134, DOI 10.1007/s002210000341
   Staudt M, 2004, ANN NEUROL, V56, P854, DOI 10.1002/ana.20297
   Suarez R, 2014, NEURON, V82, P1289, DOI 10.1016/j.neuron.2014.04.040
   van der Knaap LJ, 2011, BEHAV BRAIN RES, V223, P211, DOI 10.1016/j.bbr.2011.04.018
   Vianna-Barbosa RJ, 2017, BRAINS C FENS COP DE
   Wallace H, 1999, SOMATOSENS MOT RES, V16, P122
   WATERS RS, 1990, EXP BRAIN RES, V81, P234
   WELKER E, 1986, J NEUROSCI, V6, P3355
   WHITE EL, 1978, J COMP NEUROL, V181, P627, DOI 10.1002/cne.901810310
   Williams L, 2016, CLIN NEUROPHYSIOL, V127, P3128, DOI 10.1016/j.clinph.2016.07.004
   WISE SP, 1976, J COMP NEUROL, V168, P313, DOI 10.1002/cne.901680302
   WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3
   WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333
   WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X
   Woolsey TA, 2016, BRAIN RES, V1645, P22, DOI 10.1016/j.brainres.2016.04.029
   Xerri C, 2012, NEUROSCIENTIST, V18, P133, DOI 10.1177/1073858410397894
   Yu XJ, 2014, BRAIN RES, V1546, P9, DOI 10.1016/j.brainres.2013.12.025
NR 114
TC 1
Z9 1
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1047-3211
EI 1460-2199
J9 CEREB CORTEX
JI Cereb. Cortex
PD APR
PY 2019
VL 29
IS 4
BP 1460
EP 1472
DI 10.1093/cercor/bhy043
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA IS5GP
UT WOS:000482180900006
PM 30873555
DA 2020-12-17
ER

PT J
AU Goto-Silva, L
   Ayad, NME
   Herzog, IL
   Silva, NP
   Lamien, B
   Orlande, HRB
   Souza, AD
   Ribeiro, S
   Martins, M
   Domont, GB
   Junqueira, M
   Tovar-Moll, F
   Rehen, SK
AF Goto-Silva, Livia
   Ayad, Nadia M. E.
   Herzog, Iasmin L.
   Silva, Nilton P.
   Lamien, Bernard
   Orlande, Helcio R. B.
   Souza, Annie da Costa
   Ribeiro, Sidarta
   Martins, Michele
   Domont, Gilberto B.
   Junqueira, Magno
   Tovar-Moll, Fernanda
   Rehen, Stevens K.
TI Computational fluid dynamic analysis of physical forces playing a role
   in brain organoid cultures in two different multiplex platforms
SO BMC DEVELOPMENTAL BIOLOGY
LA English
DT Article
ID PLURIPOTENT STEM-CELLS; SUSPENSION-CULTURE; CEREBRAL ORGANOIDS
AB BackgroundOrganoid cultivation in suspension culture requires agitation at low shear stress to allow for nutrient diffusion, which preserves tissue structure. Multiplex systems for organoid cultivation have been proposed, but whether they meet similar shear stress parameters as the regularly used spinner flask and its correlation with the successful generation of brain organoids has not been determined.ResultsHere we used computational fluid dynamics (CFD) to simulate two multiplex culture conditions: steering plates on an orbital shaker and the use of a previously described bioreactor. The bioreactor had low speed and high shear stress regions that may affect cell aggregate growth, depending on volume, whereas the computed variables of the steering plates were closer to those of the spinning flask.ConclusionOur protocol improves the initial steps of the standard brain organoid formation, and the produced organoids displayed regionalized brain structures, including retinal pigmented cells. Overall, we conclude that suspension culture on orbital steering plates is a cost-effective practical alternative to previously described platforms for the cultivation of brain organoids for research and multiplex testing.
C1 [Goto-Silva, Livia; Ayad, Nadia M. E.; Tovar-Moll, Fernanda; Rehen, Stevens K.] DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
   [Herzog, Iasmin L.; Silva, Nilton P.; Lamien, Bernard; Orlande, Helcio R. B.] Univ Fed Rio de Janeiro, UFRJ, Politecn COPPE, Dept Mech Engn, Av Horacio Macedo 2030, BR-21941914 Rio De Janeiro, RJ, Brazil.
   [Souza, Annie da Costa; Ribeiro, Sidarta] Univ Fed Rio Grande do Norte, Brain Inst, Av Nascimento Castro, BR-59072970 Natal, RN, Brazil.
   [Martins, Michele; Domont, Gilberto B.; Junqueira, Magno] Univ Fed Rio de Janeiro, Inst Chem, Prote Unit, UFRJ, Av Athos da Silveira Ramos 149, BR-21941909 Rio De Janeiro, RJ, Brazil.
   [Tovar-Moll, Fernanda; Rehen, Stevens K.] Univ Fed Rio de Janeiro, Inst Biomed Sci, UFRJ, Av Carlos Chagas Filho 373,Bloco K, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Rehen, SK (corresponding author), DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.; Rehen, SK (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, UFRJ, Av Carlos Chagas Filho 373,Bloco K, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM srehen@lance-ufrj.org
RI Moll, Fernanda Tovar/N-3320-2018; ORLANDE, HELCIO/AAH-2361-2020; Rehen,
   Stevens K/J-5874-2012; Junqueira, Magno/A-7495-2012; ORLANDE, HELCIO R
   B/AAS-5889-2020
OI Moll, Fernanda Tovar/0000-0002-0292-5985; ORLANDE,
   HELCIO/0000-0002-3511-322X; Rehen, Stevens K/0000-0003-4216-9501;
   Junqueira, Magno/0000-0002-7036-0728; ORLANDE, HELCIO R
   B/0000-0002-3511-322X; Ayad, Nadia/0000-0002-4684-1943
FU Conselho Nacional de Pesquisa (CNPq)National Council for Scientific and
   Technological Development (CNPq); Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)CAPES; Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Banco Nacional de Desenvolvimento Economico e Social (BNDES);
   Financiadora de Estudos e Projetos (Finep)Ciencia Tecnologia e Inovacao
   (FINEP); D'Or Institute for Research and Education (IDOR)
FX This work was supported by the Conselho Nacional de Pesquisa (CNPq),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ), Banco Nacional de Desenvolvimento Economico e Social
   (BNDES), Financiadora de Estudos e Projetos (Finep) and intramural
   grants from D'Or Institute for Research and Education (IDOR).
CR Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Dakic V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12779-5
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Fridley KM, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt136
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hookway TA, 2016, METHODS, V101, P11, DOI 10.1016/j.ymeth.2015.11.027
   Horiguchi A, 2014, J BIOSCI BIOENG, V118, P588, DOI 10.1016/j.jbiosc.2014.04.008
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Lancaster MA, 2017, NAT BIOTECHNOL, V35, P659, DOI 10.1038/nbt.3906
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Monzel AS, 2017, STEM CELL REP, V8, P1144, DOI 10.1016/j.stemcr.2017.03.010
   Murillo Jimmy Rodriguez, 2017, EuPA Open Proteom, V16, P1, DOI 10.1016/j.euprot.2017.06.001
   Nampe D, 2017, CULTURE, V9999, P1
   Nampe D, 2017, BIOTECHNOL BIOENG, V114, P2109, DOI 10.1002/bit.26334
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047
   Salek MM, 2012, ANN BIOMED ENG, V40, P707, DOI 10.1007/s10439-011-0444-9
   Sartore RC, 2017, PEERJ, V5, DOI 10.7717/peerj.2927
   Wang Y, 2013, STEM CELL RES, V11, P1103, DOI 10.1016/j.scr.2013.07.011
NR 23
TC 0
Z9 0
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-213X
J9 BMC DEV BIOL
JI BMC Dev. Biol.
PD MAR 7
PY 2019
VL 19
AR 3
DI 10.1186/s12861-019-0183-y
PG 10
WC Developmental Biology
SC Developmental Biology
GA HO2LM
UT WOS:000460746600001
PM 30841924
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Bramati, IE
   Rodrigues, EC
   Simoes, EL
   Melo, B
   Hofle, S
   Moll, J
   Lent, R
   Tovar-Moll, F
AF Bramati, Ivanei E.
   Rodrigues, Erika C.
   Simoes, Elington L.
   Melo, Bruno
   Hofle, Sebastian
   Moll, Jorge
   Lent, Roberto
   Tovar-Moll, Fernanda
TI Lower limb amputees undergo long-distance plasticity in sensorimotor
   functional connectivity
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HUMAN CEREBRAL-CORTEX; CORTICAL REORGANIZATION; MOTOR CORTEX;
   SOMATOSENSORY CORTEX; CORPUS-CALLOSUM; HUMAN BRAIN; IN-VIVO; PHANTOM;
   NETWORKS; NEURONS
AB Amputation in adults is associated with an extensive remapping of cortical topography in primary and secondary sensorimotor areas. Here, we used tactile residual limb stimulation and 3T functional magnetic resonance imaging in humans to investigate functional connectivity changes in the sensorimotor network of patients with long-term lower limb traumatic amputations with phantom sensation, but without pain. We found a pronounced reduction of inter-hemispheric functional connectivity between homologous sensorimotor cortical regions in amputees, including the primary (S1) and secondary (S2) somatosensory areas, and primary (M1) and secondary (M2) motor areas. We additionally observed an intra-hemispheric increased functional connectivity between primary and secondary somatosensory regions, and between the primary and premotor areas, contralateral to amputation. These functional connectivity changes in specialized small-scale sensory-motor networks improve our understanding of the functional impact of lower limb amputation in the brain. Our findings in a selective group of patients with phantom limb sensations, but without pain suggest that disinhibition of neural inputs following traumatic limb amputation disrupts sensorimotor topology, unbalancing functional brain network organization. These findings step up the description of brain plasticity related with phantom sensations by showing that pain is not critical for sensorimotor network changes after peripheral injury.
C1 [Bramati, Ivanei E.; Rodrigues, Erika C.; Melo, Bruno; Hofle, Sebastian; Moll, Jorge; Lent, Roberto; Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, BR-22281100 Rio De Janeiro, Brazil.
   [Bramati, Ivanei E.; Lent, Roberto; Tovar-Moll, Fernanda] Fed Univ Rio de Janeiro UFRJ, Inst Biomed Sci, BR-21941902 Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Fed Univ Rio de Janeiro UFRJ, Natl Ctr Struct Biol & Bioimaging, BR-21941902 Rio De Janeiro, Brazil.
   [Rodrigues, Erika C.] Augusto Motta Univ Unisuam, BR-21041020 Rio De Janeiro, Brazil.
   [Simoes, Elington L.] Rio de Janeiro State Univ UERJ, BR-20550900 Rio De Janeiro, Brazil.
RP Tovar-Moll, F (corresponding author), DOr Inst Res & Educ IDOR, BR-22281100 Rio De Janeiro, Brazil.; Tovar-Moll, F (corresponding author), Fed Univ Rio de Janeiro UFRJ, Inst Biomed Sci, BR-21941902 Rio De Janeiro, Brazil.; Tovar-Moll, F (corresponding author), Fed Univ Rio de Janeiro UFRJ, Natl Ctr Struct Biol & Bioimaging, BR-21941902 Rio De Janeiro, Brazil.
EM fernanda.tovarmoll@idor.org
RI Moll, Fernanda Tovar/N-3320-2018; de Carvalho Rodrigues,
   Erika/AAE-9445-2020
OI Moll, Fernanda Tovar/0000-0002-0292-5985; de Carvalho Rodrigues,
   Erika/0000-0001-5464-2963
FU National Institute of Translational Neuroscience (INNT); National
   Council for Scientific and Technological Development (CNPq)National
   Council for Scientific and Technological Development (CNPq); Rio de
   Janeiro Foundation for the Support of Science (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); CAPES FoundationCAPES
FX We thank Rodrigo Basilio for technical advice. We thank Ana Franzoi and
   Debora O. Lima for assistance with participants' recruitment. Funding
   sources: National Institute of Translational Neuroscience (INNT),
   National Council for Scientific and Technological Development (CNPq),
   Rio de Janeiro Foundation for the Support of Science (FAPERJ), CAPES
   Foundation.
CR Aronoff R, 2010, EUR J NEUROSCI, V31, P2221, DOI 10.1111/j.1460-9568.2010.07264.x
   Bahia CP, 2019, CEREB CORTEX, V29, P1460, DOI 10.1093/cercor/bhy043
   Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042
   Berger T, 2007, J NEUROPHYSIOL, V97, P3751, DOI 10.1152/jn.01178.2006
   Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048
   BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409
   Boesen K, 2004, NEUROIMAGE, V22, P1255, DOI 10.1016/j.neuroimage.2004.03.010
   Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575
   Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048
   Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090
   Clarey JC, 1996, CEREB CORTEX, V6, P196, DOI 10.1093/cercor/6.2.196
   Cocchi L, 2012, J NEUROSCI, V32, P17753, DOI 10.1523/JNEUROSCI.3272-12.2012
   COHEN LG, 1991, BRAIN, V114, P615, DOI 10.1093/brain/114.1.615
   COHEN LG, 1991, J CLIN NEUROPHYSIOL, V8, P56, DOI 10.1097/00004691-199101000-00007
   Condes-Lara M, 2000, EUR J PAIN-LONDON, V4, P239, DOI 10.1053/eujp.2000.0176
   CONTI F, 1994, BEHAV BRAIN RES, V64, P37, DOI 10.1016/0166-4328(94)90117-1
   COOK ND, 1984, BRAIN LANG, V23, P116, DOI 10.1016/0093-934X(84)90010-5
   Davis KD, 1998, NATURE, V391, P385, DOI 10.1038/34905
   DENNIS M, 1976, NEUROPSYCHOLOGIA, V14, P455, DOI 10.1016/0028-3932(76)90074-9
   Diers M, 2010, PAIN, V149, P296, DOI 10.1016/j.pain.2010.02.020
   Eickhoff SB, 2006, CEREB CORTEX, V16, P254, DOI 10.1093/cercor/bhi105
   Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034
   Elbert T, 2004, NEUROSCIENTIST, V10, P129, DOI 10.1177/1073858403262111
   Fabri M, 2004, NEUROSCIENCE, V123, P557, DOI 10.1016/j.neuroscience.2003.09.011
   Fabri M, 2001, J COGNITIVE NEUROSCI, V13, P1071, DOI 10.1162/089892901753294365
   Fabri M, 2014, WORLD J RADIOL, V6, P895, DOI 10.4329/wjr.v6.i12.895
   Feng J. T., 2015, BRAIN IMAGING BEHAV, V10, P1
   Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007
   FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0
   Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991
   Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033
   Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008
   FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007
   Geyer S, 1999, NEUROIMAGE, V10, P63, DOI 10.1006/nimg.1999.0440
   Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0
   Geyer S., 2004, ADV ANAT EMBRYOL CEL, V174, P1, DOI DOI 10.1007/978-3-642-18910-4_1
   Giraux P, 2001, NAT NEUROSCI, V4, P691, DOI 10.1038/89472
   Graziano A, 2009, J NEUROSCI, V29, P3738, DOI 10.1523/JNEUROSCI.5388-08.2009
   Grefkes C, 2001, NEUROIMAGE, V14, P617, DOI 10.1006/nimg.2001.0858
   Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536
   Grusser SM, 2001, NEUROSCIENCE, V102, P263, DOI 10.1016/S0306-4522(00)00491-7
   Hahamy A, 2015, ELIFE, V4, DOI 10.7554/eLife.04605
   He XF, 2015, PHYSIOL BEHAV, V151, P502, DOI 10.1016/j.physbeh.2015.08.026
   Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5
   Iwamura Y, 2000, PHILOS T R SOC B, V355, P267, DOI 10.1098/rstb.2000.0563
   Karayannis T, 2007, CEREB CORTEX, V17, P1213, DOI 10.1093/cercor/bhl035
   Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001
   Liu B, 2013, NEUROSCIENCE, V243, P33, DOI 10.1016/j.neuroscience.2013.03.048
   Makin TR, 2015, NEUROIMAGE, V114, P217, DOI 10.1016/j.neuroimage.2015.02.067
   Makin TR, 2013, ELIFE, V2, DOI 10.7554/eLife.01273
   Makin TR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2571
   MANZONI T, 1986, J COMP NEUROL, V252, P245, DOI 10.1002/cne.902520208
   Pasaye EH, 2010, NEURORADIOL J, V23, P665, DOI 10.1177/197140091002300604
   Pawela CP, 2010, NEUROIMAGE, V49, P2467, DOI 10.1016/j.neuroimage.2009.09.054
   Pearson PP, 1999, EXP BRAIN RES, V128, P315, DOI 10.1007/s002210050852
   Pearson PP, 2001, EXP BRAIN RES, V138, P8, DOI 10.1007/s002210100678
   Pelled G, 2007, NEUROIMAGE, V37, P262, DOI 10.1016/j.neuroimage.2007.03.069
   Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018
   Ragert P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016150
   RAMACHANDRAN VS, 1992, NEUROREPORT, V3, P583, DOI 10.1097/00001756-199207000-00009
   Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603
   Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007
   Romero-Romo JI, 2010, NEURORADIOL J, V23, P671, DOI 10.1177/197140091002300605
   ROUILLER EM, 1994, EXP BRAIN RES, V102, P227
   Silva JPS, 2018, MAGN RESON IMAGING, V51, P151, DOI 10.1016/j.mri.2018.05.006
   Simoes EL, 2012, J NEUROSCI, V32, P3211, DOI 10.1523/JNEUROSCI.4592-11.2012
   Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062
   Stancak A, 2002, BRAIN RES, V936, P47, DOI 10.1016/S0006-8993(02)02502-7
   Vargas CD, 2009, P NATL ACAD SCI USA, V106, P7197, DOI 10.1073/pnas.0809614106
   Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073
   General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14, DOI 10.1001/jama.2013.281053
   Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910
   Xie H, 2013, J CLIN NEUROSCI, V20, P523, DOI 10.1016/j.jocn.2012.03.043
NR 73
TC 7
Z9 7
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 21
PY 2019
VL 9
AR 2518
DI 10.1038/s41598-019-39696-z
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM2IA
UT WOS:000459281500087
PM 30792514
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Azevedo-Pereira, RL
   Rangel, B
   Tovar-Moll, F
   Gasparetto, EL
   Attias, M
   Zaverucha-do-Valle, C
   Jasmin,
   Mendez-Otero, R
AF Azevedo-Pereira, Ricardo Luiz
   Rangel, Barbara
   Tovar-Moll, Fernanda
   Gasparetto, Emerson Leandro
   Attias, Marcia
   Zaverucha-do-Valle, Camila
   Jasmin
   Mendez-Otero, Rosalia
TI Superparamagnetic iron oxide nanoparticles as a tool to track mouse
   neural stem cells in vivo
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE Neural stem cells; Superparamagnetic iron oxide nanoparticle; Magnetic
   resonance imaging; Cellular therapy; Cell tracking
ID VIABILITY; THERAPY; STROKE; MODEL
AB Cell transplantation offers a promising approach in many neurological disorders. Neural stem (NS) cells are potential candidates for cell therapy. The ability to track the grafted cells in the host tissue will refine this therapy. Superparamagnetic iron oxide nanoparticles (SPION) have been suggested as a feasible method, but there is no consensus about its safety. Here we investigated the feasibility of label NS cells with SPION and track by MRI after transplantation into mouse striatum with SPION cells and its therapeutic effects by grafting the cells into mouse striatum. We demonstrated that SPION-labeled NS cells display normal patterns of cellular processes including proliferation, migration, differentiation and neurosphere formation. Transmission electron microscopy reveals SPION in the cytoplasm of the cells, which was confirmed by microanalysis. Neurons and astrocytes generated from SPION-labeled NS cells were able to carry nanoparticles after 7days under differentiation. SPION-labeled NS cells transplanted into striatum of mice were detected by magnetic resonance imaging (MRI) and microscopy 51days later. In agreement with others reports, we demonstrated that NS cells are able to incorporate SPION in vitro without altering the stemness, and can survive and be tracked by MRI after they have been grafted into mice striatum.
C1 [Azevedo-Pereira, Ricardo Luiz; Rangel, Barbara; Attias, Marcia; Zaverucha-do-Valle, Camila; Mendez-Otero, Rosalia] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda; Gasparetto, Emerson Leandro] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Jasmin] Univ Fed Rio de Janeiro, Nucleo Multidisciplinar Pesquisa Biol Duque Caxia, Rio De Janeiro, Brazil.
   [Azevedo-Pereira, Ricardo Luiz] Stanford Univ, Dept Neurosurg, Palo Alto, CA 94304 USA.
   [Zaverucha-do-Valle, Camila] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP Mendez-Otero, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
EM razevedo@stanford.edu; barbararangel@biof.ufrj.br;
   fernanda.tovarmoll@idor.org; egasparetto@ufrj.br; mattias@biof.ufrj.br;
   camila.valle@ini.fiocruz.br; jasmin@xerem.ufrj.br; rmotero@biof.ufrj.br
RI Moll, Fernanda Tovar/N-3320-2018; Mendez-Otero, Rosalia/AAL-7551-2020;
   Attias, Marcia/G-4003-2012
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Mendez-Otero,
   Rosalia/0000-0002-1798-9930; , Jasmin/0000-0001-7274-2829
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Ministry of Health
   (DECIT)
FX This work was supported by CNPq, CAPES, FAPERJ, and the Ministry of
   Health (DECIT). We are grateful to Jennifer Vu (Stanford University) for
   helpful comments on the manuscript. The authors also thank Felipe Marins
   and Suelen Serio for technical assistance.
CR Amemori T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt219
   Azevedo-Pereira RL, 2013, METHODS MOL BIOL, V1059, P157, DOI 10.1007/978-1-62703-574-3_14
   Berman SMC, 2013, MAGN RESON MED, V69, P255, DOI 10.1002/mrm.24216
   Breunig JJ, 2011, NEURON, V70, P614, DOI 10.1016/j.neuron.2011.05.005
   Bull E, 2014, INT J NANOMED, V9, P1641, DOI 10.2147/IJN.S48979
   Daadi MM, 2009, MOL THER, V17, P1282, DOI 10.1038/mt.2009.104
   Doyle KP, 2015, NEUROSCI LETT, V584, P236, DOI 10.1016/j.neulet.2014.10.041
   Eamegdool SS, 2014, BIOMATERIALS, V35, P5549, DOI 10.1016/j.biomaterials.2014.03.061
   Gutova M, 2013, STEM CELL TRANSL MED, V2, P766, DOI 10.5966/sctm.2013-0049
   Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104
   Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499
   Jasmin, 2017, INT J NANOMED, V12, P779, DOI 10.2147/IJN.S126530
   Kircher MF, 2011, NAT REV CLIN ONCOL, V8, P677, DOI 10.1038/nrclinonc.2011.141
   Lundberg J, 2009, NEURORADIOLOGY, V51, P661, DOI 10.1007/s00234-009-0551-6
   Moraes L, 2012, STEM CELL RES, V9, P143, DOI 10.1016/j.scr.2012.05.005
   Morizawa YM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00037-1
   Oses C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178011
   Pickard MR, 2010, INT J MOL SCI, V11, P967, DOI 10.3390/ijms11030967
   Pongrac IM, 2016, INT J NANOMED, V11, DOI 10.2147/IJN.S102730
   Shen WB, 2016, CELL TRANSPLANT, V25, P1085, DOI 10.3727/096368915X689550
   Shen WB, 2013, INT J NANOMED, V8, P4593, DOI 10.2147/IJN.S53012
   Silvestrini MT, 2013, STEREOT FUNCT NEUROS, V91, P92, DOI 10.1159/000343213
   Song M, 2009, NEUROSCI RES, V64, P235, DOI 10.1016/j.neures.2009.03.006
   Umashankar A, 2016, INT J NANOMED, V11, P1731, DOI 10.2147/IJN.S102006
   Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7
NR 25
TC 2
Z9 2
U1 0
U2 25
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD FEB
PY 2019
VL 46
IS 1
BP 191
EP 198
DI 10.1007/s11033-018-4460-9
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA HP9OI
UT WOS:000462022300021
PM 30421128
DA 2020-12-17
ER

PT J
AU Monteiro, M
   De Oliveira-Souza, R
   Andrade, J
   Marins, T
   Rodrigues, ED
   Bramati, I
   Lent, R
   Moll, J
   Tovar-Moll, F
AF Monteiro, Myriam
   De Oliveira-Souza, Ricardo
   Andrade, Juliana
   Marins, Theo
   Rodrigues, Erika de Carvalho
   Bramati, Ivanei
   Lent, Roberto
   Moll, Jorge
   Tovar-Moll, Fernanda
TI Cortical lateralization of cheirosensory processing in callosal
   dysgenesis
SO NEUROIMAGE-CLINICAL
LA English
DT Article
DE Callosal dysgenesis; fMRI callosal agenesis; Somatosensory cortical
   lateralization
ID POSTERIOR CORPUS-CALLOSUM; INTERHEMISPHERIC-TRANSFER; TACTILE AGNOSIA;
   CEREBRAL-CORTEX; STRUCTURAL CONNECTOME; SOMATOSENSORY CORTEX;
   MAGNETIC-RESONANCE; LANGUAGE FUNCTION; FUNCTIONAL MRI; AGENESIS
AB The paradoxical absence of a split-brain syndrome in most cases of callosal dysgenesis has originated three main hypotheses, namely, (i) bilateral cortical representation of language, (ii) bilateral thalamocortical projections of somatosensory pathways conveyed by the spinothalamic-medial lemniscus system, and (iii) a variable combination of (i) and (ii). We used functional neuroimaging to investigate the cortical representation and lateralization of somatosensory information from the palm of each hand in six cases of callosal dysgenesis (hypothesis [ii]). Cortical regions of interest were contralateral and ipsilateral S1 (areas 3a and 3b, 1 and 2 in the central sulcus and postcentral gyrus) and S2 (parts of areas 40 and 43 in the parietal operculum). The degree of cortical asymmetry was expressed by a laterality index (LI), which may assume values from -1 (fully left-lateralized) to +1 (fully right-lateralized). In callosal dysgenesis, LI values for the right and the left hands were, respectively, -1 and + 1 for both S1 and S2, indicating absence of engagement of ipsilateral S1 and S2. In controls, LI values were - 0.70 (S1) and - 0.51 (S2) for right hand stimulation, and 0.82 (S1) and 0.36 (S2) for left hand stimulation, reflecting bilateral asymmetric activations, which were significantly higher in the hemisphere contralateral to the stimulated hand. Therefore, none of the main hypotheses so far entertained to account for the callosal dysgenesis-split-brain paradox have succeeded. We conclude that the preserved interhemispheric transfer of somatosensory tactile information in callosal dysgenesis must be mediated by a fourth alternative, such as aberrant interhemispheric bundles, reorganization of subcortical commissures, or both.
C1 [Monteiro, Myriam; De Oliveira-Souza, Ricardo; Andrade, Juliana; Marins, Theo; Rodrigues, Erika de Carvalho; Bramati, Ivanei; Lent, Roberto; Moll, Jorge; Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Monteiro, Myriam; Lent, Roberto; Tovar-Moll, Fernanda] Fed Univ Rio de Janeiro UFRJ, Rio De Janeiro, Brazil.
   [De Oliveira-Souza, Ricardo; Marins, Theo; Lent, Roberto] Fed Univ State Rio de Janeiro Uni Rio, Rio De Janeiro, Brazil.
   [Rodrigues, Erika de Carvalho] Augusto Motta Univ, UNISUAM, Rio De Janeiro, Brazil.
RP Tovar-Moll, F (corresponding author), Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
EM fernanda.tovarmoll@idor.org
RI Moll, Fernanda Tovar/N-3320-2018; de Carvalho Rodrigues,
   Erika/R-6007-2017
OI Moll, Fernanda Tovar/0000-0002-0292-5985; de Carvalho Rodrigues,
   Erika/0000-0001-5464-2963; Marins, Theo/0000-0002-5017-707X
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPESCAPES; D'Or Institute for
   Research & Education (IDOR)
FX FAPERJ, CNPq, CAPES, and intramural grants from the D'Or Institute for
   Research & Education (IDOR).
CR ALBERT M, 1992, J AM GERIATR SOC, V40, P449, DOI 10.1111/j.1532-5415.1992.tb02009.x
   [Anonymous], 2000, JAMA, V284, P3043
   Balsamo M, 2008, CORTEX, V44, P1030, DOI 10.1016/j.cortex.2008.01.003
   BARKOVICH AJ, 1988, AM J ROENTGENOL, V151, P171, DOI 10.2214/ajr.151.1.171
   BEAUVOIS MF, 1978, BRAIN, V101, P381, DOI 10.1093/brain/101.3.381
   Benezit A, 2015, CORTEX, V63, P155, DOI 10.1016/j.cortex.2014.08.022
   Bodegard A, 2000, NEUROREPORT, V11, P187, DOI 10.1097/00001756-200001170-00037
   Bridgman MW, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-32
   Brown WS, 2019, J INT NEUROPSYCH SOC, V25, P324, DOI 10.1017/S135561771800111X
   Caminiti R, 2013, J NEUROSCI, V33, P14501, DOI 10.1523/JNEUROSCI.0761-13.2013
   CHIARELLO C, 1980, BRAIN LANG, V11, P128, DOI 10.1016/0093-934X(80)90116-9
   Crawford JR, 2010, COGN NEUROPSYCHOL, V27, P245, DOI 10.1080/02643294.2010.513967
   D'Antonio F, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0445
   de Oliveira-Souza R, 2015, MED HYPOTHESES, V85, P99, DOI 10.1016/j.mehy.2015.04.007
   Dellon A L, 1978, J Hand Surg Am, V3, P474
   Eickhoff SB, 2008, CEREB CORTEX, V18, P2820, DOI 10.1093/cercor/bhn039
   ENDO K, 1992, CORTEX, V28, P445, DOI 10.1016/S0010-9452(13)80154-2
   ETTLINGER G, 1972, BRAIN, V95, P327, DOI 10.1093/brain/95.2.327
   Fabri M, 1999, EUR J NEUROSCI, V11, P3983, DOI 10.1046/j.1460-9568.1999.00829.x
   Fabri M, 2005, COGNITIVE BRAIN RES, V24, P73, DOI 10.1016/j.cogbrainres.2004.12.003
   Fabri M, 2001, J COGNITIVE NEUROSCI, V13, P1071, DOI 10.1162/089892901753294365
   Francesco P, 2006, PEDIATR INT, V48, P298, DOI 10.1111/j.1442-200X.2006.02208.x
   Freeman C, 2002, SEMIN NEUROL, V22, P399, DOI 10.1055/s-2002-36762
   FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007
   GEFFEN GM, 1994, ADV BEHAV BIOL, V42, P185
   Hansson T, 1999, NEUROSCI LETT, V271, P29, DOI 10.1016/S0304-3940(99)00508-X
   HARI R, 1983, ACTA NEUROL SCAND, V68, P207, DOI 10.1111/j.1600-0404.1983.tb04828.x
   Hinkley LBN, 2016, J NEUROSCI, V36, P4522, DOI 10.1523/JNEUROSCI.3850-14.2016
   Ihori N, 2000, EUR NEUROL, V44, P65, DOI 10.1159/000008199
   Jakab A, 2015, NEUROIMAGE, V111, P277, DOI 10.1016/j.neuroimage.2015.02.038
   Kaas J. H., 2012, HUMAN NERVOUS SYSTEM, P1074, DOI [10.1016/B978-0-12-374236-0.10030-6, DOI 10.1016/B978-0-12-374236-0.10030-6]
   KAAS JH, 1983, PHYSIOL REV, V63, P206
   KENDALL BE, 1983, NEURORADIOLOGY, V25, P239, DOI 10.1007/BF00540236
   KESSLER J, 1991, INT J NEUROSCI, V58, P275, DOI 10.3109/00207459108985443
   Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512
   Komaba Y, 1998, J NEUROIMAGING, V8, P246, DOI 10.1111/jon199884246
   Labadi B, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00094
   Landry J. -B. O., 1852, ARCH GEN MED, V29, P257
   Landry J. -B. O., 1852, ARCH GEN MED, V30, P28
   LASSONDE M, 1991, NEUROPSYCHOLOGIA, V29, P481, DOI 10.1016/0028-3932(91)90006-T
   Lent R., 2010, CEM BILHOES NEURONIO
   Lum C, 2011, J NEUROIMAGING, V21, P65, DOI 10.1111/j.1552-6569.2009.00430.x
   Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042
   MAHONEY F I, 1965, Md State Med J, V14, P61
   Mai J. K., 2012, HUMAN NERVOUS SYSTEM, P618
   Marani E, 2005, ADV ANAT EMBRYOL CEL, V179, P1
   Meoded A, 2015, EUR RADIOL, V25, P1471, DOI 10.1007/s00330-014-3541-y
   Moes P, 2009, CHILD CARE HLTH DEV, V35, P656, DOI 10.1111/j.1365-2214.2009.00942.x
   Moll J, 2017, COGN BEHAV NEUROL, V30, P102, DOI 10.1097/WNN.0000000000000135
   Nihashi T, 2005, CLIN NEUROPHYSIOL, V116, P842, DOI 10.1016/j.clinph.2004.10.011
   Ocklenburg S, 2015, NEUROPSYCHOLOGY, V29, P806, DOI 10.1037/neu0000193
   OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4
   Owen JP, 2013, NEUROIMAGE, V70, P340, DOI 10.1016/j.neuroimage.2012.12.031
   Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107
   Pelletier I, 2011, NEUROPSYCHOLOGIA, V49, P1987, DOI 10.1016/j.neuropsychologia.2011.03.028
   Polonara G, 2015, J NEUROIMAGING, V25, P465, DOI 10.1111/jon.12136
   Polonara G, 1999, AM J NEURORADIOL, V20, P199
   Probst M, 1901, ARCH PSYCHIAT NERVEN, V34, P709, DOI 10.1007/BF02680175
   Reddy H, 2000, NEUROREPORT, V11, P2409, DOI 10.1097/00001756-200008030-00014
   Rehmel JL, 2016, BRAIN LANG, V160, P21, DOI 10.1016/j.bandl.2016.07.001
   Riecker A, 2007, J NEUROL, V254, P528, DOI 10.1007/s00415-006-0152-9
   Romaniello R, 2017, J CHILD NEUROL, V32, P60, DOI 10.1177/0883073816664668
   SAUL RE, 1968, NEUROLOGY, V18, P307
   SCHNITZLER A, 1995, NEUROSCI LETT, V200, P25, DOI 10.1016/0304-3940(95)12065-C
   Seghier ML, 2008, MAGN RESON IMAGING, V26, P594, DOI 10.1016/j.mri.2007.10.010
   Siffredi V, 2013, DEV NEUROPSYCHOL, V38, P36, DOI 10.1080/87565641.2012.721421
   Smith KU, 1945, J GEN PSYCHOL, V32, P39, DOI 10.1080/00221309.1945.10544482
   Sperry R. W., 1969, HDB CLINICAL NEUROLO, P273, DOI DOI 10.1023/B:HUMP.0000036333.34541.54
   Srinivas K, 1999, NEUROCASE, V5, P83, DOI 10.1093/neucas/5.2.83
   Sutherland MT, 2006, J NEUROSCI, V26, P8217, DOI 10.1523/JNEUROSCI.2698-06.2006
   ten Donkelaar HJ, 2011, CLIN NEUROANATOMY BR, P133
   Tovar-Moll F, 2007, CEREB CORTEX, V17, P531, DOI 10.1093/cercor/bhj178
   Tovar-Moll F, 2014, P NATL ACAD SCI USA, V111, P7843, DOI 10.1073/pnas.1400806111
   Veronelli L, 2014, CORTEX, V58, P206, DOI 10.1016/j.cortex.2014.06.015
   Wahl M, 2009, AM J NEURORADIOL, V30, P282, DOI 10.3174/ajnr.A1361
   WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023
   YAMADORI A, 1980, ARCH NEUROL-CHICAGO, V37, P88, DOI 10.1001/archneur.1980.00500510046007
   Zaidel E, 2003, CLIN NEUROPSYCHOLOGY, P347
   Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263
   Zilles K., 2012, HUMAN NERVOUS SYSTEM, P997
NR 80
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2213-1582
J9 NEUROIMAGE-CLIN
JI NeuroImage-Clin.
PY 2019
VL 23
AR 101808
DI 10.1016/j.nicl.2019.101808
PG 9
WC Neuroimaging
SC Neurosciences & Neurology
GA IX6OV
UT WOS:000485804400054
PM 31153001
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Andrade, J
   Meireles, F
   Suo, C
   Yucel, M
   Frydman, I
   Fontenelle, L
   Moll, FT
AF Andrade, J.
   Meireles, F.
   Suo, C.
   Yucel, M.
   Frydman, I.
   Fontenelle, L.
   Tovar Moll, F.
TI Metabolic and structural abnormalities in obsessive-compulsive disorder:
   A multimodal neuroimaging and clinical approach
SO EUROPEAN NEUROPSYCHOPHARMACOLOGY
LA English
DT Meeting Abstract
CT 31st Congress of the European-College-of-Neuropsychopharmacology (ECNP)
CY OCT 06-09, 2018
CL Barcelona, SPAIN
SP European Coll Neuropsychopharmacol
C1 [Andrade, J.; Meireles, F.; Frydman, I.; Fontenelle, L.; Tovar Moll, F.] DOr Inst Res & Educ IDOR, Neurosci, Rio De Janeiro, Brazil.
   [Suo, C.; Yucel, M.] Monash Inst Cognit & Clin Neurosci, Brain & Mental Hlth Lab, Clayton, Vic, Australia.
RI Yucel, Murat/I-3004-2014; Moll, Fernanda Tovar/N-3320-2018
OI Yucel, Murat/0000-0002-4705-452X; Moll, Fernanda
   Tovar/0000-0002-0292-5985
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0924-977X
EI 1873-7862
J9 EUR NEUROPSYCHOPHARM
JI Eur. Neuropsychopharmacol.
PY 2019
VL 29
SU 1
MA P.738
BP S506
EP S506
DI 10.1016/j.euroneuro.7018.11.753
PG 1
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA HL0RB
UT WOS:000458400500669
DA 2020-12-17
ER

PT J
AU Lourenco, MV
   Frozza, RL
   de Freitas, GB
   Zhang, H
   Kincheski, GC
   Ribeiro, FC
   Goncalves, RA
   Clarke, JR
   Beckman, D
   Staniszewski, A
   Berman, H
   Guerra, LA
   Forny-Germano, L
   Meier, S
   Wilcock, DM
   de Souza, JM
   Alves-Leon, S
   Prado, VF
   Prado, MAM
   Abisambra, JF
   Tovar-Moll, F
   Mattos, P
   Arancio, O
   Ferreira, ST
   De Felice, FG
AF Lourenco, Mychael V.
   Frozza, Rudimar L.
   de Freitas, Guilherme B.
   Zhang, Hong
   Kincheski, Grasielle C.
   Ribeiro, Felipe C.
   Goncalves, Rafaella A.
   Clarke, Julia R.
   Beckman, Danielle
   Staniszewski, Agnieszka
   Berman, Hanna
   Guerra, Lorena A.
   Forny-Germano, Leticia
   Meier, Shelby
   Wilcock, Donna M.
   de Souza, Jorge M.
   Alves-Leon, Soniza
   Prado, Vania F.
   Prado, Marco A. M.
   Abisambra, Jose F.
   Tovar-Moll, Fernanda
   Mattos, Paulo
   Arancio, Ottavio
   Ferreira, Sergio T.
   De Felice, Fernanda G.
TI Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory
   defects in Alzheimer's models
SO NATURE MEDICINE
LA English
DT Article
ID DEPRESSIVE-LIKE BEHAVIOR; AMYLOID-BETA OLIGOMERS; HIPPOCAMPAL
   INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; MOUSE MODEL; EIF2-ALPHA KINASES;
   GENE-EXPRESSION; ENERGY-INTAKE; BRAIN; DISEASE
AB Defective brain hormonal signaling has been associated with Alzheimer's disease (AD), a disorder characterized by synapse and memory failure. Irisin is an exercise-induced myokine released on cleavage of the membrane-bound precursor protein fibronectin type III domain-containing protein 5 (FNDC5), also expressed in the hippocampus. Here we show that FNDC5/irisin levels are reduced in AD hippocampi and cerebrospinal fluid, and in experimental AD models. Knockdown of brain FNDC5/irisin impairs long-term potentiation and novel object recognition memory in mice. Conversely, boosting brain levels of FNDC5/irisin rescues synaptic plasticity and memory in AD mouse models. Peripheral overexpression of FNDC5/irisin rescues memory impairment, whereas blockade of either peripheral or brain FNDC5/irisin attenuates the neuroprotective actions of physical exercise on synaptic plasticity and memory in AD mice. By showing that FNDC5/irisin is an important mediator of the beneficial effects of exercise in AD models, our findings place FNDC5/irisin as a novel agent capable of opposing synapse failure and memory impairment in AD.
C1 [Lourenco, Mychael V.; Frozza, Rudimar L.; de Freitas, Guilherme B.; Kincheski, Grasielle C.; Ribeiro, Felipe C.; Clarke, Julia R.; Beckman, Danielle; Guerra, Lorena A.; Forny-Germano, Leticia; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Lourenco, Mychael V.; Kincheski, Grasielle C.; Ribeiro, Felipe C.; Guerra, Lorena A.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Lourenco, Mychael V.; Zhang, Hong; Staniszewski, Agnieszka; Berman, Hanna; Arancio, Ottavio] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.
   [Frozza, Rudimar L.] Fiocruz MS, Oswaldo Cruz Fdn, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
   [de Freitas, Guilherme B.; Goncalves, Rafaella A.; De Felice, Fernanda G.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, Rio De Janeiro, Brazil.
   [Meier, Shelby; Wilcock, Donna M.; Abisambra, Jose F.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.
   [de Souza, Jorge M.; Alves-Leon, Soniza] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Div Neurosurg, Rio De Janeiro, Brazil.
   [de Souza, Jorge M.; Alves-Leon, Soniza] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Epilepsy Program, Div Neurol, Rio De Janeiro, Brazil.
   [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada.
   [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.
   [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada.
   [Tovar-Moll, Fernanda; Mattos, Paulo] DOr Inst Res & Educ, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Mattos, Paulo] Univ Fed Rio de Janeiro, Inst Psychiat, Rio De Janeiro, Brazil.
   [Arancio, Ottavio] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.
   [Arancio, Ottavio] Columbia Univ, Dept Med, New York, NY 10027 USA.
   [De Felice, Fernanda G.] Queens Univ, Dept Psychiat, Kingston, ON, Canada.
RP Ferreira, ST; De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.; Arancio, O (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.; De Felice, FG (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.; Arancio, O (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.; Arancio, O (corresponding author), Columbia Univ, Dept Med, New York, NY 10027 USA.; De Felice, FG (corresponding author), Queens Univ, Dept Psychiat, Kingston, ON, Canada.
EM oa1@cumc.columbia.edu; ferreira@biof.ufrj.br;
   fernanda.defelice@queensu.ca
RI Abisambra, Jose/V-6860-2019; Prado, Vania Ferreira/K-7630-2013; arancio,
   ottavio/AAB-7959-2019; Forny-Germano, Leticia/L-6639-2019; Moll,
   Fernanda Tovar/N-3320-2018; Abisambra, Joe/AAP-3269-2020; Lourenco,
   Mychael/G-2614-2014; de Mattos, Paulo Eduardo Luiz/D-2328-2014; Leon,
   Soniza V Alves/J-7786-2012; Forny-Germano, Leticia/D-1342-2017; Prado,
   Marco Antonio Maximo/K-7638-2013; Clarke, Julia/AAF-9434-2019; Ribeiro,
   Felipe Campos/W-9758-2019; Ferreira, Sergio/AAZ-1576-2020
OI Abisambra, Jose/0000-0001-6341-679X; Prado, Vania
   Ferreira/0000-0003-4994-6393; Forny-Germano,
   Leticia/0000-0001-8301-0711; Moll, Fernanda Tovar/0000-0002-0292-5985;
   Lourenco, Mychael/0000-0002-1078-0296; de Mattos, Paulo Eduardo
   Luiz/0000-0003-0709-3783; Forny-Germano, Leticia/0000-0001-8301-0711;
   Prado, Marco Antonio Maximo/0000-0002-3028-5778; Ribeiro, Felipe
   Campos/0000-0003-3028-3307; Ferreira, Sergio/0000-0001-7160-9866; De
   Freitas, Guilherme/0000-0003-4614-4280; Frozza, Rudimar
   Luiz/0000-0003-0918-4128; Berman, Hanna/0000-0002-8616-8167; Meier,
   Shelby/0000-0003-1946-9004
FU Alzheimer Society of Canada; Weston Brain Institute; National Institute
   for Translational Neuroscience (INNT/Brazil) [465346/2014-6]; Human
   Frontier Science ProgramHuman Frontier Science Program; International
   Society for Neurochemistry (CAEN 1B); National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [NIH-R01NS049442]; Canadian Institutes
   of Health ResearchCanadian Institutes of Health Research (CIHR) [CIHR
   MOP 136940, MOP 89919]; Brazilian funding agency Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [451195/2017-5,
   406436/2016-9, 473324/2013-0]; Brazilian funding agency Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [202.817/2016, 201.432/2014, 202.944/2015];
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq); Comissao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES/Brazil)CAPES [001]; NIH T32 grantUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [AG057461]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND
   STROKEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R01NS091329, R01NS091329, R01NS091329]
   Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute on Aging (NIA) [P30AG028383, P30AG028383,
   T32AG057461, P30AG028383, P30AG028383, P30AG028383, P30AG028383,
   P30AG028383, P30AG028383, P30AG028383, P30AG028383, P30AG028383,
   T32AG057461, P30AG028383, P30AG028383, P30AG028383, T32AG057461,
   P30AG028383, P30AG028383, P30AG028383, P30AG028383, P30AG028383,
   P30AG028383, P30AG028383, P30AG028383, P30AG028383, P30AG028383,
   P30AG028383, P30AG028383, P30AG028383, P30AG028383, P30AG028383,
   T32AG057461, P30AG028383] Funding Source: NIH RePORTER
FX This work was supported by grants from Alzheimer Society of Canada (to
   F.G.D.F.) and the Weston Brain Institute (to F.G.D.F.), National
   Institute for Translational Neuroscience (INNT/Brazil) (465346/2014-6 to
   S.T.F. and F.G.F.), Human Frontier Science Program (to F.G.D.F.),
   International Society for Neurochemistry (CAEN 1B to M.V.L.), National
   Institutes of Health (NIH-R01NS049442 to O.A.), Canadian Institutes of
   Health Research (CIHR MOP 136940 and MOP 89919 to V.F.P. and M.A.M.P.),
   and from the Brazilian funding agencies Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) (451195/2017-5 to
   M.V.L., 406436/2016-9 to S.T.F., and 473324/2013-0 to F.G.D.F.) and
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ) (202.817/2016 to M.V.L., 201.432/2014 to S.T.F., and
   202.944/2015 to F.G.D.F.). R.L.F, G.B.d.F., G.C.K., F.C.R., J.R.C.,
   D.B., and L.F.-G. were supported by fellowships granted by FAPERJ, CNPq,
   or Comissao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES/Brazil; financial code 001). S.M. was supported by an NIH T32
   grant (AG057461). We acknowledge the University of Kentucky Alzheimer's
   Disease Center and its Neuropathology Core, which is supported by
   NIH/NIA P30 AG028383, for brain samples. We thank W.L. Klein
   (Northwestern University) for the kind gift of oligomer-specific NU4
   antibodies, B.M. Spiegelman (Harvard University) for sharing AdGFP and
   AdFNDC5 adenoviral constructs, and J. Wang (Queen's University, Canada)
   for help with mass spectrometry analyses. We also thank A. Lepelley, M.
   Oliveira, M. Melo, A.C. Rangel, and the CENABIO team for technical
   and/or administrative assistance.
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275
   Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889
   Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307
   Beckman D, 2015, J BIOL CHEM, V290, P20488, DOI 10.1074/jbc.M115.666156
   Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189
   Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35
   Chen K, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao6298
   Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Colaianni G, 2015, P NATL ACAD SCI USA, V112, P12157, DOI 10.1073/pnas.1516622112
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2014, ALZHEIMERS DEMENT, V10, pS26, DOI 10.1016/j.jalz.2013.12.004
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   Drummond C, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00096
   During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919
   Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831
   Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046
   Grillo CA, 2015, DIABETES, V64, P3927, DOI 10.2337/db15-0596
   Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097
   Irving AJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0155
   Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3
   Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001
   Katsnelson A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aal2074
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016
   Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017
   Lepeta K, 2016, J NEUROCHEM, V138, P785, DOI 10.1111/jnc.13713
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lourenco MV, 2015, PROG NEUROBIOL, V129, P37, DOI 10.1016/j.pneurobio.2015.03.003
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486
   Madeira C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.52
   Martin KC, 1996, NEURON, V17, P567, DOI 10.1016/S0896-6273(00)80188-9
   Mattson MP, 2012, CELL METAB, V16, P706, DOI 10.1016/j.cmet.2012.08.012
   McEwen BS, 2015, P NATL ACAD SCI USA, V112, P15544, DOI 10.1073/pnas.1521416112
   Mendes ND, 2018, J NEUROSCI METH, V307, P203, DOI 10.1016/j.jneumeth.2018.05.021
   Moon HY, 2016, CELL METAB, V24, P332, DOI 10.1016/j.cmet.2016.05.025
   Mucke L, 2012, COLD SPRING HARB PER, V2
   Muller S, 2018, ALZHEIMERS DEMENT, V14, P1427, DOI 10.1016/j.jalz.2018.06.3059
   Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011
   Okonkwo OC, 2014, NEUROLOGY, V83, P1753, DOI 10.1212/WNL.0000000000000964
   Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007
   Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009
   Schaefer N, 2017, J NEUROCHEM, V142, P790, DOI 10.1111/jnc.14107
   Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/nmeth.1314, 10.1038/NMETH.1314]
   Schumacher MA, 2013, J BIOL CHEM, V288, P33738, DOI 10.1074/jbc.M113.516641
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   da Silva GSS, 2017, J BIOL CHEM, V292, P7395, DOI 10.1074/jbc.M116.753525
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   Sleiman SF, 2016, ELIFE, V5, DOI 10.7554/eLife.15092
   Smith RW, 2007, PROTEOMICS, V7, P4171, DOI 10.1002/pmic.200700573
   Suwabe K, 2018, P NATL ACAD SCI USA, V115, P10487, DOI 10.1073/pnas.1805668115
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364
   Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254
   Trinh MA, 2013, NEUROBIOL LEARN MEM, V105, P93, DOI 10.1016/j.nlm.2013.04.013
   van Praag H, 2014, J NEUROSCI, V34, P15139, DOI 10.1523/JNEUROSCI.2814-14.2014
   Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199
   Wadman M, 2012, NATURE, V485, P426, DOI 10.1038/485426a
   Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008
   Yang WZ, 2016, NEUROBIOL AGING, V41, P19, DOI 10.1016/j.neurobiolaging.2016.02.005
   Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106
NR 70
TC 111
Z9 114
U1 22
U2 111
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD JAN
PY 2019
VL 25
IS 1
BP 165
EP +
DI 10.1038/s41591-018-0275-4
PG 26
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA HG5OR
UT WOS:000455027700034
PM 30617325
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Resende, EDF
   Tovar-Moll, FF
   Ferreira, FM
   Bramati, I
   de Souza, LC
   Carmona, KC
   Guimaraes, HC
   Carvalho, VA
   Barbosa, MT
   Caramelli, P
AF Franca Resende, Elisa de Paula
   Tovar-Moll, Fernanda Freire
   Ferreira, Fernanda Meireles
   Bramati, Ivanei
   de Souza, Leonardo Cruz
   Carmona, Karoline Carvalho
   Guimaraes, Henrique Cerqueira
   Carvalho, Viviane Amaral
   Barbosa, Maira Tonidandel
   Caramelli, Paulo
TI White Matter Microstructure in Illiterate and Low-Literate Elderly
   Brazilians: Preliminary Findings
SO COGNITIVE AND BEHAVIORAL NEUROLOGY
LA English
DT Article
DE cognitive reserve; elderly; literacy; structural connectivity
ID MINI-MENTAL-STATE; COGNITIVE RESERVE; BRAIN RESERVE; DIFFUSION;
   DEMENTIA; MEMORY; PERFORMANCE; PREVALENCE; MRI; AGE
AB Objective: To investigate differences in white matter microstructure between illiterate and low-literate elderly Brazilians. Background: High literacy levels are believed to partially counteract the negative effects of neurodegenerative diseases. Investigating the impact of low literacy versus illiteracy on brain structure can contribute knowledge about cognitive reserve in elderly populations with low educational attainment. Fractional anisotropy is a measure derived from diffusion tensor imaging sequences that positively correlate with the integrity of the brain's white matter microstructure. Methods: Older adults who participated in an epidemiological study to investigate brain aging in Brazil and had magnetic resonance scans with the diffusion tensor imaging acquisition were selected (n=31). Participants were divided into two groups: (a) low-literate (n=21), with 3.4 (1.4) years of education, 79.8 (3.8) years of age, 17 cognitively healthy and four with cognitive impairment-no dementia; and (b) illiterate (n=10) with no formal schooling, 80.7 (4.1) years of age, six cognitively healthy and four with cognitive impairment-no dementia. We contrasted the two groups' white matter microstructure measures using whole-brain and region of interest approaches. Results: The low-literate participants had significantly higher fractional anisotropy values in the right superior longitudinal fasciculus than did the illiterate ones. Conclusions: Although our results are preliminary because of the sample size, they suggest that low literacy, versus illiteracy, is associated with higher fractional anisotropy values, which are indirect measurements of white matter microstructure. This finding provides insight into a possible mechanism by which literacy, even at low levels, may contribute to cognitive reserve.
C1 [Franca Resende, Elisa de Paula; de Souza, Leonardo Cruz; Carmona, Karoline Carvalho; Guimaraes, Henrique Cerqueira; Carvalho, Viviane Amaral; Barbosa, Maira Tonidandel; Caramelli, Paulo] Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Av Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil.
   [Franca Resende, Elisa de Paula; de Souza, Leonardo Cruz; Guimaraes, Henrique Cerqueira; Caramelli, Paulo] Univ Fed Minas Gerais, Programa Posgrad Neurociencias, Belo Horizonte, MG, Brazil.
   [Tovar-Moll, Fernanda Freire; Ferreira, Fernanda Meireles; Bramati, Ivanei] Dor Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda Freire] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda Freire] Univ Fed Rio de Janeiro, Natl Ctr Struct & Bioimaging Biol, Rio De Janeiro, Brazil.
RP Caramelli, P (corresponding author), Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Av Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil.
EM caramelli@ufmg.br
RI de Souza, Leonardo C/C-1833-2016; Moll, Fernanda Tovar/N-3320-2018;
   CARAMELLI, PAULO/H-9735-2012
OI de Souza, Leonardo C/0000-0001-5027-9722; Moll, Fernanda
   Tovar/0000-0002-0292-5985; CARAMELLI, PAULO/0000-0002-4786-6990
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [MCT-CNPq/MS-SCTIE-DECIT/CT-Saude (17/2006)]; Fundacao de Apoio a
   Pesquisa de Minas Gerais (FAPEMIG)Minas Gerais State Research Foundation
   (FAPEMIG)
FX Supported in part by grants from Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), grant number
   MCT-CNPq/MS-SCTIE-DECIT/CT-Saude (17/2006); and Fundacao de Apoio a
   Pesquisa de Minas Gerais (FAPEMIG) Edital Universal (2007).
CR Arenaza-Urquijo EM, 2017, NEUROBIOL AGING, V59, P72, DOI 10.1016/j.neurobiolaging.2017.06.016
   Arenaza-Urquijo EM, 2013, NEUROIMAGE, V83, P450, DOI 10.1016/j.neuroimage.2013.06.053
   AssociacAo Brasileira de Empresas de Pesquisa [Brazilian Association of Research Companies], 2003, CRIT CLASS EC BRAS
   Bartres-Faz D, 2009, BIOL PSYCHOL, V80, P256, DOI 10.1016/j.biopsycho.2008.10.005
   Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782
   Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053
   Boltzmann M, 2017, NEUROSCIENCE, V344, P229, DOI 10.1016/j.neuroscience.2016.12.049
   Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014
   Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006
   Cao XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep33212
   Caramelli P, 2011, ARQ NEURO-PSIQUIAT, V69, P579, DOI 10.1590/S0004-282X2011000500002
   Carreiras M, 2009, NATURE, V461, P983, DOI 10.1038/nature08461
   Castro-Caldas A, 1998, BRAIN, V121, P1053, DOI 10.1093/brain/121.6.1053
   Catani M., 2012, ATLAS HUMAN BRAIN CO
   Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926
   Dehaene S, 2015, NAT REV NEUROSCI, V16, P234, DOI 10.1038/nrn3924
   Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140
   EBLY EM, 1995, ARCH NEUROL-CHICAGO, V52, P612, DOI 10.1001/archneur.1995.00540300086018
   Farfel JM, 2013, NEUROLOGY, V81, P650, DOI 10.1212/WNL.0b013e3182a08f1b
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Fontenelle LF, 2011, CNS SPECTRUMS, V16, P101, DOI 10.1017/S1092852912000260
   Foubert-Samier A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.023
   Resende EDF, 2017, ARQ NEURO-PSIQUIAT, V75, P778, DOI [10.1590/0004-282X20170158, 10.1590/0004-282x20170158]
   Fratiglioni L, 2007, J ALZHEIMERS DIS, V12, P11
   Graham JE, 1997, LANCET, V349, P1793, DOI 10.1016/S0140-6736(97)01007-6
   Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510
   Hoenig MC, 2017, NEUROBIOL AGING, V57, P1, DOI 10.1016/j.neurobiolaging.2017.05.004
   Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053
   Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004
   Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631
   Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081
   Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000
   Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262
   Kurumaji A, 2017, PSYCHIAT RES-NEUROIM, V266, P66, DOI 10.1016/j.pscychresns.2017.06.005
   Lavdas I, 2014, J MAGN RESON IMAGING, V40, P682, DOI 10.1002/jmri.24397
   LECOURS AR, 1988, NEUROPSYCHOLOGIA, V26, P575, DOI 10.1016/0028-3932(88)90114-5
   Mesulam M, 2005, ANN NEUROL, V57, P5, DOI 10.1002/ana.20368
   Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058
   Nitrini R, 2005, COGN BEHAV NEUROL, V18, P211, DOI 10.1097/01.wnn.0000195292.48422.d5
   Nitrini R, 2004, J INT NEUROPSYCH SOC, V10, P634, DOI 10.1017/S1355617704104062
   Nitrini R, 2009, INT PSYCHOGERIATR, V21, P622, DOI 10.1017/S1041610209009430
   Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X
   Opdebeeck C, 2016, AGING NEUROPSYCHOL C, V23, P40, DOI 10.1080/13825585.2015.1041450
   Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.3.CO;2-A
   Park S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19390-2
   Petersson KM, 2007, EUR J NEUROSCI, V26, P791, DOI 10.1111/j.1460-9568.2007.05701.x
   Pliatsikas C, 2015, P NATL ACAD SCI USA, V112, P1334, DOI 10.1073/pnas.1414183112
   Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007
   Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284
   Scarmeas N, 2003, NEUROIMAGE, V19, P1215, DOI 10.1016/S1053-8119(03)00074-0
   Skeide MA, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602612
   Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051
   Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024
   Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061
   Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6
   Thiebaut de Schotten M, 2014, CEREB CORTEX, V24, P989, DOI 10.1093/cercor/bhs383
   Tovar-Moll F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102656
   United Nations Educational Scientific and Cultural Organization, 2012, INT STAND CLASS ED I
   United Nations Educational Scientific and Cultural Organization Institute for Statistics, 2016, 50 ANN INT LIT DAY L
   Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264
   Vaque-Alcazar L, 2017, BRAIN IMAGING BEHAV, V11, P318, DOI 10.1007/s11682-016-9584-8
   Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318
   Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027
NR 63
TC 1
Z9 1
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1543-3633
EI 1543-3641
J9 COGN BEHAV NEUROL
JI Cogn. Behav. Neurol.
PD DEC
PY 2018
VL 31
IS 4
BP 193
EP 200
DI 10.1097/WNN.0000000000000173
PG 8
WC Behavioral Sciences; Clinical Neurology
SC Behavioral Sciences; Neurosciences & Neurology
GA HF5UG
UT WOS:000454299000002
PM 30562228
DA 2020-12-17
ER

PT J
AU Garcez, PP
   Stolp, HB
   Sravanam, S
   Christoff, RR
   Ferreira, JCCG
   Dias, AA
   Pezzuto, P
   Higa, LM
   Barbeito-Andres, J
   Ferreira, RO
   Andrade, CBV
   Siqueira, M
   Santos, TMP
   Drumond, J
   Hoerder-Suabedissen, A
   de Lima, CVF
   Tovar-Moll, F
   Lopes, RT
   Fragel-Madeira, L
   Lent, R
   Ortiga-Carvalho, TM
   Stipursky, J
   Bellio, M
   Tanuri, A
   Molnar, Z
AF Garcez, P. P.
   Stolp, H. B.
   Sravanam, S.
   Christoff, R. R.
   Ferreira, J. C. C. G.
   Dias, A. A.
   Pezzuto, P.
   Higa, L. M.
   Barbeito-Andres, J.
   Ferreira, R. O.
   Andrade, C. B. V.
   Siqueira, M.
   Santos, T. M. P.
   Drumond, J.
   Hoerder-Suabedissen, A.
   de Lima, C. V. F.
   Tovar-Moll, F.
   Lopes, R. T.
   Fragel-Madeira, L.
   Lent, R.
   Ortiga-Carvalho, T. M.
   Stipursky, J.
   Bellio, M.
   Tanuri, A.
   Molnar, Z.
TI Zika virus impairs the development of blood vessels in a mouse model of
   congenital infection
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HUMAN NEUROSPHERES; BRAIN ORGANOIDS; VASCULAR NICHE; BIRTH-DEFECTS;
   STEM-CELLS; ANGIOGENESIS; NEUROGENESIS; GROWTH; MICE; CNS
AB Zika virus (ZIKV) is associated with brain development abnormalities such as primary microcephaly, a severe reduction in brain growth. Here we demonstrated in vivo the impact of congenital ZIKV infection in blood vessel development, a crucial step in organogenesis. ZIKV was injected intravenously in the pregnant type 2 interferon (IFN)-deficient mouse at embryonic day (E) 12.5. The embryos were collected at E15.5 and postnatal day (P) 2. Immunohistochemistry for cortical progenitors and neuronal markers at E15.5 showed the reduction of both populations as a result of ZIKV infection. Using confocal 3D imaging, we found that ZIKV infected brain sections displayed a reduction in the vasculature density and vessel branching compared to mocks at E15.5; altogether, cortical vessels presented a comparatively immature pattern in the infected tissue. These impaired vascular patterns were also apparent in the placenta and retina. Moreover, proteomic analysis has shown that angiogenesis proteins are deregulated in the infected brains compared to controls. At P2, the cortical size and brain weight were reduced in comparison to mock-infected animals. In sum, our results indicate that ZIKV impairs angiogenesis in addition to neurogenesis during development. The vasculature defects represent a limitation for general brain growth but also could regulate neurogenesis directly.
C1 [Garcez, P. P.; Christoff, R. R.; Ferreira, J. C. C. G.; Barbeito-Andres, J.; Ferreira, R. O.; Siqueira, M.; Drumond, J.; Tovar-Moll, F.; Lent, R.; Stipursky, J.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Garcez, P. P.; Stolp, H. B.; Sravanam, S.; Hoerder-Suabedissen, A.; Molnar, Z.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.
   [Stolp, H. B.] Kings Coll London, Ctr Dev Brain, Dept Perinatal Imaging & Hlth, London, England.
   [Dias, A. A.; Bellio, M.] Univ Fed Rio de Janeiro, Microbiol Inst Paulo Goes, Rio De Janeiro, Brazil.
   [Pezzuto, P.; Higa, L. M.; Tanuri, A.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil.
   [Andrade, C. B. V.; Ortiga-Carvalho, T. M.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Santos, T. M. P.; Lopes, R. T.] Univ Fed Rio de Janeiro, Nucl Instrumentat Lab, Rio De Janeiro, Brazil.
   [de Lima, C. V. F.; Tovar-Moll, F.] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Fragel-Madeira, L.] Fluminense Fed Univ, Inst Biol, Dept Neurobiol, Niteroi, RJ, Brazil.
RP Garcez, PP (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.; Garcez, PP; Stolp, HB; Molnar, Z (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.; Stolp, HB (corresponding author), Kings Coll London, Ctr Dev Brain, Dept Perinatal Imaging & Hlth, London, England.
EM ppgarcez@gmail.com; hstolp@rvc.ac.uk; zoltan.molnar@dpag.ox.ac.uk
RI Higa, Luiza/W-2698-2019; Hoerder-Suabedissen, Anna/G-7053-2011; Molnar,
   Zoltan/J-7281-2012; Moll, Fernanda Tovar/N-3320-2018; Ortiga-Carvalho,
   Tania/D-5093-2011; Ferreira, Raiane/AAZ-5987-2020; Garcez,
   Patricia/F-8026-2012; Stipursky, Joice/Y-1961-2019; Fragel-Madeira,
   Lucianne/V-1665-2019; Lopes, Ricardo T/O-8840-2014; BELLIO,
   MARIA/N-8525-2018
OI Molnar, Zoltan/0000-0002-6852-6004; Moll, Fernanda
   Tovar/0000-0002-0292-5985; Ortiga-Carvalho, Tania/0000-0002-0225-1132;
   Garcez, Patricia/0000-0002-9107-1335; Fragel-Madeira,
   Lucianne/0000-0001-6747-2828; Lopes, Ricardo T/0000-0001-7250-824X;
   BELLIO, MARIA/0000-0002-3360-2740; Sravanam,
   Sanskrithi/0000-0003-2965-2400
CR Bookstein F L, 1997, Med Image Anal, V1, P225
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478
   Christensen BM, 2016, PLOS NEGL TROP DIS, V10
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106
   Dowall S. D, 2016, PLOS NEGL TROP DIS, V10
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gerhardt H, 2004, DEV DYNAM, V231, P503, DOI 10.1002/dvdy.20148
   Gonzalez PN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152227
   Gonzalez PN, 2014, AM J PHYS ANTHROPOL, V154, P544, DOI 10.1002/ajpa.22545
   Javaherian A, 2009, CEREB CORTEX, V19, pI70, DOI 10.1093/cercor/bhp029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Logsdon EA, 2014, J CELL MOL MED, V18, P1491, DOI 10.1111/jcmm.12164
   Machado-Pereira M, 2017, J NEUROCHEM, V140, P692, DOI 10.1111/jnc.13914
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rounioja S, 2003, CARDIOVASC RES, V60, P156, DOI 10.1016/S0008-6363(03)00338-9
   Sagheer U, 2015, J DEV BIOL, V3, P112, DOI 10.3390/jdb3040112
   Salmaso N, 2014, CLIN PERINATOL, V41, P229, DOI 10.1016/j.clp.2013.10.007
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505
   Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026
   Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594
   Stubbs D, 2009, CEREB CORTEX, V19, pI32, DOI 10.1093/cercor/bhp040
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vasudevan A, 2008, NAT NEUROSCI, V11, P429, DOI 10.1038/nn2074
   Vates GE, 2005, J NEUROSURG, V103, P136, DOI 10.3171/jns.2005.103.1.0136
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Zou M, 2015, DEV DYNAM, V244, P86, DOI 10.1002/dvdy.24185
NR 44
TC 12
Z9 12
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 24
PY 2018
VL 8
AR 12774
DI 10.1038/s41598-018-31149-3
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GR4SO
UT WOS:000442607800003
PM 30143723
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-17
ER

PT J
AU Martins, NML
   dos Santos-Ribeiro, S
   Rodrigues, EC
   Tovar-Moll, F
   da Victoria, MS
   de Menezes, GMB
   Segraves, R
   Yucel, M
   Fontenelle, LF
AF Lins Martins, Natalia M.
   dos Santos-Ribeiro, Samara
   Rodrigues, Erika C.
   Tovar-Moll, Fernanda
   da Victoria, Mara S.
   Bezerra de Menezes, Gabriela M.
   Segraves, Rebecca
   Yucel, Murat
   Fontenelle, Leonardo F.
TI AN INTERIM ANALYSIS OF A DOUBLE-BLIND SHAM CONTROLLED STUDY ON THE ACUTE
   EFFECTS OF TRANSCRANIAL DIRECT CURRENT STIMULATION IN
   OBSESSIVE-COMPULSIVE DISORDER
SO EUROPEAN NEUROPSYCHOPHARMACOLOGY
LA English
DT Meeting Abstract
CT ICOCS 12th Scientific Meeting in conjunction with the ECNP OCRN Meeting
CY SEP 21, 2016
CL Vienna, AUSTRIA
SP ICOCS, ECNP OCRN
DE Obsessive-Compulsive Disorder; Attention; non-invasive brain
   stimulation; Transcranial direct current stimulation
C1 [Lins Martins, Natalia M.; dos Santos-Ribeiro, Samara; da Victoria, Mara S.; Bezerra de Menezes, Gabriela M.; Fontenelle, Leonardo F.] Univ Fed Rio de Janeiro, Inst Psychiat, Obsess Compuls & Anxiety Spectrum Res Program, Rio De Janeiro, Brazil.
   [Rodrigues, Erika C.; Tovar-Moll, Fernanda; Fontenelle, Leonardo F.] Inst Res & Educ, Rio De Janeiro, Brazil.
   [Segraves, Rebecca; Yucel, Murat; Fontenelle, Leonardo F.] Monash Univ, Monash Inst Cognit & Clin Neurosci, Brain & Mental Hlth Lab, Clayton, Vic, Australia.
EM lfontenelle@gmail.com
RI Moll, Fernanda Tovar/N-3320-2018; Rodrigues, Erika/R-6007-2017; de
   Carvalho Rodrigues, Erika/AAE-9445-2020
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Rodrigues,
   Erika/0000-0001-5464-2963; de Carvalho Rodrigues,
   Erika/0000-0001-5464-2963
CR Bation R, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.10.001
   Senco NM, 2015, EXPERT REV MED DEVIC, V12, P381, DOI 10.1586/17434440.2015.1037832
   Yucel M, 2007, ARCH GEN PSYCHIAT, V64, P946, DOI 10.1001/archpsyc.64.8.946
NR 3
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-977X
EI 1873-7862
J9 EUR NEUROPSYCHOPHARM
JI Eur. Neuropsychopharmacol.
PD JUN
PY 2018
VL 28
IS 6
BP 761
EP 762
DI 10.1016/j.euroneuro.2017.10.002
PG 2
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA GL0BK
UT WOS:000436626900011
DA 2020-12-17
ER

PT J
AU de Souza, AS
   de Oliveira-Szjenfeld, PS
   Melo, ASD
   de Souza, LAM
   Batista, AGM
   Tovar-Moll, F
AF de Souza, Andrea Silveira
   de Oliveira-Szjenfeld, Patricia Soares
   de Oliveira Melo, Adriana Suely
   Moreira de Souza, Luis Alberto
   Medeiros Batista, Alba Gean
   Tovar-Moll, Fernanda
TI Imaging findings in congenital Zika virus infection syndrome: an update
SO CHILDS NERVOUS SYSTEM
LA English
DT Article
DE Zika; ZIKV; Microcephaly; Congenital malformation; Brain calcifications;
   Ventriculomegaly; Arthrogryposis
ID BRAIN MRI; BRAZIL; SPECTRUM; FETUSES; PREGNANCY; PATHOLOGY; RISK
AB Background Zika virus (ZIKV) is a neurotropic and neurotoxic RNA Flavivirus prompt to cause severe fetal brain dysmorphisms during pregnancy, a period of rapid and critical central nervous system development. Awide range of clinicoradiological findings of congenital ZIKV infections were reported in the literature, such as microcephaly, overlapping sutures, cortical migrational and corpus callosum abnormalities, intracranial calcifications, ventriculomegaly, brain stem and cerebellar malformations, spinal cord involvement, and joint contractures. ZIKV is also related to other severe neurological manifestations in grown-up individuals such as Guillain-Barre syndrome and encephalomyelitis.
   Our purpose is to review the radiological central nervous system abnormalities of congenital ZIKV infection syndrome on different imaging modalities.
C1 [de Souza, Andrea Silveira; Moreira de Souza, Luis Alberto; Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro 30, BR-22281100 Botafogo, RJ, Brazil.
   [de Oliveira-Szjenfeld, Patricia Soares] Univ Fed Sao Paulo, Dept Diagnost Imaging, Sao Paulo, Brazil.
   [de Oliveira-Szjenfeld, Patricia Soares] Univ Fed Sao Paulo, Fdn Inst Educ & Res Diagnost Imaging FIDI, Sao Paulo, Brazil.
   [de Oliveira Melo, Adriana Suely; Medeiros Batista, Alba Gean] Res Inst Prof Amorim Neto IPESQ, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely] UNIFACISA, Campina Grande, PB, Brazil.
   [Medeiros Batista, Alba Gean] Hosp Pedro I, Campina Grande, PB, Brazil.
   [Tovar-Moll, Fernanda] Fed Univ Rio De Janeiro UFRJ, Rio De Janeiro, Brazil.
RP Tovar-Moll, F (corresponding author), DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro 30, BR-22281100 Botafogo, RJ, Brazil.; Tovar-Moll, F (corresponding author), Fed Univ Rio De Janeiro UFRJ, Rio De Janeiro, Brazil.
EM fernanda.tovarmoll@idor.org
RI Moll, Fernanda Tovar/N-3320-2018; Melo, Adriana S O/H-5650-2016; de
   Souza, Andrea Silveira/AAL-1976-2020
OI Moll, Fernanda Tovar/0000-0002-0292-5985; de Souza, Andrea
   Silveira/0000-0002-1553-2312; Soares de Oliveira Szejnfeld,
   Patricia/0000-0002-3780-5182
FU Brazilian Council for Development of Science and Technology
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [440909/2016-3]; CAPES FoundationCAPES; Brazilian Ministry of
   Education [88887.116625/2016-01]; Rio de Janeiro Foundation for the
   Support of Science (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/201.319/2016];
   D'Or Institute for Research and Education (IDOR, PNeuro); Medical
   Research CouncilMedical Research Council UK (MRC) [MC_PC_15102] Funding
   Source: researchfish
FX This work was funded by different grants from the Brazilian Council for
   Development of Science and Technology (CNPq, Ref: 440909/2016-3), the
   CAPES Foundation, the Brazilian Ministry of Education (Ref.
   88887.116625/2016-01), the Rio de Janeiro Foundation for the Support of
   Science (FAPERJ, Ref: E-26/201.319/2016), and intramural grants from the
   D'Or Institute for Research and Education (IDOR, PNeuro).
CR Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1045, DOI 10.3174/ajnr.A5125
   Aragao MFVV, 2017, ZIKA FOCUS POSTNATAL
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   Barkovich AJ, 1999, AM J NEURORADIOL, V20, P1814
   Bhat Venkatraman, 2014, Indian J Radiol Imaging, V24, P389, DOI 10.4103/0971-3026.143901
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carvalho NS, 2017, AM J REPROD IMMUNOL, V77
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   Carvalho FHC, 2017, PRENATAL DIAG, V37, P207, DOI 10.1002/pd.4985
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kowalczyk B, 2016, ARCH MED SCI, V12, P10, DOI 10.5114/aoms.2016.57578
   Leyser M, 2017, JAMA NEUROL, V74, P610, DOI 10.1001/jamaneurol.2017.0048
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Sarno M, 2016, ULTRASOUND OBSTET GY
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schaub B, 2017, LANCET CHILD ADOLESC, V1, P45, DOI 10.1016/S2352-4642(17)30001-9
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-0429-ED, 10.5858/arpa.2016-04]
   Shastry Siri, 2016, Emerg Med Clin North Am, V34, pe25, DOI 10.1016/j.emc.2016.04.001
   Ticconi C, 2016, PATHOG GLOB HEALTH, V110, P262, DOI 10.1080/20477724.2016.1234804
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   World Health Organization, 2016, ZIK SIT REP ZIK POT
   Zacharias N, 2017, AJP REP, V7, P68, DOI 10.1055/s-0037-1601890
NR 44
TC 10
Z9 10
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD JAN
PY 2018
VL 34
IS 1
BP 85
EP 93
DI 10.1007/s00381-017-3637-1
PG 9
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA FS7GQ
UT WOS:000419966300017
PM 29181810
DA 2020-12-17
ER

PT J
AU Schneider, MA
   Spritzer, PM
   Soll, BMB
   Fontanari, AMV
   Carneiro, M
   Tovar-Moll, F
   Costa, AB
   da Silva, DC
   Schwarz, K
   Anes, M
   Tramontina, S
   Lobato, MIR
AF Schneider, Maiko A.
   Spritzer, Poli M.
   Borba Soll, Bianca Machado
   Fontanari, Anna M. V.
   Carneiro, Marina
   Tovar-Moll, Fernanda
   Costa, Angelo B.
   da Silva, Dhiordan C.
   Schwarz, Karine
   Anes, Mauricio
   Tramontina, Silza
   Lobato, Maria I. R.
TI Brain Maturation, Cognition and Voice Pattern in a Gender Dysphoria Case
   under Pubertal Suppression
SO FRONTIERS IN HUMAN NEUROSCIENCE
LA English
DT Article
DE gender dysphoria; pubertal suppression; white matter; WISC-IV; cognition
ID WHITE-MATTER DEVELOPMENT; GNRH AGONIST TREATMENT; WORKING-MEMORY;
   SEX-DIFFERENCES; SPATIAL MEMORY; ADOLESCENCE; TRANSGENDER; CHILDHOOD;
   DISORDERS; PEOPLE
AB Introduction: Gender dysphoria (GD) (DMS-5) is a condition marked by increasing psychological suffering that accompanies the incongruence between one's experienced or expressed gender and one's assigned gender. Manifestation of GD can be seen early on during childhood and adolescence. During this period, the development of undesirable sexual characteristics marks an acute suffering of being opposite to the sex of birth. Pubertal suppression with gonadotropin releasing hormone analogs (GnRHa) has been proposed for these individuals as a reversible treatment for postponing the pubertal development and attenuating psychological suffering. Recently, increased interest has been observed on the impact of this treatment on brain maturation, cognition and psychological performance.
   Objectives: The aim of this clinical report is to review the effects of puberty suppression on the brain white matter (WM) during adolescence. WM Fractional anisotropy, voice and cognitive functions were assessed before and during the treatment. MRI scans were acquired before, and after 22 and 28 months of hormonal suppression.
   Methods: We performed a longitudinal evaluation of a pubertal transgender girl undergoing hormonal treatment with GnRH analog. Three longitudinal magnetic resonance imaging (MRI) scans were performed for diffusion tensor imaging (DTI), regarding Fractional Anisotropy (FA) for regions of interest analysis. In parallel, voice samples for acoustic analysis as well as executive functioning with the Wechsler Intelligence Scale (WISC-IV) were performed.
   Results: During the follow-up, white matter fractional anisotropy did not increase, compared to normal male puberty effects on the brain. After 22 months of pubertal suppression, operational memory dropped 9 points and remained stable after 28 months of follow-up. The fundamental frequency of voice varied during the first year; however, it remained in the female range.
   Conclusion: Brain white matter fractional anisotropy remained unchanged in the GD girl during pubertal suppression with GnRHa for 28 months, which may be related to the reduced serum testosterone levels and/or to the patient's baseline low average cognitive performance.Global performance on the Weschler scale was slightly lower during pubertal suppression compared to baseline, predominantly due to a reduction in operational memory. Either a baseline of low average cognition or the hormonal status could play a role in cognitive performance during pubertal suppression. The voice pattern during the follow-up seemed to reflect testosterone levels under suppression by GnRHa treatment.
C1 [Schneider, Maiko A.; Spritzer, Poli M.; Borba Soll, Bianca Machado; Fontanari, Anna M. V.; Costa, Angelo B.; da Silva, Dhiordan C.; Schwarz, Karine; Tramontina, Silza; Lobato, Maria I. R.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Gender Ident Program, Porto Alegre, RS, Brazil.
   [Spritzer, Poli M.] Univ Fed Rio Grande do Sul, Dept Physiol, Porto Alegre, RS, Brazil.
   [Spritzer, Poli M.] Hosp Clin Porto Alegre, Serv Endocrinol, Porto Alegre, RS, Brazil.
   [Carneiro, Marina; Tovar-Moll, Fernanda] Inst DOr Pesquisa & Ensino, Porto Alegre, RS, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Costa, Angelo B.] Pontificia Univ Catolica Rio Grande do Sul, Grad Program Psychol, Porto Alegre, RS, Brazil.
   [Anes, Mauricio] Hosp Clin Porto Alegre, Div Med Phys, Porto Alegre, RS, Brazil.
   [Tramontina, Silza] Hosp Clin Porto Alegre, Child & Adolescent Psychiat Serv, Porto Alegre, RS, Brazil.
   [Lobato, Maria I. R.] Hosp Clin Porto Alegre, Psychiat & Forensn Med Serv, Porto Alegre, RS, Brazil.
RP Schneider, MA (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Gender Ident Program, Porto Alegre, RS, Brazil.
EM maikoschneider@hcpa.edu
RI Moll, Fernanda Tovar/N-3320-2018; Spritzer, Poli/A-3357-2019; Costa,
   Angelo Brandelli/E-6988-2015; DA SILVA, DHIORDAN CARDOSO/V-1252-2019;
   Fontanari, Anna Martha Vaitses/O-3185-2019; Spritzer, Poli
   Mara/R-8405-2019
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Costa, Angelo
   Brandelli/0000-0002-0742-8152; Spritzer, Poli Mara/0000-0002-5204-107X;
   CARDOSO DA SILVA, DHIORDAN/0000-0003-4825-6868; Lobato, Maria
   Ines/0000-0003-3925-4051
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Porto
   Alegre, Brazil [CNPq/INCT465482/2014-7]
FX This work was supported in part by a grant from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq/INCT465482/2014-7), Porto
   Alegre, Brazil.
CR Arcelus J, 2016, J SEX MED, V13, P402, DOI 10.1016/j.jsxm.2016.01.003
   Brasil H. H. A., 1996, ENTREVISTA DIAGNOSTI
   BUCK John N. H-T-P, 2003, H T P CASA ARVORE PE
   Campisi P, 2002, ARCH OTOLARYNGOL, V128, P156, DOI 10.1001/archotol.128.2.156
   Chavarria MC, 2014, NEUROSCIENCE, V265, P1, DOI 10.1016/j.neuroscience.2014.01.030
   Clayden JD, 2012, CEREB CORTEX, V22, P1738, DOI 10.1093/cercor/bhr243
   Cohen-Kettenis PT, 2011, ARCH SEX BEHAV, V40, P843, DOI 10.1007/s10508-011-9758-9
   Coleman E, 2012, INT J TRANSGENDERISM, V13, P165, DOI 10.1080/15532739.2011.700873
   Connolly MD, 2016, J ADOLESCENT HEALTH, V59, P489, DOI 10.1016/j.jadohealth.2016.06.012
   Costa R, 2015, J SEX MED, V12, P2206, DOI 10.1111/jsm.13034
   Cromheeke S, 2014, CHILD MALTREATMENT, V19, P38, DOI 10.1177/1077559513511522
   Cunha J. A., 2000, ESCALAS WECHSLER
   de Vries ALC, 2011, J SEX MED, V8, P2276, DOI 10.1111/j.1743-6109.2010.01943.x
   Feder S, 2017, EAT DISORD, V25, P310, DOI 10.1080/10640266.2017.1297112
   Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003
   Gomide P. I. C., 2006, INVENTARIO ESTILOS P
   Hari Kumar K V S, 2016, Indian J Endocrinol Metab, V20, P590
   Hembree WC, 2009, J CLIN ENDOCR METAB, V94, P3132, DOI 10.1210/jc.2009-0345
   Herting MM, 2017, PSYCHONEUROENDOCRINO, V81, P70, DOI 10.1016/j.psyneuen.2017.03.017
   Hough D, 2017, PSYCHONEUROENDOCRINO, V77, P1, DOI 10.1016/j.psyneuen.2016.11.029
   Hough D, 2017, PSYCHONEUROENDOCRINO, V75, P173, DOI 10.1016/j.psyneuen.2016.10.016
   Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053
   Li M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146356
   Menzies L, 2015, DEV COGN NEUROS-NETH, V11, P116, DOI 10.1016/j.dcn.2014.10.002
   Mishra V, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00721
   Moura LM, 2017, BRAIN IMAGING BEHAV, V11, P808, DOI 10.1007/s11682-016-9555-0
   Nusbaum F, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00173
   Nygren U, 2013, CLIN ENDOCRINOL, V79, P859, DOI 10.1111/cen.12226
   Pangelinan MM, 2016, BRAIN STRUCT FUNCT, V221, P1083, DOI 10.1007/s00429-014-0956-9
   Pesaresi M, 2015, NEUROIMAGE, V115, P191, DOI 10.1016/j.neuroimage.2015.04.048
   Reisner SL, 2015, J ADOLESCENT HEALTH, V56, P274, DOI 10.1016/j.jadohealth.2014.10.264
   Robles R, 2016, LANCET PSYCHIAT, V3, P850, DOI 10.1016/S2215-0366(16)30165-1
   Roughan L, 2011, LEARN INDIVID DIFFER, V21, P759, DOI 10.1016/j.lindif.2011.07.011
   Rueda F. J. M., 2013, ESCALA WECHSLER INTE
   SCHUERGER JM, 1989, J CLIN PSYCHOL, V45, P294, DOI 10.1002/1097-4679(198903)45:2<294::AID-JCLP2270450218>3.0.CO;2-N
   Seunarine KK, 2016, BRAIN CONNECT, V6, P37, DOI 10.1089/brain.2015.0340
   Smith KP, 2014, PHARMACOTHERAPY, V34, P1282, DOI 10.1002/phar.1487
   Soleman RS, 2013, J SEX MED, V10, P1969, DOI 10.1111/jsm.12083
   Soll BM, 2018, REV BRAS PSIQUIATR, V40, P174, DOI 10.1590/1516-4446-2016-2224
   Staphorsius AS, 2015, PSYCHONEUROENDOCRINO, V56, P190, DOI 10.1016/j.psyneuen.2015.03.007
   Swift-Gallant A, 2017, FRONT NEUROENDOCRIN, V46, P32, DOI 10.1016/j.yfrne.2017.04.003
   Tanner J., 1962, GROWTH ADOLESCENCE
   Wang YY, 2012, BRAIN RES, V1478, P1, DOI 10.1016/j.brainres.2012.08.038
   Wojniusz S, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01053
   Wong A. P., 2017, CEREB CORTEX, P1, DOI DOI 10.1093/CERCOR/BHX186
   Zhang JN, 2013, BRAIN RES, V1531, P94, DOI 10.1016/j.brainres.2013.07.042
NR 46
TC 10
Z9 10
U1 0
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1662-5161
J9 FRONT HUM NEUROSCI
JI Front. Hum. Neurosci.
PD NOV 14
PY 2017
VL 11
AR 528
DI 10.3389/fnhum.2017.00528
PG 9
WC Neurosciences; Psychology
SC Neurosciences & Neurology; Psychology
GA FM5JK
UT WOS:000415069700001
PM 29184488
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Resende, EDF
   Tovar-Moll, FF
   Ferreira, FM
   Bramati, I
   de Souza, LC
   Carmona, KC
   Guimaraes, HC
   Carvalho, VA
   Barbosa, MT
   Caramelli, P
AF Franca Resende, Elisa de Paula
   Tovar-Moll, Fernanda Freire
   Ferreira, Fernanda Meireles
   Bramati, Ivanei
   de Souza, Leonardo Cruz
   Carmona, Karoline Carvalho
   Guimaraes, Henrique Cerqueira
   Carvalho, Viviane Amaral
   Barbosa, Maira Tonidandel
   Caramelli, Paulo
TI Integrity of white matter structure is related to episodic memory
   performance in the low-educated elderly
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE episodic memory; aging; white matter; health vulnerability
ID COGNITIVE IMPAIRMENT; DIFFUSION; BRAIN; MRI; DEMENTIA; TRACTOGRAPHY;
   POPULATION; CORTEX; BRAZIL
AB The low-educated elderly are a vulnerable population in whom studying the role of white matter integrity on memory may provide insights for understanding how memory declines with aging and disease. Methods: Thirty-one participants (22 women), 23 cognitively healthy and eight with cognitive impairment-no dementia, aged 80.4 +/- 3.8 years, with 2.2 +/- 1.9 years of education, underwent an MRI scan with diffusion tensor imaging (DTI) acquisition. We verified if there were correlations between the performance on the Brief Cognitive Screening Battery (BCSB) and the Rey Auditory Verbal Learning Test (RAVLT) with DTI parameters. Results: The BCSB delayed recall task correlated with frontotemporoparietal connection bundles, with the hippocampal part of the cingulum bilaterally and with the right superior longitudinal fasciculus. The RAVLT learning and delayed recall scores also correlated with the hippocampal part of the cingulum bilaterally. Conclusions: Although preliminary, our study suggests that the integrity of white matter frontotemporoparietal fasciculi seems to play a role in episodic memory performance in the low-educated elderly. This finding opens opportunities to study potential targets for memory decline prevention in vulnerable populations.
C1 [Franca Resende, Elisa de Paula; de Souza, Leonardo Cruz; Carmona, Karoline Carvalho; Guimaraes, Henrique Cerqueira; Carvalho, Viviane Amaral; Barbosa, Maira Tonidandel; Caramelli, Paulo] Univ Fed Minas Gerais, Fac Med Belo Horizonte, Dept Clin Med, Grp Pesquisa Neurol Cognit & Comportamento, Belo Horizonte, MG, Brazil.
   [Tovar-Moll, Fernanda Freire; Ferreira, Fernanda Meireles; Bramati, Ivanei] IDOR Inst DOr Pesquisa Ensino, Rio De Janeiro, RJ, Brazil.
RP Caramelli, P (corresponding author), Av Prof Alfredo Balena 190,Sala 246, BR-30130100 Belo Horizonte, MG, Brazil.
EM caramelli@ufmg.br
RI CARAMELLI, PAULO/H-9735-2012; de Souza, Leonardo C/C-1833-2016; Moll,
   Fernanda Tovar/N-3320-2018
OI CARAMELLI, PAULO/0000-0002-4786-6990; de Souza, Leonardo
   C/0000-0001-5027-9722; Moll, Fernanda Tovar/0000-0002-0292-5985
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); Fundacao de Apoio a Pesquisa de Minas Gerais; Instituto Hermes
   Pardini; CNPq (bolsa de produtividade em pesquisa)
FX CNPq, Fundacao de Apoio a Pesquisa de Minas Gerais and Instituto Hermes
   Pardini. Paulo Caramelli is funded by CNPq (bolsa de produtividade em
   pesquisa).
CR Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782
   Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014
   Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459
   Caracciolo B, 2008, NEUROLOGY, V70, P1778, DOI 10.1212/01.wnl.0000288180.21984.cb
   Caramelli P, 2011, ARQ NEURO-PSIQUIAT, V69, P579, DOI 10.1590/S0004-282X2011000500002
   Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004
   Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926
   Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4
   Goldstein FC, 2009, BRAIN IMAGING BEHAV, V3, P132, DOI 10.1007/s11682-008-9055-y
   Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053
   Irish M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113081
   Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004
   Kantarci K, 2011, NEUROLOGY, V77, P26, DOI 10.1212/WNL.0b013e31822313dc
   Lavdas I, 2014, J MAGN RESON IMAGING, V40, P682, DOI 10.1002/jmri.24397
   Lee DY, 2009, NEUROLOGY, V73, P1722, DOI 10.1212/WNL.0b013e3181c33afb
   Lockhart SN, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00056
   Malloy-Diniz LF, 2007, REV BRAS PSIQUIATR, V29, P324, DOI 10.1590/S1516-44462006005000053
   Mesulam M, 2005, ANN NEUROL, V57, P5, DOI 10.1002/ana.20368
   Metzler-Baddeley C, 2011, J NEUROSCI, V31, P13236, DOI 10.1523/JNEUROSCI.2317-11.2011
   Nitrini R, 2004, J INT NEUROPSYCH SOC, V10, P634, DOI 10.1017/S1355617704104062
   Nitrini R, 2009, INT PSYCHOGERIATR, V21, P622, DOI 10.1017/S1041610209009430
   Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.3.CO;2-A
   SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11
   Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051
   Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024
   Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114
   Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318
   Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027
   Zhuang L, 2012, NEUROLOGY, V79, P748, DOI 10.1212/WNL.0b013e3182661f4d
   ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555
NR 30
TC 1
Z9 1
U1 0
U2 2
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD NOV
PY 2017
VL 75
IS 11
BP 778
EP 784
DI 10.1590/0004-282X20170158
PG 7
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA FP4XM
UT WOS:000417620300005
PM 29236820
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Puccioni-Sohler, M
   Ornelas, AMM
   de Souza, AS
   Cabral-Castro, MJ
   Ramos, JTMA
   Rosadas, C
   Salgado, MCF
   Castiglione, AA
   Ferry, F
   Peralta, JM
   Voloch, CM
   Tanuri, A
   Tovar-Moll, F
   Aguiar, RS
AF Puccioni-Sohler, Marzia
   Ornelas, Alice M. M.
   de Souza, Andrea S.
   Cabral-Castro, Mauro Jorge
   Ramos, Jessyca T. M. A.
   Rosadas, Carolina
   Salgado, Maria Cecilia F.
   Castiglione, Alexandre A.
   Ferry, Fernando
   Peralta, Jose Mauro
   Voloch, Carolina Moreira
   Tanuri, Amilcar
   Tovar-Moll, Fernanda
   Aguiar, Renato Santana
TI First report of persistent dengue-1-associated autoimmune neurological
   disturbance: neuromyelitis optica spectrum disorder
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Article
DE Dengue virus; Neuromyelitis optica spectrum disorder; Magnetic resonance
   imaging; Cerebrospinal fluid
ID DENGUE; INFECTION
AB Dengue virus (DENV) causes immune-mediated diseases. Neurological involvement represents a severe condition that is rarely observed in DENV-1 infection. Neuromyelitis optica (NMO)/NMO spectrum disorders (NMOSD) are idiopathic immune-mediated demyelinating syndromes of the central nervous system. We report a 17-year-old female with oligosymptomatic DENV-1 viremia, diagnosed as NMOSD. Magnetic resonance imaging showed spinal cord and brainstem lesions. Antibody for aquaporin 4 was negative. DENV-1 RNA infection was detected by serial RT-PCR and confirmed by phylogenetic analysis in serum. Although there are some reports of NMO post-dengue infection, there are not any published accounts of NMOSD with coexistent and persistent DENV-1 infection.
C1 [Puccioni-Sohler, Marzia; Ramos, Jessyca T. M. A.; Salgado, Maria Cecilia F.; Ferry, Fernando] Univ Fed Estado Rio de Janeiro UNIRIO, Rio De Janeiro, Brazil.
   [Puccioni-Sohler, Marzia; Ornelas, Alice M. M.; Cabral-Castro, Mauro Jorge; Rosadas, Carolina; Peralta, Jose Mauro; Voloch, Carolina Moreira; Tanuri, Amilcar; Tovar-Moll, Fernanda; Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Puccioni-Sohler, Marzia] Univ Fed Estado Rio de Janeiro, Hosp Univ Gaffree e Guinle, Rua Mariz e Barros 775, BR-22270004 Rio de Janeiro, Brazil.
   [de Souza, Andrea S.; Tovar-Moll, Fernanda] DOr Inst Pesquisa & Educ IDOR, Rio De Janeiro, Brazil.
   [Castiglione, Alexandre A.] Hosp Municipal Jesus, Rio De Janeiro, Brazil.
RP Puccioni-Sohler, M (corresponding author), Univ Fed Estado Rio de Janeiro UNIRIO, Rio De Janeiro, Brazil.; Puccioni-Sohler, M (corresponding author), Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.; Puccioni-Sohler, M (corresponding author), Univ Fed Estado Rio de Janeiro, Hosp Univ Gaffree e Guinle, Rua Mariz e Barros 775, BR-22270004 Rio de Janeiro, Brazil.
EM m_puccioni@yahoo.com.br
RI Voloch, Carolina M/F-8874-2013; de Souza, Andrea Silveira/AAL-1976-2020;
   Aguiar, Renato S/G-3542-2015; Moll, Fernanda Tovar/N-3320-2018;
   Cabral-Castro, Mauro Jorge/L-8868-2016
OI Voloch, Carolina M/0000-0001-5182-4366; de Souza, Andrea
   Silveira/0000-0002-1553-2312; Aguiar, Renato S/0000-0001-5180-3717;
   Moll, Fernanda Tovar/0000-0002-0292-5985; Cabral-Castro, Mauro
   Jorge/0000-0002-1755-999X
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Edital Programa Pesquisa em Zika, Chikungunya e Dengue
   [18/2015]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Edital Apoio Rede Zika Multicwntrico [439928/2016-8]
FX The authors thank "Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)", "Edital Programa Pesquisa em Zika, Chikungunya e
   Dengue-no. 18/2015" and "Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq)", "Edital Apoio Rede Zika Multicwntrico
   (439928/2016-8)" for their financial support for this study. The authors
   also thank Dr. Carlos Senne (Senne Liquor Diagnostico, Sao Paulo) for
   the performing of paired CSF/serum oligoclonal IgG band analysis, Dr.
   Osvaldo Nascimento (Universidade Federal Fluminense, Niteroi) for the
   somatosensory evoked potential and EMG studies, Dr. Ana Cristina
   Favoreto from Hospital Municipal Jesus, Dr. Luiz Eduardo Motta Ferreira,
   and the group from Hospital Universitario Gaffree e Guinle/UNIRIO for
   their clinical assistance during the patient's hospitalization.
CR [Anonymous], 2009, DENG GUID DIAGN TREA
   de Sousa Adriano Miranda, 2006, Journal of Infection and Chemotherapy, V12, P396, DOI 10.1007/s10156-006-0475-6
   Dettogni RS, 2015, HUM IMMUNOL, V76, P717, DOI 10.1016/j.humimm.2015.09.026
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Klein RS, 2017, IMMUNITY, V46, P891, DOI 10.1016/j.immuni.2017.06.012
   Kunishige M, 2004, NEUROLOGY, V63, P1980, DOI 10.1212/01.WNL.0000144194.29643.D0
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Machado C, 2015, J NEUROL SCI, V358, P520, DOI 10.1016/j.jns.2015.09.374
   Masuda S, 2015, J NEUROL NEUROSUR PS, V86, P1137, DOI 10.1136/jnnp-2014-308095
   Puccioni-Sohler M, 2009, NEUROLOGY, V73, P1413, DOI 10.1212/WNL.0b013e3181bd8258
   Sellner J, 2010, J AUTOIMMUN, V34, P371, DOI 10.1016/j.jaut.2009.09.013
   Tran C, 2007, J INTERN MED, V261, P500, DOI 10.1111/j.1365-2796.2007.01794.x
   Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729
NR 13
TC 3
Z9 4
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD OCT
PY 2017
VL 23
IS 5
BP 768
EP 771
DI 10.1007/s13365-017-0555-7
PG 4
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA FK7PI
UT WOS:000413699100014
PM 28748449
DA 2020-12-17
ER

PT J
AU Lima, F
   Garcia, C
   Geraldo, LH
   Fonseca, AC
   Correa, AH
   Tovar-Moll, F
AF Lima, F.
   Garcia, C.
   Geraldo, L. H.
   Fonseca, A. C.
   Correa, A. H.
   Tovar-Moll, F.
TI The role of parenchymal cellular prion protein during glioblastoma
   progression
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT ISN-ESN Meeting
CY AUG 20-24, 2017
CL Paris, FRANCE
SP Int Soc Neurochemistry, Amer Soc Neurochemistry, ESN
C1 [Lima, F.; Garcia, C.; Geraldo, L. H.; Fonseca, A. C.; Correa, A. H.; Tovar-Moll, F.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Ctr Ciencias Saude, Rio De Janeiro, Brazil.
RI Moll, Fernanda Tovar/N-3320-2018
OI Moll, Fernanda Tovar/0000-0002-0292-5985
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPESCAPES; Cancer Foundation RJ;
   INCT-INNT
FX Supported by: FAPERJ, CNPq, CAPES, Cancer Foundation RJ, INCT-INNT.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2017
VL 142
SU 1
SI SI
MA MTU01-10
BP 81
EP 81
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA FD3HY
UT WOS:000407425300152
DA 2020-12-17
ER

PT J
AU Chimelli, L
   Melo, ASO
   Avvad-Portari, E
   Wiley, CA
   Camacho, AHS
   Lopes, VS
   Machado, HN
   Andrade, CV
   Dock, DCA
   Moreira, ME
   Tovar-Moll, F
   Oliveira-Szejnfeld, PS
   Carvalho, ACG
   Ugarte, ON
   Batista, AGM
   Amorim, MMR
   Melo, FO
   Ferreira, TA
   Marinho, JRL
   Azevedo, GS
   Leal, JIBF
   da Costa, RFM
   Rehen, S
   Arruda, MB
   Brindeiro, RM
   Delvechio, R
   Aguiar, RS
   Tanuri, A
AF Chimelli, Leila
   Melo, Adriana S. O.
   Avvad-Portari, Elyzabeth
   Wiley, Clayton A.
   Camacho, Aline H. S.
   Lopes, Vania S.
   Machado, Heloisa N.
   Andrade, Cecilia V.
   Dock, Dione C. A.
   Moreira, Maria Elisabeth
   Tovar-Moll, Fernanda
   Oliveira-Szejnfeld, Patricia S.
   Carvalho, Angela C. G.
   Ugarte, Odile N.
   Batista, Alba G. M.
   Amorim, Melania M. R.
   Melo, Fabiana O.
   Ferreira, Thales A.
   Marinho, Jacqueline R. L.
   Azevedo, Girlene S.
   Leal, Jeime I. B. F.
   Madeiro da Costa, Rodrigo F.
   Rehen, Stevens
   Arruda, Monica B.
   Brindeiro, Rodrigo M.
   Delvechio, Rodrigo
   Aguiar, Renato S.
   Tanuri, Amilcar
TI The spectrum of neuropathological changes associated with congenital
   Zika virus infection
SO ACTA NEUROPATHOLOGICA
LA English
DT Article
DE Zika virus; Congenital ZIKV infection; Microcephaly; Calcification; In
   situ hybridization; Neuropathology
ID TRANSMISSION; OUTBREAK; BRAZIL
AB A major concern associated with ZIKV infection is the increased incidence of microcephaly with frequent calcifications in infants born from infected mothers. To date, postmortem analysis of the central nervous system (CNS) in congenital infection is limited to individual reports or small series. We report a comprehensive neuropathological study in ten newborn babies infected with ZIKV during pregnancy, including the spinal cords and dorsal root ganglia (DRG), and also muscle, pituitaries, eye, systemic organs, and placentas. Using in situ hybridization (ISH) and electron microscopy, we investigated the role of direct viral infection in the pathogenesis of the lesions. Nine women had Zika symptoms between the 4th and 18th and one in the 28th gestational week. Two babies were born at 32, one at 34 and 36 weeks each and six at term. The cephalic perimeter was reduced in four, and normal or enlarged in six patients, although the brain weights were lower than expected. All had arthrogryposis, except the patient infected at 28 weeks gestation. We defined three patterns of CNS lesions, with different patterns of destructive, calcification, hypoplasia, and migration disturbances. Ventriculomegaly was severe in the first pattern due to midbrain damage with aqueduct stenosis/distortion. The second pattern had small brains and mild/moderate (ex-vacuo) ventriculomegaly. The third pattern, a well-formed brain with mild calcification, coincided with late infection. The absence of descending fibres resulted in hypoplastic basis pontis, pyramids, and cortico-spinal tracts. Spinal motor cell loss explained the intrauterine akinesia, arthrogryposis, and neurogenic muscle atrophy. DRG, dorsal nerve roots, and columns were normal. Lymphohistiocytic inflammation was mild. ISH showed meningeal, germinal matrix, and neocortical infection, consistent with neural progenitors death leading to proliferation and migration disorders. A secondary ischemic process may explain the destructive lesions. In conclusion, we characterized the destructive and malformative consequences of ZIKV in the nervous system, as reflected in the topography and severity of lesions, anatomic localization of the virus, and timing of infection during gestation. Our findings indicate a developmental vulnerability of the immature CNS, and shed light on possible mechanisms of brain injury of this newly recognized public health threat.
C1 [Chimelli, Leila; Camacho, Aline H. S.] State Inst Brain Paulo Niemeyer, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Chimelli, Leila; Camacho, Aline H. S.] Univ Fed Rio de Janeiro, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Melo, Adriana S. O.; Amorim, Melania M. R.; Melo, Fabiana O.; Ferreira, Thales A.; Azevedo, Girlene S.] Res Inst Prof Amorim Neto, Rua Duque Caxias 330, BR-58400506 Campina Grande, PB, Brazil.
   [Melo, Adriana S. O.; Batista, Alba G. M.; Marinho, Jacqueline R. L.; Leal, Jeime I. B. F.] Hlth Secretary Campina Grande, Rua Duque Caxias 330, BR-58400506 Campina Grande, PB, Brazil.
   [Avvad-Portari, Elyzabeth; Machado, Heloisa N.; Andrade, Cecilia V.; Dock, Dione C. A.; Moreira, Maria Elisabeth] Fiocruz MS, Fernandes Figueira Inst, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Wiley, Clayton A.] UPMC Presbiterian Hosp, Div Neuropathol, S701 Scaife Hall 200 Lothrop St, Pittsburgh, PA 15213 USA.
   [Lopes, Vania S.; Carvalho, Angela C. G.; Ugarte, Odile N.] Univ Fed Fluminense, Antonio Pedro Univ Hosp, Dept Pathol, Rua Marques Parana 303, BR-24033900 Niteroi, RJ, Brazil.
   [Tovar-Moll, Fernanda; Madeiro da Costa, Rodrigo F.; Rehen, Stevens] DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
   [Tovar-Moll, Fernanda; Madeiro da Costa, Rodrigo F.; Rehen, Stevens] Univ Fed Rio de Janeiro, Rua Diniz Cordeiro 30, BR-22281100 Rio de Janeiro, RJ, Brazil.
   [Oliveira-Szejnfeld, Patricia S.] Fdn Inst Educ & Res Diagnost Imaging FIDI, Fetal Med Res, Rua Napoleao Barros 800, BR-04024002 Sao Paulo, SP, Brazil.
   [Arruda, Monica B.; Brindeiro, Rodrigo M.; Delvechio, Rodrigo; Aguiar, Renato S.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, CCS, Inst Biol, Lab Med Virol,Dept Genet, Bloco A,Sala 121, BR-21941902 Rio de Janeiro, RJ, Brazil.
RP Chimelli, L (corresponding author), State Inst Brain Paulo Niemeyer, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.; Chimelli, L (corresponding author), Univ Fed Rio de Janeiro, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
EM chimelli@hucff.ufrj.br
RI Aguiar, Renato S/G-3542-2015; Ferreira, Thales Araujo/AAA-6252-2019;
   Amorim, Melania M/C-5807-2013; Melo, Adriana S O/H-5650-2016; Moll,
   Fernanda Tovar/N-3320-2018; Rehen, Stevens K/J-5874-2012; ANDRADE,
   CECILIA/B-5916-2017
OI Aguiar, Renato S/0000-0001-5180-3717; Amorim, Melania
   M/0000-0003-1047-2514; Moll, Fernanda Tovar/0000-0002-0292-5985; Rehen,
   Stevens K/0000-0003-4216-9501; Soares de Oliveira Szejnfeld,
   Patricia/0000-0002-3780-5182; FERREIRA, THALES/0000-0002-6699-5886;
   ANDRADE, CECILIA/0000-0001-7980-4367
FU National Institute of Health (NIH) IH NIAID grant [U01 AI 111598];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   [CNPq]National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Rio de Janeiro [FAPERJ]Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U01AI111598, U01AI111598, U01AI111598,
   U01AI111598, U01AI111598, U01AI111598] Funding Source: NIH RePORTER;
   Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15102]
   Funding Source: researchfish
FX We thank DEbora Silva, Diego Santos, and Luciana Bitana for technical
   assistance in histological and immunohistochemical preparations, and
   Centro Nacional de Biologia Estrutural e Bioimagem (CENABIO) for
   technical assistance in transmission electron microscopy. These studies
   received partial support from the National Institute of Health (NIH) IH
   NIAID grant U01 AI 111598 (C.A.W.) and from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico [CNPq] and Fundacao de Amparo a
   Pesquisa do Rio de Janeiro [FAPERJ] (A.T).
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brien JD, 2009, J EXP MED, V206, P2735, DOI 10.1084/jem.20090222
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellison D, 2012, NEUROPATHOLOGY REFER
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larroche J-C, 1977, DEV PATHOLOGY NEONAT, P1
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Love S, 2015, GREENFIELD'S NEUROPATHOLOGY, 9TH EDITION, VOLS 1AND 2, P1087
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mecharles S, 2016, LANCET, V8, P6736, DOI DOI 10.1136/BCR-2012-007094.4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   SNIJDERS RJM, 1994, ULTRASOUND OBST GYN, V4, P34, DOI 10.1046/j.1469-0705.1994.04010034.x
   Solomon IH, 2016, J NEUROINFECT DIS, V7, P220, DOI DOI 10.4172/2314-7326.1000220
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Tadros MA, 2015, J NEUROPHYSIOL, V114, P2661, DOI 10.1152/jn.00682.2015
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 49
TC 74
Z9 77
U1 1
U2 30
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0001-6322
EI 1432-0533
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PD JUN
PY 2017
VL 133
IS 6
BP 983
EP 999
DI 10.1007/s00401-017-1699-5
PG 17
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA EU6HB
UT WOS:000401134000008
PM 28332092
DA 2020-12-17
ER

PT J
AU Hoogman, M
   Bralten, J
   Hibar, DP
   Mennes, M
   Zwiers, MP
   Schweren, LSJ
   van Hulzen, KJE
   Medland, SE
   Shumskaya, E
   Jahanshad, N
   de Zeeuw, P
   Szekely, E
   Sudre, G
   Wolfers, T
   Onnink, AMH
   Dammers, JT
   Mostert, JC
   Vives-Gilabert, Y
   Kohls, G
   Oberwelland, E
   Seitz, J
   Schulte-Ruther, M
   Ambrosino, S
   Doyle, AE
   Hovik, MF
   Dramsdahl, M
   Tamm, L
   van Erp, TGM
   Dale, A
   Schork, A
   Conzelmann, A
   Zierhut, K
   Baur, R
   McCarthy, H
   Yoncheva, YN
   Cubillo, A
   Chantiluke, K
   Mehta, MA
   Paloyelis, Y
   Hohmann, S
   Baumeister, S
   Bramati, I
   Mattos, P
   Tovar-Moll, F
   Douglas, P
   Banaschewski, T
   Brandeis, D
   Kuntsi, J
   Asherson, P
   Rubia, K
   Kelly, C
   Di Martino, A
   Milham, MP
   Castellanos, FX
   Frodl, T
   Zentis, M
   Lesch, KP
   Reif, A
   Pauli, P
   Jernigan, TL
   Haavik, J
   Plessen, KJ
   Lundervold, AJ
   Hugdahl, K
   Seidman, LJ
   Biederman, J
   Rommelse, N
   Heslenfeld, DJ
   Hartman, CA
   Hoekstra, PJ
   Oosterlaan, J
   von Polier, G
   Konrad, K
   Vilarroya, O
   Ramos-Quiroga, JA
   Soliva, JC
   Durston, S
   Buitelaar, JK
   Faraone, SV
   Shaw, P
   Thompson, PM
   Franke, B
AF Hoogman, Martine
   Bralten, Janita
   Hibar, Derrek P.
   Mennes, Maarten
   Zwiers, Marcel P.
   Schweren, Lizanne S. J.
   van Hulzen, Kimm J. E.
   Medland, Sarah E.
   Shumskaya, Elena
   Jahanshad, Neda
   de Zeeuw, Patrick
   Szekely, Eszter
   Sudre, Gustavo
   Wolfers, Thomas
   Onnink, Alberdingk M. H.
   Dammers, Janneke T.
   Mostert, Jeanette C.
   Vives-Gilabert, Yolanda
   Kohls, Gregor
   Oberwelland, Eileen
   Seitz, Jochen
   Schulte-Ruether, Martin
   Ambrosino, Sara
   Doyle, Alysa E.
   Hovik, Marie F.
   Dramsdahl, Margaretha
   Tamm, Leanne
   van Erp, Theo G. M.
   Dale, Anders
   Schork, Andrew
   Conzelmann, Annette
   Zierhut, Kathrin
   Baur, Ramona
   McCarthy, Hazel
   Yoncheva, Yuliya N.
   Cubillo, Ana
   Chantiluke, Kaylita
   Mehta, Mitul A.
   Paloyelis, Yannis
   Hohmann, Sarah
   Baumeister, Sarah
   Bramati, Ivanei
   Mattos, Paulo
   Tovar-Moll, Fernanda
   Douglas, Pamela
   Banaschewski, Tobias
   Brandeis, Daniel
   Kuntsi, Jonna
   Asherson, Philip
   Rubia, Katya
   Kelly, Clare
   Di Martino, Adriana
   Milham, Michael P.
   Castellanos, Francisco X.
   Frodl, Thomas
   Zentis, Mariam
   Lesch, Klaus-Peter
   Reif, Andreas
   Pauli, Paul
   Jernigan, Terry L.
   Haavik, Jan
   Plessen, Kerstin J.
   Lundervold, Astri J.
   Hugdahl, Kenneth
   Seidman, Larry J.
   Biederman, Joseph
   Rommelse, Nanda
   Heslenfeld, Dirk J.
   Hartman, Catharina A.
   Hoekstra, Pieter J.
   Oosterlaan, Jaap
   von Polier, Georg
   Konrad, Kerstin
   Vilarroya, Oscar
   Antoni Ramos-Quiroga, Josep
   Carles Soliva, Joan
   Durston, Sarah
   Buitelaar, Jan K.
   Faraone, Stephen V.
   Shaw, Philip
   Thompson, Paul M.
   Franke, Barbara
TI Subcortical brain volume differences in participants with attention
   deficit hyperactivity disorder in children and adults: a cross-sectional
   mega-analysis
SO LANCET PSYCHIATRY
LA English
DT Article
ID CALLOUS-UNEMOTIONAL TRAITS; MEDICATION-NAIVE CHILDREN;
   DEFICIT/HYPERACTIVITY DISORDER; EPISODIC MEMORY; STRUCTURAL MRI;
   METAANALYSIS; ADHD; ABNORMALITIES; DEPRESSION; AMYGDALA
AB Background Neuroimaging studies have shown structural alterations in several brain regions in children and adults with attention deficit hyperactivity disorder (ADHD). Through the formation of the international ENIGMA ADHD Working Group, we aimed to address weaknesses of previous imaging studies and meta-analyses, namely inadequate sample size and methodological heterogeneity. We aimed to investigate whether there are structural differences in children and adults with ADHD compared with those without this diagnosis.
   Methods In this cross-sectional mega-analysis, we used the data from the international ENIGMA Working Group collaboration, which in the present analysis was frozen at Feb 8, 2015. Individual sites analysed structural T1-weighted MRI brain scans with harmonised protocols of individuals with ADHD compared with those who do not have this diagnosis. Our primary outcome was to assess case-control differences in subcortical structures and intracranial volume through pooling of all individual data from all cohorts in this collaboration. For this analysis, p values were significant at the false discovery rate corrected threshold of p=0.0156.
   Findings Our sample comprised 1713 participants with ADHD and 1529 controls from 23 sites with a median age of 14 years (range 4-63 years). The volumes of the accumbens (Cohen's d=-0.15), amygdala (d=-0.19), caudate (d=-0.11), hippocampus (d=-0.11), putamen (d=-0.14), and intracranial volume (d=-0.10) were smaller in individuals with ADHD compared with controls in the mega-analysis. There was no difference in volume size in the pallidum (p=0.95) and thalamus (p=0.39) between people with ADHD and controls. Exploratory lifespan modelling suggested a delay of maturation and a delay of degeneration, as effect sizes were highest in most subgroups of children (< 15 years) versus adults (> 21 years): in the accumbens (Cohen's d=-0.19 vs -0.10), amygdala (d=-0.18 vs -0.14), caudate (d=-0.13 vs -0.07), hippocampus (d=-0.12 vs -0.06), putamen (d=-0.18 vs -0.08), and intracranial volume (d=-0.14 vs 0.01). There was no difference between children and adults for the pallidum (p=0.79) or thalamus (p=0.89). Case-control differences in adults were non-significant (all p > 0.03). Psychostimulant medication use (all p > 0.15) or symptom scores (all p > 0.02) did not influence results, nor did the presence of comorbid psychiatric disorders (all p > 0.5).
   Interpretation With the largest dataset to date, we add new knowledge about bilateral amygdala, accumbens, and hippocampus reductions in ADHD. We extend the brain maturation delay theory for ADHD to include subcortical structures and refute medication effects on brain volume suggested by earlier meta-analyses. Lifespan analyses suggest that, in the absence of well powered longitudinal studies, the ENIGMA cross-sectional sample across six decades of ages provides a means to generate hypotheses about lifespan trajectories in brain phenotypes.
C1 [Hoogman, Martine; Bralten, Janita; van Hulzen, Kimm J. E.; Shumskaya, Elena; Wolfers, Thomas; Onnink, Alberdingk M. H.; Mostert, Jeanette C.; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, POB 9101, Nijmegen, Netherlands.
   [Dammers, Janneke T.; Rommelse, Nanda; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, Nijmegen, Netherlands.
   [Buitelaar, Jan K.] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, Nijmegen, Netherlands.
   [Hoogman, Martine; Bralten, Janita; Mennes, Maarten; Zwiers, Marcel P.; van Hulzen, Kimm J. E.; Shumskaya, Elena; Wolfers, Thomas; Onnink, Alberdingk M. H.; Dammers, Janneke T.; Mostert, Jeanette C.; Buitelaar, Jan K.; Franke, Barbara] Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.
   [Hibar, Derrek P.; Jahanshad, Neda; Thompson, Paul M.] Univ Southern Calif, Keck Sch Med, Mark & Mary Stevens Inst Neuroimaging & Informat, Imaging Genet Ctr, Marina Del Rey, CA USA.
   [Schweren, Lizanne S. J.; Hartman, Catharina A.; Hoekstra, Pieter J.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands.
   [Medland, Sarah E.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.
   [de Zeeuw, Patrick; Ambrosino, Sara; Durston, Sarah] Univ Med Ctr Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, NICHE Lab, Utrecht, Netherlands.
   [Szekely, Eszter; Sudre, Gustavo; Shaw, Philip] Natl Human Genome Res Inst, Neurobehav Clin Res Sect, Bethesda, MD USA.
   [Vives-Gilabert, Yolanda] Asoc Innovac Anal Gest & Procesamiento Datos Cien, Barcelona, Spain.
   [Kohls, Gregor; Oberwelland, Eileen; Schulte-Ruether, Martin; von Polier, Georg; Konrad, Kerstin] Univ Hosp Aachen, Child Neuropsychol Sect, Aachen, Germany.
   [Seitz, Jochen] Univ Hosp Aachen, Dept Child & Adolescent Psychiat, Aachen, Germany.
   [Oberwelland, Eileen; Schulte-Ruether, Martin] Res Ctr Juelich, JARA Translat Brain Med, Aachen, Germany.
   [Doyle, Alysa E.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA USA.
   [Doyle, Alysa E.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA USA.
   [Doyle, Alysa E.] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA USA.
   [Hovik, Marie F.] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Tamm, Leanne] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA.
   [van Erp, Theo G. M.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA USA.
   [Dale, Anders] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA.
   [Dale, Anders] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA.
   [Dale, Anders] UCSD Ctr Translat Imaging & Precis Med, San Diego, CA USA.
   [Schork, Andrew] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA USA.
   [Conzelmann, Annette] Univ Tubingen, Dept Child & Adolescent Psychiat & Psychotherapy, Tubingen, Germany.
   [Zierhut, Kathrin] Univ Wurzburg, Dept Med Psychol & Psychotherapy, Med Sociol & Rehabil Sci, Wurzburg, Germany.
   [Conzelmann, Annette; Zierhut, Kathrin; Baur, Ramona; Pauli, Paul] Univ Wurzburg, Dept Psychol, Wurzburg, Germany.
   [Lesch, Klaus-Peter] Univ Wurzburg, Div Mol Psychiat, Ctr Mental Hlth, Wurzburg, Germany.
   [McCarthy, Hazel; Kelly, Clare; Frodl, Thomas] Univ Dublin, Trinity Coll Dublin, Dept Psychiat, Dublin, Ireland.
   [Yoncheva, Yuliya N.; Kelly, Clare; Di Martino, Adriana; Castellanos, Francisco X.] NYU Langone Med Ctr, Ctr Child Study, New York, NY USA.
   [Cubillo, Ana; Chantiluke, Kaylita; Rubia, Katya] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Child & Adolescent Psychiat, London, England.
   [Mehta, Mitul A.; Paloyelis, Yannis] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Neuroimaging, London, England.
   [Kuntsi, Jonna; Asherson, Philip] Kings Coll London, Inst Psychiat Psychol & Neurosci, Social Genet & Dev Psychiat, London, England.
   [Hohmann, Sarah; Baumeister, Sarah; Banaschewski, Tobias; Brandeis, Daniel] Heidelberg Univ, Cent Inst Mental Hlth Med Fac Mannheim, Dept Child & Adolescent Psychiat & Psychotherapy, Mannheim, Germany.
   [Bramati, Ivanei; Mattos, Paulo; Tovar-Moll, Fernanda] DOr Inst Res & Educ, Rio De Janeiro, Brazil.
   [Mattos, Paulo] Univ Fed Rio de Janeiro, Inst Psychiat, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Morphol Sci Program, Rio De Janeiro, Brazil.
   [Douglas, Pamela] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA.
   [Brandeis, Daniel] Univ Zurich, Dept Child & Adolescent Psychiat, Hosp Psychiat, Zurich, Switzerland.
   [Brandeis, Daniel] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.
   [Brandeis, Daniel] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland.
   [Brandeis, Daniel] ETH, Zurich, Switzerland.
   [Kelly, Clare] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland.
   [Milham, Michael P.] Child Mind Inst, Ctr Developing Brain, New York, NY USA.
   [Milham, Michael P.] Nathan S Kline Inst Psychiat Res, Ctr Biomed Imaging & Neuromodulat, Orangeburg, NY USA.
   [Castellanos, Francisco X.] Nathan S Kline Inst Psychiat Res, Div Child & Adolescent Psychiat Res, Orangeburg, NY USA.
   [Frodl, Thomas; Zentis, Mariam] Otto Von Guericke Univ, Univ Hosp, Dept Psychiat & Psychotherapy, Magdeburg, Germany.
   [Lesch, Klaus-Peter] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Translat Neurosci, Maastricht, Netherlands.
   [Reif, Andreas] Univ Hosp Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany.
   [Jernigan, Terry L.] Univ Calif San Diego, Dept Cognit Sci, San Diego, CA USA.
   [Jernigan, Terry L.] Univ Calif San Diego, Dept Psychiat, San Diego, CA USA.
   [Jernigan, Terry L.] Univ Calif San Diego, Dept Radiol, San Diego, CA USA.
   [Jernigan, Terry L.] Univ Calif San Diego, Ctr Human Dev, San Diego, CA USA.
   [Haavik, Jan; Faraone, Stephen V.] Univ Bergen, Dept Biomed, KG Jebsen Ctr Neuropsychiat Disorders, Bergen, Norway.
   [Haavik, Jan; Hugdahl, Kenneth] Haukeland Hosp, Dept Psychiat, Bergen, Norway.
   [Hugdahl, Kenneth] Haukeland Hosp, Dept Radiol, Bergen, Norway.
   [Plessen, Kerstin J.] Child & Adolescent Mental Hlth Ctr, Capital Region, Denmark.
   [Lundervold, Astri J.; Hugdahl, Kenneth] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway.
   [Seidman, Larry J.; Biederman, Joseph] Harvard Med Sch, Dept Psychiat, Boston, MA USA.
   [Seidman, Larry J.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
   [Biederman, Joseph] Massachusetts Gen Hosp, Clin & Res Programs Pediat Psychopharmacol & Adul, Boston, MA 02114 USA.
   [Rommelse, Nanda; Buitelaar, Jan K.] Karakter Child & Adolescent Psychiat, Nijmegen, Netherlands.
   [Heslenfeld, Dirk J.] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.
   [Heslenfeld, Dirk J.; Oosterlaan, Jaap] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands.
   [Vilarroya, Oscar; Antoni Ramos-Quiroga, Josep; Carles Soliva, Joan] Univ Autonoma Barcelona, Dept Psychiat & Legal Med, Barcelona, Spain.
   [Vilarroya, Oscar] Fdn IMIM, Barcelona, Spain.
   [Antoni Ramos-Quiroga, Josep] CIBERSAM, Hosp Univ Vall Hebron, Dept Psychiat, Barcelona, Spain.
   [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA.
   [Shaw, Philip] NIMH, Bethesda, MD 20892 USA.
RP Hoogman, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, POB 9101, Nijmegen, Netherlands.
EM martine.hoogman@radboudumc.nl
RI Medland, Sarah/AAT-7595-2020; Haavik, Jan/AAI-3974-2020; Milham, Michael
   P./Y-3160-2019; Kohls, Gregor/AAH-6429-2020; Kuntsi,
   Jonna/AAU-1195-2020; Frodl, Thomas/D-8118-2012; Rommelse,
   Nanda/D-4872-2009; Buitelaar, J.K./AAY-7522-2020; Hoogman,
   Martine/G-8958-2015; Mostert, Jeanette/E-4745-2015; Konrad,
   Kerstin/H-7747-2013; de Mattos, Paulo Eduardo Luiz/D-2328-2014; Di
   Martino, Adriana/X-5030-2019; Haavik, Jan/ABE-1535-2020; Cubillo, Ana
   I/J-6822-2019; Medland, Sarah E/C-7630-2013; Faraone,
   Stephen/AAE-7334-2019; Moll, Fernanda Tovar/N-3320-2018; Wolfers,
   Thomas/ABF-1461-2020; Castellanos, Francisco Xavier/K-1892-2014; Kelly,
   Clare/H-4629-2016; Franke, Barbara/D-4836-2009; Seitz,
   Jochen/AAE-7363-2019; Zwiers, Marcel P/D-2968-2009; Banaschewski,
   Tobias/ABE-5985-2020; Faraone, Stephen V/O-7239-2018; Mennes,
   Maarten/C-9924-2011; Bralten, Janita/AAB-9566-2019; Lesch,
   Klaus-Peter/J-4906-2013; Thompson, Paul M/C-4194-2018; Shaw,
   Philip/A-1129-2008; Wolfers, Thomas/G-9575-2015; Rubia,
   Katya/H-7497-2012; Schulte-Ruther, Martin/F-4784-2013
OI Medland, Sarah/0000-0003-1382-380X; Haavik, Jan/0000-0001-7865-2808;
   Kuntsi, Jonna/0000-0002-0113-8162; Rommelse, Nanda/0000-0002-1711-0359;
   Hoogman, Martine/0000-0002-1261-7628; Mostert,
   Jeanette/0000-0002-0033-1622; Konrad, Kerstin/0000-0001-9039-2615; de
   Mattos, Paulo Eduardo Luiz/0000-0003-0709-3783; Di Martino,
   Adriana/0000-0001-6927-290X; Medland, Sarah E/0000-0003-1382-380X;
   Faraone, Stephen/0000-0002-9217-3982; Moll, Fernanda
   Tovar/0000-0002-0292-5985; Castellanos, Francisco
   Xavier/0000-0001-9192-9437; Kelly, Clare/0000-0001-8253-357X; Franke,
   Barbara/0000-0003-4375-6572; Seitz, Jochen/0000-0002-0110-7980; Zwiers,
   Marcel P/0000-0001-5483-2935; Banaschewski, Tobias/0000-0003-4595-1144;
   Faraone, Stephen V/0000-0002-9217-3982; Mennes,
   Maarten/0000-0002-7279-3439; Bralten, Janita/0000-0003-1440-8675; Lesch,
   Klaus-Peter/0000-0001-8348-153X; Thompson, Paul M/0000-0002-4720-8867;
   Hugdahl, Kenneth/0000-0002-0008-4326; Shaw, Philip/0000-0002-1313-2526;
   Lundervold, Astri Johansen/0000-0002-6819-6164; douglas,
   pamela/0000-0003-2277-7526; Ramos-Quiroga, Josep
   Antoni/0000-0003-1622-0350; Paloyelis, Yannis/0000-0002-4029-3720;
   Vives-Gilabert, Yolanda/0000-0002-3744-5893; Douglas,
   PK/0000-0002-3506-6857; Wolfers, Thomas/0000-0002-7693-0621; Rubia,
   Katya/0000-0002-1410-7701; Schulte-Ruther, Martin/0000-0002-7198-9923;
   Asherson, Philip/0000-0003-2667-2254; Vilarroya,
   Oscar/0000-0001-8285-5624; Cubillo, Ana/0000-0001-5657-7341; Tamm,
   Leanne/0000-0001-6066-1669; Yoncheva, Yuliya/0000-0001-6495-7504
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA; Medical Research
   CouncilMedical Research Council UK (MRC) [G0300189] Funding Source:
   researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Human Genome Research Institute (NHGRI) [ZIAHG200378,
   ZIAHG200378, ZIAHG200378, ZIAHG200378, ZIAHG200378, ZIAHG200378,
   ZIAHG200378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015922,
   P41EB015922, U54EB020403, P41EB015922, U54EB020403, P41EB015922,
   U54EB020403, P41EB015922, P41EB015922, U54EB020403, U54EB020403,
   U54EB020403, P41EB015922, P41EB015922, P41EB015922, U54EB020403,
   U54EB020403, P41EB015922, U54EB020403, U54EB020403, U54EB020403,
   P41EB015922, U54EB020403, P41EB015922, P41EB015922, U54EB020403,
   U54EB020403, U54EB020403, P41EB015922, P41EB015922, P41EB015922,
   U54EB020403, U54EB020403, P41EB015922, U54EB020403, U54EB020403,
   U54EB020403, P41EB015922, P41EB015922, P41EB015922, P41EB015922,
   U54EB020403, P41EB015922, P41EB015922, U54EB020403, P41EB015922,
   U54EB020403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL
   HEALTHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [T32MH067763, R01MH062152, R01MH062873, R01MH083246, U01MH099059,
   K01MH110645, R01MH062152, R01MH081803, U01MH099059, R21MH091461,
   T32MH067763, R01MH094639, T32MH067763, R01MH062873, K23MH087770,
   R01MH062873, R01MH062873, U01MH099059, T32MH067763, K23MH087770,
   T32MH067763, R01MH083246, T32MH067763, R01MH062873, R01MH062152,
   K23MH087770, T32MH067763, T32MH067763, R01MH083246, U01MH099059,
   R01MH062152, T32MH067763, R21MH091461, T32MH067763, K23MH087770,
   T32MH067763, R01MH094639, R01MH062873, K01MH110645, K01MH110645,
   R01MH094639, R01MH094639, U01MH099059, R01MH062152, K01MH110645,
   R01MH094639] Funding Source: NIH RePORTER
FX National Institutes of Health.
CR AGGLETON JP, 1993, TRENDS NEUROSCI, V16, P328, DOI 10.1016/0166-2236(93)90110-8
   Ahrendts J, 2011, WORLD J BIOL PSYCHIA, V12, P260, DOI 10.3109/15622975.2010.518624
   Montes LGA, 2010, J PSYCHIATR NEUROSCI, V35, P238, DOI 10.1503/jpn.090099
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004
   Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9
   Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740
   Cha J, 2015, NEUROPSYCHOPHARMACOL, V40, P1717, DOI 10.1038/npp.2015.18
   Conzelmann A, 2009, BIOL PSYCHIAT, V65, P578, DOI 10.1016/j.biopsych.2008.10.038
   Ellison-Wright I, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-51
   ENIGMA, STRUCT IM PROC PROT
   Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X
   Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x
   Frodl T, 2010, ACTA PSYCHIAT SCAND, V121, P111, DOI 10.1111/j.1600-0447.2009.01489.x
   Guadalupe T, 2014, HUM BRAIN MAPP, V35, P3277, DOI 10.1002/hbm.22401
   Halperin JM, 2006, PSYCHOL BULL, V132, P560, DOI 10.1037/0033-2909.132.4.560
   Herpers PCM, 2012, SOC PSYCH PSYCH EPID, V47, P2045, DOI 10.1007/s00127-012-0513-x
   Hibar DP, 2016, MOL PSYCHIATR, V21, P1710, DOI 10.1038/mp.2015.227
   Hoogman M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031273
   Musser ED, 2013, J AM ACAD CHILD PSY, V52, P163, DOI 10.1016/j.jaac.2012.11.009
   Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281
   Norman LJ, 2016, JAMA PSYCHIAT, V73, P815, DOI 10.1001/jamapsychiatry.2016.0700
   Onnink AMH, 2014, EUR NEUROPSYCHOPHARM, V24, P397, DOI 10.1016/j.euroneuro.2013.11.011
   Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942
   Posner J, 2014, PSYCHIAT RES-NEUROIM, V224, P112, DOI 10.1016/j.pscychresns.2014.08.006
   Ruigrok ANV, 2014, NEUROSCI BIOBEHAV R, V39, P34, DOI 10.1016/j.neubiorev.2013.12.004
   Schmaal L, 2016, MOL PSYCHIATR, V21, P806, DOI 10.1038/mp.2015.69
   Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104
   Shaw P, 2014, AM J PSYCHIAT, V171, P276, DOI 10.1176/appi.ajp.2013.13070966
   Shaw P, 2011, AM J PSYCHIAT, V168, P143, DOI 10.1176/appi.ajp.2010.10030385
   Shigemune Y, 2010, NEUROSCI RES, V67, P72, DOI 10.1016/j.neures.2010.01.003
   Sonuga-Barke EJS, 2010, J AM ACAD CHILD PSY, V49, P345, DOI 10.1016/j.jaac.2009.12.018
   Tajima-Pozo K, 2016, J ATTEN DISORD
   Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011
   van Erp TGM, 2016, MOL PSYCHIATR, V21, P547, DOI 10.1038/mp.2015.63
   Viding E, 2012, AM J PSYCHIAT, V169, P1109, DOI 10.1176/appi.ajp.2012.12020191
NR 36
TC 208
Z9 212
U1 7
U2 228
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2215-0374
J9 LANCET PSYCHIAT
JI Lancet Psychiatry
PD APR
PY 2017
VL 4
IS 4
BP 310
EP 319
DI 10.1016/S2215-0366(17)30049-4
PG 10
WC Psychiatry
SC Psychiatry
GA EP4BA
UT WOS:000397324300026
PM 28219628
OA Green Published, Green Accepted
DA 2020-12-17
ER

PT J
AU Ebadi, A
   da Rocha, JLD
   Nagaraju, DB
   Tovar-Moll, F
   Bramati, I
   Coutinho, G
   Sitaram, R
   Rashidi, P
AF Ebadi, Ashkan
   da Rocha, Josue L. Dalboni
   Nagaraju, Dushyanth B.
   Tovar-Moll, Fernanda
   Bramati, Ivanei
   Coutinho, Gabriel
   Sitaram, Ranganatha
   Rashidi, Parisa
TI Ensemble Classification of Alzheimer's Disease and Mild Cognitive
   Impairment Based on Complex Graph Measures from Diffusion Tensor Images
SO FRONTIERS IN NEUROSCIENCE
LA English
DT Article
DE Alzheimer's disease; ensemble classification; diffusion tensor images;
   machine learning; graph measures
ID RESTING-STATE FMRI; BRAIN NETWORKS; CONNECTIVITY; CENTRALITY;
   VALIDATION; PARAMETER
AB The human brain is a complex network of interacting regions. The gray matter regions of brain are interconnected by whitematter tracts, together forming one integrative complex network. In this article, we report our investigation about the potential of applying brain connectivity patterns as an aid in diagnosing Alzheimer's disease and Mild Cognitive Impairment (MCI). We performed pattern analysis of graph theoretical measures derived from Diffusion Tensor Imaging (DTI) data representing structural brain networks of 45 subjects, consisting of 15 patients of Alzheimer's disease (AD), 15 patients of MCI, and 15 healthy subjects (CT). We considered pair-wise class combinations of subjects, defining three separate classification tasks, i.e., AD-CT, AD-MCI, and CT-MCI, and used an ensemble classification module to perform the classification tasks. Our ensemble framework with feature selection shows a promising performance with classification accuracy of 83.3% for AD vs. MCI, 80% for AD vs. CT, and 70% for MCI vs. CT. Moreover, our findings suggest that AD can be related to graph measures abnormalities at Brodmann areas in the sensorimotor cortex and piriform cortex. In this way, node redundancy coefficient and load centrality in the primary motor cortex were recognized as good indicators of AD in contrast to MCI. In general, load centrality, betweenness centrality, and closeness centrality were found to be the most relevant network measures, as they were the top identified features at different nodes. The present study can be regarded as a "proof of concept" about a procedure for the classification of MRI markers between AD dementia, MCI, and normal old individuals, due to the small and not well-defined groups of AD and MCI patients. Future studies with larger samples of subjects and more sophisticated patient exclusion criteria are necessary toward the development of a more precise technique for clinical diagnosis.
C1 [Ebadi, Ashkan; Rashidi, Parisa] Univ Florida, Dept Biomed Engn, Gainesville, FL 32611 USA.
   [da Rocha, Josue L. Dalboni] Univ Geneva, Dept Clin Neurosci, Brain & Language Lab, Geneva, Switzerland.
   [Nagaraju, Dushyanth B.] Univ Florida, Dept Comp & Informat Sci & Engn, Gainesville, FL USA.
   [Tovar-Moll, Fernanda; Bramati, Ivanei; Coutinho, Gabriel] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda; Coutinho, Gabriel] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Sitaram, Ranganatha] Pontificia Univ Catolica Chile, Inst Biol & Med Engn, Sch Engn, Santiago, Chile.
   [Sitaram, Ranganatha] Pontificia Univ Catolica Chile, Sch Biol, Santiago, Chile.
   [Sitaram, Ranganatha] Pontificia Univ Catolica Chile, Sch Med, Santiago, Chile.
   [Sitaram, Ranganatha] Pontificia Univ Catolica Chile, Dept Psychiat, Santiago, Chile.
   [Sitaram, Ranganatha] Pontificia Univ Catolica Chile, Sect Neurosci, Santiago, Chile.
   [Sitaram, Ranganatha] Pontificia Univ Catolica Chile, Lab Brain Machine Interfaces & Neuromodulat, Santiago, Chile.
RP Rashidi, P (corresponding author), Univ Florida, Dept Biomed Engn, Gainesville, FL 32611 USA.; Sitaram, R (corresponding author), Pontificia Univ Catolica Chile, Inst Biol & Med Engn, Sch Engn, Santiago, Chile.; Sitaram, R (corresponding author), Pontificia Univ Catolica Chile, Sch Biol, Santiago, Chile.; Sitaram, R (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Santiago, Chile.; Sitaram, R (corresponding author), Pontificia Univ Catolica Chile, Dept Psychiat, Santiago, Chile.; Sitaram, R (corresponding author), Pontificia Univ Catolica Chile, Sect Neurosci, Santiago, Chile.; Sitaram, R (corresponding author), Pontificia Univ Catolica Chile, Lab Brain Machine Interfaces & Neuromodulat, Santiago, Chile.
EM rasitaram@uc.cl; parisa.rashidi@ufl.edu
RI Rashidi, Parisa/AAP-7261-2020; Moll, Fernanda Tovar/N-3320-2018; Ebadi,
   Ashkan/AAI-5123-2020
OI Rashidi, Parisa/0000-0003-4530-2048; Moll, Fernanda
   Tovar/0000-0002-0292-5985; Ebadi, Ashkan/0000-0002-4542-9105; Dalboni da
   Rocha, Josue Luiz/0000-0001-8939-6395
FU NIA NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   [P30 AG028740] Funding Source: Medline; NATIONAL INSTITUTE ON
   AGINGUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   [P30AG028740, P30AG028740, P30AG028740, P30AG028740, P30AG028740,
   P30AG028740, P30AG028740, P30AG028740, P30AG028740, P30AG028740,
   P30AG028740, P30AG028740, P30AG028740, P30AG028740, P30AG028740,
   P30AG028740, P30AG028740, P30AG028740, P30AG028740, P30AG028740,
   P30AG028740, P30AG028740, P30AG028740, P30AG028740, P30AG028740,
   P30AG028740, P30AG028740, P30AG028740, P30AG028740, P30AG028740,
   P30AG028740, P30AG028740, P30AG028740, P30AG028740, P30AG028740,
   P30AG028740, P30AG028740, P30AG028740, P30AG028740, P30AG028740,
   P30AG028740, P30AG028740, P30AG028740, P30AG028740, P30AG028740,
   P30AG028740, P30AG028740, P30AG028740, P30AG028740, P30AG028740,
   P30AG028740, P30AG028740, P30AG028740, P30AG028740, P30AG028740,
   P30AG028740, P30AG028740, P30AG028740, P30AG028740, P30AG028740,
   P30AG028740, P30AG028740, P30AG028740, P30AG028740, P30AG028740,
   P30AG028740, P30AG028740, P30AG028740, P30AG028740, P30AG028740,
   P30AG028740, P30AG028740, P30AG028740, P30AG028740, P30AG028740,
   P30AG028740, P30AG028740, P30AG028740, P30AG028740, P30AG028740,
   P30AG028740, P30AG028740] Funding Source: NIH RePORTER
CR Alzheimer A., 1907, ALLG Z PSYCHIAT, V64, P146, DOI DOI 10.1002/CA.980080612
   Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022
   Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008
   Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd
   Bergstra J, 2012, J MACH LEARN RES, V13, P281
   Bermingham ML, 2015, SCI REP-UK, V5, DOI 10.1038/srep10312
   Bihan D. L., 1985, CR HEBD ACAD SCI, V93, P27
   Binnewijzend MAA, 2014, HUM BRAIN MAPP, V35, P2383, DOI 10.1002/hbm.22335
   Bishop C., 2007, PATTERN RECOGNITION
   Bohnen NI, 2012, J NUCL MED, V53, P59, DOI 10.2967/jnumed.111.096578
   Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249
   Brandes U, 2008, SOC NETWORKS, V30, P136, DOI 10.1016/j.socnet.2007.11.001
   Brier MR, 2012, J NEUROSCI, V32, P8890, DOI 10.1523/JNEUROSCI.5698-11.2012
   Brodmann K., 1909, VERGLEICHENDE LOKALI
   Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381
   Brown G., 2005, Information Fusion, V6, P5, DOI 10.1016/j.inffus.2004.04.004
   Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575
   Burns A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b158
   Casanova R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044877
   Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199
   Chatterjee N, 2008, PROG BRAIN RES, V168, P145, DOI 10.1016/S0079-6123(07)68012-1
   Chen G, 2011, RADIOLOGY, V259, P213, DOI 10.1148/radiol.10100734
   Crook T H 3rd, 1992, Int Psychogeriatr, V4, P165, DOI 10.1017/S1041610292000991
   Dai ZJ, 2012, NEUROIMAGE, V59, P2187, DOI 10.1016/j.neuroimage.2011.10.003
   Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563
   DEAN RB, 1951, ANAL CHEM, V23, P636, DOI 10.1021/ac60052a025
   Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1
   Drzezga A, 2003, EUR J NUCL MED MOL I, V30, P1104, DOI 10.1007/s00259-003-1194-1
   Dubois B, 2004, LANCET NEUROL, V3, P246, DOI 10.1016/S1474-4422(04)00710-0
   Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0
   Dyrba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064925
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
   FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543
   Friston Karl J., 1996, P363
   Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701
   Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102
   Gould P., 1967, T I BRIT GEOGR, V42, P63, DOI DOI 10.2307/621372
   Hahn K, 2013, NEUROIMAGE, V81, P96, DOI 10.1016/j.neuroimage.2013.05.011
   Heron M., 2009, DEATHS FINAL DATA 20
   Hoekzema E, 2014, HUM BRAIN MAPP, V35, P1261, DOI 10.1002/hbm.22250
   Howard JD, 2009, NAT NEUROSCI, V12, P932, DOI 10.1038/nn.2324
   Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049
   Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504
   Junker B. H., 2011, ANAL BIOL NETWORKS
   KATZ L, 1953, PSYCHOMETRIKA, V18, P39, DOI DOI 10.1007/BF02289026
   Khan UA, 2014, NAT NEUROSCI, V17, P304, DOI 10.1038/nn.3606
   Khazaee A, 2015, CLIN NEUROPHYSIOL, V126, P2132, DOI 10.1016/j.clinph.2015.02.060
   Klyachko VA, 2003, P NATL ACAD SCI USA, V100, P7937, DOI 10.1073/pnas.0932745100
   Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143
   Kreher BW, 2008, NEUROIMAGE, V43, P81, DOI 10.1016/j.neuroimage.2008.06.023
   Kuncheva LI, 2003, MACH LEARN, V51, P181, DOI 10.1023/A:1022859003006
   Latapy M, 2008, SOC NETWORKS, V30, P31, DOI 10.1016/j.socnet.2007.04.006
   Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701
   Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070390
   Lillemark L, 2014, BMC MED IMAGING, V14, DOI 10.1186/1471-2342-14-21
   Lind PG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056127
   LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/tit.1982.1056489
   Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010
   Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010
   Mai J. K., 2008, ATLAS HUMAN BRAIN
   Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466
   Moore D. S., 2007, BASIC PRACTICE STAT, V2
   Newman M., 2008, NEW PALGRAVE ENCY EC, V2, P1, DOI DOI 10.1057/9780230226203.1064
   Opitz D., 1999, J ARTIF INTELL RES, V11, P169, DOI DOI 10.1613/jair.614
   Page L., 1999, PAGERANK CITATION RA
   Panagiotakos DB, 2008, OPEN CARDIOVASC MED, V2, P97, DOI 10.2174/1874192400802010097
   Sesmero MP, 2015, WIRES DATA MIN KNOWL, V5, P21, DOI 10.1002/widm.1143
   Petersen R C, 1997, Int Psychogeriatr, V9 Suppl 1, P65, DOI 10.1017/S1041610297004717
   Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985
   Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7
   SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527
   Sarazin M, 2010, J ALZHEIMERS DIS, V22, P285, DOI 10.3233/JAD-2010-091150
   Snedecor G., 1989, STAT METHODS
   Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002
   Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042
   Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369
   Sullivan D., 2007, WHAT IS GOOGLE PAGER
   Suva D, 1999, J NEUROPATH EXP NEUR, V58, P1125, DOI 10.1097/00005072-199911000-00002
   Tang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060652
   Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596
   Teipel SJ, 2008, EUR J NUCL MED MOL I, V35, pS58, DOI 10.1007/s00259-007-0703-z
   Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.002, 10.1016/j.jalz.2011.02.004]
   Varkuti B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014801
   Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91
   Von Ahn L, 2008, HUBS AUTHORITIES SCI
   Wang K, 2006, LECT NOTES COMPUT SC, V4191, P340
   Wang LA, 2010, J NEUROSCI, V30, P13171, DOI 10.1523/JNEUROSCI.3514-10.2010
   Wasserman S., 1994, SOCIAL NETWORK ANAL
   Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918
   Wolz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025446
   Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713
   Yeh FC, 2011, NEUROIMAGE, V58, P91, DOI 10.1016/j.neuroimage.2011.06.021
   YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4
   Zeng LL, 2014, HUM BRAIN MAPP, V35, P1630, DOI 10.1002/hbm.22278
   Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018
   Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049
NR 96
TC 18
Z9 18
U1 0
U2 15
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1662-453X
J9 FRONT NEUROSCI-SWITZ
JI Front. Neurosci.
PD FEB 28
PY 2017
VL 11
AR 56
DI 10.3389/fnins.2017.00056
PG 17
WC Neurosciences
SC Neurosciences & Neurology
GA EL7NH
UT WOS:000394807100001
PM 28293162
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU de Oliveira, RR
   de Mattos, RM
   Rebelo, LM
   Ferreira, FGM
   Tovar-Moll, F
   Nasciutti, LE
   Brito, GAD
AF de Oliveira, Rodrigo Ribeiro
   de Mattos, Romulo Medina
   Rebelo, Luciana Magalhaes
   Meireles Ferreira, Fernanda Guimaraes
   Tovar-Moll, Fernanda
   Nasciutti, Luiz Eurico
   de Castro Brito, Gerly Anne
TI Experimental Diabetes Alters the Morphology and Nano-Structure of the
   Achilles Tendon
SO PLOS ONE
LA English
DT Article
ID RAT MODEL; TENDINOPATHY; MELLITUS; FOOT
AB Although of several studies that associate chronic hyperglycemia with tendinopathy, the connection between morphometric changes as witnessed by magnetic resonance (MR) images, nanostructural changes, and inflammatory markers have not yet been fully established. Therefore, the present study has as a hypothesis that the Achilles tendons of rats with diabetes mellitus (DM) exhibit structural changes. The animals were randomly divided into two experimental groups: Control Group (n = 06) injected with a vehicle (sodium citrate buffer solution) and Diabetic Group (n = 06) consisting of rats submitted to intraperitoneal administration of streptozotocin. MR was performed 24 days after the induction of diabetes and images were used for morphometry using ImageJ software. Morphology of the collagen fibers within tendons was examined using Atomic Force microscopy (AFM). An increase in the dimension of the coronal plane area was observed in the diabetic group (8.583 +/- 0.646 mm(2)/100g) when compared to the control group (4.823 +/- 0.267 mm(2)/100g) resulting in a significant difference (p = 0.003) upon evaluating the Achilles tendons. Similarly, our analysis found an increase in the size of the transverse section area in the diabetic group (1.328 +/- 0.103 mm(2)/100g) in comparison to the control group (0.940 +/- 0.01 mm(2)/100g) p = 0.021. The tendons of the diabetic group showed great irregularity in fiber bundles, including modified grain direction and jagged junctions and deformities in the form of collagen fibrils bulges. Despite the morphological changes observed in the Achilles tendon of diabetic animals, IL1 and TNF-alpha did not change. Our results suggest that DM promotes changes to the Achilles tendon with important structural modifications as seen by MR and AFM, excluding major inflammatory changes.
C1 [de Oliveira, Rodrigo Ribeiro; Nasciutti, Luiz Eurico; de Castro Brito, Gerly Anne] Univ Fed Rio de Janeiro, Fed Univ Ceara, Interinst Doctorate Program Morphol Sci, Rio De Janeiro, Brazil.
   [de Oliveira, Rodrigo Ribeiro] Univ Fed Ceara, Dept Phys Therapy, Fortaleza, Ceara, Brazil.
   [de Oliveira, Rodrigo Ribeiro] Tendon Res Grp, Fortaleza, Ceara, Brazil.
   [de Mattos, Romulo Medina; Nasciutti, Luiz Eurico] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Rebelo, Luciana Magalhaes] Univ Fed Ceara, Fac Phys, Dept Phys, Fortaleza, Ceara, Brazil.
   [Meireles Ferreira, Fernanda Guimaraes; Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Meireles Ferreira, Fernanda Guimaraes; Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.
RP de Oliveira, RR (corresponding author), Univ Fed Rio de Janeiro, Fed Univ Ceara, Interinst Doctorate Program Morphol Sci, Rio De Janeiro, Brazil.; de Oliveira, RR (corresponding author), Univ Fed Ceara, Dept Phys Therapy, Fortaleza, Ceara, Brazil.; de Oliveira, RR (corresponding author), Tendon Res Grp, Fortaleza, Ceara, Brazil.
EM rodrigo@ufc.br
RI Moll, Fernanda Tovar/N-3320-2018; Alencar, Luciana M Rebelo/O-6736-2018;
   de Oliveira, Rodrigo Ribeiro/N-9892-2013; de Castro Brito, Gerly
   Anne/C-8597-2013
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Alencar, Luciana M
   Rebelo/0000-0001-8210-2016; de Oliveira, Rodrigo
   Ribeiro/0000-0002-5810-3737; de Castro Brito, Gerly
   Anne/0000-0002-8214-4379
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [477692/2011-7]; CAPESCAPES [23038044935/2009-12]
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq-Universal nu 477692/2011-7) and by a
   fellowship from the CAPES for Inter-institutional Doctorate Program in
   Morphological Sciences-Federal University of Ceara-UFC/Federal
   University of Rio de Janeiro-UFRJ-Brazil (Nu23038044935/2009-12). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Akturk M, 2007, EXP CLIN ENDOCR DIAB, V115, P92, DOI 10.1055/s-2007-955097
   Akturk M, 2002, DIABETES CARE, V25, P408, DOI 10.2337/diacare.25.2.408
   Alfredson H, 1999, KNEE SURG SPORT TR A, V7, P378, DOI 10.1007/s001670050184
   Batista F, 2008, FOOT ANKLE INT, V29, P498, DOI 10.3113/FAI.2008.0498
   Bohm S, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0009-9
   Bolton NRM, 2005, CLIN BIOMECH, V20, P540
   Dall'Ago P, 2002, BRAZ J MED BIOL RES, V35, P843, DOI 10.1590/S0100-879X2002000700013
   de Oliveira RR, 2011, DIABETIC MED, V28, P886, DOI 10.1111/j.1464-5491.2010.03197.x
   de Oliveira RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074942
   de Oliveira RR, 2012, J DIABETES COMPLICAT, V26, P163, DOI 10.1016/j.jdiacomp.2012.03.017
   de Oliveira RR, 2011, ANN BIOMED ENG, V39, P1528, DOI 10.1007/s10439-011-0247-z
   Fox AJS, 2011, J ORTHOPAEDIC RES
   Giacomozzi C, 2005, CLIN BIOMECH, V20, P532, DOI 10.1016/j.clinbiomech.2005.01.011
   Glazebrook MA, 2008, J ORTHOP RES, V26, P840, DOI 10.1002/jor.20546
   Gonzalez AD, 2014, J BIOMECH, V47, P681, DOI 10.1016/j.jbiomech.2013.11.045
   Kannus P, 1997, SCAND J MED SCI SPOR, V7, P107
   Karjalainen PT, 2000, AM J ROENTGENOL, V175, P251, DOI 10.2214/ajr.175.1.1750251
   LE JM, 1987, J IMMUNOL, V138, P2137
   Lichtwark GA, 2010, J EXP BIOL, V213, P707, DOI 10.1242/jeb.038026
   Maffulli N, 2002, J BONE JOINT SURG BR, V84B, P1, DOI 10.1302/0301-620X.84B1.12792
   Maffulli N, 2005, TENDON INJURIES
   Nakama LH, 2005, J ORTHOP RES, V23, P1199, DOI 10.1016/j.orthres.2005.03.006
   Odetti P, 2000, DIABETES-METAB RES, V16, P74, DOI 10.1002/(SICI)1520-7560(200003/04)16:2<74::AID-DMRR80>3.3.CO;2-T
   Paavola M, 2002, J BONE JOINT SURG AM, V84A, P2062, DOI 10.2106/00004623-200211000-00024
   Papanas N, 2009, EXP CLIN ENDOCR DIAB, V117, P645, DOI 10.1055/s-0029-1224121
   Ranger TA, 2015, BRIT J SPORTS MED
   Riley G, 2004, RHEUMATOLOGY, V43, P131, DOI 10.1093/rheumatology/keg448
   Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850
   Szkudelski T, 2001, PHYSIOL RES, V50, P537
   Yoo SD, 2012, LASER MED SCI, V27, P1195, DOI 10.1007/s10103-011-1049-0
   Zhang ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108337
NR 31
TC 7
Z9 8
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 17
PY 2017
VL 12
IS 1
AR e0169513
DI 10.1371/journal.pone.0169513
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EI3EK
UT WOS:000392372300021
PM 28095484
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Levine, D
   de Oliveira-Szejnfeld, PS
   Melo, ASD
   Tovarmoll, F
AF Levine, Deborah
   de Oliveira-Szejnfeld, Patricia Soares
   de Oliveira Melo, Adriana Suely
   Tovarmoll, Fernanda
TI Congenital Brain Abnormalities and Zika Virus Response
SO RADIOLOGY
LA English
DT Letter
C1 [Levine, Deborah] Beth Israel Deaconess Med Ctr, Dept Radiol, 330 Brookline Ave, Boston, MA 02215 USA.
   [de Oliveira-Szejnfeld, Patricia Soares] Univ Fed Sao Paulo, Dept Diagnost Imaging, Sao Paulo, Brazil.
   [de Oliveira-Szejnfeld, Patricia Soares] Univ Fed Sao Paulo, Dept Diagnost Imaging, Fdn Inst Educ & Res Diagnost Imaging, Sao Paulo, Brazil.
   [de Oliveira Melo, Adriana Suely] Inst Pesquisa Prof Amorim Neto, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely] Inst Saude Elpidio Almeida, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely] Fac Ciencias Med Campina Grande, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely] Hosp Municipal Pedro I, Serv Municipal Atendimento Transdisciplinar Gesta, Campina Grande, PB, Brazil.
   [Tovarmoll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Tovarmoll, Fernanda] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.
   [Tovarmoll, Fernanda] DOr Inst Res & Educ, Rua Diniz Cordeiro 30, BR-22881100 Rio De Janeiro, RJ, Brazil.
RP Tovarmoll, F (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.; Tovarmoll, F (corresponding author), Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.; Tovarmoll, F (corresponding author), DOr Inst Res & Educ, Rua Diniz Cordeiro 30, BR-22881100 Rio De Janeiro, RJ, Brazil.
EM Fernanda.tovarmoll@idor.org
RI Melo, Adriana S O/H-5650-2016; Moll, Fernanda Tovar/N-3320-2018
OI Moll, Fernanda Tovar/0000-0002-0292-5985
CR de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
NR 1
TC 0
Z9 0
U1 0
U2 0
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD JAN
PY 2017
VL 282
IS 1
BP 302
EP 303
PG 3
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA EM7VG
UT WOS:000395519800037
DA 2020-12-17
ER

PT J
AU Melo, ASD
   Aguiar, RS
   Amorim, MMR
   Arruda, MB
   Melo, FD
   Ribeiro, STC
   Batista, AGM
   Ferreira, T
   dos Santos, MP
   Sampaio, VV
   Moura, SRM
   Rabello, LP
   Gonzaga, CE
   Malinger, G
   Ximenes, R
   de Oliveira-Szejnfeld, PS
   Tovar-Moll, F
   Chimelli, L
   Silveira, PP
   Delvechio, R
   Higa, L
   Campanati, L
   Nogueira, RMR
   Filippis, AMB
   Szejnfeld, J
   Voloch, CM
   Ferreira, OC
   Brindeiro, RM
   Tanuri, A
AF de Oliveira Melo, Adriana Suely
   Aguiar, Renato Santana
   Ramos Amorim, Melania Maria
   Arruda, Monica B.
   Melo, Fabiana de Oliveira
   Clementino Ribeiro, Suelem Tais
   Medeiros Batista, Alba Gean
   Ferreira, Thales
   dos Santos, Mayra Pereira
   Sampaio, Virginia Vilar
   Martins Moura, Sarah Rogeria
   Rabello, Luciana Portela
   Gonzaga, Clarissa Emanuelle
   Malinger, Gustavo
   Ximenes, Renato
   de Oliveira-Szejnfeld, Patricia Soares
   Tovar-Moll, Fernanda
   Chimelli, Leila
   Silveira, Paola Paz
   Delvechio, Rodrigo
   Higa, Luiza
   Campanati, Loraine
   Nogueira, Rita M. R.
   Bispo Filippis, Ana Maria
   Szejnfeld, Jacob
   Voloch, Carolina Moreira
   Ferreira, Orlando C., Jr.
   Brindeiro, Rodrigo M.
   Tanuri, Amilcar
TI Congenital Zika Virus Infection Beyond Neonatal Microcephaly
SO JAMA NEUROLOGY
LA English
DT Article
ID CYTOMEGALOVIRUS-INFECTION; DIAGNOSTIC-APPROACH; TRANSMISSION; CHILDREN
AB IMPORTANCE Recent studies have reported an increase in the number of fetuses and neonates with microcephaly whose mothers were infected with the Zika virus (ZIKV) during pregnancy. To our knowledge, most reports to date have focused on select aspects of the maternal or fetal infection and fetal effects.
   OBJECTIVE To describe the prenatal evolution and perinatal outcomes of 11 neonates who had developmental abnormalities and neurological damage associated with ZIKV infection in Brazil.
   DESIGN, SETTING, AND PARTICIPANTS We observed 11 infants with congenital ZIKV infection from gestation to 6 monthus in the state of Paraba, Brazil. Ten of 11 women included in this study presented with symptoms of ZIKV infection during the first half of pregnancy, and all 11 had laboratory evidence of the infection in several tissues by serology or polymerase chain reaction. Brain damage was confirmed through intrauterine ultrasonography and was complemented by magnetic resonance imaging. Histopathological analysis was performed on the placenta and brain tissue from infants who died. The ZIKV genome was investigated in several tissues and sequenced for further phylogenetic analysis.
   MAIN OUTCOMES AND MEASURES Description of the major lesions caused by ZIKV congenital infection.
   RESULTS Of the 11 infants, 7 (63.6%) were female, and the median (SD) maternal age at delivery was 25 (6) years. Three of 11 neonates died, giving a perinatal mortality rate of 27.3%. The median (SD) cephalic perimeter at birth was 31 (3) cm, a value lower than the limit to consider a microcephaly case. In all patients, neurological impairments were identified, including microcephaly, a reduction in cerebral volume, ventriculomegaly, cerebellar hypoplasia, lissencephaly with hydrocephalus, and fetal akinesia deformation sequence (ie, arthrogryposis). Results of limited testing for other causes of microcephaly, such as genetic disorders and viral and bacterial infections, were negative, and the ZIKV genome was found in both maternal and neonatal tissues (eg, amniotic fluid, cord blood, placenta, and brain). Phylogenetic analyses showed an intrahost virus variation with some polymorphisms in envelope genes associated with different tissues.
   CONCLUSIONS AND RELEVANCE Combined findings from clinical, laboratory, imaging, and pathological examinations provided a more complete picture of the severe damage and developmental abnormalities caused by ZIKV infection than has been previously reported. The term congenital Zika syndrome is preferable to refer to these cases, as microcephaly is just one of the clinical signs of this congenital malformation disorder.
C1 [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria; Melo, Fabiana de Oliveira] Inst Pesquisa Prof Amorim Neto IPESQ, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria; Melo, Fabiana de Oliveira; Clementino Ribeiro, Suelem Tais; dos Santos, Mayra Pereira] Inst Saude Elpidio de Almeida, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria; Clementino Ribeiro, Suelem Tais; Sampaio, Virginia Vilar; Martins Moura, Sarah Rogeria; Rabello, Luciana Portela] Fac Ciencias Med Campina Grande, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely; Medeiros Batista, Alba Gean; Sampaio, Virginia Vilar; Martins Moura, Sarah Rogeria; Rabello, Luciana Portela; Gonzaga, Clarissa Emanuelle] Hosp Municipal Pedro I, Campina Grande, Paraiba, Brazil.
   [Aguiar, Renato Santana; Arruda, Monica B.; Silveira, Paola Paz; Delvechio, Rodrigo; Higa, Luiza; Voloch, Carolina Moreira; Ferreira, Orlando C., Jr.; Brindeiro, Rodrigo M.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Ramos Amorim, Melania Maria; Ferreira, Thales] Univ Fed Campina Grande, Campina Grande, Paraiba, Brazil.
   [Malinger, Gustavo] Tel Aviv Univ, Div Ultrasound Obstet & Gynecol, Lis Matern Hosp, Tel Aviv Sourasky Med Ctr,Sackler Fac Med, Tel Aviv, Israel.
   [Ximenes, Renato] Fundacao Med Fetal Latino Amer, Sao Paulo, Brazil.
   [de Oliveira-Szejnfeld, Patricia Soares] Univ Fed Sao Paulo, Fundacao Inst Pesquisa & Ensino Diagnost Imagem, Sao Paulo, Brazil.
   [Tovar-Moll, Fernanda; Campanati, Loraine] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Inst DOr Pesquisa & Ensino, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Inst Estadual Cerebro Paulo Niemeyer, Lab Neuropatol, Rio De Janeiro, Brazil.
   [Nogueira, Rita M. R.; Bispo Filippis, Ana Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Szejnfeld, Jacob] Univ Fed Sao Paulo, Dept Diagnost Imagem, Sao Paulo, Brazil.
RP Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Virol Mol, CCS Bloco Sala 121, BR-21941902 Rio De Janeiro, Brazil.
EM atanuri1@gmail.com
RI Campanati, Loraine/V-2632-2018; Higa, Luiza/W-2698-2019; Voloch,
   Carolina M/F-8874-2013; Melo, Adriana S O/H-5650-2016; Moll, Fernanda
   Tovar/N-3320-2018; Amorim, Melania M/C-5807-2013; Aguiar, Renato
   S/G-3542-2015; Ferreira, Thales Araujo/AAA-6252-2019
OI Campanati, Loraine/0000-0001-9172-1951; Voloch, Carolina
   M/0000-0001-5182-4366; Moll, Fernanda Tovar/0000-0002-0292-5985; Amorim,
   Melania M/0000-0003-1047-2514; Aguiar, Renato S/0000-0001-5180-3717;
   Malinger, Gustavo/0000-0003-0864-206X
FU Consellho Nacional de Desenvolvimento e Pesquisa; Fundacao de Amparo a
   Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Prefeitura Municipal
   de Campina Grande; Medical Research CouncilMedical Research Council UK
   (MRC) [MC_PC_15102] Funding Source: researchfish
FX This study was supported by Consellho Nacional de Desenvolvimento e
   Pesquisa, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro,
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and
   Prefeitura Municipal de Campina Grande.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Besnard M, 2014, EURO SURVEILL, V19
   Bosnjak VM, 2011, COLLEGIUM ANTROPOL, V35, P229
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Hall JG, 1997, J PEDIATR ORTHOP B, V6, P159, DOI 10.1097/01202412-199707000-00002
   Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003
   Kouame N, 2013, Diagn Interv Imaging, V94, P433, DOI 10.1016/j.diii.2013.01.002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller-Oehring EM, 2010, NEUROPSYCHOLOGIA, V48, P1133, DOI 10.1016/j.neuropsychologia.2009.12.015
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Romaniello R, 2015, BRAIN DEV-JPN, V37, P273, DOI 10.1016/j.braindev.2014.06.002
   Stadlbauer A, 2012, EUR RADIOL, V22, P232, DOI 10.1007/s00330-011-2247-7
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zucca C, 2003, NEUROLOGY, V61, P710, DOI 10.1212/WNL.61.5.710
NR 33
TC 187
Z9 187
U1 1
U2 48
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD DEC 1
PY 2016
VL 73
IS 12
BP 1407
EP 1416
DI 10.1001/jamaneurol.2016.3720
PG 10
WC Clinical Neurology
SC Neurosciences & Neurology
GA EG5ZB
UT WOS:000391122200011
PM 27695855
OA Bronze
DA 2020-12-17
ER

PT J
AU de Oliveira-Szejnfeld, PS
   Levine, D
   Melo, ASD
   Amorim, MMR
   Batista, AGM
   Chimelli, L
   Tanuri, A
   Aguiar, RS
   Malinger, G
   Ximenes, R
   Robertson, R
   Szejnfeld, J
   Tovar-Moll, F
AF de Oliveira-Szejnfeld, Patricia Soares
   Levine, Deborah
   de Oliveira Melo, Adriana Suely
   Ramos Amorim, Melania Maria
   Batista, Alba Gean M.
   Chimelli, Leila
   Tanuri, Amilcar
   Aguiar, Renato Santana
   Malinger, Gustavo
   Ximenes, Renato
   Robertson, Richard
   Szejnfeld, Jacob
   Tovar-Moll, Fernanda
TI Congenital Brain Abnormalities and Zika Virus: What the Radiologist Can
   Expect to See Prenatally and Postnatally
SO RADIOLOGY
LA English
DT Article
ID INFECTION; ULTRASOUND; OUTBREAK; GROWTH; BRAZIL
AB Purpose: To document the imaging findings associated with congenital Zika virus infection as found in the Instituto de Pesquisa in Campina Grande State Paraiba (IPESQ) in northeastern Brazil, where the congenital infection has been particularly severe.
   Materials and Methods: From June 2015 to May 2016, 438 patients were referred to the IPESQ for rash occurring during pregnancy or for suspected fetal central nervous system abnormality. Patients who underwent imaging at IPESQ were included, as well as those with documented Zika virus infection in fluid or tissue (n = 17, confirmed infection cohort) or those with brain findings suspicious for Zika virus infection, with intracranial calcifications (n = 28, presumed infection cohort). Imaging examinations included 12 fetal magnetic resonance (MR) examinations, 42 postnatal brain computed tomographic examinations, and 11 postnatal brain MR examinations. Images were reviewed by four radiologists, with final opinion achieved by means of consensus.
   Results: Brain abnormalities seen in confirmed (n = 17) and presumed (n = 28) congenital Zika virus infections were similar, with ventriculomegaly in 16 of 17 (94%) and 27 of 28 (96%) infections, respectively; abnormalities of the corpus callosum in 16 of 17 (94%) and 22 of 28 (78%) infections, respectively; and cortical migrational abnormalities in 16 of 17 (94%) and 28 of 28 (100%) infections, respectively. Although most fetuses underwent at least one examination that showed head circumference below the 5th percentile, head circumference could be normal in the presence of severe ventriculomegaly (seen in three fetuses). Intracranial calcifications were most commonly seen at the gray matter-white matter junction, in 15 of 17 (88%) and 28 of 28 (100%) confirmed and presumed infections, respectively. The basal ganglia and/or thalamus were also commonly involved with calcifications in 11 of 17 (65%) and 18 of 28 (64%) infections, respectively. The skull frequently had a collapsed appearance with overlapping sutures and redundant skin folds and, occasionally, intracranial herniation of orbital fat and clot in the confluence of sinuses.
   Conclusion: The spectrum of findings associated with congenital Zika virus infection in the IPESQ in northeastern Brazil is illustrated to aid the radiologist in identifying Zika virus infection at imaging. (C) RSNA, 2016
C1 [de Oliveira-Szejnfeld, Patricia Soares; Ximenes, Renato; Szejnfeld, Jacob] Univ Fed Sao Paulo, Dept Diagnost Imaging, Sao Paulo, Brazil.
   [de Oliveira-Szejnfeld, Patricia Soares; Szejnfeld, Jacob] Univ Fed Sao Paulo, Dept Diagnost Imaging, Fdn Inst Educ & Res Diagnost Imaging, Sao Paulo, Brazil.
   [Levine, Deborah] Harvard Med Sch, Dept Radiol, Beth Israel Deaconess Med Ctr, Boston, MA USA.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria] Inst Pesquisa Prof Amorim Neto, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria] Inst Saude Elpidio Almeida, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely] Fac Ciencias Med Campina Grande, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely; Batista, Alba Gean M.] Hosp Municipal Pedro I, Serv Municipal Atendimento Transdisciplinar Gesta, Campina Grande, PB, Brazil.
   [Ramos Amorim, Melania Maria] Univ Fed Campina Grande, Campina Grande, PB, Brazil.
   [Chimelli, Leila] State Inst Brain, Neuropathol Lab, Rio De Janeiro, Brazil.
   [Tanuri, Amilcar; Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Malinger, Gustavo] Tel Aviv Univ, Sackler Fac Med, Div Ultrasound Obstet & Gynecol, Tel Aviv Sourasky Med Ctr,Lis Matern Hosp, Tel Aviv, Israel.
   [Ximenes, Renato] Fetal Med Fdn Latinamerica FMFLA, Centrus Fetal Med, Campinas, SP, Brazil.
   [Robertson, Richard] Boston Childrens Hosp, Boston, MA USA.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] DOr Inst Res & Educ, Rua Diniz Cordeiro 30, BR-22881100 Rio De Janeiro, RJ, Brazil.
RP Tovar-Moll, F (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.; Tovar-Moll, F (corresponding author), Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.; Tovar-Moll, F (corresponding author), DOr Inst Res & Educ, Rua Diniz Cordeiro 30, BR-22881100 Rio De Janeiro, RJ, Brazil.
EM Fernanda.tovarmoll@idor.org
RI Aguiar, Renato S/G-3542-2015; Moll, Fernanda Tovar/N-3320-2018; Amorim,
   Melania M/C-5807-2013; Melo, Adriana S O/H-5650-2016
OI Aguiar, Renato S/0000-0001-5180-3717; Moll, Fernanda
   Tovar/0000-0002-0292-5985; Amorim, Melania M/0000-0003-1047-2514; Soares
   de Oliveira Szejnfeld, Patricia/0000-0002-3780-5182; Robertson,
   Richard/0000-0001-8811-4405; Malinger, Gustavo/0000-0003-0864-206X
FU Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15102]
   Funding Source: Medline
CR [Anonymous], 2016, HEAD CIRC FOR AG
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, N ENGL J MED
   Brazilian Ministry of Health, 2016, MIN SAUD CONF 1656 C
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention, ALL COUNTR TERR ACT
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ESTROFF JA, 1992, J ULTRAS MED, V11, P686
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GV, 2016, LANCET
   Freitas BP, 2016, JAMA OPHTHALMOL
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo A, JAMA NEUROL IN PRESS
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moinuddin A, 2003, PRENATAL DIAG, V23, P797, DOI 10.1002/pd.688
   Nonaka H, 2003, J NEUROPATH EXP NEUR, V62, P154, DOI 10.1093/jnen/62.2.154
   Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2
   Picone O, 2008, PRENATAL DIAG, V28, P753, DOI 10.1002/pd.2037
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 32
TC 128
Z9 134
U1 0
U2 13
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD OCT
PY 2016
VL 281
IS 1
BP 203
EP 218
DI 10.1148/radiol.2016161584
PG 16
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA EG8NJ
UT WOS:000391313600023
PM 27552432
OA Bronze
DA 2020-12-17
ER

PT J
AU Galliez, RM
   Spitz, M
   Rafful, PP
   Cagy, M
   Escosteguy, C
   Germano, CSB
   Sasse, E
   Goncalves, AL
   Silveira, PP
   Pezzuto, P
   Ornelas, AMD
   Tanuri, A
   Aguiar, RS
   Moll, FT
AF Galliez, Rafael Mello
   Spitz, Mariana
   Rafful, Patricia Piazza
   Cagy, Marcelo
   Escosteguy, Claudia
   Brito Germano, Caroline Sposito
   Sasse, Elisa
   Goncalves, Alessandro Luis
   Silveira, Paola Paz
   Pezzuto, Paula
   de Magalhaes Ornelas, Alice Maria
   Tanuri, Amilcar
   Aguiar, Renato Santana
   Moll, Fernanda Tovar
TI Zika Virus Causing Encephalomyelitis Associated With Immunoactivation
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE encephalomyelitis; neurological manifestations; proinflammatory
   cytokines; Zika virus
ID JAPANESE ENCEPHALITIS
AB Brazil has experienced a Zika virus (ZIKV) outbreak with increased incidence of congenital malformations and neurological manifestations. We describe a case of a 26-year-old Brazilian Caucasian man infected with ZIKV and diagnosed with encephalomyelitis. Brain and spinal cord images showed hyperintense lesions on T2 and fluid-attenuated inversion recovery (FLAIR), and levels of proinflammatory cytokines in the cerebrospinal fluid showed a remarkable increase of interleukin (IL)-6 and IL-8. The observed pattern suggests immune activation during the acute phase, along with the neurological impairment, with normalization in the recovery phase. This is the first longitudinal report of ZIKV infection causing encephalomyelitis with documented immune activation.
C1 [Galliez, Rafael Mello] Inst Estadual Infectol Sao Sebastiao, Rio De Janeiro, Brazil.
   [Galliez, Rafael Mello] Univ Fed Rio de Janeiro, Fac Med, Programa Posgrad Clin Med, Rio De Janeiro, Brazil.
   [Spitz, Mariana; Cagy, Marcelo; Brito Germano, Caroline Sposito; Sasse, Elisa] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil.
   [Spitz, Mariana; Cagy, Marcelo; Brito Germano, Caroline Sposito; Sasse, Elisa] Hosp Fed Servidores Estado, Neurol Serv, Rio De Janeiro, Brazil.
   [Escosteguy, Claudia] Hosp Fed Servidores Estado, Epidemiol Serv, Rio De Janeiro, Brazil.
   [Rafful, Patricia Piazza; Goncalves, Alessandro Luis; Silveira, Paola Paz; Pezzuto, Paula; Moll, Fernanda Tovar] Dor Inst Res & Educ, Rio De Janeiro, Brazil.
   [Rafful, Patricia Piazza] Univ Fed Rio de Janeiro, Radiol Dept, BR-21941 Rio De Janeiro, Brazil.
   [Goncalves, Alessandro Luis; Silveira, Paola Paz; Pezzuto, Paula; de Magalhaes Ornelas, Alice Maria; Tanuri, Amilcar; Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Genet Dept, Inst Biol, BR-21941 Rio De Janeiro, Brazil.
   [Moll, Fernanda Tovar] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941 Rio De Janeiro, Brazil.
   [Moll, Fernanda Tovar] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, BR-21941 Rio De Janeiro, Brazil.
RP Moll, FT (corresponding author), Rua Diniz Cordeiro 30, BR-22281100 Botafogo, RJ, Brazil.
EM fernanda.tovarmoll@idor.org
RI Escosteguy, Claudia Caminha/D-1043-2010; Moll, Fernanda
   Tovar/N-3320-2018; Galliez, Rafael Mello/AAA-2724-2020; Aguiar, Renato
   S/G-3542-2015
OI Escosteguy, Claudia Caminha/0000-0003-0273-6911; Moll, Fernanda
   Tovar/0000-0002-0292-5985; Galliez, Rafael Mello/0000-0003-0348-8374;
   Aguiar, Renato S/0000-0001-5180-3717
FU Brazilian Council for Development of Science and Technology; CAPES
   FoundationCAPES; Brazilian Ministry of Education; Rio de Janeiro
   Foundation; D'Or Institute for Research and Education
FX This work was funded by different grants from the Brazilian Council for
   Development of Science and Technology, the CAPES Foundation, Brazilian
   Ministry of Education, the Rio de Janeiro Foundation for the Support of
   Science, and intramural grants from D'Or Institute for Research and
   Education.
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Jeha LE, 2003, NEUROLOGY, V61, P55, DOI 10.1212/01.WNL.0000073617.08185.0A
   Kalita J, 2000, J NEUROL SCI, V174, P3, DOI 10.1016/S0022-510X(99)00318-4
   Mecharles S, 2016, LANCET, V8, P6736, DOI DOI 10.1136/BCR-2012-007094.4
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nandan VA, 2013, CASE REP INFECT DIS, DOI 10.1155/2013/487659
   Thabet FI, 2013, PEDIATR NEUROL, V48, P393, DOI 10.1016/j.pediatrneurol.2012.12.017
   Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328
NR 9
TC 15
Z9 16
U1 0
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD FAL
PY 2016
VL 3
IS 4
DI 10.1093/ofid/ofw203
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA ED0ZI
UT WOS:000388572800009
PM 28053996
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU de Oliveira-Souza, R
   Monteiro, M
   Pacheco, P
   Tovar-Moll, F
   Mattos, P
   Moll, J
   Nazar, BP
AF de Oliveira-Souza, Ricardo
   Monteiro, Myriam
   Pacheco, Paula
   Tovar-Moll, Fernanda
   Mattos, Paulo
   Moll, Jorge
   Nazar, Bruno Palazzo
TI Right hemisphere dominance for language in a woman with schizophrenia
   and a porencephalic cyst of the left hemisphere
SO NEUROCASE
LA English
DT Article
DE Porencephaly; schizophrenia; neuroplasticity; Wernicke's area; acquired
   sociopathy; hemispheric dominance
ID PATHOLOGICAL LEFT-HANDEDNESS; HUMAN BRAIN; SPEECH; LATERALIZATION
AB A large left hemisphere porencephalic cyst was incidentally found in a 48-year-old woman (MS) with a Diagnostic and Statistical Manual (DSM)-5 diagnosis of schizophrenia. The encephaloclastic characteristics of the cyst indicated that it was acquired between the 22nd and 24th gestational weeks, after the major waves of neuronal migration had tapered off. The cyst destroyed the left temporal and occipital lobes, and the inferior parietal lobule. Surprisingly, MS had no evidence of aphasia, alexia, agraphia, or ideational apraxia; in contrast, cognitive functions dependent on the integrity of the right hemisphere were severely impaired. To test the hypothesis that the development of language in MS took place at the expense of functions that are normally carried out by the right hemisphere, we investigated MS's correlates of oral comprehension with fMRI as a proxy for auditory comprehension and other cognitive functions strongly lateralized to the posterior left hemisphere, such as ideational praxis and reading. Comprehension of spoken language engaged the homologous of Wernicke's area in the right planum temporale. Porencephaly may represent a natural model of neuroplasticity supervening at predictable epochs of prenatal development.
C1 [de Oliveira-Souza, Ricardo; Monteiro, Myriam; Tovar-Moll, Fernanda; Mattos, Paulo; Moll, Jorge] DOr Inst Res & Educ IDOR, Dept Clin Neurosci, Rio De Janeiro, Brazil.
   [de Oliveira-Souza, Ricardo] Fed Univ State Rio de Janeiro Uni Rio, Dept Neurol & Psychiat, Rio De Janeiro, Brazil.
   [Pacheco, Paula; Mattos, Paulo; Nazar, Bruno Palazzo] Fed Univ Rio de Janeiro UFRJ, Inst Psychiat, Rio De Janeiro, Brazil.
RP de Oliveira-Souza, R (corresponding author), DOr Inst Res & Educ IDOR, Dept Clin Neurosci, Rio De Janeiro, Brazil.; de Oliveira-Souza, R (corresponding author), Fed Univ State Rio de Janeiro Uni Rio, Dept Neurol & Psychiat, Rio De Janeiro, Brazil.
EM rdeoliveira@gmail.com
RI de Mattos, Paulo Eduardo Luiz/D-2328-2014; Moll, Fernanda
   Tovar/N-3320-2018; Nazar, Bruno Palazzo/I-3104-2013
OI de Mattos, Paulo Eduardo Luiz/0000-0003-0709-3783; Moll, Fernanda
   Tovar/0000-0002-0292-5985; Nazar, Bruno Palazzo/0000-0002-8325-1088
CR American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   American Psychiatric Association, 2000, DIAGN STAT MAN DIS
   BASSER LS, 1962, BRAIN, V85, P427, DOI 10.1093/brain/85.3.427
   Benton A.L., 1994, CONTRIBUTIONS NEUROP
   Benton A. L., 1994, MULTILINGUAL APHASIA
   Binder JR, 2015, NEUROLOGY, V85, P2170, DOI 10.1212/WNL.0000000000002219
   Bonnemann CG, 1996, AM J MED GENET, V63, P428
   Boyer L, 2011, PROG NEURO-PSYCHOPH, V35, P288, DOI 10.1016/j.pnpbp.2010.09.022
   Cai Q, 2013, P NATL ACAD SCI USA, V110, pE322, DOI 10.1073/pnas.1212956110
   CHAPMAN LF, 1959, ARCH NEUROL-CHICAGO, V1, P357, DOI 10.1001/archneur.1959.03840040001001
   Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241
   Curry CJ, 2005, AM J MED GENET A, V137A, P181, DOI 10.1002/ajmg.a.30862
   Dorst R., 1997, MED LAW, V16, P487
   Douzenis A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-19
   Folkerth RD, 2008, GREENFIELDS NEUROPAT
   GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186
   Granata T, 2008, HAND CLINIC, V87, P235, DOI 10.1016/S0072-9752(07)87015-1
   GRAY F, 2004, ESCOUROLLE POIRIER M
   HECAEN H, 1976, BRAIN LANG, V3, P114, DOI 10.1016/0093-934X(76)90009-2
   Howard D., 1992, PYRAMIDS PALM TREES
   Kernberg O, 1988, REV PSIQUIATRIA SANT, V5, P101
   KRASHEN SD, 1973, LANG LEARN, V23, P63, DOI 10.1111/j.1467-1770.1973.tb00097.x
   KURTHEN M, 1992, BRAIN LANG, V43, P694, DOI 10.1016/0093-934X(92)90091-R
   LeCount ER, 1925, ARCH NEURO PSYCHIATR, V14, P365, DOI 10.1001/archneurpsyc.1925.02200150078007
   Lezak M. D., 1995, NEUROPSYCHOLOGICAL A, V3rd
   MESULAM MM, 1985, JAMA-J AM MED ASSOC, V253, P2559, DOI 10.1001/jama.253.17.2559
   Moll J, 2000, NEUROLOGY, V54, P1331, DOI 10.1212/WNL.54.6.1331
   ORSINI DL, 1986, ARCH NEUROL-CHICAGO, V43, P333, DOI 10.1001/archneur.1986.00520040021012
   OWENS DGC, 1980, J NEUROL NEUROSUR PS, V43, P1065, DOI 10.1136/jnnp.43.12.1065
   Pae C. U., 2009, CNS SPECTRUMS, V13, pe1
   Rasmussen T, 1977, Ann N Y Acad Sci, V299, P355, DOI 10.1111/j.1749-6632.1977.tb41921.x
   Riecher-Rossler A, 2011, CURR TOP BEHAV NEURO, V8, P155, DOI 10.1007/7854_2010_100
   SATZ P, 1985, BRAIN COGNITION, V4, P27, DOI 10.1016/0278-2626(85)90052-1
   SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3
   Staudt M, 2002, NEUROIMAGE, V16, P954, DOI 10.1006/nimg.2002.1108
   Tranel D, 1994, Prog Exp Pers Psychopathol Res, P285
   Warrington E. K., 1991, VISUAL OBJECT SPACE
   Weinberg SM, 2007, SCHIZOPHR RES, V89, P72, DOI 10.1016/j.schres.2006.09.002
NR 38
TC 1
Z9 1
U1 1
U2 9
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1355-4794
EI 1465-3656
J9 NEUROCASE
JI Neurocase
PD JUN
PY 2016
VL 22
IS 3
BP 324
EP 331
DI 10.1080/13554794.2016.1186199
PG 8
WC Clinical Neurology; Psychiatry; Psychology
SC Neurosciences & Neurology; Psychiatry; Psychology
GA DR5IN
UT WOS:000379936800014
PM 27283036
DA 2020-12-17
ER

PT J
AU Chimelli, L
   Melo, ASO
   Tovar-Moll, F
   Oliveira-Szejnfeld, PS
   Camacho, AHS
   Gomes, GC
   Melo, FO
   Batista, AGM
   Machado, HN
   Awad, E
   Ferreira, TA
   Andrade, RD
   Mello, RJV
   Arruda, MB
   Brindeiro, RM
   Delvechio, R
   Tanuri, A
AF Chimelli, Leila
   Melo, Adriana S. O.
   Tovar-Moll, Fernanda
   Oliveira-Szejnfeld, Patricia S.
   Camacho, Aline H. S.
   Gomes, Giovanna C.
   Melo, Fabiana O.
   Batista, Alba G. M.
   Machado, Heloisa N.
   Awad, Elizabeth
   Ferreira, Thales A.
   Andrade, Rodrigo D.
   Mello, Roberto J. V.
   Arruda, Monica B.
   Brindeiro, Rodrigo M.
   Delvechio, Rodrigo
   Tanuri, Amilcar
TI Neuropathological aspects of congenital Zika virus infection in Brazil
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Meeting Abstract
CT 92nd Annual Meeting of the American-Association-of-Neuropathologist-Inc
CY JUN 16-19, 2016
CL Baltimore, MD
SP Amer Assoc Neuropathologist Inc
C1 [Chimelli, Leila; Camacho, Aline H. S.; Gomes, Giovanna C.] State Inst Brain, Rio De Janeiro, RJ, Brazil.
   [Melo, Adriana S. O.; Melo, Fabiana O.] Res Inst Prof Amorim Neto, Campina Grande, PB, Brazil.
   [Melo, Adriana S. O.; Batista, Alba G. M.] Hlth Secretary Campina Grande, Campina Grande, PB, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.
   [Oliveira-Szejnfeld, Patricia S.] Fdn Inst Educ & Res Diagnost Imaging FIDI, Fetal Med Res, Sao Paulo, SP, Brazil.
   [Machado, Heloisa N.; Awad, Elizabeth] Fiocruz MS, Fernandes Figueira Inst, BR-21045900 Rio De Janeiro, Brazil.
   [Ferreira, Thales A.] Univ Fed Pernambuco, Dept Pathol, Recife, PE, Brazil.
   [Andrade, Rodrigo D.] Univ Fed Campina Grande, Campina Grande, Paraiba, Brazil.
   [Mello, Roberto J. V.] Hlth Inst Elpidio de Almeida, Campina Grande, PB, Brazil.
   [Arruda, Monica B.; Brindeiro, Rodrigo M.; Delvechio, Rodrigo; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Mol Virol Lab, Rio De Janeiro, RJ, Brazil.
RI Moll, Fernanda Tovar/N-3320-2018; Ferreira, Thales Araujo/AAA-6252-2019;
   Melo, Adriana S O/H-5650-2016
OI Moll, Fernanda Tovar/0000-0002-0292-5985; 
NR 0
TC 0
Z9 0
U1 0
U2 55
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0022-3069
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD JUN
PY 2016
VL 75
IS 6
MA 2
BP 567
EP 567
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA DO3FC
UT WOS:000377665000011
DA 2020-12-17
ER

PT J
AU Lazarev, VV
   Monteiro, MD
   Vianna-Barbosa, R
   deAzevedo, LC
   Lent, R
   Tovar-Moll, F
AF Lazarev, Vladimir V.
   Monteiro, Myriam de Carvalho
   Vianna-Barbosa, Rodrigo
   deAzevedo, Leonardo C.
   Lent, Roberto
   Tovar-Moll, Fernanda
TI Electrophysiological Correlates of Morphological Neuroplasticity in
   Human Callosal Dysgenesis
SO PLOS ONE
LA English
DT Article
ID INTERHEMISPHERIC EEG COHERENCE; CORPUS-CALLOSUM; STRUCTURAL CONNECTOME;
   HUMAN BRAIN; AGENESIS; CONNECTIVITY; ABSENCE; SLEEP; CALLOSOTOMY;
   TRACKING
AB In search for the functional counterpart of the alternative Probst and sigmoid bundles, considered as morphological evidence of neuroplasticity in callosal dysgenesis, electroencephalographic (EEG) coherence analysis was combined with high resolution and diffusion tensor magnetic resonance imaging. Data of two patients with callosal agenesis, plus two with typical partial dysgenesis with a remnant genu, and one atypical patient with a substantially reduced genu were compared to those of fifteen neurotypic controls. The interhemispheric EEG coherence between homologous nontemporal brain regions corresponded to absence or partial presence of callosal connections. A generalized coherence reduction was observed in complete acallosal patients, as well as coherence preservation in the anterior areas of the two patients with a remnant genu. jThe sigmoid bundles found in three patients with partial dysgenesis correlated with augmented EEG coherence between anterior regions of one hemisphere and posterior regions of the other. These heterologous (crossed) interhemispheric connections were asymmetric in both imaging and EEG patterns, with predominance of the right-anterior-to-left-posterior connections over the mirror ones. The Probst bundles correlated with higher intrahemispheric long-distance coherence in all patients. The significant correlations observed for the delta, theta and alpha bands indicate that these alternative pathways are functional, although the neuropsychological nature of this function is still unknown.
C1 [Lazarev, Vladimir V.; Monteiro, Myriam de Carvalho; deAzevedo, Leonardo C.] Fundacao Oswaldo Cruz, Natl Inst Women Children & Adolescents Hlth Ferna, Rio De Janeiro, Brazil.
   [Monteiro, Myriam de Carvalho; Vianna-Barbosa, Rodrigo; Lent, Roberto; Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Monteiro, Myriam de Carvalho; Vianna-Barbosa, Rodrigo; Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
RP Lazarev, VV (corresponding author), Fundacao Oswaldo Cruz, Natl Inst Women Children & Adolescents Hlth Ferna, Rio De Janeiro, Brazil.
EM vlad.v@iname.com
RI Moll, Fernanda Tovar/N-3320-2018
OI Moll, Fernanda Tovar/0000-0002-0292-5985
FU Brazilian Council for Development of Science and Technology
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); CAPES FoundationCAPES; Brazilian Ministry of Education; Rio de
   Janeiro Foundation for the Support of Science (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); D'Or Institute for Research and Education (IDOR)
FX This work was funded by different grants from the Brazilian Council for
   Development of Science and Technology (CNPq), the CAPES Foundation,
   Brazilian Ministry of Education, the Rio de Janeiro Foundation for the
   Support of Science (FAPERJ) and intramural grants from D'Or Institute
   for Research and Education (IDOR). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Armitage P., 2002, STAT METHODS MED RES
   CARTER GC, 1987, P IEEE, V75, P236, DOI 10.1109/PROC.1987.13723
   Coben R, 2008, CLIN NEUROPHYSIOL, V119, P1002, DOI 10.1016/j.clinph.2008.01.013
   da Silva FL, 2010, EEG-FMRI: PHYSIOLOGICAL BASIS, TECHNIQUE AND APPLICATIONS, P19, DOI 10.1007/978-3-540-87919-0_2
   Edwards TJ, 2014, BRAIN, V137, P1579, DOI 10.1093/brain/awt358
   ETTLINGER G, 1972, BRAIN, V95, P327, DOI 10.1093/brain/95.2.327
   Hinkley LBN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039804
   Jakab A, 2015, NEUROIMAGE, V111, P277, DOI 10.1016/j.neuroimage.2015.02.038
   Jenkins G. M., 1968, SPECTRAL ANAL ITS AP
   Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004
   Koeda T, 1995, ELECTROEN CLIN NEURO, V95, P397, DOI 10.1016/0013-4694(95)00171-9
   KUKS JBM, 1987, ELECTROEN CLIN NEURO, V66, P8, DOI 10.1016/0013-4694(87)90132-5
   LASSONDE M, 1991, NEUROPSYCHOLOGIA, V29, P481, DOI 10.1016/0028-3932(91)90006-T
   Lazarev VV, 2010, CLIN NEUROPHYSIOL, V121, P145, DOI 10.1016/j.clinph.2009.10.010
   Lazarev VV, 2015, J AUTISM DEV DISORD, V45, P537, DOI 10.1007/s10803-013-1959-8
   LIVANOV MN, 1977, SPATIAL ORG CEREBRAL
   MONTPLAISIR J, 1990, CLIN ELECTROENCEPHAL, V21, P42, DOI 10.1177/155005949002100114
   Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3
   NAGASE Y, 1994, CLIN ELECTROENCEPHAL, V25, P36, DOI 10.1177/155005949402500110
   Niedermeyer E., 2005, ELECTROENCEPHALOGRAP
   NIELSEN T, 1992, J SLEEP RES, V1, P197, DOI 10.1111/j.1365-2869.1992.tb00038.x
   NIELSEN T, 1993, EUR NEUROL, V33, P173, DOI 10.1159/000116928
   Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7
   Owen JP, 2013, NEUROIMAGE, V70, P340, DOI 10.1016/j.neuroimage.2012.12.031
   Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.3.CO;2-A
   Papakostopoulos D., 1980, RHYTHMIC EEG ACTIVIT, P179
   Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107
   Pogarell O, 2005, J NEUROL NEUROSUR PS, V76, P109, DOI 10.1136/jnnp.2004.036566
   Probst M, 1901, ARCH PSYCHIAT NERVEN, V34, P709, DOI 10.1007/BF02680175
   Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x
   SAUERWEIN HC, 1981, NEUROPSYCHOLOGIA, V19, P445, DOI 10.1016/0028-3932(81)90074-9
   Siffredi V, 2013, DEV NEUROPSYCHOL, V38, P36, DOI 10.1080/87565641.2012.721421
   Sperry R. W., 1969, HDB CLINICAL NEUROLO, P273, DOI DOI 10.1023/B:HUMP.0000036333.34541.54
   Tovar-Moll F, 2007, CEREB CORTEX, V17, P531, DOI 10.1093/cercor/bhj178
   Tovar-Moll F, 2014, P NATL ACAD SCI USA, V111, P7843, DOI 10.1073/pnas.1400806111
   TUCKER DM, 1986, ELECTROEN CLIN NEURO, V63, P242, DOI 10.1016/0013-4694(86)90092-1
   Tyszka JM, 2011, J NEUROSCI, V31, P15154, DOI 10.1523/JNEUROSCI.1453-11.2011
   Wahl M, 2009, AM J NEURORADIOL, V30, P282, DOI 10.3174/ajnr.A1361
   Wang SY, 2004, J NEUROSCI METH, V136, P197, DOI 10.1016/j.jneumeth.2004.01.008
   Zaveri HP, 1999, CLIN NEUROPHYSIOL, V110, P1717, DOI 10.1016/S1388-2457(99)00136-4
NR 40
TC 6
Z9 6
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 7
PY 2016
VL 11
IS 4
AR e0152668
DI 10.1371/journal.pone.0152668
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DI6KO
UT WOS:000373608000033
PM 27055255
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU de Oliveira-Souza, R
   Moll, J
   Tovar-Moll, F
AF de Oliveira-Souza, Ricardo
   Moll, Jorge
   Tovar-Moll, Fernanda
TI Broca's Aphemia: The Tortuous Story of a Nonaphasic Nonparalytic
   Disorder of Speech
SO JOURNAL OF THE HISTORY OF THE NEUROSCIENCES
LA English
DT Article
DE Finkelnburg; aphemia; apraxia; Trousseau; speech; aphasia; Liepmann;
   language; hemispheric dominance; Broca; asymbolia
ID LEBORGNE BRAIN; APHASIA; BROCA,PAUL; INFARCTION; APRAXIA; ARTICULATION;
   TRANSLATION; DOMINANCE; ANARTHRIA; LANGUAGE
AB Broca coined the neologism "aphemia" to describe a syndrome consisting of a loss of the ability to speak without impairment of language and paralysis of the faciolingual territories in actions unrelated to speech, such as protruding the tongue or pursing the lips. Upon examining the brains of patients with aphemia, Broca concluded that the minimum possible lesion responsible for aphemia localized to the posterior left inferior frontal gyrus and lower portion of the middle frontal gyrus. A review of Broca's writings led us to conclude that (a) Broca localized speech, not language, to the left hemisphere, (b) Broca's aphemia is a form of apraxia, (c) Broca's aphemia is not, therefore, a terminological forerunner of aphasia, and (d) Broca was an outspoken equipotentialist concerning the cerebral localization of language. Broca's claim about the role of the left hemisphere in the organization of speech places him as the legitimate forebear of the two most outstanding achievements of Liepmann's work, namely, the concepts of apraxia and of a left hemisphere specialization for action.
C1 [de Oliveira-Souza, Ricardo; Moll, Jorge; Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Dept Neurosci, BR-22281100 Rio De Janeiro, Brazil.
   [de Oliveira-Souza, Ricardo] Fed Univ State Rio de Janeiro Uni Rio, Dept Neurol, Rio De Janeiro, Brazil.
RP de Oliveira-Souza, R (corresponding author), DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro,30-2 Andar, BR-22281100 Rio De Janeiro, Brazil.
EM rdeoliveira@gmail.com
RI Moll, Fernanda Tovar/N-3320-2018
OI Moll, Fernanda Tovar/0000-0002-0292-5985
CR Al-Ajmi AM, 2012, CAN J NEUROL SCI, V39, P658, DOI 10.1017/S0317167100015432
   ALAJOUANINE T, 1959, Rev Neurol (Paris), V100, P493
   ALAJOUANINE T, 1980, B ACAD NAT MED PARIS, V164, P545
   Ballet G, 1886, LANGAGE INTERIEUR DI
   Bastian HC, 1898, TREATISE APHASIA OTH
   BENSON DF, 1986, CORTEX, V22, P71, DOI 10.1016/S0010-9452(86)80033-8
   BENTON A, 1984, NEUROPSYCHOLOGIA, V22, P807, DOI 10.1016/0028-3932(84)90105-2
   BENTON AL, 1965, CAN PSYCHOLOGIST, V6, P332, DOI 10.1037/h0083084
   BENTON AL, 1998, ACQUIRED APHASIA, P1
   BERKER EA, 1986, ARCH NEUROL-CHICAGO, V43, P1065, DOI 10.1001/archneur.1986.00520100069017
   Bernheim F, 1901, APHASIE MOTRICE ETUD
   BOLLER F, 1978, BRAIN LANG, V5, P149, DOI 10.1016/0093-934X(78)90015-9
   Bonilha L, 2006, NEUROREPORT, V17, P1027, DOI 10.1097/01.wnr.0000223388.28834.50
   Bouchard C, 1865, COMPTES RENDUS SOC B, V4, P1
   Bouchard C, 1864, COMPTES RENDUS SOC B, V4, P111
   BOUILLAUD JB, 1825, ARCH GEN MED, V8, P25
   Broca MP, 1861, B SOC ANAT PARIS, VVI, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018
   Broca P, 1865, B SOC ANTHROPOL PAR, P377, DOI DOI 10.3406/BMSAP.1865.9495
   Broca P., 1861, B SOC ANTHROPOL PAR, V2, P235
   Broca P., 1866, B SOC ANTHROPOL PAR, V1, P377
   Broca P. P., 1864, GAZETTE HOPITAUX CIV, V37, P35
   Broca PP, 1863, B SOC ANTHR, V4, P200, DOI DOI 10.1515/9783110807783-002
   Brodmann K, 1908, J PSYCHOL NEUROL, V10, P231
   CASTAIGNE P, 1979, B ACAD NAT MED PARIS, V163, P663
   CASTAIGNE P, 1980, REV NEUROL, V136, P563
   Catani M, 2013, BRAIN, V136, P2619, DOI 10.1093/brain/awt163
   Charcot J. M., 1863, GAZ HEBD MED CHIR, V10, P473
   COHEN L, 1993, J NEUROL NEUROSUR PS, V56, P923, DOI 10.1136/jnnp.56.8.923
   Crary MA, 1985, CLIN APH C 15 ASHL O, P113
   Critchley M., 1979, DIVINE BANQUET BRAIN, P72
   DAVID AS, 1984, J NEUROL NEUROSUR PS, V47, P1342, DOI 10.1136/jnnp.47.12.1342
   Dax M, 1865, GAZETTE HEBDOMADAIRE, V2, P259
   de Oliveira-Souza R, 2007, ARQ NEURO-PSIQUIAT, V65, P1220, DOI 10.1590/S0004-282X2007000700025
   DEJERINE J, 1906, PRESSE MED, V14, P453
   DENNYBRO.D, 1965, AUST J EXP BIOL MED, V43, P455, DOI 10.1038/icb.1965.31
   Domanski CW, 2013, J HIST NEUROSCI, V22, P47, DOI 10.1080/0964704X.2012.667528
   Dronkers NF, 2007, BRAIN, V130, P1432, DOI 10.1093/brain/awm042
   DUFFY RJ, 1979, J SPEECH HEAR DISORD, V44, P156, DOI 10.1044/jshd.4402.156
   Ferrier D, 1874, P ROY SOC LOND B BIO, V22, P229, DOI 10.1098/rspl.1873.0032
   Finger S, 2009, HDB CLIN NEUROLOGY, V95, P117
   Finkelnburg FCM, 1870, BERLINER KLIN WOCHEN, V37, P449
   Finkelnburg FCM, 1870, BERLINER KLIN WOCHEN, V38, P460
   Foulis D, 1879, Br Med J, V1, P383
   Fox RJ, 2001, CLIN NEUROL NEUROSUR, V103, P123, DOI 10.1016/S0303-8467(01)00126-3
   Gallassi R, 2009, ANN NEUROL, V65, P357, DOI 10.1002/ana.21572
   Geschwind N, 1964, Int J Neurol, V4, P207
   Geschwind N, 1963, SPEECH LANGUAGE COMM, V3, P1
   Goldberg G., 2013, APRAXIA COGNITIVE SI
   HENDERSON VW, 1990, ARCH NEUROL-CHICAGO, V47, P85, DOI 10.1001/archneur.1990.00530010107028
   JOYNT RJ, 1964, NEUROLOGY, V14, P851, DOI 10.1212/WNL.14.9.851
   JOYNT RJ, 1964, CORTEX, V1, P206
   KIMURA D, 1980, TRANSLATIONS LIEPMAN
   Ladame P, 1902, REV NEUROL, V10, P13
   Ladame PL, 1908, ENCEPHALE, V3, P193
   Laignel-Lavastine P-MM, 1906, B MEM SOC MED HOP P, V23, P1298
   Lazar RM, 2011, NEUROPSYCHOL REV, V21, P236, DOI 10.1007/s11065-011-9176-8
   Lebrun Y., 1990, J NEUROLINGUIST, V5, P379
   LECOURS AR, 1976, BRAIN LANG, V3, P88, DOI 10.1016/0093-934X(76)90008-0
   LEE DA, 1981, NEUROLOGY, V31, P600, DOI 10.1212/WNL.31.5.600
   Liepmann H, 1905, DEUT MED WOCHENSCHR, V31, P1492, DOI 10.1055/s-0029-1188347
   Liepmann H., 1908, DREI AUFSATZE APRAXI
   Liepmann H, 1905, MUNCHEN MED WOCHEN, V49, P2375
   LIEPMANN H, 1905, MUNCHEN MED WOCHEN, V49, P2322
   Luzzatti C, 2001, ARCH NEUROL-CHICAGO, V58, P1157, DOI 10.1001/archneur.58.7.1157
   Marce LV, 1856, COMPTE RENDU SOC BIO, V3, P93
   Marie P., 1906, SEM MED, V26, P241
   MARIE P, 1906, B MEM SOC MED HOP P, V23, P1152
   Mohr J., 1976, STUDIES NEUROLINGUIS, V1, P201
   NAESER MA, 1989, BRAIN, V112, P1, DOI 10.1093/brain/112.1.1
   NIELSEN JM, 1965, AGNOSIA APRAXIA APHA
   Ogar J, 2005, NEUROCASE, V11, P427, DOI 10.1080/13554790500263529
   OSBORNE J, 1833, DUBLIN J MED CHEM SC, V4, P157
   Ottomeyer C, 2009, J NEUROL, V256, P1166, DOI 10.1007/s00415-009-5055-0
   Parrot J., 1863, B SOC ANAT, V8, P372
   Rheims S, 2006, EUR NEUROL, V55, P225, DOI 10.1159/000093874
   Ropper AH, 2009, ADAMS VICTORS PRINCI
   RUFF RL, 1981, NEUROLOGY, V31, P353, DOI 10.1212/WNL.31.3.353
   RYALLS J, 1984, BRAIN LANG, V21, P358, DOI 10.1016/0093-934X(84)90059-2
   SCHIFF HB, 1983, ARCH NEUROL-CHICAGO, V40, P720, DOI 10.1001/archneur.1983.04050110038005
   Schiller Francis, 1992, P BROCA FOUNDER FREN
   Selnes O A, 2000, J Hist Neurosci, V9, P233, DOI 10.1076/0964-704X(200012)9:3;1-#;FT233
   SIGNORET JL, 1984, BRAIN LANG, V22, P303, DOI 10.1016/0093-934X(84)90096-8
   SOUQUES A, 1906, B SOC MED HOPITAUX, V23, P971
   SQUARE PA, 1997, APRAXIA NEUROPSYCHOL, P173
   Terao Y, 2007, J NEUROL, V254, P442, DOI 10.1007/s00415-006-0385-7
   Trousseau A, 1864, GAZETTE HOPITAUX CIV, V37, p[25, 13]
   Trousseau A, 1864, GAZETTE HOPITAUX CIV, V37, P37
   TROUSSEAU A, 1865, CLIN MED HOTEL DIEU, V2, P571
   Trousseau A, 1864, GAZETTE HOPITAUX CIV, V37, P49
   Trousseau A, 1864, GAZETTE HEBDOMADAIRE, V22, P358
   Trousseau A, 1864, GAZETTE HEBDOMADAIRE, V20, P323
   Trousseau A, 1864, GAZETTE HOPITAUX CIV, V37, P25
   Trousseau A, 1864, GAZETTE HEBDOMADAIRE, V26, P432
   Trousseau A, 1864, GAZETTE HEBDOMADAIRE, V21, P342
   Trousseau A, 1864, GAZETTE HEBDOMADAIRE, V25, P414
   WERNICKE C, 1910, MODERN CLIN MED DISE, P265
   WHITAKER HA, 1993, BRAIN LANG, V45, P560, DOI 10.1006/brln.1993.1060
NR 97
TC 1
Z9 1
U1 0
U2 17
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0964-704X
EI 1744-5213
J9 J HIST NEUROSCI
JI J. Hist. Neurosci.
PD APR 2
PY 2016
VL 25
IS 2
BP 142
EP 168
DI 10.1080/0964704X.2015.1041346
PG 27
WC History & Philosophy Of Science; Neurosciences
SC History & Philosophy of Science; Neurosciences & Neurology
GA DG5HR
UT WOS:000372108600002
PM 26452688
DA 2020-12-17
ER

PT J
AU Gubert, F
   Decotelli, AB
   Bonacossa-Pereira, I
   Figueiredo, FR
   Zaverucha-do-Valle, C
   Tovar-Moll, F
   Hoffmann, L
   Urmenyi, TP
   Santiago, MF
   Mendez-Otero, R
AF Gubert, Fernanda
   Decotelli, Ana B.
   Bonacossa-Pereira, Igor
   Figueiredo, Fernanda R.
   Zaverucha-do-Valle, Camila
   Tovar-Moll, Fernanda
   Hoffmann, Luisa
   Urmenyi, Turan P.
   Santiago, Marcelo F.
   Mendez-Otero, Rosalia
TI Intraspinal bone-marrow cell therapy at pre- and symptomatic phases in a
   mouse model of amyotrophic lateral sclerosis
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Amyotrophic lateral sclerosis; Bone marrow cell therapy; Neuronal
   degeneration
ID STEM-CELLS; DISEASE PROGRESSION; MOTOR-NEURONS; MONONUCLEAR-CELLS; ALS
   MICE; TRANSGENIC MICE; INHERITED ALS; ANIMAL-MODEL; FAMILIAL ALS;
   LIFE-SPAN
AB Background: Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that selectively affects the motor neurons. The details of the mechanisms of selective motor-neuron death remain unknown and no effective therapy has been developed. We investigated the therapy with bone-marrow mononuclear cells (BMMC) in a mouse model of ALS (SOD1(G93A) mice).
   Methods: We injected 10(6) BMMC into the lumbar portion of the spinal cord of SOD1(G93A) mice in presymptomatic (9 weeks old) and symptomatic (14 weeks old) phases. In each condition, we analyzed the progression of disease and the lifespan of the animals.
   Results: We observed a mild transitory delay in the disease progression in the animals injected with BMMC in the presymptomatic phase. However, we observed no increase in the lifespan. When we injected BMMC in the symptomatic phase, we observed no difference in the animals' lifespan or in the disease progression. Immunohistochemistry for NeuN showed a decrease in the number of motor neurons during the course of the disease, and this decrease was not affected by either treatment. Using different strategies to track the BMMC, we noted that few cells remained in the spinal cord after transplantation. This observation could explain why the BMMC therapy had only a transitory effect.
   Conclusion: This is the first report of intraspinal BMMC therapy in a mouse model of ALS. We conclude this cellular therapy has only a mild transitory effect when performed in the presymptomatic phase of the disease.
C1 [Gubert, Fernanda; Decotelli, Ana B.; Bonacossa-Pereira, Igor; Figueiredo, Fernanda R.; Hoffmann, Luisa; Urmenyi, Turan P.; Santiago, Marcelo F.; Mendez-Otero, Rosalia] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, Sala G2-028,Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Zaverucha-do-Valle, Camila] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis INI, Ave Brasil 4365Maguinhos, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Tovar-Moll, Fernanda] Fundacao Oswaldo Cruz, Ctr Ciencias Saude, Inst Biomed Sci, Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Tovar-Moll, Fernanda] Fundacao Oswaldo Cruz, Ctr Ciencias Saude, Natl Ctr Struct Biol & Bioimaging, CENABIO, Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Tovar-Moll, Fernanda] Inst DOr Pesquisa & Educ IDOR, Rua Diniz Cordeiro 30Botafogo, BR-22281100 Rio De Janeiro, RJ, Brazil.
RP Gubert, F (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, Sala G2-028,Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM fegubert@biof.ufrj.br
RI Santiago, Marcelo F/H-3943-2011; Santiago, Marcelo
   Felippe/AAZ-3553-2020; Mendez-Otero, Rosalia/AAL-7551-2020; Moll,
   Fernanda Tovar/N-3320-2018; Gubert, Fernanda/G-7619-2014
OI Santiago, Marcelo F/0000-0003-2428-9606; Santiago, Marcelo
   Felippe/0000-0003-2428-9606; Mendez-Otero, Rosalia/0000-0002-1798-9930;
   Moll, Fernanda Tovar/0000-0002-0292-5985; Gubert,
   Fernanda/0000-0002-0568-7935
CR Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282
   Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105
   Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103
   Beers DR, 2011, BRAIN BEHAV IMMUN, V25, P1025, DOI 10.1016/j.bbi.2010.12.008
   Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015
   Blanquer M, 2012, STEM CELLS, V30, P1277, DOI 10.1002/stem.1080
   Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511
   Borlongan CV, 2011, PROG NEUROBIOL, V95, P213, DOI 10.1016/j.pneurobio.2011.08.005
   Choi CI, 2008, J NEUROL SCI, V268, P40, DOI 10.1016/j.jns.2007.10.024
   Corti S, 2004, BRAIN, V127, P2518, DOI 10.1093/brain/awh273
   Corti S, 2007, BRAIN, V130, P1289, DOI 10.1093/brain/awm043
   Corti S, 2010, HUM MOL GENET, V19, P3782, DOI 10.1093/hmg/ddq293
   Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885
   dos Santos AD, 2010, BRAIN RES, V1306, P149, DOI 10.1016/j.brainres.2009.09.094
   ENGELHARDT JI, 1993, ARCH NEUROL-CHICAGO, V50, P30, DOI 10.1001/archneur.1993.00540010026013
   Gubert F, 2013, STEM CELL RES, V10, P241, DOI 10.1016/j.scr.2012.11.009
   GURNEY ME, 1994, NEW ENGL J MED, V331, P1721, DOI 10.1056/NEJM199412223312516
   Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957
   Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5
   Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248
   Kocsis JD, 2012, PROG BRAIN RES, V201, P79, DOI 10.1016/B978-0-444-59544-7.00005-6
   Kondo T, 2014, STEM CELL REP, V3, P242, DOI 10.1016/j.stemcr.2014.05.017
   Morita E, 2008, EXP NEUROL, V213, P431, DOI 10.1016/j.expneurol.2008.07.011
   Morrison KE, 2002, CURR OPIN PHARMACOL, V2, P302, DOI 10.1016/S1471-4892(02)00169-8
   Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001
   Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876
   Ohnishi S, 2009, BRAIN RES, V1296, P216, DOI 10.1016/j.brainres.2009.08.012
   Pastor D, 2012, STEM CELL REV REP, V8, P445, DOI 10.1007/s12015-011-9295-x
   Ramos AB, 2013, BRAIN RES, V1522, P1, DOI 10.1016/j.brainres.2013.05.024
   Rosado-de-Castro PH, 2013, STEM CELLS DEV, V22, P2095, DOI 10.1089/scd.2013.0089
   Rosado-de-Castro PH, 2013, REGEN MED, V8, P145, DOI [10.2217/RME.13.2, 10.2217/rme.13.2]
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300
   Sharma AK, 2015, AM J STEM CELLS, V4, P50
   Solomon JN, 2006, GLIA, V53, P744, DOI 10.1002/glia.20331
   Suzuki M, 2008, MOL THER, V16, P2002, DOI 10.1038/mt.2008.197
   Leal MMT, 2014, NEUROCHEM RES, V39, P259, DOI 10.1007/s11064-013-1217-7
   Uccelli A, 2012, MOL MED, V18, P794, DOI 10.2119/molmed.2011.00498
   Vercelli A, 2008, NEUROBIOL DIS, V31, P395, DOI 10.1016/j.nbd.2008.05.016
   Zaverucha-Do-Valle C, 2014, BRAIN RES, V1587, P54, DOI 10.1016/j.brainres.2014.08.070
   Zaverucha-do-Valle C, 2011, CELL TRANSPLANT, V20, P391, DOI 10.3727/096368910X524764
   Zhou C, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-52
NR 42
TC 10
Z9 10
U1 0
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD MAR 15
PY 2016
VL 7
AR 41
DI 10.1186/s13287-016-0293-4
PG 14
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
SC Cell Biology; Research & Experimental Medicine
GA DG9YP
UT WOS:000372440000002
PM 26979533
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Nunes, AKD
   Raposo, C
   de Oliveira, WH
   Thome, R
   Verinaud, L
   Tovar-Moll, F
   Peixoto, CA
AF de Santana Nunes, Ana Karolina
   Raposo, Catarina
   de Oliveira, Wilma Helena
   Thome, Rodolfo
   Verinaud, Liana
   Tovar-Moll, Fernanda
   Peixoto, Christina Alves
TI Phosphodiesterase-5 inhibition promotes remyelination by MCP-1/CCR-2 and
   MMP-9 regulation in a cuprizone-induced demyelination model
SO EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Sildenafil; Neuroinflammation; Demyelination; Oligodendrocyte; Cuprizone
ID MULTIPLE-SCLEROSIS; CNS REMYELINATION; PROTEIN-KINASE; OLIGODENDROCYTES;
   DIFFERENTIATION; NEUROPROTECTION; EXPRESSION; STROKE; BRAIN; CELLS
AB While it has recently been shown that sildenafil (Viagra (R)) has a protective effect on myelination/remyelination, the mechanism of this protection is still unknown. In general, cytokines, chemokines and metalloproteinases have a pro-inflammatory action, but can also exert a role in modulating glial cell activation, contributing to the balance of cell response. Investigating these molecules can contribute to clarifying the mechanisms of sildenafil neuroprotection. In addition, it is not known. whether sildenafil is able to restore an already installed neurodegenerative process or if the treatment period is critical for its action. The aim of the present study was to evaluate, in a cuprizone (CPZ)-induced demyelination model, the effects and mechanisms of time-dependent treatment with sildenafil (beginning 15 days after neurodegeneration and continuing for 15 days, or starting concomitantly with neurodegeneration and continuing for 30 days) on neuroinflammation and remyelination. Neuroinflammation and demyelination induced by CPZ in rodents has been widely used as a model of multiple sclerosis (MS). In the present study, five male G7BL/6 mice aged 7-10 weeks were used per group. For four weeks, the groups received either cuprizone (CPZ) 0.2% mixed in feed or CPZ combined with the administration of sildenafil (Viagra, Pfizer, 25 mg/kg) orally in drinking water, starting concurrently with (sild-T0) or 15 days (sild-T15) after the start of CPZ treatment. Control animals received pure food and water. The cerebella were dissected and processed for immunohistochemistry, immunofluorescence (frozen), Western blotting, Luxol fast blue staining and transmission electron microscopy. Magnetic resonance was performed for live animals, after the same treatment, using CPZ 0.3%. CPZ induced an increase in the expression of IL-1 beta and a decrease in MCP-1, CCR-2, MBP and GST-pi, as well as promoting damage in the structure and ultra-structure of the myelin sheath. Interestingly, the administering of sild-TO promoted a further increase of MMP-9, MCP-1, and CCR-2, possibly contributing to changes in the microglia phenotype, which becomes more phagocytic, cleaning myelin debris. It was also observed that, after sild-TO treatment the expression of GST-pi and MBP increased and the myelin structure was improved. However, sild-T15 was not efficient in all aspects, probably due to the short treatment period and to starting after the installation of the degenerative process. Therefore, the present study shows that sildenafil modulates inflammation, with the involvement of MMP-9, MCP-1, and CCR-2, and also contributes to myelin repair. These protective effects were dependent on the therapeutic strategy used. This clarification can strengthen research proposals into the mechanism of action of sildenafil and contribute to the control of neurodegenerative diseases such as MS. (C) 2015 Elsevier Inc. All rights reserved.
C1 [de Santana Nunes, Ana Karolina; de Oliveira, Wilma Helena; Peixoto, Christina Alves] Aggeu Magalhaes Res Ctr CPqAM, Lab Ultrastruct, BR-50670420 Recife, PE, Brazil.
   [de Santana Nunes, Ana Karolina; de Oliveira, Wilma Helena] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Raposo, Catarina] State Univ Campinas UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil.
   [Thome, Rodolfo; Verinaud, Liana] Univ Campinas UNICAMP, Dept Struct & Funct Biol, Campinas, SP, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci ICB, Rio De Janeiro, RJ, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging CENABIO, Rio De Janeiro, RJ, Brazil.
RP Nunes, AKD (corresponding author), Aggeu Magalhaes Res Ctr CPqAM, Lab Ultrastruct, Ave Prof Moraes Rego S-N, BR-50670420 Recife, PE, Brazil.
EM nunes.aks@gmail.com
RI Oliveira, Wilma Helena/AAD-9715-2019; Moll, Fernanda Tovar/N-3320-2018;
   PEIXOTO, CHRISTINA/AAD-9608-2019; Thome, Rodolfo/C-1564-2012
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Thome,
   Rodolfo/0000-0001-7627-4137
FU Brazilian fostering agency FACEPE; Brazilian fostering agency CAPES;
   Brazilian fostering agency INBEB [57.3767/2008-4]; Brazilian fostering
   agency FAPESP; CAPESCAPES; FACEPE [AMD-0094-2.00/1]; FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/08005-6]
FX The authors would like to thank Ms. Anne Gabrielle Vasconcelos for
   technical assistance, Ms. Denise Rocha Gomes for animal care, and the
   Dept. of Pharmacology (FCM/UNICAMP) and CPqAM for the animal lodging
   facilities. The study was funded by grants from the Brazilian fostering
   agencies FACEPE, CAPES, INBEB (57.3767/2008-4) and FAPESP. AKSN was a
   PhD student granted with a scholarship from CAPES and FACEPE
   (#AMD-0094-2.00/1). CR was a post-doctoral researcher granted with a
   scholarship from FAPESP (2011/08005-6). CAP [IB (CP-II) ] is a research
   fellow of the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) (301777/2012-8).
CR Acs P, 2009, GLIA, V57, P807, DOI 10.1002/glia.20806
   Saraiva KLA, 2006, REPROD TOXICOL, V22, P754, DOI 10.1016/j.reprotox.2006.07.008
   Saraiva KLA, 2009, INT J EXP PATHOL, V90, P454, DOI 10.1111/j.1365-2613.2009.00660.x
   Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664
   [Anonymous], 2016, NEUROLOGY, V275, P143
   Arnold S, 2009, J NEUROCHEM, V110, P1, DOI 10.1111/j.1471-4159.2009.06133.x
   Benardais K, 2013, NEUROTOX RES, V24, P244, DOI 10.1007/s12640-013-9380-9
   Boran MS, 2008, GLIA, V56, P394, DOI 10.1002/glia.20618
   CAMMER W, 1995, J NEUROSCI RES, V40, P451, DOI 10.1002/jnr.490400404
   Cammer W, 1999, J NEUROL SCI, V168, P116, DOI 10.1016/S0022-510X(99)00181-1
   Castier Y, 2009, ANTIOXID REDOX SIGN, V11, P1641, DOI 10.1089/ARS.2008.2393
   Charriaut-Marlangue C, 2014, STROKE, V45, P850, DOI 10.1161/STROKEAHA.113.003606
   Chen XM, 2014, CNS NEUROSCI THER, V20, P40, DOI 10.1111/cns.12162
   Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010
   Nunes AKD, 2012, CYTOKINE, V60, P540, DOI 10.1016/j.cyto.2012.06.011
   Harkness KA, 2003, J NEUROIMMUNOL, V142, P1, DOI 10.1016/S0165-5728(03)00251-0
   Hsieh HL, 2008, GLIA, V56, P619, DOI 10.1002/glia.20637
   Jiang Y, 2013, NEUROPHARMACOLOGY, V73, P415, DOI 10.1016/j.neuropharm.2013.06.023
   Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033664
   Kipp M, 2009, ACTA NEUROPATHOL, V118, P723, DOI 10.1007/s00401-009-0591-3
   Komoly S., 2009, J NEUROL SCI
   Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006
   Liu C, 2014, INT J CLIN EXP PATHO, V7, P8342
   Liu XS, 2007, J NEUROSCI RES, V85, P2120, DOI 10.1002/jnr.21359
   Low QEH, 2001, AM J PATHOL, V159, P457, DOI 10.1016/S0002-9440(10)61717-8
   McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9
   Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469
   Morello N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020173
   Nunes A. K. S., 2015, BRAIN RES IN PRESS
   Oh LYS, 1999, J NEUROSCI, V19, P8464
   Pasquini LA, 2007, NEUROCHEM RES, V32, P279, DOI 10.1007/s11064-006-9165-0
   Pham LDD, 2012, GLIA, V60, P875, DOI 10.1002/glia.22320
   Pifarre P, 2011, ACTA NEUROPATHOL, V121, P499, DOI 10.1007/s00401-010-0795-6
   Ramamurthy S, 2006, J PHYSIOL-LONDON, V574, P85, DOI 10.1113/jphysiol.2006.110122
   Raposo C, 2014, BRAIN RES BULL, V104, P60, DOI 10.1016/j.brainresbull.2014.04.002
   Raposo C, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/321460
   Rawji KS, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/948976
   Riccitelli G, 2012, MULT SCLER J, V18, P1027, DOI 10.1177/1352458512439239
   Salinas Tejedor L., 2015, HISTOL HISTOPATHOL, V25, P11640
   Sekton B., 2010, RES REP BIOL, DOI http://dx.doi.org/102147/RRB.S12043
   Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240
   Shields SD, 2012, ANN NEUROL, V71, P186, DOI 10.1002/ana.22665
   Tanaka Tatsuhide, 2014, Biomol Concepts, V5, P289, DOI 10.1515/bmc-2014-0015
   Xiao YS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009425.pub2
   Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59
   Zhou W, 2009, GASTROENTEROLOGY, V137, P1403, DOI 10.1053/j.gastro.2009.06.049
NR 46
TC 15
Z9 15
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4886
EI 1090-2430
J9 EXP NEUROL
JI Exp. Neurol.
PD JAN
PY 2016
VL 275
BP 143
EP 153
DI 10.1016/j.expneurol.2015.10.013
PN 1
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA CZ9MA
UT WOS:000367420500016
PM 26515692
DA 2020-12-17
ER

PT J
AU Marins, TF
   Rodrigues, EC
   Engel, A
   Hoefle, S
   Basilio, R
   Lent, R
   Moll, J
   Tovar-Moll, F
AF Marins, Theo F.
   Rodrigues, Erika C.
   Engel, Annerose
   Hoefle, Sebastian
   Basilio, Rodrigo
   Lent, Roberto
   Moll, Jorge
   Tovar-Moll, Fernanda
TI Enhancing Motor Network Activity Using Real-Time Functional MRI
   Neurofeedback of Left Premotor Cortex
SO FRONTIERS IN BEHAVIORAL NEUROSCIENCE
LA English
DT Article
DE neurofeedback; motor imagery; left premotor cortex; neuromodulation;
   motor rehabilitation
ID BRAIN ACTIVATION; FMRI NEUROFEEDBACK; IMAGERY; MOVEMENTS;
   REORGANIZATION; MODULATION; REPRESENTATION; PLASTICITY; STROKE; SYSTEM
AB Neurofeedback by functional magnetic resonance imaging (fMRI) is a technique of potential therapeutic relevance that allows individuals to be aware of their own neurophysiological responses and to voluntarily modulate the activity of specific brain regions, such as the premotor cortex (PMC), important for motor recovery after brain injury. We investigated (i) whether healthy human volunteers are able to up-regulate the activity of the left PMC during a right hand finger tapping motor imagery (MI) task while receiving continuous fMRI-neurofeedback, and (ii) whether successful modulation of brain activity influenced non-targeted motor control regions. During the MI task, participants of the neurofeedback group (NFB) received ongoing visual feedback representing the level of fMRI responses within their left PMC. Control (CTL) group participants were shown similar visual stimuli, but these were non-contingent on brain activity. Both groups showed equivalent levels of behavioral ratings on arousal and MI, before and during the fMRI protocol. In the NFB, but not in CLT group, brain activation during the last run compared to the first run revealed increased activation in the left PMC. In addition, the NFB group showed increased activation in motor control regions extending beyond the left PMC target area, including the supplementary motor area, basal ganglia and cerebellum. Moreover, in the last run, the NFB group showed stronger activation in the left PMC/inferior frontal gyrus when compared to the CTL group. Our results indicate that modulation of PMC and associated motor control areas can be achieved during a single neurofeedback-fMRI session. These results contribute to a better understanding of the underlying mechanisms of MI-based neurofeedback training, with direct implications for rehabilitation strategies in severe brain disorders, such as stroke.
C1 [Marins, Theo F.; Rodrigues, Erika C.; Engel, Annerose; Hoefle, Sebastian; Basilio, Rodrigo; Lent, Roberto; Moll, Jorge; Tovar-Moll, Fernanda] DOr Inst Res & Educ, Rio De Janeiro, Brazil.
   [Marins, Theo F.; Lent, Roberto; Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Rodrigues, Erika C.] Augusto Motta Univ Unisuam, Rio De Janeiro, Brazil.
   [Engel, Annerose] Univ Hosp Leipzig, Clin Cognit Neurol, Leipzig, Germany.
   [Lent, Roberto; Moll, Jorge; Tovar-Moll, Fernanda] INNT, Rio De Janeiro, Brazil.
RP Tovar-Moll, F (corresponding author), DOr Inst Res & Educ, Rio De Janeiro, Brazil.
EM fernanda.tovarmoll@idor.org
RI Moll, Fernanda Tovar/N-3320-2018; Rodrigues, Erika/R-6007-2017; Coish,
   Elizabeth/AAU-1245-2020; de Carvalho Rodrigues, Erika/AAE-9445-2020
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Rodrigues,
   Erika/0000-0001-5464-2963; de Carvalho Rodrigues,
   Erika/0000-0001-5464-2963; Marins, Theo/0000-0002-5017-707X
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPESCAPES; D'Or Institute for
   Research and Education (IDOR)
FX This research was supported by grants provided by FAPERJ, CNPq, CAPES,
   as well as by intramural grants from D'Or Institute for Research and
   Education (IDOR).
CR Basilio R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00003
   Berman BD, 2012, NEUROIMAGE, V59, P917, DOI 10.1016/j.neuroimage.2011.07.035
   Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633
   Blefari ML, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00018
   Caria A, 2007, NEUROIMAGE, V35, P1238, DOI 10.1016/j.neuroimage.2007.01.018
   Caria A, 2010, BIOL PSYCHIAT, V68, P425, DOI 10.1016/j.biopsych.2010.04.020
   Cavanagh JF, 2012, PSYCHOPHYSIOLOGY, V49, P220, DOI 10.1111/j.1469-8986.2011.01293.x
   Chiew M, 2012, NEUROIMAGE, V61, P21, DOI 10.1016/j.neuroimage.2012.02.053
   COX RW, 1995, MAGNET RESON MED, V33, P230, DOI 10.1002/mrm.1910330213
   Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039
   Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005
   Decety J, 1996, BEHAV BRAIN RES, V72, P127
   deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102
   DeCharms RC, 2004, NEUROIMAGE, V21, P436, DOI 10.1016/j.neuroimage.2003.08.041
   Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004
   Foerster BU, 2005, MAGNET RESON MED, V54, P1261, DOI 10.1002/mrm.20695
   Fridman EA, 2004, BRAIN, V127, P747, DOI 10.1093/brain/awh082
   FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018
   Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093
   Hamilton JP, 2011, HUM BRAIN MAPP, V32, P22, DOI 10.1002/hbm.20997
   Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002
   HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150
   Hui MQ, 2014, NEUROPSYCHOLOGIA, V62, P111, DOI 10.1016/j.neuropsychologia.2014.07.012
   Johansen-Berg H, 2002, P NATL ACAD SCI USA, V99, P14518, DOI 10.1073/pnas.222536799
   Liu Y, 1999, EXP BRAIN RES, V128, P149, DOI 10.1007/s002210050830
   Lotze M, 1999, J COGNITIVE NEUROSCI, V11, P491, DOI 10.1162/089892999563553
   Ma LS, 2010, BRAIN RES, V1318, P64, DOI 10.1016/j.brainres.2009.12.073
   Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042
   Malouin Francine, 2007, J Neurol Phys Ther, V31, P20
   Matsuzaka Y, 2007, J NEUROPHYSIOL, V97, P1819, DOI 10.1152/jn.00784.2006
   Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004
   Megumi F, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00160
   Mihara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032234
   Miyai I, 1999, STROKE, V30, P1380, DOI 10.1161/01.STR.30.7.1380
   Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024
   Nyberg L, 2006, NEUROPSYCHOLOGIA, V44, P711, DOI 10.1016/j.neuropsychologia.2005.08.006
   OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4
   Olsson C-J, 2008, Open Neuroimag J, V2, P5, DOI 10.2174/1874440000802010005
   Porro CA, 1996, J NEUROSCI, V16, P7688
   Posse S, 2003, NEUROIMAGE, V18, P760, DOI 10.1016/S1053-8119(03)00004-1
   Sato JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081658
   Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc
   Sitaram R, 2012, NEUROREHAB NEURAL RE, V26, P256, DOI 10.1177/1545968311418345
   STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373
   Sulzer J, 2013, NEUROIMAGE, V76, P386, DOI 10.1016/j.neuroimage.2013.03.033
   Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631
   Ward NS, 2004, CURR OPIN NEUROL, V17, P725, DOI 10.1097/00019052-200412000-00013
   Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145
   WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023
   Yoo SS, 2008, INT J IMAG SYST TECH, V18, P69, DOI 10.1002/ima.20139
   Yoo SS, 2002, NEUROREPORT, V13, P1377, DOI 10.1097/00001756-200208070-00005
   Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263
   Zeiler SR, 2013, CURR OPIN NEUROL, V26, P609, DOI 10.1097/WCO.0000000000000025
   Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036052
   Zhang H, 2011, BRAIN RES, V1407, P38, DOI 10.1016/j.brainres.2011.06.038
NR 55
TC 15
Z9 15
U1 0
U2 25
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1662-5153
J9 FRONT BEHAV NEUROSCI
JI Front. Behav. Neurosci.
PD DEC 24
PY 2015
VL 9
AR 341
DI 10.3389/fnbeh.2015.00341
PG 12
WC Behavioral Sciences; Neurosciences
SC Behavioral Sciences; Neurosciences & Neurology
GA CZ8CH
UT WOS:000367327200001
PM 26733832
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Lins-Martins, NM
   Yucel, M
   Tovar-Moll, F
   Rodrigues, EC
   Fontenelle, LF
AF Lins-Martins, Natalia M.
   Yuecel, Murat
   Tovar-Moll, Fernanda
   Rodrigues, Erika C.
   Fontenelle, Leonardo F.
TI Electroconvulsive Therapy in Obsessive-Compulsive Disorder: A Chart
   Review and Evaluation of Its Potential Therapeutic Effects
SO JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
LA English
DT Article
ID PHARMACOTHERAPY
AB In a chart review of patients with obsessive-compulsive disorder (OCD) attending a university clinic, ECT was prescribed for five subjects (1.2%), only because of severe intervening manic (N=1) or depressive episodes (N=4). Although affective symptoms improved in four of the five patients, OCD symptoms remained unchanged (N=3) or transiently worsened (N=2).
C1 [Lins-Martins, Natalia M.; Fontenelle, Leonardo F.] Univ Fed Rio de Janeiro, Inst Psychiat, Anxiety & Obsess Compuls Spectrums Res Program, Rio De Janeiro, Brazil.
   [Yuecel, Murat] Monash Univ, Monash Biomed Imaging Facil, Sch Psychol Sci, Monash Clin & Imaging Neurosci Lab, Melbourne, Vic 3004, Australia.
   [Tovar-Moll, Fernanda; Rodrigues, Erika C.; Fontenelle, Leonardo F.] DOr Inst Res & Educ, Rio De Janeiro, Brazil.
   [Fontenelle, Leonardo F.] Univ Fed Fluminense, Hosp Univ Antonio Pedro, Dept Psychiat & Mental Hlth, Niteroi, RJ, Brazil.
RP Fontenelle, LF (corresponding author), Univ Fed Rio de Janeiro, Inst Psychiat, Anxiety & Obsess Compuls Spectrums Res Program, Rio De Janeiro, Brazil.
EM lfontenelle@gmail.com
RI Yucel, Murat/I-3004-2014; Fontenelle, Leonardo/D-3321-2013; de Carvalho
   Rodrigues, Erika/AAE-9445-2020; Rodrigues, Erika/R-6007-2017; Yucel,
   Murat/AAY-8124-2020; Moll, Fernanda Tovar/N-3320-2018
OI Yucel, Murat/0000-0002-4705-452X; Fontenelle,
   Leonardo/0000-0001-9075-8226; de Carvalho Rodrigues,
   Erika/0000-0001-5464-2963; Rodrigues, Erika/0000-0001-5464-2963; Yucel,
   Murat/0000-0002-4705-452X; Moll, Fernanda Tovar/0000-0002-0292-5985
CR Antunes Paula Barros, 2009, Rev. Bras. Psiquiatr., V31, pS26, DOI 10.1590/S1516-44462009000500005
   APA, 2013, DIAGN STAT MAN MENT
   BEALE MD, 1995, J CLIN PSYCHIAT, V56, P81
   Blomstedt P, 2012, WORLD NEUROSURG, V78, DOI 10.1016/j.wneu.2011.12.013
   Bolwig TG, 2011, CAN J PSYCHIAT, V56, P13, DOI 10.1177/070674371105600104
   Brunoni AR, 2013, EUR NEUROPSYCHOPHARM, V23, P1530, DOI 10.1016/j.euroneuro.2013.03.009
   Fontenelle LF, 2007, EXPERT OPIN PHARMACO, V8, P563, DOI 10.1517/14656566.8.5.563
   Goto S, 2012, J AFFECT DISORDERS, V136, P1062, DOI 10.1016/j.jad.2011.11.020
   Hanisch F, 2009, EUR J MED RES, V14, P367, DOI 10.1186/2047-783X-14-8-367
   JENIKE MA, 1998, OBSESSIVE COMPULSIVE, P469
   KALINOWSKY L, 1969, PHARM CONVULSIVE OTH
   Loi S, 2010, INT PSYCHOGERIATR, V22, P830, DOI 10.1017/S1041610210000451
   Mataix-Cols D, 2005, AM J PSYCHIAT, V162, P228, DOI 10.1176/appi.ajp.162.2.228
   MELLMAN LA, 1984, AM J PSYCHIAT, V141, P596
   MUKHERJEE S, 1994, AM J PSYCHIAT, V151, P169
   Rosario-Campos MC, 2006, MOL PSYCHIATR, V11, P495, DOI 10.1038/sj.mp.4001798
   Stein DJ, 2012, CURR PSYCHIAT REP, V14, P211, DOI 10.1007/s11920-012-0268-9
NR 17
TC 3
Z9 4
U1 0
U2 35
PU AMER PSYCHIATRIC PUBLISHING, INC
PI WASHINGTON
PA 800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA
SN 0895-0172
EI 1545-7222
J9 J NEUROPSYCH CLIN N
JI J. Neuropsychiatr. Clin. Neurosci.
PD WIN
PY 2015
VL 27
IS 1
BP 65
EP 68
DI 10.1176/appi.neuropsych.13080184
PG 4
WC Clinical Neurology; Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA CD3ZS
UT WOS:000351023000010
PM 25111446
DA 2020-12-17
ER

PT J
AU Acioly, MA
   Cunha, AM
   Parise, M
   Rodrigues, E
   Tovar-Moll, F
AF Acioly, Marcus Andre
   Cunha, Alexandre Martins
   Parise, Maud
   Rodrigues, Erika
   Tovar-Moll, Fernanda
TI Recruitment of Contralateral Supplementary Motor Area in Functional
   Recovery Following Medial Frontal Lobe Surgery: An fMRI Case Study
SO JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY
LA English
DT Article
DE brain plasticity; functional magnetic resonance imaging; supplementary
   motor area syndrome
ID POSTOPERATIVE DEFICITS; CORTICAL ACTIVATION; PLASTICITY; TUMORS;
   HEMISPHERE; RESECTION; CORTEX
AB Background and ObjectiveSupplementary motor area (SMA) syndrome, an executive disorder with motor and speech dysfunctions, is rather unpredictable with typically a complete or almost complete functional recovery within weeks or months. Compensatory mechanisms are associated with contralateral cortical recruitment of the lateral premotor circuitry. We sought to investigate the role of healthy SMA for motor recovery following surgery in the medial frontal lobe.
   MethodsA 48-year-old right-handed man presented with focal motor seizures. The diagnostic work-up revealed a low-grade glioma at the superior frontal gyrus. The patient was operated on with intraoperative monitoring of motor pathways, and resection was taken to the functional boundaries.
   ResultsPostoperatively, the patient experienced a typical SMA syndrome that almost completely resolved in the long term. Motor recovery occurred concurrently with a shift of SMA activation to the healthy hemisphere together with an increased lateral premotor circuitry, especially for the hand map.
   ConclusionOur results confirm brain remodeling of the lateral premotor cortex, as previously described, and indicate that functional improvement is also paralleled with a shift of SMA activation toward the healthy hemisphere.
C1 [Acioly, Marcus Andre; Cunha, Alexandre Martins; Parise, Maud] State Univ Rio Janeiro Surg Specialties, Div Neurosurg, BR-20551030 Rio De Janeiro, RJ, Brazil.
   [Rodrigues, Erika; Tovar-Moll, Fernanda] IDor Neuroimaging Inst, Dept Neuroimaging, Rio De Janeiro, RJ, Brazil.
RP Acioly, MA (corresponding author), State Univ Rio Janeiro Surg Specialties, Div Neurosurg, 28 Setembro Ave 77,4 Andar Neurocirurgia, BR-20551030 Rio De Janeiro, RJ, Brazil.
EM marcusacioly@yahoo.com.br
RI Rodrigues, Erika/R-6007-2017; Moll, Fernanda Tovar/N-3320-2018; de
   Carvalho Rodrigues, Erika/AAE-9445-2020
OI Rodrigues, Erika/0000-0001-5464-2963; Moll, Fernanda
   Tovar/0000-0002-0292-5985; de Carvalho Rodrigues,
   Erika/0000-0001-5464-2963; Cunha, Alexandre/0000-0003-1014-975X
FU Carlos Chagas Filho Foundation
FX This study was partially funded by the Carlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro.
CR Boy F, 2010, EXP BRAIN RES, V206, P441, DOI 10.1007/s00221-010-2417-x
   Duffau H, 2006, J NEURO-ONCOL, V79, P77, DOI 10.1007/s11060-005-9109-6
   Huda S, 2008, NEUROREPORT, V19, P1573, DOI 10.1097/WNR.0b013e328311ca1c
   Krainik A, 2001, NEUROLOGY, V57, P871, DOI 10.1212/WNL.57.5.871
   Krainik A, 2003, NEUROLOGY, V60, P587, DOI 10.1212/01.WNL.0000048206.07837.59
   Krainik A, 2004, NEUROLOGY, V62, P1323, DOI 10.1212/01.WNL.0000120547.83482.B1
   LAPLANE D, 1977, J NEUROL SCI, V34, P301, DOI 10.1016/0022-510X(77)90148-4
   Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478
   Nelson L, 2002, J NEUROSURG, V97, P1108, DOI 10.3171/jns.2002.97.5.1108
   Ogg RJ, 2009, J NEUROSURG-PEDIATR, V4, P317, DOI 10.3171/2009.4.PEDS08402
   Orr ELR, 2008, NEUROREPORT, V19, P625, DOI 10.1097/WNR.0b013e3282fbf9e0
   PENFIELD W, 1951, AMA ARCH NEUROL PSY, V66, P289, DOI 10.1001/archneurpsyc.1951.02320090038004
   Reinges MHT, 2005, NEUROIMAGE, V24, P1248, DOI 10.1016/j.neuroimage.2004.11.002
   Rosenberg K, 2010, J NEUROSURG, V113, P1152, DOI 10.3171/2010.6.JNS1090
   ROSTOMILY RC, 1991, J NEUROSURG, V75, P62, DOI 10.3171/jns.1991.75.1.0062
   Roux FE, 1997, STEREOT FUNCT NEUROS, V68, P106, DOI 10.1159/000099910
   Russell SM, 2007, NEUROSURGERY, V61, P358, DOI [10.1227/01.neu.0000279229.58449.d1, 10.1227/01.NEU.0000047670.56996.53]
   Sailor J, 2003, AM J NEURORADIOL, V24, P1837
   Thulborn KR, 1999, STROKE, V30, P749, DOI 10.1161/01.STR.30.4.749
   Weiller C, 1996, NEUROIMAGE, V4, P105, DOI 10.1006/nimg.1996.0034
   Zentner J, 1996, J NEUROSURG, V85, P542, DOI 10.3171/jns.1996.85.4.0542
NR 21
TC 13
Z9 13
U1 0
U2 4
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 2193-6315
EI 2193-6323
J9 J NEUROL SURG PART A
JI J. Neurol. Surg. Part A
PD NOV
PY 2015
VL 76
IS 6
BP 508
EP 512
DI 10.1055/s-0035-1558408
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA CV5TI
UT WOS:000364333700011
PM 26291886
DA 2020-12-17
ER

PT J
AU Trentin-Sonoda, M
   da Silva, RC
   Kmit, FV
   Abrahao, MV
   Cahli, GM
   Brasil, GV
   Muzi, H
   Silva, PA
   Tovar-Moll, FF
   Vieyra, A
   Medei, E
   Carneiro-Ramos, MS
AF Trentin-Sonoda, Mayra
   da Silva, Rogerio Cirino
   Kmit, Fernanda Vieira
   Abrahao, Mariana Vieira
   Cahli, Gustavo Monnerat
   Brasil, Guilherme Visconde
   Muzi-Filho, Humberto
   Silva, Paulo Andre
   Tovar-Moll, Fernanda Freire
   Vieyra, Adalberto
   Medei, Emiliano
   Carneiro-Ramos, Marcela Sorelli
TI Knockout of Toll-Like Receptors 2 and 4 Prevents Renal
   Ischemia-Reperfusion-Induced Cardiac Hypertrophy in Mice
SO PLOS ONE
LA English
DT Article
ID NF-KAPPA-B; ISCHEMIA/REPERFUSION INJURY; MYOCARDIAL-INFARCTION; HEART;
   INFLAMMATION; ACTIVATION; MECHANISMS; KIDNEY; TLR4; DYSFUNCTION
AB We investigated whether the pathways linked to Toll-like receptors 2 and 4 (TLRs) are involved in renal ischemia-reperfusion (I/R)-induced cardiac hypertrophy. Wild type (WT) C57BL/6J, TLR2(-/-) and TLR4(-/-) mice were subjected to left kidney ischemia for 60 min followed by reperfusion for 5, 8, 12 and 15 days. Proton density magnetic resonance showed alterations in the injured kidney from WT mice, together with signs of parenchymal edema and higher levels of vimentin mRNA, accompanied by: (i) small, but significant, increase in serum urea after 24 h, (ii) 100% increase in serum creatinine at 24 h. A serum peak of inflammatory cytokines occurred after 5 days of reperfusion. Heart weight/body weight and heart weight/tibia length ratios increased after 12 and 15 days of reperfusion, respectively. Cardiac hypertrophy markers, B-type natriuretic peptide (BNP) and alpha-actin, left ventricle mass, cardiac wall thickness and myocyte width increased after 15 days of reperfusion, together with longer QTc and action potential duration. Cardiac TLRs, MyD88, HSP60 and HSP70 mRNA levels also increased. After 15 days of reperfusion, absence of TLRs prevented cardiac hypertrophy, as reflected by similar values of left ventricular cardiac mass and heart weight/body weight ratio compared to the transgenic Sham. Renal tissular injury also ameliorated in both knockout mice, as revealed by the comparison of their vimentin mRNA levels with those found in the WT on the same day after I/R. The I/R TLR2(-/-) group had TNF-alpha, IFN-gamma and IL-1 beta levels similar to the non-I/R group, whereas the TLR4(-/-) group conserved the p-NF-kappa B/NF-kappa B ratio contrasting with that found in TLR2(-/-). We conclude: (i) TLRs are involved in renal I/R-induced cardiac hypertrophy; (ii) absence of TLRs prevents I/R-induced cardiac hypertrophy, despite renal lesions seeming to evolve towards those of chronic disease; (iii) TLR2 and TLR4 selectively regulate the systemic inflammatory profile and NF-kappa B activation.
C1 [Trentin-Sonoda, Mayra; da Silva, Rogerio Cirino; Kmit, Fernanda Vieira; Abrahao, Mariana Vieira; Carneiro-Ramos, Marcela Sorelli] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, Brazil.
   [Cahli, Gustavo Monnerat; Brasil, Guilherme Visconde; Muzi-Filho, Humberto; Silva, Paulo Andre; Vieyra, Adalberto; Medei, Emiliano] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.
   [Cahli, Gustavo Monnerat; Brasil, Guilherme Visconde; Muzi-Filho, Humberto; Silva, Paulo Andre; Tovar-Moll, Fernanda Freire; Vieyra, Adalberto; Medei, Emiliano] Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda Freire] Inst DOr Pesquisa & Ensino, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda Freire] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.
RP Carneiro-Ramos, MS (corresponding author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, Brazil.
EM marcela.ramos@ufabc.edu.br
RI BRASIL, GUILHERME VISCONDE/M-7286-2019; Sonoda, Mayra
   Trentin/R-9943-2019; cahli, gustavo monnerat/J-6907-2019; Trentin
   Sonoda, Mayra/N-9762-2014; Moll, Fernanda Tovar/N-3320-2018; monnerat,
   gustavo/E-3398-2015; Carneiro-Ramos, Marcela S/I-6191-2017
OI BRASIL, GUILHERME VISCONDE/0000-0002-4695-4710; Sonoda, Mayra
   Trentin/0000-0003-2446-7783; Trentin Sonoda, Mayra/0000-0003-2446-7783;
   Moll, Fernanda Tovar/0000-0002-0292-5985; monnerat,
   gustavo/0000-0002-1010-6314; Carneiro-Ramos, Marcela
   S/0000-0003-2666-1280; Medei, Emiliano/0000-0002-0044-1311; Muzi-Filho,
   Humberto/0000-0002-9183-1699
FU FAPESP agencyFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2008/1015-4]; Brazilian National Research Council
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [308168/2012-7, 475218/2012-4]; Carlos Chagas Filho Rio de
   Janeiro State Research Foundation (FAPERJ)Carlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/103.222/2011, E-26/111.171/2011]; National Institute of Science
   and Technology for Structural Biology and Bioimaging, Brazil
   [573767/2008-4]
FX FAPESP agency (grant N. 2008/1015-4) for financial support. This work
   was also funded by the Brazilian National Research Council (CNPq,
   grants: 308168/2012-7 and 475218/2012-4), the Carlos Chagas Filho Rio de
   Janeiro State Research Foundation (FAPERJ, grants: E-26/103.222/2011 and
   E-26/111.171/2011) and the National Institute of Science and Technology
   for Structural Biology and Bioimaging (grant: 573767/2008-4), Brazil.
CR Arslan F, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/704202
   Arslan F, 2010, CIRCULATION, V121, P80, DOI 10.1161/CIRCULATIONAHA.109.880187
   Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5
   Bagchi AK, 2013, CYTOKINE, V61, P304, DOI 10.1016/j.cyto.2012.10.013
   Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020
   Beddhu S, 2002, KIDNEY INT, V62, P1776, DOI 10.1046/j.1523-1755.2002.00629.x
   Bian ZY, 2014, J CELL BIOCHEM, V115, P349, DOI 10.1002/jcb.24669
   Carneiro-Ramos MS, 2007, J PHYSIOL-LONDON, V583, P213, DOI 10.1113/jphysiol.2007.134080
   Carroll CJ, 2013, J INTERF CYTOK RES, V33, P542, DOI 10.1089/jir.2012.0165
   Chandrasekar B, 1997, FEBS LETT, V401, P30, DOI 10.1016/S0014-5793(96)01426-3
   Chang NS, 1997, AM J PHYSIOL-CELL PH, V273, pC1987
   Cheng Y, 2013, AM J PHYSIOL-HEART C, V305, pH52, DOI 10.1152/ajpheart.00929.2012
   Cho E, 2013, NEPHROL DIAL TRANSPL, V28, P2766, DOI 10.1093/ndt/gft376
   Dai DF, 2012, ANTIOXID REDOX SIGN, V16, P1492, DOI 10.1089/ars.2011.4179
   de Bruyne MC, 1999, EUR HEART J, V20, P278, DOI 10.1053/euhj.1998.1276
   Devaraj S, 2011, CYTOKINE, V55, P441, DOI 10.1016/j.cyto.2011.03.023
   Devaraj S, 2011, ARTERIOSCL THROM VAS, V31, P1796, DOI 10.1161/ATVBAHA.111.228924
   Elias RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044004
   Feitoza CQ, 2008, MOL MED, V14, P724, DOI 10.2119/2008-00064.Feitoza
   Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709
   Frantz S, 2006, FASEB J, V20, P1918, DOI 10.1096/fj.05-5133fje
   Ha TZ, 2006, AM J PHYSIOL-HEART C, V290, pH985, DOI 10.1152/ajpheart.00720.2005
   Ha TZ, 2005, CARDIOVASC RES, V68, P224, DOI 10.1016/j.cardiores.2005.05.025
   Higashikuni Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000267
   Jiang DS, 2014, HYPERTENSION, V63, P96, DOI 10.1161/HYPERTENSIONAHA.113.01506
   Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498
   Krause M, 2015, CLIN SCI, V128, P789, DOI 10.1042/CS20140695
   Kuster N, 2013, ANN BIOL CLIN-PARIS, V71, P409, DOI 10.1684/abc.2013.0877
   Kuwabara T, 2012, DIABETOLOGIA, V55, P2256, DOI 10.1007/s00125-012-2578-1
   Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832
   Levin ER, 1998, NEW ENGL J MED, V339, P321
   Lewis R., 2012, UNDERSTANDING CHRONI
   Liang FQ, 1999, J CLIN INVEST, V104, P1603, DOI 10.1172/JCI7362
   Ma YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040763
   Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298
   Mathur S, 2011, CIRC J, V75, P2445, DOI 10.1253/circj.CJ-11-0194
   Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059
   McCullough PA, 2013, CONTRIB NEPHROL, V182, P82, DOI [10.1159/000349966, 10.1159/000361059]
   Medei E, 2010, J MOL CELL CARDIOL, V49, P165, DOI 10.1016/j.yjmcc.2010.04.014
   Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131
   Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa
   Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7
   POOLEWILSON PA, 1993, J AM COLL CARDIOL, V22, pA22, DOI 10.1016/0735-1097(93)90458-D
   Rayego-Mateos S, 2013, J PATHOL, V231, P480, DOI 10.1002/path.4250
   Riad A, 2008, EUR J HEART FAIL, V10, P233, DOI 10.1016/j.ejheart.2008.01.004
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   Ronco C, 2009, BLOOD PURIFICAT, V27, P114, DOI 10.1159/000167018
   SAFIRSTEIN R, 1991, AM J PHYSIOL, V261, pF1095
   Shishido T, 2006, BIOCHEM BIOPH RES CO, V345, P1446, DOI 10.1016/j.bbrc.2006.05.056
   Silva RC, 2013, CELL PHYSIOL BIOCHEM, V31, P179, DOI 10.1159/000343359
   Smith G, 2007, EXP PHYSIOL, V92, P973, DOI 10.1113/expphysiol.2007.034314
   Suurmeijer AJH, 2003, J PATHOL, V199, P387, DOI 10.1002/path.1311
   Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tang T, 2013, J MOL CELL CARDIOL, V60, P60, DOI 10.1016/j.yjmcc.2013.04.005
   Tang Y, 2009, ANAT REC, V292, P1630, DOI 10.1002/ar.20952
   Toldo S, 2013, EXP PHYSIOL, V98, P734, DOI 10.1113/expphysiol.2012.069831
   WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214
   Wu HL, 2014, KIDNEY INT, V85, P824, DOI 10.1038/ki.2013.475
   Zanin-Zhorov A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00211
NR 60
TC 18
Z9 19
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 8
PY 2015
VL 10
IS 10
AR e0139350
DI 10.1371/journal.pone.0139350
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CT0TW
UT WOS:000362511000022
PM 26448184
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Coutinho, G
   Drummond, C
   de Oliveira-Souza, R
   Moll, J
   Tovar-Moll, F
   Mattos, P
AF Coutinho, Gabriel
   Drummond, Claudia
   de Oliveira-Souza, Ricardo
   Moll, Jorge
   Tovar-Moll, Fernanda
   Mattos, Paulo
TI Immediate story recall in elderly individuals with memory complaints:
   how much does it contribute to memory assessment?
SO INTERNATIONAL PSYCHOGERIATRICS
LA English
DT Article
DE mild cognitive impairment; memory; Alzheimer's disease; story memory;
   logical memory; aging
ID MILD COGNITIVE IMPAIRMENT; MINI-MENTAL-STATE; ALZHEIMERS-DISEASE;
   WORKING-MEMORY; DIAGNOSIS; SCORES
AB Background:Prose memory tests exhibit ecological validity, but the influence of non-memory functions on immediate recall in elderly subjects with memory complaints has not been fully investigated. This study examined (1) whether the ability to immediately recall a story can distinguish among clinical controls, amnesic mild cognitive impairment (MCI) and dementia due to Alzheimer's disease (AD) and (2) which cognitive functions contribute to immediate recall performance.Methods:A total of 73 consecutive volunteers (50 women and 23 men) aged 47-88 (mean age = 71.85 9.41) and with a mean schooling level of 12.51 (SD = 4.09) participated in the experiment. All individuals were seeking specialized evaluation because of memory complaints. Diagnoses were made by considering clinical, neuropsychological, and MRI assessments collected by a multidisciplinary team of neurologists, neuropsychologists, and speech-language therapists. A total of 26 individuals were classified as clinical controls; 27 as MCI patients; and 20 as having AD dementia. All individuals in the AD group had a Clinical Dementia Rating (CDR) 1.Results:Immediate recall was only able to distinguish AD subjects from MCI patients and clinical controls (p > 0.05). Stepwise multiple linear regression analysis revealed that mental status (MMSE), semantic memory (WAIS-III vocabulary) and episodic memory (RAVLT primacy) explained approximately 62% of the variance in immediate recall.Conclusions:Understanding the value and limitations of immediate story recall in distinguishing between MCI and AD may help clinicians in better choosing cognitive tests to diagnose MCI.
C1 [Coutinho, Gabriel; Drummond, Claudia; de Oliveira-Souza, Ricardo; Moll, Jorge; Tovar-Moll, Fernanda; Mattos, Paulo] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Coutinho, Gabriel; Drummond, Claudia; Tovar-Moll, Fernanda; Mattos, Paulo] Univ Fed Rio de Janeiro, Inst Biomed Sci ICB, Morphol Sci Program PCM, BR-21941 Rio De Janeiro, Brazil.
   [de Oliveira-Souza, Ricardo] Fed Univ State Rio de Janeiro UNI Rio, Rio De Janeiro, Brazil.
   [Mattos, Paulo] Univ Fed Rio de Janeiro, Inst Psychiat IPUB, BR-21941 Rio De Janeiro, Brazil.
RP Coutinho, G (corresponding author), Rua Diniz Cordeiro 30,2 Andar, BR-22281100 Rio De Janeiro, RJ, Brazil.
EM gabrielccoutinho@gmail.com
RI Moll, Fernanda Tovar/N-3320-2018; de Mattos, Paulo Eduardo
   Luiz/D-2328-2014
OI Moll, Fernanda Tovar/0000-0002-0292-5985; de Mattos, Paulo Eduardo
   Luiz/0000-0003-0709-3783
FU Brazilian National Counsel of Technological and Scientific Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordination for the Improvement of Higher Education Personnel
   (CAPES)CAPES; Rio de Janeiro Foundation for the Support of Research
   (FAPERJ)
FX The project was supported by grants and fellowships provided by the
   Brazilian National Counsel of Technological and Scientific Development
   (CNPq), the Coordination for the Improvement of Higher Education
   Personnel (CAPES), and the Rio de Janeiro Foundation for the Support of
   Research (FAPERJ).
CR Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Baddeley A, 2002, NEUROPSYCHOLOGIA, V40, P1737, DOI 10.1016/S0028-3932(01)00146-4
   Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2
   Baddeley A, 2011, J COGNITIVE NEUROSCI, V23, P3855, DOI 10.1162/jocn_a_00066
   Benton A. L., 1989, MULTILINGUAL APHASIA
   Brooks BL, 2008, J INT NEUROPSYCH SOC, V14, P463, DOI 10.1017/S1355617708080521
   Brucki SMD, 2004, BRAZ J MED BIOL RES, V37, P1771, DOI 10.1590/S0100-879X2004001200002
   Castro-Costa E, 2008, ARQ NEURO-PSIQUIAT, V66, P524, DOI 10.1590/S0004-282X2008000400016
   Foldi NS, 2011, J INT NEUROPSYCH SOC, V17, P69, DOI 10.1017/S1355617710001165
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Greenberg DL, 2010, J INT NEUROPSYCH SOC, V16, P748, DOI 10.1017/S1355617710000676
   Huntley J, 2011, BRIT J PSYCHIAT, V198, P398, DOI 10.1192/bjp.bp.110.083857
   Jefferies E, 2004, J MEM LANG, V51, P623, DOI 10.1016/j.jml.2004.07.005
   Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5
   La Rue A, 2008, ALZHEIMERS DEMENT, V4, P285, DOI 10.1016/j.jalz.2008.03.009
   Larigauderie P, 2011, AGING NEUROPSYCHOL C, V18, P147, DOI 10.1080/13825585.2010.521813
   LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179
   Lezak M.D., 2004, NEUROPSYCHOLOGICAL A
   Malloy-Diniz LF, 2007, REV BRAS PSIQUIATR, V29, P324, DOI 10.1590/S1516-44462006005000053
   MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
   Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303
   Reisberg B, 2008, INT PSYCHOGERIATR, V20, P1, DOI 10.1017/S1041610207006412
   Reitan R. M., 1985, HALSTEAD REITAN NEUR
   Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2
   Stern Y, 2005, CEREB CORTEX, V15, P394, DOI 10.1093/cercor/bhh142
   Strauss ES, 2006, COMPENDIUM NEUROPSYC
   Wechsler D., 1997, WECHSLER MEMORY SCAL
   Wechsler D, 1997, WECHSLER ADULT INTEL
   Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x
NR 30
TC 3
Z9 4
U1 0
U2 24
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1041-6102
EI 1741-203X
J9 INT PSYCHOGERIATR
JI Int. Psychogeriatr.
PD OCT
PY 2015
VL 27
IS 10
SI SI
BP 1679
EP 1686
DI 10.1017/S1041610215000307
PG 8
WC Psychology, Clinical; Geriatrics & Gerontology; Gerontology; Psychiatry;
   Psychology
SC Psychology; Geriatrics & Gerontology; Psychiatry
GA CR5LP
UT WOS:000361384300011
PM 25765673
DA 2020-12-17
ER

PT J
AU Drummond, C
   Coutinho, G
   Fonseca, RP
   Assuncao, N
   Teldeschi, A
   de Oliveira-Souza, R
   Moll, J
   Tovar-Moll, F
   Mattos, P
AF Drummond, Claudia
   Coutinho, Gabriel
   Fonseca, Rochele Paz
   Assuncao, Naima
   Teldeschi, Alina
   de Oliveira-Souza, Ricardo
   Moll, Jorge
   Tovar-Moll, Fernanda
   Mattos, Paulo
TI Deficits in narrative discourse elicited by visual stimuli are already
   present in patients with mild cognitive impairment
SO FRONTIERS IN AGING NEUROSCIENCE
LA English
DT Article
DE narrative discourse; language; mild cognitive impairment; Alzheimer's
   disease; aging
ID ALZHEIMERS-DISEASE; VERBAL FLUENCY; COMPREHENSION; NEUROPSYCHOLOGY;
   PERFORMANCE; DEMENTIA; DECLINE; SPEECH; INJURY; ADULTS
AB Language batteries used to assess the skills of elderly individuals, such as naming and semantic verbal fluency, present some limitations in differentiating healthy controls from patients with amnestic mild cognitive impairment (a-MCl). Deficits in narrative discourse occur early in dementia caused by Alzheimer's disease (AD), and the narrative discourse abilities of a-MCl patients are poorly documented. The present study sought to propose and evaluate parameters for investigating narrative discourse in these populations. After a pilot study of 30 healthy subjects who served as a preliminary investigation of macro- and micro-linguistic aspects, 77 individuals (patients with AD and a-MCI and a control group) were evaluated. The experimental task required the participants to narrate a story based on a sequence of actions visually presented. The Control and AD groups differed in all parameters except narrative time and the total number of words recalled. The a-MCI group displayed mild discursive difficulties that were characterized as an intermediate stage between the Control and AD groups' performances. The a-MCl and Control groups differed from the AD group with respect to global coherence, discourse type and referential cohesion. The a-MCI and AD groups were similar to one another but differed from the Control group with respect to the type of words recalled, the repetition of words in the same sentence, the narrative structure and the inclusion of irrelevant propositions in the narrative. The narrative parameter that best distinguished the three groups was the speech effectiveness index. The proposed task was able to reveal differences between healthy controls and groups with cognitive decline. According to our findings, patients with a-MCI already present narrative deficits that are characterized by mild discursive difficulties that are less severe than those found in patients with AD.
C1 [Drummond, Claudia; Coutinho, Gabriel; Assuncao, Naima; Teldeschi, Alina; de Oliveira-Souza, Ricardo; Moll, Jorge; Tovar-Moll, Fernanda; Mattos, Paulo] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Drummond, Claudia; Coutinho, Gabriel; Tovar-Moll, Fernanda; Mattos, Paulo] Univ Fed Rio de Janeiro, Inst Biomed Sci, Morphol Sci Program, Rio De Janeiro, Brazil.
   [Drummond, Claudia] Univ Fed Rio de Janeiro, Dept Speech & Hearing Pathol, Rio De Janeiro, Brazil.
   [Fonseca, Rochele Paz] Pontificial Catholic Univ Rio Grande do Sul, Dept Psychol, Lab Clin & Expt Neuropsychol, Porto Alegre, RS, Brazil.
   [Mattos, Paulo] Univ Fed Rio de Janeiro, Inst Psychiat, Dept Psychiat & Forens Med, Rio De Janeiro, Brazil.
RP Drummond, C (corresponding author), Rua Diniz Cordeiro 30,2 Andar, BR-22281100 Botafogo, RJ, Brazil.
EM claudiadrummond@terra.com.br
RI Moll, Fernanda Tovar/N-3320-2018; de Mattos, Paulo Eduardo
   Luiz/D-2328-2014
OI Moll, Fernanda Tovar/0000-0002-0292-5985; de Mattos, Paulo Eduardo
   Luiz/0000-0003-0709-3783
FU Rede D'Or Sao Luiz; CNPq (Conselho Nacional de Pesquisa)National Council
   for Scientific and Technological Development (CNPq); CAPES (Coordenacao
   de Aperfeicoamento de Pessoal de Ensino Superior)CAPES; FAPERJ (Fundacao
   de Amparo a Pesquisa do Rio de Janeiro)Carlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
FX This research was supported by Rede D'Or Sao Luiz, CNPq (Conselho
   Nacional de Pesquisa), CAPES (Coordenacao de Aperfeicoamento de Pessoal
   de Ensino Superior), and FAPERJ (Fundacao de Amparo a Pesquisa do Rio de
   Janeiro).
CR American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Ash S, 2007, BRAIN LANG, V103, P181, DOI 10.1016/j.bandl.2007.07.105
   Beinhoff U, 2005, DEMENT GERIATR COGN, V20, P278, DOI 10.1159/000088249
   Bertolucci PHF, 2001, ARQ NEURO-PSIQUIAT, V59, P532, DOI 10.1590/S0004-282X2001000400009
   Bidelman GM, 2014, NEUROBIOL AGING, V35, P2526, DOI 10.1016/j.neurobiolaging.2014.05.006
   Brandao L, 2011, PSICOL-REFLEX CRIT, V24, P161, DOI 10.1590/S0102-79722011000100019
   Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014
   Burke DM, 2007, HDB AGING COGNITION, P2013
   Cannizzaro Michael S, 2012, Perspect Neurophysiol Neurogenic Speech Lang Disord, V22, P67
   Cannizzaro MS, 2013, J PSYCHOLINGUIST RES, V42, P527, DOI 10.1007/s10936-012-9231-5
   Carlomagno S, 2005, CORTEX, V41, P520, DOI 10.1016/S0010-9452(08)70192-8
   Caselli RJ, 2014, ALZHEIMERS DEMENT, V10, P84, DOI 10.1016/j.jalz.2013.01.004
   Chapman SB, 2002, ALZ DIS ASSOC DIS, V16, P177, DOI 10.1097/00002093-200207000-00008
   Chen TB, 2014, DEMENT GER COGN D EX, V4, P86, DOI [10.1159/000360695, 10.1159/000354359]
   Coelho C, 2012, NEUROPSYCHOLOGIA, V50, P3564, DOI 10.1016/j.neuropsychologia.2012.09.005
   Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003
   de Lira JO, 2011, INT PSYCHOGERIATR, V23, P404, DOI 10.1017/S1041610210001092
   Duong A, 2005, BRAIN LANG, V93, P173, DOI 10.1016/j.bandl.2004.10.007
   Duong A, 2003, BRAIN COGNITION, V53, P177, DOI 10.1016/S0278-2626(03)00104-0
   Ferre P, 2011, REHABIL RES PRACT, V2011, DOI 10.1155/2011/131820
   Ferris SH, 2013, CLIN INTERV AGING, V8, P1007, DOI 10.2147/CIA.S39959
   Fonseca Rochele Paz, 2008, Pró-Fono R. Atual. Cient., V20, P285, DOI 10.1590/S0104-56872008000400014
   Forbes-McKay KE, 2005, NEUROL SCI, V26, P243, DOI 10.1007/s10072-005-0467-9
   Gilani AM, 2013, APPL ANIM BEHAV SCI, V148, P54, DOI 10.1016/j.applanim.2013.07.014
   Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284
   Kemper S, 2001, PSYCHOL AGING, V16, P600, DOI 10.1037//0882-7974.16.4.600
   KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363
   Leitao M. M., 2005, THESIS, V1, P235
   Leitao M. M., 2012, REV LINGUIST, V8, P35
   Lezak M.D., 2012, NEUROPSYCHOLOGICAL A
   Lin MC, 2004, J AGING STUD, V18, P261, DOI 10.1016/j.jaging.2004.03.006
   Lopez-Higes R, 2014, REV NEUROLOGIA, V58, P493, DOI 10.33588/rn.5811.2014048
   Maas CJM, 2003, QUAL QUANT, V37, P71, DOI 10.1023/A:1022545930672
   Madhavan KM, 2014, BRAIN RES, V1562, P11, DOI 10.1016/j.brainres.2014.03.012
   Mansur Letícia Lessa, 2005, Psicol. Reflex. Crit., V18, P300, DOI 10.1590/S0102-79722005000300002
   Mar RA, 2004, NEUROPSYCHOLOGIA, V42, P1414, DOI 10.1016/j.neuropsychologia.2003.12.016
   Marini A, 2005, BRAIN LANG, V93, P46, DOI 10.1016/j.bandl.2004.08.002
   MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
   Miller S., 2013, DEV RES METHODS
   Muthen L.K., 1998, MPLUS USERS GUIDE
   Peelle JE, 2010, CEREB CORTEX, V20, P773, DOI 10.1093/cercor/bhp142
   Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x
   Petersen RC, 2011, NEW ENGL J MED, V364, P2227, DOI 10.1056/NEJMcp0910237
   QUADE D, 1967, J AM STAT ASSOC, V62, P1187, DOI 10.2307/2283769
   Radanovic M, 2009, INT PSYCHOGERIATR, V21, P1081, DOI 10.1017/S1041610209990639
   Scherer LC, 2012, ILHA DESTERRO, V63, P129, DOI 10.5007/2175-8026.2012n63p129
   Scherer LC, 2012, BRAIN LANG, V121, P174, DOI 10.1016/j.bandl.2011.09.008
   Schwab A. J, 2006, ANAL MISSING DATA CO
   Senhorini MCT, 2006, J CLIN EXP NEUROPSYC, V28, P1191, DOI 10.1080/13803390500350969
   Ska Bernadette, 2005, Psychol Neuropsychiatr Vieil, V3, P125
   Stamatakis EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014496
   Stein N., 1979, NEW DIRECTIONS DISCO, P53
   Steiner Veronique Agnes Guernet, 2008, Dement. neuropsychol., V2, P328, DOI 10.1590/S1980-57642009DN20400017
   Taler V, 2008, J CLIN EXP NEUROPSYC, V30, P501, DOI 10.1080/13803390701550128
   Teichmann M, 2013, REV NEUROL-FRANCE, V169, P680, DOI 10.1016/j.neurol.2013.06.001
   Testa JA, 2004, J INT NEUROPSYCH SOC, V10, P504, DOI 10.1017/S1355617704104177
   Troiani V, 2008, NEUROIMAGE, V40, P932, DOI 10.1016/j.neuroimage.2007.12.002
   Tsantali E, 2013, ARCH GERONTOL GERIAT, V57, P263, DOI 10.1016/j.archger.2013.03.011
   TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170
   Urbanowitsch N, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00194
   Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x
   Wright HH, 2011, J SPEECH LANG HEAR R, V54, P900, DOI 10.1044/1092-4388(2010/09-0253)
NR 62
TC 35
Z9 38
U1 1
U2 16
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-4365
J9 FRONT AGING NEUROSCI
JI Front. Aging Neurosci.
PD MAY 28
PY 2015
VL 7
AR 96
DI 10.3389/fnagi.2015.00096
PG 11
WC Geriatrics & Gerontology; Neurosciences
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA CM0QC
UT WOS:000357382200001
PM 26074814
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Lent, R
   Tovar-Moll, F
AF Lent, Roberto
   Tovar-Moll, Fernanda
TI How can development and plasticity contribute to understanding evolution
   of the human brain?
SO FRONTIERS IN HUMAN NEUROSCIENCE
LA English
DT Editorial Material
DE neurons; cortex; evolution; molecular; chemical; development; evo-devo
ID CELLULAR SCALING RULES
C1 [Lent, Roberto; Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Neuroplast Lab, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Dor Inst Res & Educ, Rio De Janeiro, Brazil.
RP Lent, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Neuroplast Lab, Rio De Janeiro, Brazil.
EM rlent@icb.ufrj.br
RI Moll, Fernanda Tovar/N-3320-2018
OI Moll, Fernanda Tovar/0000-0002-0292-5985
CR Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y
   FISHER J., 1949, BRITISH BIRDS, V42, P347
   GREENOUGH WT, 1987, CHILD DEV, V58, P539, DOI 10.1111/j.1467-8624.1987.tb01400.x
   Herculano-Houzel S, 2007, P NATL ACAD SCI USA, V104, P3562, DOI 10.1073/pnas.0611396104
   Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103
   Kappeler L, 2010, BIOESSAYS, V32, P818, DOI 10.1002/bies.201000015
   Kawai M., 1965, PRIMATES, V6, P1, DOI DOI 10.1007/BF01794457
   Lent R, 2012, EUR J NEUROSCI, V35, P1, DOI 10.1111/j.1460-9568.2011.07923.x
   Tovar-Moll F, 2014, P NATL ACAD SCI USA, V111, P7843, DOI 10.1073/pnas.1400806111
   von Economo C, 1925, CYTOARCHITECTONIK HI
NR 10
TC 2
Z9 2
U1 0
U2 16
PU FRONTIERS RESEARCH FOUNDATION
PI LAUSANNE
PA PO BOX 110, LAUSANNE, 1015, SWITZERLAND
SN 1662-5161
J9 FRONT HUM NEUROSCI
JI Front. Hum. Neurosci.
PD APR 14
PY 2015
VL 9
DI 10.3389/fnhum.2015.00208
PG 2
WC Neurosciences; Psychology
SC Neurosciences & Neurology; Psychology
GA CF8LV
UT WOS:000352812600001
PM 25926786
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Tovar-Moll, F
   Evangelou, IE
   Chiu, AW
   Auh, S
   Chen, C
   Ehrmantraut, M
   Ohayon, JM
   Richert, N
   Bagnato, F
AF Tovar-Moll, Fernanda
   Evangelou, Iordanis E.
   Chiu, Annie W.
   Auh, Sungyoung
   Chen, Christina
   Ehrmantraut, Mary
   Ohayon, Joan M.
   Richert, Nancy
   Bagnato, Francesca
TI Diffuse and Focal Corticospinal Tract Disease and Its Impact on Patient
   Disability in Multiple Sclerosis
SO JOURNAL OF NEUROIMAGING
LA English
DT Article
DE Multiple sclerosis; diffusion tensor imaging; black holes; white matter
   damage
ID CORPUS-CALLOSUM; PYRAMIDAL TRACT; BLACK-HOLES; TENSOR; BRAIN;
   TRACTOGRAPHY; LESIONS; MRI; DYSFUNCTION; IMPAIRMENT
AB BACKGROUND AND PURPOSEWe investigated the impact of focal and diffuse corticospinal tracts damage on sensory-motor disability in multiple sclerosis (MS) patients.
   METHODSTwenty-five MS patients underwent 3.0 Tesla (3T) magnetic resonance imaging with diffusion tensor imaging (DTI). The Expanded Disability Status Scale (EDSS) and the Timed 25-Foot Walk test (T25FW) quantified patient physical disability. Fractional anisotropy (FA) and mean diffusivity (MD) of the corticospinal tracts, whole brain and corticospinal tracts lesion volume were also computed. Spearman rank correlation analyses measured the associations between DTI-derived metrics and other measures of disease. Partial correlation analyses between DTI and disability measures were performed and corrected for lesion volumes as appropriate.
   RESULTSSignificant associations were seen between FA of the corticospinal tracts and EDSS (r = -.500, P = .0011), motor-EDSS (r = -.519, P = .008), and T25WF (r = -.637, P = .001) scores and MD of the corticospinal tracts and motor-EDSS (r = .469, P = .018) and T25WF (r = .428, P = .033) scores. When correcting for lesion volumes, only the association between FA of the corticospinal tracts and EDSS (r -.516, p .01) or motor-EDSS score (r -.516, p .01) persisted.
   CONCLUSIONSDTI at 3T shows that the impact of diffuse corticospinal tracts disease on sensory-motor disability is greatly mediated by focal lesions in MS.
C1 [Tovar-Moll, Fernanda; Evangelou, Iordanis E.; Chiu, Annie W.; Chen, Christina; Ehrmantraut, Mary; Ohayon, Joan M.; Richert, Nancy; Bagnato, Francesca] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA.
   [Auh, Sungyoung] NINDS, Off Clin Director, NIH, Bethesda, MD 20892 USA.
   [Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging CENABIO, Rio De Janeiro, Brazil.
RP Bagnato, F (corresponding author), Univ Maryland, Dept Neurol, 110 S Paca St, Baltimore, MD 21201 USA.
EM fbagnato@umm.edu
RI Moll, Fernanda Tovar/N-3320-2018
OI Moll, Fernanda Tovar/0000-0002-0292-5985
FU NINDS-NIH, Bethesda, MD, USAUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Neurological Disorders & Stroke (NINDS)
FX The study was supported by the Intramural program of the NINDS-NIH,
   Bethesda, MD, USA.
CR Bagnato F, 2003, BRAIN, V126, P1782, DOI 10.1093/brain/awg182
   Barkhof F, 1999, MULT SCLER J, V5, P283, DOI 10.1177/135245859900500415
   Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022
   Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782
   Bester M, 2013, J NEUROL SCI, V330, P61, DOI 10.1016/j.jns.2013.04.005
   Bonilha L, 2014, STROKE, V45, P988, DOI 10.1161/STROKEAHA.113.004137
   Bucci M, 2013, NEUROIMAGE-CLIN, V3, P361, DOI 10.1016/j.nicl.2013.08.008
   Ceccarelli A, 2010, EUR J NEUROSCI, V31, P1273, DOI 10.1111/j.1460-9568.2010.07147.x
   Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871
   Fisher E, 2007, ANN NEUROL, V62, P219, DOI 10.1002/ana.21113
   Giorgio A, 2010, J MAGN RESON IMAGING, V31, P309, DOI 10.1002/jmri.22062
   Gorgoraptis N, 2010, MULT SCLER J, V16, P555, DOI 10.1177/1352458510362440
   Gupta S, 2005, MULT SCLER J, V11, P658, DOI 10.1191/1352458505ms1229oa
   Hickman SJ, 2005, AM J NEURORADIOL, V26, P951
   Hu B, 2011, EUR J RADIOL, V79, P101, DOI 10.1016/j.ejrad.2009.11.021
   JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111
   Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Lin F, 2007, AM J NEURORADIOL, V28, P278
   Liu YO, 2012, EUR J RADIOL, V81, P2826, DOI 10.1016/j.ejrad.2011.11.022
   Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907
   Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3
   Naismith RT, 2013, NEUROLOGY, V80, P2201, DOI 10.1212/WNL.0b013e318296e8f1
   O'Sullivan M, 2004, NEUROLOGY, V62, P702, DOI 10.1212/01.WNL.0000113760.72706.D2
   Oh J, 2004, J NEUROL NEUROSUR PS, V75, P1281, DOI 10.1136/jnnp.2004.039032
   Onu M, 2012, EUR J RADIOL, V81, pE386, DOI 10.1016/j.ejrad.2011.12.014
   Ozturk A, 2010, MULT SCLER J, V16, P166, DOI 10.1177/1352458509353649
   Pardini M, 2014, HIPPOCAMPUS, V24, P436, DOI 10.1002/hipo.22237
   POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302
   Reich DS, 2008, AM J NEURORADIOL, V29, P333, DOI 10.3174/ajnr.A0788
   Reich DS, 2007, NEUROIMAGE, V38, P271, DOI 10.1016/j.neuroimage.2007.07.049
   Rovaris M, 2002, J NEUROL SCI, V195, P103, DOI 10.1016/S0022-510X(01)00690-6
   Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040
   Tillema JM, 2013, THER ADV NEUROL DISO, V6, P249, DOI 10.1177/1756285613478870
   Tir M, 2014, REV NEUROL-FRANCE, V170, P266, DOI 10.1016/j.neurol.2013.10.013
   Tovar-Moll F, 2009, AM J NEURORADIOL, V30, P1380, DOI 10.3174/ajnr.A1564
   Tovar-Moll F, 2007, NEUROREPORT, V18, P1417, DOI 10.1097/WNR.0b013e3282e9a509
   Trip SA, 2006, NEUROIMAGE, V30, P498, DOI 10.1016/j.neuroimage.2005.09.024
   Truyen L, 1996, NEUROLOGY, V47, P1469, DOI 10.1212/WNL.47.6.1469
   van der Walt A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083825
   van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747
   Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049
   Wilson M, 2003, J NEUROL NEUROSUR PS, V74, P203, DOI 10.1136/jnnp.74.2.203
   Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027
NR 44
TC 18
Z9 18
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1051-2284
EI 1552-6569
J9 J NEUROIMAGING
JI J. Neuroimaging
PD MAR-APR
PY 2015
VL 25
IS 2
BP 200
EP 206
DI 10.1111/jon.12171
PG 7
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA CD7WO
UT WOS:000351306000006
PM 25318661
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Mello, EA
   Cohen, LG
   dos Anjos, SM
   Conti, J
   Andrade, KNF
   Moll, FT
   Marins, T
   Fernandes, CA
   Rodrigues, W
   Conforto, AB
AF Mello, Eduardo Arruda
   Cohen, Leonardo G.
   dos Anjos, Sarah Monteiro
   Conti, Juliana
   Andrade, Karina Nocelo F.
   Moll, Fernanda Tovar
   Marins, Theo
   Fernandes, Corina A.
   Rodrigues, Waldyr, Jr.
   Conforto, Adriana Bastos
TI Increase in Short-Interval Intracortical Facilitation of the Motor
   Cortex after Low-Frequency Repetitive Magnetic Stimulation of the
   Unaffected Hemisphere in the Subacute Phase after Stroke
SO NEURAL PLASTICITY
LA English
DT Article
ID CONTROLLED TRIAL; RTMS; HEMIPARESIS; HAND; INHIBITION; PLASTICITY;
   THERAPY; BRAIN
AB Low-frequency repetitive transcranial magnetic stimulation of the unaffected hemisphere (UH-LF-rTMS) in patients with stroke can decrease interhemispheric inhibition from the unaffected to the affected hemisphere and improve hand dexterity and strength of the paretic hand. The objective of this proof-of-principle study was to explore, for the first time, effects of UH-LF-rTMS as add-on therapy to motor rehabilitation on short-termintracortical inhibition (SICI) and intracortical facilitation (ICF) of the motor cortex of the unaffected hemisphere (M1(UH)) in patients with ischemic stroke. Eighteen patients were randomized to receive, immediately before rehabilitation treatment, either active or sham UH-LF-rTMS, during two weeks. Resting motor threshold (rMT), SICI, and ICF weremeasured in M1(UH) before the first session and after the last session of treatment. There was a significant increase in ICF in the active group compared to the sham group after treatment, and there was no significant differences in changes in rMT or SICI. ICF is a measure of intracortical synaptic excitability, with a relative contribution of spinal mechanisms. ICF is typically upregulated by glutamatergic agonists and downregulated by gabaergic antagonists. The observed increase in ICF in the active group, in this hypothesis-generating study, may be related to M1(UH) reorganization induced by UH-LF-rTMS.
C1 [Mello, Eduardo Arruda; dos Anjos, Sarah Monteiro; Conti, Juliana; Andrade, Karina Nocelo F.; Fernandes, Corina A.; Rodrigues, Waldyr, Jr.; Conforto, Adriana Bastos] Univ Sao Paulo, Hosp & Clin, Clin Hosp, Neurol Clin Div, BR-05403010 Sao Paulo, SP, Brazil.
   [Cohen, Leonardo G.] NINDS, Human Cort Physiol & Stroke Rehabil Sect, NIH, Bethesda, MD 20892 USA.
   [Moll, Fernanda Tovar; Marins, Theo] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Moll, Fernanda Tovar; Marins, Theo] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging CENABIO, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Moll, Fernanda Tovar; Marins, Theo] DOr Inst Res & Educ IDOR, BR-22281032 Rio De Janeiro, RJ, Brazil.
   [Conforto, Adriana Bastos] Hosp Israelita Albert Einstein, Inst Ensino & Pesquisa, BR-05601901 Sao Paulo, Brazil.
RP Conforto, AB (corresponding author), Univ Sao Paulo, Hosp & Clin, Clin Hosp, Neurol Clin Div, Ave Dr Eneas C Aguiar 255-5084, BR-05403010 Sao Paulo, SP, Brazil.
EM adriana.conforto@gmail.com
RI Conforto, Adriana Bastos/C-9371-2014; ANJOS, SARAH M DOS/G-9277-2015;
   Moll, Fernanda Tovar/N-3320-2018
OI Conforto, Adriana Bastos/0000-0001-7869-3490; ANJOS, SARAH M
   DOS/0000-0002-7792-862X; Moll, Fernanda Tovar/0000-0002-0292-5985;
   Marins, Theo/0000-0002-5017-707X
CR Anjos SM, 2014, STROKE, V45, P1495, DOI 10.1161/STROKEAHA.113.003572
   Avenanti A, 2012, NEUROLOGY, V78, P256, DOI 10.1212/WNL.0b013e3182436558
   Bolognini N, 2010, J NEUROSCI, V30, P9647, DOI 10.1523/JNEUROSCI.1990-10.2010
   Boroojerdi B, 2000, CLIN NEUROPHYSIOL, V111, P988, DOI 10.1016/S1388-2457(00)00279-0
   Chang WH, 2010, J REHABIL MED, V42, P758, DOI 10.2340/16501977-0590
   Chen R, 2004, EXP BRAIN RES, V154, P1, DOI 10.1007/s00221-003-1684-1
   Conforto AB, 2004, CLIN NEUROPHYSIOL, V115, P812, DOI 10.1016/j.clinph.2003.11.010
   Conforto AB, 2012, J NEUROL, V259, P1399, DOI 10.1007/s00415-011-6364-7
   de Caneda MAG, 2006, ARQ NEURO-PSIQUIAT, V64, P690, DOI 10.1590/S0004-282X2006000400034
   Delvendahl I, 2012, BRAIN STIMUL, V5, P586, DOI 10.1016/j.brs.2011.11.005
   Di Lazzaro V, 2006, J NEUROPHYSIOL, V96, P1765, DOI 10.1152/jn.00360.2006
   Etoh S, 2013, J REHABIL MED, V45, P843, DOI 10.2340/16501977-1175
   Fregni F, 2006, STROKE, V37, P2115, DOI 10.1161/01.STR.0000231390.58967.6b
   Kaelin-Lang A, 2000, J NEUROSCI METH, V102, P81, DOI 10.1016/S0165-0270(00)00284-3
   Kakuda W, 2010, BRAIN INJURY, V24, P1505, DOI 10.3109/02699052.2010.523040
   Kirton A, 2008, LANCET NEUROL, V7, P507, DOI 10.1016/S1474-4422(08)70096-6
   KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912
   Mansur CG, 2005, NEUROLOGY, V64, P1802, DOI 10.1212/01.WNL.0000161839.38079.92
   OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4
   Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824
   Romero JR, 2002, CLIN NEUROPHYSIOL, V113, P101, DOI 10.1016/S1388-2457(01)00693-9
   Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016
   ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9
   Sterr A, 2013, NEUROIMAGE-CLIN, V2, P797, DOI 10.1016/j.nicl.2013.05.005
   Swayne OBC, 2008, CEREB CORTEX, V18, P1909, DOI 10.1093/cercor/bhm218
   Takeuchi N, 2005, STROKE, V36, P2681, DOI 10.1161/01.STR.0000189658.51972.34
   Takeuchi N, 2008, J REHABIL MED, V40, P298, DOI 10.2340/16501977-0181
   Wittenberg GF, 2003, NEUROREHAB NEURAL RE, V17, P48, DOI 10.1177/0888439002250456
   Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006
NR 29
TC 10
Z9 10
U1 0
U2 4
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2090-5904
EI 1687-5443
J9 NEURAL PLAST
JI Neural. Plast.
PY 2015
VL 2015
AR 407320
DI 10.1155/2015/407320
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA CH8US
UT WOS:000354312200001
PM 26060584
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Garcia, C
   Dubois, LG
   Xavier, AL
   Geraldo, LH
   da Fonseca, ACC
   Correia, AH
   Meirelles, F
   Ventura, G
   Romao, L
   Canedo, NHS
   de Souza, JM
   de Menezes, JRL
   Moura-Neto, V
   Tovar-Moll, F
   Lima, FRS
AF Garcia, Celina
   Dubois, Luiz Gustavo
   Xavier, Anna Lenice
   Geraldo, Luiz Henrique
   Carvalho da Fonseca, Anna Carolina
   Correia, Ana Helena
   Meirelles, Fernanda
   Ventura, Grasiella
   Romao, Luciana
   Silva Canedo, Nathalie Henriques
   de Souza, Jorge Marcondes
   Lacerda de Menezes, Joao Ricardo
   Moura-Neto, Vivaldo
   Tovar-Moll, Fernanda
   Souza Lima, Flavia Regina
TI The orthotopic xenotransplant of human glioblastoma successfully
   recapitulates glioblastoma-microenvironment interactions in a
   non-immunosuppressed mouse model
SO BMC CANCER
LA English
DT Article
DE Glioblastoma; Microglia; Angiogenesis; Reactive gliosis
AB Background: Glioblastoma (GBM) is the most common primary brain tumor and the most aggressive glial tumor. This tumor is highly heterogeneous, angiogenic, and insensitive to radio- and chemotherapy. Here we have investigated the progression of GBM produced by the injection of human GBM cells into the brain parenchyma of immunocompetent mice.
   Methods: Xenotransplanted animals were submitted to magnetic resonance imaging (MRI) and histopathological analyses.
   Results: Our data show that two weeks after injection, the produced tumor presents histopathological characteristics recommended by World Health Organization for the diagnosis of GBM in humans. The tumor was able to produce reactive gliosis in the adjacent parenchyma, angiogenesis, an intense recruitment of macrophage and microglial cells, and presence of necrosis regions. Besides, MRI showed that tumor mass had enhanced contrast, suggesting a blood-brain barrier disruption.
   Conclusions: This study demonstrated that the xenografted tumor in mouse brain parenchyma develops in a very similar manner to those found in patients affected by GBM and can be used to better understand the biology of GBM as well as testing potential therapies.
C1 [Garcia, Celina; Dubois, Luiz Gustavo; Xavier, Anna Lenice; Geraldo, Luiz Henrique; Carvalho da Fonseca, Anna Carolina; Ventura, Grasiella; Lacerda de Menezes, Joao Ricardo; Moura-Neto, Vivaldo; Tovar-Moll, Fernanda; Souza Lima, Flavia Regina] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21949590 Rio De Janeiro, Brazil.
   [Correia, Ana Helena; Silva Canedo, Nathalie Henriques; de Souza, Jorge Marcondes] Univ Fed Rio de Janeiro, Serv Anat Patol, Serv Neurocirurgia, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Romao, Luciana] Univ Fed Rio de Janeiro Macae, BR-27930560 Macae, Brazil.
   [Meirelles, Fernanda; Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Meirelles, Fernanda; Tovar-Moll, Fernanda] Natl Ctr Struct Biol & Bioimaging CENABIO, BR-22281100 Rio De Janeiro, Brazil.
RP Lima, FRS (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, CCS Bloco F, BR-21949590 Rio De Janeiro, Brazil.
EM flima@icb.ufrj.br
RI Romao, Luciana/I-4291-2015; da Fonseca, Anna Carolina
   Carvalho/C-5825-2015; Moura-Neto, VIVALDO/V-9913-2019; Moll, Fernanda
   Tovar/N-3320-2018; da Fonseca, Anna Carolina Carvalho/AAQ-7440-2020;
   Menezes, Joao R. L./D-5668-2012; Feijo Dubois, Luiz Gustavo/O-9904-2015
OI da Fonseca, Anna Carolina Carvalho/0000-0002-8366-3146; Moura-Neto,
   VIVALDO/0000-0002-6266-043X; Moll, Fernanda Tovar/0000-0002-0292-5985;
   da Fonseca, Anna Carolina Carvalho/0000-0002-8366-3146; Feijo Dubois,
   Luiz Gustavo/0000-0002-9765-5315; Ribeiro Xavier, Anna
   Lenice/0000-0001-5143-6531; Geraldo, Luiz Henrique/0000-0003-3318-4697;
   Souza Lima, Flavia Regina/0000-0003-0799-9235
FU Instituto Nacional de Neurociencia Translacional (INNT)/Instituto
   Nacional de Ciencia e Tecnologia (INCT); Conselho Nacional de
   Desenvolvimento Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq); Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)CAPES; Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Programa de Oncobiologia da Universidade Federal do Rio de
   Janeiro; Programa de Pos-Graduacao em Ciencias Morfologicas (PCM), UFRJ
FX We thank Fabio Jorge M. da Silva, Josilane Sant'Ana and Adiel do
   Nascimento for technical assistance. This work was supported by
   Instituto Nacional de Neurociencia Translacional (INNT)/Instituto
   Nacional de Ciencia e Tecnologia (INCT), Conselho Nacional de
   Desenvolvimento Tecnologico (CNPq), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES), Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Programa de
   Oncobiologia da Universidade Federal do Rio de Janeiro, and Programa de
   Pos-Graduacao em Ciencias Morfologicas (PCM), UFRJ.
CR Alves TR, 2011, LIFE SCI, V89, P532, DOI 10.1016/j.lfs.2011.04.022
   Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011
   BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394
   Brehar FM, 2008, J MED LIFE, V1, P12
   da Fonseca ACC, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/264124
   Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136
   Das S, 2013, NEW ENGL J MED, V369, P4
   Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824
   Doblas S, 2012, NMR BIOMED, V25, P685, DOI 10.1002/nbm.1785
   Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218
   Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991
   Dvorak HF, 2011, J SURG ONCOL, V103, P468, DOI 10.1002/jso.21709
   Faria J, 2006, DIFFERENTIATION, V74, P562, DOI 10.1111/j.1432-0436.2006.00090.x
   FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0
   Graeber MB, 2002, GLIA, V40, P252, DOI 10.1002/glia.10147
   Habberstad AH, 2012, CLIN NEUROPATHOL, V31, P361, DOI 10.5414/NP300439
   Hambardzumyan D, 2011, GLIA, V59, P14
   Hedlund A, 2011, INT J NANOMED, V6, P8
   Horbinski C, 2009, J NEUROPATHOL EXP NE, V68, P7
   Huse JT, 2010, NAT REV CANCER, V10, P13
   Huysentruyt LC, 2011, ASN NEURO, V3, P183, DOI 10.1042/AN20110011
   Ichimura K, 2009, NEURO-ONCOLOGY, V11, P8
   Ishii-Ohba H, 2007, MUTAT RES, V619, P10
   Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175
   Kahn SA, 2013, CURR TOP MED CHEM, V12, P12
   Kleihues P, 2000, CANCER, V88, P2887, DOI 10.1002/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F
   Lee J, 2006, CANCER CELL, V9, P13
   Lima FR, 2012, BIOCHIM BIOPHYS ACTA, V1826, P12
   Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4
   Maher EA, 2001, GENE DEV, V15, P23
   Markovic DS, 2005, J NEUROPATHOL EXP NE, V64, P9
   Moore SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060498
   Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337
   Radaelli E, 2009, HISTOL HISTOPATHOL, V24, P879, DOI 10.14670/HH-24.879
   Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557
   Rodrigues JC, 2010, NEURO-ONCOLOGY, V12, P15
   Rolls A, 2009, NAT REV NEUROSCI, V10, P7
   Russell PS, 2011, TRANSPLANTATION, V91, P847, DOI 10.1097/TP.0b013e3182122f82
   Sausville EA, 2006, CANCER RES, V66, P5
   Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477
   Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017
   Suematsu S, 2004, NAT BIOTECHNOL, V22, P1539, DOI 10.1038/nbt1039
   Varlet P, 2004, NEUROSURGERY, V55, P1377, DOI 10.1227/01.NEU.0000143033.36582.40
   Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P13
   Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624
   Weller M, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13210
   Woodworth DC, 2013, J NEUROONCOL, V116, P8
   Wu A, 2010, NEURO-ONCOLOGY, V12, P13
   Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710
   Yi L, 2013, INT J ONCOL, V43, P477, DOI 10.3892/ijo.2013.1962
   Zhang Z, 2006, NEUROSCIENCE, V138, P47, DOI 10.1016/j.neuroscience.2005.11.036
NR 51
TC 16
Z9 17
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2407
J9 BMC CANCER
JI BMC Cancer
PD DEC 8
PY 2014
VL 14
AR 923
DI 10.1186/1471-2407-14-923
PG 11
WC Oncology
SC Oncology
GA AX3AG
UT WOS:000346812600001
PM 25482099
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Zaverucha-Do-Valle, C
   Mesentier-Louro, L
   Gubert, F
   Mortari, N
   Padilha, AB
   Paredes, BD
   Mencalha, A
   Abdelhay, E
   Teixeira, C
   Ferreira, FGM
   Tovar-Moll, F
   de Souza, SAL
   Gutfilen, B
   Mendez-Otero, R
   Santiago, MF
AF Zaverucha-do-Valle, Camila
   Mesentier-Louro, Louise
   Gubert, Fernanda
   Mortari, Nicoli
   Padilha, Ana Beatriz
   Paredes, Bruno D.
   Mencalha, Andre
   Abdelhay, Eliana
   Teixeira, Camila
   Ferreira, Fernanda G. M.
   Tovar-Moll, Fernanda
   Lopes de Souza, Sergio Augusto
   Gutfilen, Bianca
   Mendez-Otero, Rosalia
   Santiago, Marcelo F.
TI Sustained effect of bone marrow mononuclear cell therapy in axonal
   regeneration in a model of optic nerve crush
SO BRAIN RESEARCH
LA English
DT Article
DE Optic nerve; Bone marrow mononuclear cell; Cell therapy; Retinal
   ganglion cell survival; Axonal regeneration
ID RETINAL GANGLION-CELLS; MESENCHYMAL STEM-CELLS; NEUROTROPHIC FACTOR;
   IN-VIVO; BCL-2 OVEREXPRESSION; CEREBRAL-ISCHEMIA; STROMAL CELLS;
   GROWTH-FACTOR; RAT MODEL; TRANSPLANTATION
AB In adult mammals, the regeneration of the optic nerve is very limited and at the moment there are several groups trying different approaches to increase retinal ganglion cell (RGC) survival and axonal outgrowth. One promising approach is cell therapy. In previous work, we performed intravitreal transplantation of bone-marrow mononuclear cells (BMNICs) after optic nerve crush in adult rats and we demonstrated an increase in RGC survival and axon outgrowth 14 days after injury. In the present work, we investigated if these results could be sustained for a longer period of time. Optic nerve crush was performed in Lister-hooded adult rats and BMMC or saline injections were performed shortly after injury. Neuronal survival and regeneration were evaluated in rats retina and optic nerve after 28 days. We demonstrated an increase of 5.2 fold in the axon outgrowth 28 days after lesion, but the BMMCs had no effect on RGC survival. In an attempt to prolong RGC survival, we established a new protocol with two BMMC injections, the second one 7 days after the injury. Untreated animals received two injections of saline. We observed that although the axonal outgrowth was still increased after the second BMMC injection, the RGC survival was not significantly different from untreated animals. These results demonstrate that BMMCs transplantation promotes neuroregeneration at least until 28 days after injury. However, the effects on RGC survival previously observed by us at 14 days were not sustained at 28 days and could not be prolonged with a second dose of BMMC. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Zaverucha-do-Valle, Camila; Mesentier-Louro, Louise; Gubert, Fernanda; Mortari, Nicoli; Padilha, Ana Beatriz; Paredes, Bruno D.; Mendez-Otero, Rosalia; Santiago, Marcelo F.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Zaverucha-do-Valle, Camila; Mesentier-Louro, Louise; Gubert, Fernanda; Mortari, Nicoli; Padilha, Ana Beatriz; Paredes, Bruno D.; Teixeira, Camila; Ferreira, Fernanda G. M.; Tovar-Moll, Fernanda; Lopes de Souza, Sergio Augusto; Mendez-Otero, Rosalia; Santiago, Marcelo F.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Mencalha, Andre; Abdelhay, Eliana] Ctr Nacl Transplante Medula Ossea, Inst Nacl Canc, Lab Celulas Tronco, Rio De Janeiro, Brazil.
   [Mencalha, Andre] Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Dept Biofis & Biometria, BR-20550011 Rio De Janeiro, Brazil.
   [Ferreira, Fernanda G. M.; Tovar-Moll, Fernanda] Inst DOr Pesquisa & Educ IDOR, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, RJ, Brazil.
   Univ Fed Rio de Janeiro, Fac Med, Dept Radiol, Rio De Janeiro, Brazil.
RP Zaverucha-Do-Valle, C (corresponding author), Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, Sala G2-028,Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM camilazv@biof.ufrj.br
RI Santiago, Marcelo F/H-3943-2011; Santiago, Marcelo
   Felippe/AAZ-3553-2020; Gutfilen, Bianca/C-3116-2013; Mendez-Otero,
   Rosalia/AAL-7551-2020; Mencalha, Andre Luiz/AAC-6700-2019; de Souza,
   Sergio Augusto Lopes/A-9431-2013; Moll, Fernanda Tovar/N-3320-2018;
   Mencalha, Andre Luiz/Y-2522-2019; Gubert, Fernanda/G-7619-2014
OI Santiago, Marcelo F/0000-0003-2428-9606; Santiago, Marcelo
   Felippe/0000-0003-2428-9606; Mendez-Otero, Rosalia/0000-0002-1798-9930;
   Mencalha, Andre Luiz/0000-0003-3229-8094; de Souza, Sergio Augusto
   Lopes/0000-0002-7901-4805; Moll, Fernanda Tovar/0000-0002-0292-5985;
   Gubert, Fernanda/0000-0002-0568-7935
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Brazilian Ministry of Health
FX This study was supported by Grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior, Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro, and the Brazilian Ministry of
   Health. We thank Felipe Matins and Suelen Serio for technical
   assistance.
CR Abreu SC, 2013, RESP PHYSIOL NEUROBI, V187, P190, DOI 10.1016/j.resp.2013.03.014
   da Fonseca LMB, 2010, EXP NEUROL, V221, P122, DOI 10.1016/j.expneurol.2009.10.010
   da Fonseca LMB, 2009, CIRCULATION, V120, P539, DOI 10.1161/CIRCULATIONAHA.109.863084
   Battistella V, 2011, REGEN MED, V6, P45, DOI 10.2217/RME.10.97
   Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793
   Carvalho AB, 2008, STEM CELLS, V26, P1307, DOI 10.1634/stemcells.2007-0941
   Chierzi S, 1999, J NEUROSCI, V19, P8367
   de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109
   dos Santos AD, 2010, BRAIN RES, V1306, P149, DOI 10.1016/j.brainres.2009.09.094
   Fischer D, 2000, INVEST OPHTH VIS SCI, V41, P3943
   Friedrich MAG, 2012, CELL TRANSPLANT, V21, pS13, DOI 10.3727/096368912X612512
   Galindo-Romero C, 2013, INVEST OPHTH VIS SCI, V54, P974, DOI 10.1167/iovs.12-11207
   Giraldi-Guimaraes A., 2009, BRAIN RES
   Goldberg JL, 2004, CURR OPIN NEUROBIOL, V14, P551, DOI 10.1016/j.conb.2004.08.012
   Gubert F, 2013, STEM CELL RES, V10, P241, DOI 10.1016/j.scr.2012.11.009
   Harper MM, 2011, INVEST OPHTH VIS SCI, V52, P4506, DOI 10.1167/iovs.11-7346
   Inoue T, 2002, J NEUROSCI, V22, P4468, DOI 10.1523/JNEUROSCI.22-11-04468.2002
   Isenmann S, 1998, EUR J NEUROSCI, V10, P2751, DOI 10.1046/j.1460-9568.1998.00325.x
   Johnson TV, 2014, BRAIN, V137, P503, DOI 10.1093/brain/awt292
   Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P2051, DOI 10.1167/iovs.09-4509
   Jonas JB, 2008, ACTA OPHTHALMOL, V86, P225, DOI 10.1111/j.1600-0420.2007.00987.x
   Kilic U, 2006, J NEUROSCI, V26, P12439, DOI 10.1523/JNEUROSCI.0434-06.2006
   Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010
   Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000
   Levkovitch-Verbin H, 2010, INVEST OPHTH VIS SCI, V51, P6394, DOI 10.1167/iovs.09-4310
   Li N, 2009, GRAEF ARCH CLIN EXP, V247, P503, DOI 10.1007/s00417-008-1009-y
   Lindoso RS, 2011, CELL PHYSIOL BIOCHEM, V28, P267, DOI 10.1159/000331739
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lodovichi C, 2001, EUR J NEUROSCI, V13, P833, DOI 10.1046/j.1460-9568.2001.01440.x
   MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632
   Mesentier-Louro LA, 2012, INVEST OPHTH VIS SCI, V53, P4720, DOI 10.1167/iovs.11-8198
   Moraes L, 2012, STEM CELL RES, V9, P143, DOI 10.1016/j.scr.2012.05.005
   Muller A, 2007, BRAIN, V130, P3308, DOI 10.1093/brain/awm257
   Muller A, 2009, MOL CELL NEUROSCI, V41, P233, DOI 10.1016/j.mcn.2009.03.002
   Omori Y, 2008, BRAIN RES, V1236, P30, DOI 10.1016/j.brainres.2008.07.116
   Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566
   Quintanilha LF, 2008, CELL TRANSPLANT, V17, P943, DOI 10.3727/096368908786576453
   Ribeiro-Resende VT, 2009, NEUROSCIENCE, V159, P540, DOI 10.1016/j.neuroscience.2008.12.059
   Ribeiro-Resende VT, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-34
   Rost N.S., 2012, J NEUROINTERV SURG
   Sapieha PS, 2003, MOL CELL NEUROSCI, V24, P656, DOI 10.1016/S1044-7431(03)00228-8
   SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025
   Siqueira RC, 2011, RETINA-J RET VIT DIS, V31, P1207, DOI 10.1097/IAE.0b013e3181f9c242
   Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021
   Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594
   Suzuki J., 2012, BRAIN RES
   Vasconcelos-dos-Santos A, 2012, STEM CELL RES, V9, P1, DOI 10.1016/j.scr.2012.02.002
   Weise J, 2000, NEUROBIOL DIS, V7, P212, DOI 10.1006/nbdi.2000.0285
   Wu MM, 2010, CELL TRANSPLANT, V19, P159, DOI 10.3727/096368910X492625
   Yin YQ, 2003, J NEUROSCI, V23, P2284
   Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701
   Yin YQ, 2009, P NATL ACAD SCI USA, V106, P19587, DOI 10.1073/pnas.0907085106
   Yu S, 2006, BIOCHEM BIOPH RES CO, V344, P1071, DOI 10.1016/j.bbrc.2006.03.231
   Zaverucha-do-Valle C, 2011, CELL TRANSPLANT, V20, P391, DOI 10.3727/096368910X524764
   Zhang Y, 2011, CARDIOVASC PATHOL, V20, P204, DOI [10.1016/j.carpath.2010.06.007, 10.1088/1674-1056/20/11/110204]
NR 55
TC 14
Z9 14
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0006-8993
EI 1872-6240
J9 BRAIN RES
JI Brain Res.
PD OCT 31
PY 2014
VL 1587
BP 54
EP 68
DI 10.1016/j.brainres.2014.08.070
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA AT8JQ
UT WOS:000345180200006
PM 25204691
DA 2020-12-17
ER

PT J
AU Mesentier-Louro, LA
   Zaverucha-do-Valle, C
   da Silva, AJ
   Nascimento-dos-Santos, G
   Gubert, F
   de Figueiredo, ABP
   Torres, AL
   Paredes, BD
   Teixeira, C
   Tovar-Moll, F
   Mendez-Otero, R
   Santiago, MF
AF Mesentier-Louro, Louise Alessandra
   Zaverucha-do-Valle, Camila
   da Silva-Junior, Almir Jordao
   Nascimento-dos-Santos, Gabriel
   Gubert, Fernanda
   Padilha de Figueiredo, Ana Beatriz
   Torres, Ana Luiza
   Paredes, Bruno D.
   Teixeira, Camila
   Tovar-Moll, Fernanda
   Mendez-Otero, Rosalia
   Santiago, Marcelo F.
TI Distribution of Mesenchymal Stem Cells and Effects on Neuronal Survival
   and Axon Regeneration after Optic Nerve Crush and Cell Therapy
SO PLOS ONE
LA English
DT Article
ID RETINAL GANGLION-CELLS; MARROW MONONUCLEAR-CELLS; EXPERIMENTAL
   AUTOIMMUNE ENCEPHALOMYELITIS; CILIARY NEUROTROPHIC FACTOR; AMYLOID-BETA
   DEPOSITION; BONE-MARROW; STROMAL CELLS; LENS INJURY; SPINAL-CORD;
   ALZHEIMERS-DISEASE
AB Bone marrow-derived cells have been used in different animal models of neurological diseases. We investigated the therapeutic potential of mesenchymal stem cells (MSC) injected into the vitreous body in a model of optic nerve injury. Adult (3-5 months old) Lister Hooded rats underwent unilateral optic nerve crush followed by injection of MSC or the vehicle into the vitreous body. Before they were injected, MSC were labeled with a fluorescent dye or with superparamagnetic iron oxide nanoparticles, which allowed us to track the cells in vivo by magnetic resonance imaging. Sixteen and 28 days after injury, the survival of retinal ganglion cells was evaluated by assessing the number of Tuj1-or Brn3a-positive cells in flat-mounted retinas, and optic nerve regeneration was investigated after anterograde labeling of the optic axons with cholera toxin B conjugated to Alexa 488. Transplanted MSC remained in the vitreous body and were found in the eye for several weeks. Cell therapy significantly increased the number of Tuj1-and Brn3a-positive cells in the retina and the number of axons distal to the crush site at 16 and 28 days after optic nerve crush, although the RGC number decreased over time. MSC therapy was associated with an increase in the FGF-2 expression in the retinal ganglion cells layer, suggesting a beneficial outcome mediated by trophic factors. Interleukin-1 beta expression was also increased by MSC transplantation. In summary, MSC protected RGC and stimulated axon regeneration after optic nerve crush. The long period when the transplanted cells remained in the eye may account for the effect observed. However, further studies are needed to overcome eventually undesirable consequences of MSC transplantation and to potentiate the beneficial ones in order to sustain the neuroprotective effect overtime.
C1 [Mesentier-Louro, Louise Alessandra; Zaverucha-do-Valle, Camila; da Silva-Junior, Almir Jordao; Nascimento-dos-Santos, Gabriel; Gubert, Fernanda; Padilha de Figueiredo, Ana Beatriz; Torres, Ana Luiza; Paredes, Bruno D.; Mendez-Otero, Rosalia; Santiago, Marcelo F.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.
   [Mesentier-Louro, Louise Alessandra; Zaverucha-do-Valle, Camila; da Silva-Junior, Almir Jordao; Nascimento-dos-Santos, Gabriel; Gubert, Fernanda; Padilha de Figueiredo, Ana Beatriz; Torres, Ana Luiza; Paredes, Bruno D.; Mendez-Otero, Rosalia; Santiago, Marcelo F.] INBEB, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil.
   [Teixeira, Camila; Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging CENABIO, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci ICB, Rio De Janeiro, Brazil.
RP Santiago, MF (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.
EM marcelo.santiago@biof.ufrj.br
RI Santiago, Marcelo Felippe/AAZ-3553-2020; Mendez-Otero,
   Rosalia/AAL-7551-2020; Silva-Junior, Almir/AAX-5736-2020; Moll, Fernanda
   Tovar/N-3320-2018; Santiago, Marcelo F/H-3943-2011; Gubert,
   Fernanda/G-7619-2014
OI Santiago, Marcelo Felippe/0000-0003-2428-9606; Mendez-Otero,
   Rosalia/0000-0002-1798-9930; Moll, Fernanda Tovar/0000-0002-0292-5985;
   Santiago, Marcelo F/0000-0003-2428-9606; Nascimento dos Santos,
   Gabriel/0000-0001-6362-8573; Gubert, Fernanda/0000-0002-0568-7935
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Brazilian Ministry of Health; Instituto Nacional de
   Ciencia e Tecnologia de Biologia Estrutural e Bioimagem, INBEB
FX This study was supported by grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (www.cnpq.br), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br),
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (www. faperj. br), and the Brazilian Ministry of Health (www.
   saude. gov. br). The study was supported from grants from the Instituto
   Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem,
   INBEB. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Ahmed Z, 2010, NEUROBIOL DIS, V37, P441, DOI 10.1016/j.nbd.2009.10.024
   Akiyama Y, 2002, J NEUROSCI, V22, P6623
   Bahr M, 2000, TRENDS NEUROSCI, V23, P483, DOI 10.1016/S0166-2236(00)01637-4
   Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109
   da Fonseca LMB, 2010, EXP NEUROL, V221, P122, DOI 10.1016/j.expneurol.2009.10.010
   Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X
   Benowitz L, 2008, EXP NEUROL, V209, P389, DOI 10.1016/j.expneurol.2007.05.025
   BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994
   Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028
   Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198
   Cen LP, 2012, NEUROREPORT, V23, P692, DOI 10.1097/WNR.0b013e328355f1d6
   Chen Q, 2005, J NEUROSCI RES, V80, P611, DOI 10.1002/jnr.20494
   Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334
   Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029
   Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4
   de Lima S, 2012, INT REV NEUROBIOL, V106, P153, DOI 10.1016/B978-0-12-407178-0.00007-7
   Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838
   Diem R, 2003, MOL CELL NEUROSCI, V22, P487, DOI 10.1016/S1044-7431(02)00042-8
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   dos Santos AD, 2010, BRAIN RES, V1306, P149, DOI 10.1016/j.brainres.2009.09.094
   Dreyfus H, 1998, ANN NY ACAD SCI, V845, P240, DOI 10.1111/j.1749-6632.1998.tb09677.x
   English K, 2013, IMMUNOL CELL BIOL, V91, P19, DOI 10.1038/icb.2012.56
   Fischer D, 2000, INVEST OPHTH VIS SCI, V41, P3943
   Fischer D, 2004, J NEUROSCI, V24, P1646, DOI 10.1523/JNEUROSCI.5119-03.2004
   Fischer D, 2008, MOL CELL NEUROSCI, V37, P471, DOI 10.1016/j.mcn.2007.11.002
   Furtado JM, 2012, SURV OPHTHALMOL, V57, P149, DOI 10.1016/j.survophthal.2011.07.002
   Giraldi-Guimaraes A., 2009, BRAIN RES
   Giunti D, 2012, STEM CELLS, V30, P2044, DOI 10.1002/stem.1174
   Hauk TG, 2010, INVEST OPHTH VIS SCI, V51, P459, DOI 10.1167/iovs.09-4203
   Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P2222, DOI 10.1089/scd.2011.0596
   Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071
   Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559
   Isenmann S, 1997, EUR J NEUROSCI, V9, P1763, DOI 10.1111/j.1460-9568.1997.tb01534.x
   Jasmin, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-4
   JOHNSON EM, 1993, ANNU REV NEUROSCI, V16, P31, DOI 10.1146/annurev.ne.16.030193.000335
   Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P2051, DOI 10.1167/iovs.09-4509
   Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P960, DOI 10.1167/iovs.09-3884
   Karussis D, 2008, J NEUROL SCI, V265, P131, DOI 10.1016/j.jns.2007.05.005
   Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753
   Kassis I, 2011, CURR STEM CELL RES T, V6, P63, DOI 10.2174/157488811794480762
   Kaushik DK, 2013, J NEUROCHEM, V127, P233, DOI 10.1111/jnc.12382
   Kermer P, 2000, MOL BRAIN RES, V85, P144, DOI 10.1016/S0169-328X(00)00256-4
   Kermer P, 1999, FEBS LETT, V453, P361, DOI 10.1016/S0014-5793(99)00747-4
   Kikuchi M, 2000, J NEUROSCI, V20, P5037
   Kim H, 2010, NEUROSCI LETT, V468, P190, DOI 10.1016/j.neulet.2009.10.074
   Kim YJ, 2009, GLIA, V57, P13, DOI 10.1002/glia.20731
   Kurimoto T, 2013, J NEUROSCI, V33, P14816, DOI 10.1523/JNEUROSCI.5511-12.2013
   Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010
   Laroni A., 2013, J NEUROIMMUNE PHARM
   Lee JK, 2012, STEM CELLS, V30, P1544, DOI 10.1002/stem.1125
   Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277
   Lee JK, 2009, NEUROSCI LETT, V450, P136, DOI 10.1016/j.neulet.2008.11.059
   Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.310
   Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.126
   Leibinger M, 2012, NEUROBIOL DIS, V46, P314, DOI 10.1016/j.nbd.2012.01.004
   Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009
   Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000
   Levkovitch-Verbin H, 2004, EYE, V18, P1066, DOI 10.1038/sj.eye.6701576
   Levkovitch-Verbin H, 2006, INVEST OPHTH VIS SCI, V47, P2491, DOI 10.1167/iovs.05-0996
   Levkovitch-Verbin H, 2010, INVEST OPHTH VIS SCI, V51, P6394, DOI 10.1167/iovs.09-4310
   Li N, 2009, GRAEF ARCH CLIN EXP, V247, P503, DOI 10.1007/s00417-008-1009-y
   Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514
   Lingor P, 2008, BRAIN, V131, P250, DOI 10.1093/brain/awm284
   Lingor P, 2007, J NEUROCHEM, V103, P181, DOI 10.1111/j.1471-4159.2007.04756.x
   Liu R, 2013, STEM CELLS DEV, V22, P1053, DOI 10.1089/scd.2012.0463
   Lorber B, 2005, EUR J NEUROSCI, V21, P2029, DOI 10.1111/j.1460-9568.2005.04034.x
   Lu LL, 2005, BRAIN RES PROTOC, V15, P46, DOI 10.1016/j.brainresprot.2005.03.002
   Magharious M, 2011, J PROTEOME RES, V10, P3344, DOI 10.1021/pr2004055
   Mesentier-Louro LA, 2012, INVEST OPHTH VIS SCI, V53, P4720, DOI 10.1167/iovs.11-8198
   Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737
   Muller A, 2007, BRAIN, V130, P3308, DOI 10.1093/brain/awm257
   Muller A, 2009, MOL CELL NEUROSCI, V41, P233, DOI 10.1016/j.mcn.2009.03.002
   Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830
   Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267
   Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105
   Osaka M, 2010, BRAIN RES, V1343, P226, DOI 10.1016/j.brainres.2010.05.011
   Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566
   Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757
   Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015
   PERRY VH, 1980, PROC R SOC SER B-BIO, V208, P415, DOI 10.1098/rspb.1980.0060
   Petcu EB, 2008, CURR NEUROVASC RES, V5, P214, DOI 10.2174/156720208786413424
   Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9
   Pirouzmand F, 2012, J CRANIOFAC SURG, V23, P516, DOI 10.1097/SCS.0b013e31824cd4a7
   Pousset F, 2000, EUR CYTOKINE NETW, V11, P427
   Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500
   Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167
   Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014
   Ribeiro-Resende VT, 2009, NEUROSCIENCE, V159, P540, DOI 10.1016/j.neuroscience.2008.12.059
   Rosado-de-Castro PH, 2013, STEM CELLS DEV
   Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269
   Sanchez-Migallon MC, 2011, EXP EYE RES, V92, P260, DOI 10.1016/j.exer.2011.02.001
   Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004
   Smith JNP, 2013, STEM CELLS, V31, P1044, DOI 10.1002/stem.1370
   Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021
   Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594
   Suzuki M, 2008, MOL THER, V16, P2002, DOI 10.1038/mt.2008.197
   Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3574, DOI 10.2174/138161208786848739
   Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001
   Uccelli A, 2012, MOL MED, V18, P794, DOI 10.2119/molmed.2011.00498
   Wong EV, 2003, J NEUROSCI, V23, P3112
   Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570
   XIANG MQ, 1995, J NEUROSCI, V15, P4762
   Yanai A, 2012, CELL TRANSPLANT, V21, P1137, DOI 10.3727/096368911X627435
   Yin YQ, 2003, J NEUROSCI, V23, P2284
   Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701
   Yin YQ, 2009, P NATL ACAD SCI USA, V106, P19587, DOI 10.1073/pnas.0907085106
   Yoshihara T, 2007, J NEUROTRAUM, V24, P1026, DOI 10.1089/neu.2007.132R
   Yu S, 2006, BIOCHEM BIOPH RES CO, V344, P1071, DOI 10.1016/j.bbrc.2006.03.231
   Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496
   Zaverucha-do-Valle C, 2011, CELL TRANSPLANT, V20, P391, DOI 10.3727/096368910X524764
   Zhao CP, 2007, CYTOTHERAPY, V9, P414, DOI 10.1080/14653240701376413
NR 111
TC 46
Z9 48
U1 1
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 27
PY 2014
VL 9
IS 10
AR e110722
DI 10.1371/journal.pone.0110722
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AZ1JF
UT WOS:000347994900027
PM 25347773
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Tovar-Moll, F
   de Oliveira-Souza, R
   Bramati, IE
   Zahn, R
   Cavanagh, A
   Tierney, M
   Moll, J
   Grafman, J
AF Tovar-Moll, Fernanda
   de Oliveira-Souza, Ricardo
   Bramati, Ivanei Edson
   Zahn, Roland
   Cavanagh, Alyson
   Tierney, Michael
   Moll, Jorge
   Grafman, Jordan
TI White Matter Tract Damage in the Behavioral Variant of Frontotemporal
   and Corticobasal Dementia Syndromes
SO PLOS ONE
LA English
DT Article
ID LOBAR DEGENERATION; ALZHEIMERS-DISEASE; PICKS-DISEASE; ATROPHY; BRAIN;
   TRACTOGRAPHY; DIAGNOSIS; PATHOLOGY; PATHWAYS; PATTERNS
AB The phenotypes of the behavioral variant of frontotemporal dementia and the corticobasal syndrome present considerable clinical and anatomical overlap. The respective patterns of white matter damage in these syndromes have not been directly contrasted. Beyond cortical involvement, damage to white matter pathways may critically contribute to both common and specific symptoms in both conditions. Here we assessed patients with the behavioral variant of frontotemporal dementia and corticobasal syndrome with whole-brain diffusion tensor imaging to identify the white matter networks underlying these pathologies. Twenty patients with the behavioral variant of frontotemporal dementia, 19 with corticobasal syndrome, and 15 healthy controls were enrolled in the study. Differences in tract integrity between (i) patients and controls, and (ii) patients with the corticobasal syndrome and the behavioral variant of frontotemporal dementia were assessed with whole brain tract-based spatial statistics and analyses of regions of interest. Behavioral variant of frontotemporal dementia and the corticobasal syndrome shared a pattern of bilaterally decreased white matter integrity in the anterior commissure, genu and body of the corpus callosum, corona radiata and in the long intrahemispheric association pathways. Patients with the behavioral variant of frontotemporal dementia showed greater damage to the uncinate fasciculus, genu of corpus callosum and forceps minor. In contrast, corticobasal syndrome patients had greater damage to the midbody of the corpus callosum and perirolandic corona radiata. Whereas several compact white matter pathways were damaged in both the behavioral variant of frontotemporal dementia and corticobasal syndrome, the distribution and degree of white matter damage differed between them. These findings concur with the distinctive clinical manifestations of these conditions and may improve the in vivo neuroanatomical and diagnostic characterization of these disorders.
C1 [Tovar-Moll, Fernanda; de Oliveira-Souza, Ricardo; Bramati, Ivanei Edson; Zahn, Roland; Moll, Jorge] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda; Bramati, Ivanei Edson] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda; Bramati, Ivanei Edson] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging CENABIO, Rio De Janeiro, Brazil.
   [Zahn, Roland] Kings Coll London, Inst Psychiat, London WC2R 2LS, England.
   [Cavanagh, Alyson; Tierney, Michael; Grafman, Jordan] NINDS, NIH, Bethesda, MD 20892 USA.
   [Grafman, Jordan] Rehabil Inst Chicago, Chicago, IL 60611 USA.
RP Tovar-Moll, F (corresponding author), DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
EM fernanda.tovarmoll@idor.org; jgrafman@northwestern.edu
RI Zahn, Roland/O-8944-2019; Zahn, Roland/C-4665-2008; Moll, Fernanda
   Tovar/N-3320-2018
OI Zahn, Roland/0000-0002-8447-1453; Zahn, Roland/0000-0002-8447-1453;
   Moll, Fernanda Tovar/0000-0002-0292-5985
FU National Institute of Neurological Disorders and Stroke, National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Neurological Disorders & Stroke (NINDS); Medical Research
   CouncilMedical Research Council UK (MRC) [G0902304] Funding Source:
   researchfish
FX This research was supported by the Intramural Research Program of the
   National Institute of Neurological Disorders and Stroke, National
   Institutes of Health. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Agosta F, 2012, CEREB CORTEX, V22, P2705, DOI 10.1093/cercor/bhr288
   Aralasmak A, 2006, J COMPUT ASSIST TOMO, V30, P695, DOI 10.1097/01.rct.0000226397.43235.8b
   Bak Thomas H, 2008, Handb Clin Neurol, V89, P509, DOI 10.1016/S0072-9752(07)01247-X
   Boccardi M, 2005, NEUROBIOL AGING, V26, P37, DOI 10.1016/j.neurobiolaging.2004.02.019
   Boelmans K, 2009, MOVEMENT DISORD, V24, P168, DOI 10.1002/mds.22193
   Borroni B, 2009, ARCH NEUROL-CHICAGO, V64, P246
   BRUN A, 1987, ARCH GERONTOL GERIAT, V6, P193, DOI 10.1016/0167-4943(87)90021-5
   Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004
   Chao LL, 2007, ARCH NEUROL-CHICAGO, V64, P1619, DOI 10.1001/archneur.64.11.1619
   Coenen VA, 2011, NEUROSCI BIOBEHAV R, V35, P1971, DOI 10.1016/j.neubiorev.2010.12.009
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155
   CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308
   Davies RR, 2006, ARCH NEUROL-CHICAGO, V63, P1627, DOI 10.1001/archneur.63.11.1627
   DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004
   Hornberger M, 2009, J NEUROL NEUROSUR PS, V80, P591, DOI 10.1136/jnnp.2008.163873
   Huey ED, 2009, NEUROLOGY, V72, P453, DOI 10.1212/01.wnl.0000341781.39164.26
   Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004
   Josephs KA, 2008, ANN NEUROL, V64, P4, DOI 10.1002/ana.21426
   Kertesz A, 2006, CAN J NEUROL SCI, V33, P141, DOI 10.1017/S0317167100004893
   Kertesz A, 2000, NEUROLOGY, V55, P1368, DOI 10.1212/WNL.55.9.1368
   Kohler CG, 2000, NEUROPSY NEUROPSY BE, V13, P67
   Kril JJ, 2005, J NEUROL SCI, V232, P83, DOI 10.1016/j.jns.2005.02.003
   Ling HL, 2010, BRAIN, V133, P2045, DOI 10.1093/brain/awq123
   Mahoney CJ, 2014, HUM BRAIN MAPP, V35, P4163, DOI 10.1002/hbm.22468
   Mattis S., 2001, DEMENTIA RATING SCAL
   McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803
   Mendez Mario F., 2009, V24, P168, DOI 10.1159/000197896
   Migneco O, 2001, NEUROIMAGE, V13, P896, DOI 10.1006/nimg.2000.0741
   Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114
   Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546
   Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058
   Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.3.CO;2-A
   Pereira JMS, 2009, NEUROLOGY, V72, P1653, DOI 10.1212/WNL.0b013e3181a55fa2
   Rohrer JD, 2011, BRAIN, V134, P2565, DOI 10.1093/brain/awr198
   Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284
   Sajjadi SA, 2013, BRAIN, V136, P2253, DOI 10.1093/brain/awt118
   Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38
   Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051
   Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024
   Starkstein SE, 1997, J NERV MENT DIS, V185, P108, DOI 10.1097/00005053-199702000-00007
   VanHoesen GW, 1997, J NEUROPSYCH CLIN N, V9, P331
   Wang JL, 2010, BRAIN RES, V1357, P184, DOI 10.1016/j.brainres.2010.08.018
   Whitwell JL, 2010, NEUROLOGY, V75, P1879, DOI 10.1212/WNL.0b013e3181feb2e8
   YAKOVLEV PI, 1950, J NEUROPATH EXP NEUR, V9, P250, DOI 10.1097/00005072-195007000-00002
   Zahn R, 2009, CEREB CORTEX, V19, P276, DOI 10.1093/cercor/bhn080
NR 45
TC 20
Z9 20
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 23
PY 2014
VL 9
IS 7
AR e102656
DI 10.1371/journal.pone.0102656
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AM1NT
UT WOS:000339614100043
PM 25054218
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Bado, P
   Engel, A
   de Oliveira-Souza, R
   Bramati, IE
   Paiva, FF
   Basilio, R
   Sato, JR
   Tovar-Moll, F
   Moll, J
AF Bado, Patricia
   Engel, Annerose
   de Oliveira-Souza, Ricardo
   Bramati, Ivanei E.
   Paiva, Fernando F.
   Basilio, Rodrigo
   Sato, Joao R.
   Tovar-Moll, Fernanda
   Moll, Jorge
TI Functional dissociation of ventral frontal and dorsomedial default mode
   network components during resting state and emotional autobiographical
   recall
SO HUMAN BRAIN MAPPING
LA English
DT Article
DE fMRI; default mode; autobiographical memory; emotion; functional
   dissociation
ID MEDIAL PREFRONTAL CORTEX; INDIVIDUAL-DIFFERENCES; PARIETAL CORTEX; BRAIN
   ACTIVITY; VOXEL VOLUME; MEMORY; FMRI; SELF; CONNECTIVITY; FLUCTUATIONS
AB Humans spend a substantial share of their lives mind-wandering. This spontaneous thinking activity usually comprises autobiographical recall, emotional, and self-referential components. While neuroimaging studies have demonstrated that a specific brain default mode network (DMN) is consistently engaged by the resting state of the mind, the relative contribution of key cognitive components to DMN activity is still poorly understood. Here we used fMRI to investigate whether activity in neural components of the DMN can be differentially explained by active recall of relevant emotional autobiographical memories as compared with the resting state. Our study design combined emotional autobiographical memory, neutral memory and resting state conditions, separated by a serial subtraction control task. Shared patterns of activation in the DMN were observed in both emotional autobiographical and resting conditions, when compared with serial subtraction. Directly contrasting autobiographical and resting conditions demonstrated a striking dissociation within the DMN in that emotional autobiographical retrieval led to stronger activation of the dorsomedial core regions (medial prefrontal cortex, posterior cingulate cortex), whereas the resting state condition engaged a ventral frontal network (ventral striatum, subgenual and ventral anterior cingulate cortices) in addition to the IPL. Our results reveal an as yet unreported dissociation within the DMN. Whereas the dorsomedial component can be explained by emotional autobiographical memory, the ventral frontal one is predominantly associated with the resting state proper, possibly underlying fundamental motivational mechanisms engaged during spontaneous unconstrained ideation. Hum Brain Mapp 35:3302-3313, 2014. (c) 2013 Wiley Periodicals, Inc.
C1 [Bado, Patricia; Engel, Annerose; de Oliveira-Souza, Ricardo; Bramati, Ivanei E.; Paiva, Fernando F.; Basilio, Rodrigo; Sato, Joao R.; Tovar-Moll, Fernanda; Moll, Jorge] DOr Inst Res & Educ IDOR, Cognit & Behav Neurosci Unit, Rio De Janeiro, Brazil.
   [Bado, Patricia; Bramati, Ivanei E.; Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, ICB, Rio De Janeiro, Brazil.
   [Engel, Annerose] Max Planck Inst Human Cognit & Brain Sci, Mus Cognit & Action Grp, Leipzig, Germany.
   [de Oliveira-Souza, Ricardo] Fed Univ State Rio de Janeiro, Gaffree & Guinle Univ Hosp, Rio De Janeiro, Brazil.
   [Paiva, Fernando F.] Univ Sao Paulo, Ctr Imagens & Espectroscopia In Vivo Ressonancia, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil.
   [Sato, Joao R.] Univ Fed ABC, Ctr Math Computat & Cognit, Santo Andre, Brazil.
RP Moll, J (corresponding author), DOr Inst Res & Educ, Cognit & Behav Neurosci Unit, Rua Diniz Cordeiro,30-3 Andar, BR-22281100 Rio De Janeiro, Brazil.
EM jorge.moll@idor.org
RI Moll, Fernanda Tovar/N-3320-2018; Paiva, Fernando F/C-1429-2012
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Paiva, Fernando
   F/0000-0002-8989-9707
FU FAPERJ (Pronex grant); FAPERJ (INNT grant); CAPESCAPES; CNPqNational
   Council for Scientific and Technological Development (CNPq); IDOR,
   Brazil
FX Contract grant sponsors: FAPERJ (Pronex and INNT grants) (to J.R.S.),
   CAPES, CNPq, and IDOR, Brazil.
CR ALHEID GF, 1988, NEUROSCIENCE, V27, P1, DOI 10.1016/0306-4522(88)90217-5
   Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005
   Bellgowan PSF, 2006, NEUROIMAGE, V29, P1244, DOI 10.1016/j.neuroimage.2005.08.042
   Bodurka J, 2007, NEUROIMAGE, V34, P542, DOI 10.1016/j.neuroimage.2006.09.039
   Brewer JA, 2011, P NATL ACAD SCI USA, V108, P20254, DOI 10.1073/pnas.1112029108
   Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011
   Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004
   Bzdok D, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00232
   Bzdok D, 2012, BRAIN STRUCT FUNCT, V217, P783, DOI 10.1007/s00429-012-0380-y
   Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005
   Carhart-Harris RL, 2012, P NATL ACAD SCI USA, V109, P2138, DOI 10.1073/pnas.1119598109
   Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261
   Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041
   Fisher C M, 1983, Clin Neurosurg, V31, P9
   Foster BL, 2012, P NATL ACAD SCI USA, V109, P15514, DOI 10.1073/pnas.1206580109
   Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102
   Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201
   Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113
   FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018
   Fukunaga M, 2006, MAGN RESON IMAGING, V24, P979, DOI 10.1016/j.mri.2006.04.018
   Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100
   Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537
   Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098
   Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500
   Harrison BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001794
   Harrison BJ, 2008, P NATL ACAD SCI USA, V105, P9781, DOI 10.1073/pnas.0711791105
   Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428
   Ino Tadashi, 2011, Open Neuroimag J, V5, P14, DOI 10.2174/1874440001105010014
   Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672
   Kim H, 2010, NEUROIMAGE, V50, P1648, DOI 10.1016/j.neuroimage.2010.01.051
   Krienen FM, 2010, J NEUROSCI, V30, P13906, DOI 10.1523/JNEUROSCI.2180-10.2010
   Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009
   Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101
   Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042
   Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5
   Masterman DL, 1997, J PSYCHOPHARMACOL, V11, P107, DOI 10.1177/026988119701100203
   Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8
   Mcvay JC, 2010, PSYCHOL BULL, V136, P188, DOI 10.1037/a0018298
   Moll J, 2012, J NEUROSCI, V32, P12499, DOI 10.1523/JNEUROSCI.6508-11.2012
   Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005
   Northoff G, 2008, TRENDS COGN SCI, V12, P259, DOI 10.1016/j.tics.2008.04.007
   OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4
   Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087
   Pitroda S, 2008, NEUROSCI LETT, V443, P72, DOI 10.1016/j.neulet.2008.07.050
   Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004
   Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676
   Ray RD, 2005, COGN AFFECT BEHAV NE, V5, P156, DOI 10.3758/CABN.5.2.156
   Rempel-Clower NL, 1998, J COMP NEUROL, V398, P393, DOI 10.1002/(SICI)1096-9861(19980831)398:3<393::AID-CNE7>3.0.CO;2-V
   Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013
   Schilbach L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030920
   Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011
   SINGER JL, 1975, AM PSYCHOL, V30, P727, DOI 10.1037/h0076928
   Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946
   Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282
   Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029
   Stellar, 1994, PSYCHOL REV, V101, P301
   Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023
   Whitfield-Gabrieli S, 2011, NEUROIMAGE, V55, P225, DOI 10.1016/j.neuroimage.2010.11.048
   WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023
   Zahn R, 2009, NEUROSCI LETT, V457, P107, DOI 10.1016/j.neulet.2009.03.090
   Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263
NR 61
TC 28
Z9 29
U1 0
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1065-9471
EI 1097-0193
J9 HUM BRAIN MAPP
JI Hum. Brain Mapp.
PD JUL
PY 2014
VL 35
IS 7
BP 3302
EP 3313
DI 10.1002/hbm.22403
PG 12
WC Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA AJ5SC
UT WOS:000337746800033
PM 25050426
OA Other Gold, Green Published
DA 2020-12-17
ER

PT J
AU Tovar-Moll, F
   Monteiro, M
   Andrade, J
   Bramati, IE
   Vianna-Barbosa, R
   Marins, T
   Rodrigues, E
   Dantas, N
   Behrens, TEJ
   de Oliveira-Souza, R
   Moll, J
   Lent, R
AF Tovar-Moll, Fernanda
   Monteiro, Myriam
   Andrade, Juliana
   Bramati, Ivanei E.
   Vianna-Barbosa, Rodrigo
   Marins, Theo
   Rodrigues, Erika
   Dantas, Natalia
   Behrens, Timothy E. J.
   de Oliveira-Souza, Ricardo
   Moll, Jorge
   Lent, Roberto
TI Structural and functional brain rewiring clarifies preserved
   interhemispheric transfer in humans born without the corpus callosum
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE callosal agenesis; callosal plasticity; human connectome
ID CONNECTIVITY; AGENESIS; REGISTRATION; TACTILE; ROBUST; REORGANIZATION;
   OPTIMIZATION; TRACTOGRAPHY; INFORMATION; COMMISSURE
AB Why do humans born without the corpus callosum, the major interhemispheric commissure, lack the disconnection syndrome classically described in callosotomized patients? This paradox was discovered by Nobel laureate Roger Sperry in 1968, and has remained unsolved since then. To tackle the hypothesis that alternative neural pathways could explain this puzzle, we investigated patients with callosal dysgenesis using structural and functional neuroimaging, as well as neuropsychological assessments. We identified two anomalouswhite-matter tracts by deterministic and probabilistic tractography, and provide supporting resting-state functional neuroimaging and neuropsychological evidence for their functional role in preserved interhemispheric transfer of complex tactile information, such as object recognition. These compensatory pathways connect the homotopic posterior parietal cortical areas (Brodmann areas 39 and surroundings) via the posterior and anterior commissures. We propose that anomalous brain circuitry of callosal dysgenesis is determined by long-distance plasticity, a set of hardware changes occurring in the developing brain after pathological interference. So far unknown, these pathological changes somehow divert growing axons away from the dorsal midline, creating alternative tracts through the ventral fore-brain and the dorsal midbrain midline, with partial compensatory effects to the interhemispheric transfer of cortical function.
C1 [Tovar-Moll, Fernanda; Monteiro, Myriam; Andrade, Juliana; Bramati, Ivanei E.; Vianna-Barbosa, Rodrigo; Marins, Theo; Rodrigues, Erika; Dantas, Natalia; de Oliveira-Souza, Ricardo; Moll, Jorge; Lent, Roberto] DOr Inst Res & Educ IDOR, BR-22281032 Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda; Monteiro, Myriam; Andrade, Juliana; Bramati, Ivanei E.; Vianna-Barbosa, Rodrigo; Marins, Theo; Dantas, Natalia; Lent, Roberto] Univ Fed Rio de Janeiro, Inst Biomed Sci ICB, BR-21941902 Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging CENABIO, BR-21941902 Rio De Janeiro, Brazil.
   [Rodrigues, Erika] Augusto Motta Univ Unisuam, BR-21041020 Rio De Janeiro, Brazil.
   [Behrens, Timothy E. J.] Univ Oxford, Ctr Funct Magnet Resonance Imaging Brain, Oxford OX3 9DU, England.
RP Tovar-Moll, F (corresponding author), DOr Inst Res & Educ IDOR, BR-22281032 Rio De Janeiro, Brazil.
EM fernanda.tovarmoll@idor.org; rlent@icb.ufrj.br
RI de Carvalho Rodrigues, Erika/AAE-9445-2020; Moll, Fernanda
   Tovar/N-3320-2018; Rodrigues, Erika/R-6007-2017
OI de Carvalho Rodrigues, Erika/0000-0001-5464-2963; Moll, Fernanda
   Tovar/0000-0002-0292-5985; Rodrigues, Erika/0000-0001-5464-2963; Marins,
   Theo/0000-0002-5017-707X
FU Brazilian Council for Development of Science and Technology; Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior Foundation of the
   Brazilian Ministry of EducationCAPES; Rio de Janeiro Foundation
FX We thank Debora O. Lima for coordination of patient visits, and Marcia
   Triunfol (at Publicase) for help with the manuscript. The project was
   supported by grants and fellowships provided by the Brazilian Council
   for Development of Science and Technology, the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior Foundation of the Brazilian
   Ministry of Education, and the Rio de Janeiro Foundation for the Support
   of Research. F.T.-M., R.L., and J.M. are members of the National
   Institute of Translational Neuroscience, Brazilian Ministry of Science,
   Technology and Innovation.
CR [Anonymous], 2000, JAMA, V284, P3043
   Barr MS, 2002, NEUROPSYCHOLOGY, V16, P459, DOI 10.1037//0894-4105.16.4.459
   Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043
   Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018
   Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609
   Chedotal A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001917
   DENNIS M, 1976, NEUROPSYCHOLOGIA, V14, P455, DOI 10.1016/0028-3932(76)90074-9
   Duquette M, 2008, NEUROPSYCHOLOGIA, V46, P2274, DOI 10.1016/j.neuropsychologia.2008.02.017
   Fabri M, 2005, COGNITIVE BRAIN RES, V24, P73, DOI 10.1016/j.cogbrainres.2004.12.003
   GAZZANIGA MS, 1962, P NATL ACAD SCI USA, V48, P1765, DOI 10.1073/pnas.48.10.1765
   Gazzaniga MS, 2005, NAT REV NEUROSCI, V6, P653, DOI 10.1038/nrn1723
   Grant E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00053
   Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059
   Hagmann P, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00043
   Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722
   Jansons KM, 2003, LECT NOTES COMPUT SC, V2732, P672
   Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132
   Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6
   Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015
   Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004
   Kalil K, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00062
   Kasprian G, 2013, BRAIN, V136, P168, DOI 10.1093/brain/aws332
   Keene MFL, 1938, J ANAT, V72, P488
   Klug A, 2012, J NEUROSCI, V32, P14058, DOI 10.1523/JNEUROSCI.3348-12.2012
   LASSONDE M, 1991, NEUROPSYCHOLOGIA, V29, P481, DOI 10.1016/0028-3932(91)90006-T
   Lassonde MC, 2002, IS CL CO NE, P357
   Lee SK, 2004, AM J NEURORADIOL, V25, P25
   Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3
   Nugent AA, 2012, CURR OPIN NEUROBIOL, V22, P837, DOI 10.1016/j.conb.2012.02.006
   O'Reilly JX, 2013, P NATL ACAD SCI USA, V110, P13982, DOI 10.1073/pnas.1305062110
   Owen JP, 2013, NEUROIMAGE, V70, P340, DOI 10.1016/j.neuroimage.2012.12.031
   Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.3.CO;2-A
   Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107
   Probst M, 1901, ARCH PSYCHIAT NERVEN, V34, P709, DOI 10.1007/BF02680175
   Reed CL, 2005, NEUROIMAGE, V25, P718, DOI 10.1016/j.neuroimage.2004.11.044
   Reed CL, 2004, HUM BRAIN MAPP, V21, P236, DOI 10.1002/hbm.10162
   Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284
   Shizukuishi T, 2013, MAGN RESON MED SCI, V12, P153, DOI 10.2463/mrms.2012-0082
   Short SJ, 2013, NEUROIMAGE, V64, P156, DOI 10.1016/j.neuroimage.2012.09.021
   SPERRY RW, 1968, DEV BIOL, VS, P306
   Sperry RW, 1970, EARLY EXPERIENCE VIS, P167
   Staudt M, 2010, J ANAT, V217, P469, DOI 10.1111/j.1469-7580.2010.01262.x
   Tipping ME, 1999, J ROY STAT SOC B, V61, P611, DOI 10.1111/1467-9868.00196
   Tovar-Moll F, 2007, CEREB CORTEX, V17, P531, DOI 10.1093/cercor/bhj178
   Tyszka JM, 2011, J NEUROSCI, V31, P15154, DOI 10.1523/JNEUROSCI.1453-11.2011
   Uddin LQ, 2008, NEUROREPORT, V19, P703, DOI 10.1097/WNR.0b013e3282fb8203
   Wahl M, 2009, AM J NEURORADIOL, V30, P282, DOI 10.3174/ajnr.A1361
   Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049
NR 48
TC 45
Z9 47
U1 1
U2 13
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 27
PY 2014
VL 111
IS 21
BP 7843
EP 7848
DI 10.1073/pnas.1400806111
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AH8TO
UT WOS:000336411300074
PM 24821757
OA Green Published, Bronze
DA 2020-12-17
ER

PT J
AU Furukawa, E
   Bado, P
   Tripp, G
   Mattos, P
   Wickens, JR
   Bramati, IE
   Alsop, B
   Ferreira, FM
   Lima, D
   Tovar-Moll, F
   Sergeant, JA
   Moll, J
AF Furukawa, Emi
   Bado, Patricia
   Tripp, Gail
   Mattos, Paulo
   Wickens, Jeff R.
   Bramati, Ivanei E.
   Alsop, Brent
   Ferreira, Fernanda Meireles
   Lima, Debora
   Tovar-Moll, Fernanda
   Sergeant, Joseph A.
   Moll, Jorge
TI Abnormal Striatal BOLD Responses to Reward Anticipation and Reward
   Delivery in ADHD
SO PLOS ONE
LA English
DT Article
ID ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY
   DISORDER; DELAY AVERSION; DOPAMINE INNERVATION; VOXEL VOLUME;
   SELF-CONTROL; DSM-IV; CHILDREN; SENSITIVITY; INHIBITION
AB Altered reward processing has been proposed to contribute to the symptoms of attention deficit hyperactivity disorder (ADHD). The neurobiological mechanism underlying this alteration remains unclear. We hypothesize that the transfer of dopamine release from reward to reward-predicting cues, as normally observed in animal studies, may be deficient in ADHD. Functional magnetic resonance imaging (fMRI) was used to investigate striatal responses to reward-predicting cues and reward delivery in a classical conditioning paradigm. Data from 14 high-functioning and stimulant-naive young adults with elevated lifetime symptoms of ADHD (8 males, 6 females) and 15 well-matched controls (8 males, 7 females) were included in the analyses. During reward anticipation, increased blood-oxygen-level-dependent (BOLD) responses in the right ventral and left dorsal striatum were observed in controls, but not in the ADHD group. The opposite pattern was observed in response to reward delivery; the ADHD group demonstrated significantly greater BOLD responses in the ventral striatum bilaterally and the left dorsal striatum relative to controls. In the ADHD group, the number of current hyperactivity/impulsivity symptoms was inversely related to ventral striatal responses during reward anticipation and positively associated with responses to reward. The BOLD response patterns observed in the striatum are consistent with impaired predictive dopamine signaling in ADHD, which may explain altered reward-contingent behaviors and symptoms of ADHD.
C1 [Furukawa, Emi; Tripp, Gail; Wickens, Jeff R.] Okinawa Inst Sci & Technol Grad Univ OIST, Okinawa, Japan.
   [Bado, Patricia; Mattos, Paulo; Bramati, Ivanei E.; Ferreira, Fernanda Meireles; Lima, Debora; Tovar-Moll, Fernanda; Moll, Jorge] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Bado, Patricia; Mattos, Paulo; Bramati, Ivanei E.; Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Alsop, Brent] Univ Otago, Dunedin, New Zealand.
   [Sergeant, Joseph A.] Vrije Univ Amsterdam, Amsterdam, Netherlands.
RP Furukawa, E (corresponding author), Okinawa Inst Sci & Technol Grad Univ OIST, Okinawa, Japan.
EM furukawa@oist.jp
RI Moll, Fernanda Tovar/N-3320-2018; de Mattos, Paulo Eduardo
   Luiz/D-2328-2014; Furukawa, Emi/I-8387-2015; Wickens, Jeffery
   R/N-6055-2014
OI Moll, Fernanda Tovar/0000-0002-0292-5985; de Mattos, Paulo Eduardo
   Luiz/0000-0003-0709-3783; Wickens, Jeffery R/0000-0002-8795-1209
FU OIST (Okinawa Institute of Science and Technology Graduate University);
   IDOR (D'Or Institute for Research and Education)
FX This study was supported by a joint research agreement between OIST
   (Okinawa Institute of Science and Technology Graduate University) and
   IDOR (D'Or Institute for Research and Education). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Amorim Patricia, 2000, Revista Brasileira de Psiquiatria, V22, P106
   Antrop I, 2006, J CHILD PSYCHOL PSYC, V47, P1152, DOI 10.1111/j.1469-7610.2006.01619.x
   Barkley RA, 2002, J CLIN PSYCHIAT, V63, P36
   Bellgowan PSF, 2006, NEUROIMAGE, V29, P1244, DOI 10.1016/j.neuroimage.2005.08.042
   Bitsakou P, 2009, NEUROPSYCHOLOGIA, V47, P446, DOI 10.1016/j.neuropsychologia.2008.09.015
   Bobb AJ, 2005, AM J MED GENET B, V132B, P109
   Bodurka J, 2007, NEUROIMAGE, V34, P542, DOI 10.1016/j.neuroimage.2006.09.039
   Bullmore ET, 1999, HUM BRAIN MAPP, V7, P38, DOI 10.1002/(SICI)1097-0193(1999)7:1<38::AID-HBM4>3.3.CO;2-H
   Carlson CL, 2000, J CONSULT CLIN PSYCH, V68, P73, DOI 10.1037/0022-006X.68.1.73
   Carmona S, 2012, HUM BRAIN MAPP, V33, P2350, DOI 10.1002/hbm.21368
   Clark JJ, 2013, J NEUROSCI, V33, P3526, DOI 10.1523/JNEUROSCI.5119-12.2013
   Crone EA, 2003, J CHILD PSYCHOL PSYC, V44, P214, DOI 10.1111/1469-7610.00115
   del Campo N, 2013, BRAIN, V136, P3252, DOI 10.1093/brain/awt263
   Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062
   DESCARRIES L, 1987, NEUROSCIENCE, V21, P807, DOI 10.1016/0306-4522(87)90038-8
   DOUCET G, 1986, NEUROSCIENCE, V19, P427, DOI 10.1016/0306-4522(86)90272-1
   DOUGLAS VI, 1994, J ABNORM CHILD PSYCH, V22, P281, DOI 10.1007/BF02168075
   Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106
   Epstein JN, 2007, PSYCHIAT RES-NEUROIM, V155, P75, DOI 10.1016/j.pscychresns.2006.12.009
   Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024
   Fayyad J, 2007, BRIT J PSYCHIAT, V190, P402, DOI 10.1192/bjp.bp.106.034389
   FERSTER CB, 1953, PSYCHOL BULL, V50, P263, DOI 10.1037/h0055514
   FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018
   Galvan A, 2005, J NEUROSCI, V25, P8650, DOI 10.1523/JNEUROSCI.2431-05.2005
   GARRUD P, 1981, Q J EXP PSYCHOL-B, V33, P123, DOI 10.1080/14640748108400817
   Gill M, 1997, MOL PSYCHIATR, V2, P311, DOI 10.1038/sj.mp.4000290
   Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x
   Grevet EH, 2005, ARQ NEURO-PSIQUIAT, V63, P307, DOI 10.1590/S0004-282X2005000200019
   HAENLEIN M, 1987, J AM ACAD CHILD PSY, V26, P356, DOI 10.1097/00004583-198705000-00014
   Hoerger ML, 2006, J APPL BEHAV ANAL, V39, P147, DOI 10.1901/jaba.2006.171-04
   Hoogman M, 2011, AM J PSYCHIAT, V168, P1099, DOI 10.1176/appi.ajp.2011.10101446
   Iaboni F, 1997, PSYCHOPHYSIOLOGY, V34, P116, DOI 10.1111/j.1469-8986.1997.tb02422.x
   Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021
   KIMURA M, 1986, Neuroscience Research, V3, P436, DOI 10.1016/0168-0102(86)90035-0
   Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016
   Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7
   Konrad K, 2000, CHILD NEUROPSYCHOL, V6, P286, DOI 10.1076/chin.6.4.286.3145
   Kuntsi J, 2001, J CHILD PSYCHOL PSYC, V42, P199, DOI 10.1111/1469-7610.00711
   Li JA, 2011, P NATL ACAD SCI USA, V108, P55, DOI 10.1073/pnas.1014938108
   Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012
   LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145
   Luman M, 2005, CLIN PSYCHOL REV, V25, P183, DOI 10.1016/j.cpr.2004.11.001
   Luman M, 2008, J CHILD PSYCHOL PSYC, V49, P712, DOI 10.1111/j.1469-7610.2008.01910.x
   Luman M, 2008, J ABNORM CHILD PSYCH, V36, P445, DOI 10.1007/s10802-007-9190-8
   Luman M, 2007, J CHILD PSYCHOL PSYC, V48, P890, DOI 10.1111/j.1469-7610.2007.01769.x
   Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042
   Marx I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067002
   Marx I, 2010, J NEURAL TRANSM, V117, P403, DOI 10.1007/s00702-009-0345-3
   Mattos P., 2006, REV PSIQUIATRIA CLIN, V33, P188, DOI DOI 10.1590/S0101-60832006000
   McInerney RJ, 2003, CHILD NEUROPSYCHOL, V9, P91, DOI 10.1076/chin.9.2.91.14506
   Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0
   O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285
   O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7
   O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7
   OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4
   Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802
   Paloyelis Y, 2012, J AM ACAD CHILD PSY, V51, P722, DOI 10.1016/j.jaac.2012.05.006
   Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005
   Plichta MM, 2014, NEUROSCI BIOBEHAV R, V38, P125, DOI 10.1016/j.neubiorev.2013.07.012
   Plichta MM, 2013, J NEUROSCI, V33, P14526, DOI 10.1523/JNEUROSCI.0631-13.2013
   Plichta MM, 2009, BIOL PSYCHIAT, V65, P7, DOI 10.1016/j.biopsych.2008.07.008
   Sacchet MD, 2013, NEUROIMAGE, V66, P270, DOI 10.1016/j.neuroimage.2012.10.056
   Sagvolden T, 2005, BEHAV BRAIN SCI, V28, P397, DOI 10.1017/S0140525X05000075
   Scheres A, 2007, BIOL PSYCHIAT, V61, P720, DOI 10.1016/j.biopsych.2006.04.042
   Scheres A, 2006, NEUROPSYCHOLOGIA, V44, P2092, DOI 10.1016/j.neuropsychologia.2005.10.012
   Scheres A, 2010, BIOL PSYCHIAT, V67, P641, DOI 10.1016/j.biopsych.2009.10.033
   Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008
   Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593
   Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4
   Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1
   Schultz W, 1999, NEWS PHYSIOL SCI, V14, P249
   SCHWEITZER JB, 1995, J CHILD PSYCHOL PSYC, V36, P671, DOI 10.1111/j.1469-7610.1995.tb02321.x
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi
   Slusarek M, 2001, J AM ACAD CHILD PSY, V40, P355, DOI 10.1097/00004583-200103000-00016
   Solanto MV, 2001, J ABNORM CHILD PSYCH, V29, P215, DOI 10.1023/A:1010329714819
   Sonuga-Barke EJS, 2008, CHILD ADOL PSYCH CL, V17, P367, DOI 10.1016/j.chc.2007.11.008
   Sonuga-Barke EJS, 2002, BEHAV BRAIN RES, V130, P29, DOI 10.1016/S0166-4328(01)00432-6
   Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008
   Stark R, 2011, NEUROPSYCHOLOGIA, V49, P426, DOI 10.1016/j.neuropsychologia.2010.12.012
   Stoy M, 2011, PSYCHOPHARMACOLOGY, V215, P467, DOI 10.1007/s00213-011-2166-y
   Strohle A, 2008, NEUROIMAGE, V39, P966, DOI 10.1016/j.neuroimage.2007.09.044
   Swanson JM, 2000, NEUROSCI BIOBEHAV R, V24, P21, DOI 10.1016/S0149-7634(99)00062-7
   Swanson JM, 1998, MOL PSYCHIATR, V3, P38, DOI 10.1038/sj.mp.4000354
   Tripp G, 1999, J CLIN CHILD PSYCHOL, V28, P366, DOI 10.1207/S15374424jccp280309
   Tripp G, 2001, J CHILD PSYCHOL PSYC, V42, P691, DOI 10.1111/1469-7610.00764
   Tripp G, 2008, J CHILD PSYCHOL PSYC, V49, P691, DOI 10.1111/j.1469-7610.2007.01851.x
   Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1084, DOI 10.1001/jama.2009.1308
   Wilbertz G, 2012, NEUROIMAGE, V60, P353, DOI 10.1016/j.neuroimage.2011.12.011
   Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8
   Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004
   WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023
   Yates DB, 2006, AVALIACAO PSICOLOGIC, V5, P227
   Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279
NR 93
TC 41
Z9 42
U1 0
U2 35
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 26
PY 2014
VL 9
IS 2
AR e89129
DI 10.1371/journal.pone.0089129
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AC3BC
UT WOS:000332389000027
PM 24586543
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Neves, K
   Ferreira, FM
   Tovar-Moll, F
   Gravett, N
   Bennett, NC
   Kaswera, C
   Gilissen, E
   Manger, PR
   Herculano-Houzel, S
AF Neves, Kleber
   Ferreira, Fernanda M.
   Tovar-Moll, Fernanda
   Gravett, Nadine
   Bennett, Nigel C.
   Kaswera, Consolate
   Gilissen, Emmanuel
   Manger, Paul R.
   Herculano-Houzel, Suzana
TI Cellular scaling rules for the brain of afrotherians
SO FRONTIERS IN NEUROANATOMY
LA English
DT Article
DE evolution; glia-neuron ratio; numbers of neurons; cortical expansion;
   gyrification
ID ISOTROPIC FRACTIONATOR; NEURON NUMBERS; MAMMALS; SIZE; CORTEX;
   QUANTIFICATION; CONSOLIDATE; DENSITY; MATTER; CELLS
AB Quantitative analysis of the cellular composition of rodent, primate and eulipotyphlan brains has shown that non-neuronal scaling rules are similar across these mammalian orders that diverged about 95 million years ago, and therefore appear to be conserved in evolution, while neuronal scaling rules appear to be free to vary in evolution in a clade-specific manner. Here we analyze the cellular scaling rules that apply to the brain of afrotherians, believed to be the first clade to radiate from the common eutherian ancestor. We find that afrotherians share non-neuronal scaling rules with rodents, primates and eulipotyphlans, as well as the coordinated scaling of numbers of neurons in the cerebral cortex and cerebellum. Afrotherians share with rodents and eulipotyphlans, but not with primates, the scaling of number of neurons in the cortex and in the cerebellum as a function of the number of neurons in the rest of the brain. Afrotheria also share with rodents and eulipotyphlans the neuronal scaling rules that apply to the cerebral cortex. Afrotherians share with rodents, but not with eulipotyphlans nor primates, the neuronal scaling rules that apply to the cerebellum. Importantly, the scaling of the folding index of the cerebral cortex with the number of neurons in the cerebral cortex is not shared by either afrotherians, rodents, or primates. The sharing of some neuronal scaling rules between afrotherians and rodents, and of some additional features with eulipotyphlans and primates, raise the interesting possibility that these shared characteristics applied to the common eutherian ancestor. In turn, the clade-specific characteristics that relate to the distribution of neurons along the surface of the cerebral cortex and to its degree of gyrification suggest that these characteristics compose an evolutionarily plastic suite of features that may have defined and distinguished mammalian groups in evolution.
C1 [Neves, Kleber; Tovar-Moll, Fernanda; Herculano-Houzel, Suzana] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, Brazil.
   [Neves, Kleber; Tovar-Moll, Fernanda; Herculano-Houzel, Suzana] CNPq MCT, Inst Nacl Neurociencia Translac, Sao Paulo, Brazil.
   [Ferreira, Fernanda M.; Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Ferreira, Fernanda M.; Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Bioimaging Natl Ctr, Rio De Janeiro, Brazil.
   [Gravett, Nadine] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa.
   [Bennett, Nigel C.] Univ Kisangani, Fac Sci, Kisangani, DEM REP CONGO.
   [Kaswera, Consolate] Royal Museum Cent Africa, Dept African Zool, Tervuren, Belgium.
   [Gilissen, Emmanuel] Univ Libre Bruxelles, Lab Histol & Neuropathol, Brussels, Belgium.
   [Gilissen, Emmanuel] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA.
   [Manger, Paul R.] Univ Witwatersrand, Sch Anat Sci, Johannesburg, South Africa.
RP Herculano-Houzel, S (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rua Carlos Chagas Filho 373,Sala F1-009, BR-21941902 Rio De Janeiro, Brazil.
EM suzanahh@gmail.com
RI Moll, Fernanda Tovar/N-3320-2018; Bennett, Nigel/E-4238-2010
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Neves,
   Kleber/0000-0001-9519-4909; Bennett, Nigel/0000-0001-9748-2947
CR Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974
   Bahney J, 2014, J NEUROSCI METH, V222, P165, DOI 10.1016/j.jneumeth.2013.11.002
   Gabi M, 2010, BRAIN BEHAV EVOLUT, V76, P32, DOI 10.1159/000319872
   Gittins R, 2004, BRAIN RES BULL, V63, P155, DOI 10.1016/j.brainresbull.2004.02.005
   HAUG H, 1987, AM J ANAT, V180, P126, DOI 10.1002/aja.1001800203
   Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005
   Herculano-Houzel S, 2007, P NATL ACAD SCI USA, V104, P3562, DOI 10.1073/pnas.0611396104
   Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103
   Herculano-Houzel S, 2011, BRAIN BEHAV EVOLUT, V78, P302, DOI 10.1159/000330825
   Herculano-Houzel S, 2011, BRAIN BEHAV EVOLUT, V78, P22, DOI 10.1159/000327318
   Herculano-Houzel S, 2011, ANN NY ACAD SCI, V1225, P191, DOI 10.1111/j.1749-6632.2011.05976.x
   Herculano-Houzel S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00012
   Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009
   HOFMAN MA, 1985, BRAIN BEHAV EVOLUT, V27, P28, DOI 10.1159/000118718
   JERISON HJ, 1985, PHILOS T ROY SOC B, V308, P21, DOI 10.1098/rstb.1985.0007
   Kaufman JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058667
   Kuntner M, 2011, ZOOL SCR, V40, P1, DOI 10.1111/j.1463-6409.2010.00452.x
   Maseko BC, 2012, ANAT REC, V295, P661, DOI 10.1002/ar.22425
   Mota B, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00003
   MULLEN RJ, 1992, DEVELOPMENT, V116, P201
   Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807
   Poulakakis N, 2010, SYST BIODIVERS, V8, P395, DOI 10.1080/14772000.2010.484436
   Sarko DK, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.008.2009
   Skinner JD, 2005, MAMMALS SO AFRICAN S, DOI [10.1017/CBO9781107340992, DOI 10.1017/CB09781107340992, 10.1017/CB09781107340992]
   Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006
   Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967
   STOLZENBURG JU, 1989, GLIA, V2, P78, DOI 10.1002/glia.440020203
   Tabuce R, 2007, P ROY SOC B-BIOL SCI, V274, P1159, DOI 10.1098/rspb.2006.0229
   TOWER DB, 1954, J COMP NEUROL, V101, P19, DOI 10.1002/cne.901010103
   Ventura-Antunes L, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00003
   WILLIAMS RW, 1988, ANNU REV NEUROSCI, V11, P423, DOI 10.1146/annurev.ne.11.030188.002231
   Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197
NR 32
TC 23
Z9 23
U1 0
U2 15
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1662-5129
J9 FRONT NEUROANAT
JI Front. Neuroanat.
PD FEB 17
PY 2014
VL 8
AR 5
DI 10.3389/fnana.2014.00005
PG 13
WC Anatomy & Morphology; Neurosciences
SC Anatomy & Morphology; Neurosciences & Neurology
GA AC6LA
UT WOS:000332633100001
PM 24596544
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Sato, JR
   Basilio, R
   Paiva, FF
   Garrido, GJ
   Bramati, IE
   Bado, P
   Tovar-Moll, F
   Zahn, R
   Moll, J
AF Sato, Joao R.
   Basilio, Rodrigo
   Paiva, Fernando F.
   Garrido, Griselda J.
   Bramati, Ivanei E.
   Bado, Patricia
   Tovar-Moll, Fernanda
   Zahn, Roland
   Moll, Jorge
TI Real-Time fMRI Pattern Decoding and Neurofeedback Using FRIEND: An
   FSL-Integrated BCI Toolbox
SO PLOS ONE
LA English
DT Article
ID BRAIN ACTIVITY; CORTEX ACTIVITY; NATURAL IMAGES; ACTIVATION; STATES;
   FEEDBACK; CORTICES; REGIONS; SCORES; ROBUST
AB The demonstration that humans can learn to modulate their own brain activity based on feedback of neurophysiological signals opened up exciting opportunities for fundamental and applied neuroscience. Although EEG-based neurofeedback has been long employed both in experimental and clinical investigation, functional MRI (fMRI)-based neurofeedback emerged as a promising method, given its superior spatial resolution and ability to gauge deep cortical and subcortical brain regions. In combination with improved computational approaches, such as pattern recognition analysis (e. g., Support Vector Machines, SVM), fMRI neurofeedback and brain decoding represent key innovations in the field of neuromodulation and functional plasticity. Expansion in this field and its applications critically depend on the existence of freely available, integrated and user-friendly tools for the neuroimaging research community. Here, we introduce FRIEND, a graphic-oriented user-friendly interface package for fMRI neurofeedback and real-time multivoxel pattern decoding. The package integrates routines for image preprocessing in real-time, ROI-based feedback (single-ROI BOLD level and functional connectivity) and brain decoding-based feedback using SVM. FRIEND delivers an intuitive graphic interface with flexible processing pipelines involving optimized procedures embedding widely validated packages, such as FSL and libSVM. In addition, a user-defined visual neurofeedback module allows users to easily design and run fMRI neurofeedback experiments using ROI-based or multivariate classification approaches. FRIEND is open-source and free for non-commercial use. Processing tutorials and extensive documentation are available.
C1 [Sato, Joao R.; Basilio, Rodrigo; Paiva, Fernando F.; Garrido, Griselda J.; Bramati, Ivanei E.; Bado, Patricia; Tovar-Moll, Fernanda; Zahn, Roland; Moll, Jorge] DOr Inst Res & Educ IDOR, Cognit & Behav Neurosci Unit, Rio De Janeiro, Brazil.
   [Sato, Joao R.; Basilio, Rodrigo; Paiva, Fernando F.; Garrido, Griselda J.; Bramati, Ivanei E.; Bado, Patricia; Tovar-Moll, Fernanda; Zahn, Roland; Moll, Jorge] DOr Inst Res & Educ IDOR, Neuroinformat Workgrp, Rio De Janeiro, Brazil.
   [Sato, Joao R.] Univ Fed ABC, Ctr Math Computat & Cognit, Santo Andre, Brazil.
   [Paiva, Fernando F.] Univ Sao Paulo, Inst Phys Sao Carlos, Sao Carlos, SP, Brazil.
   [Bramati, Ivanei E.; Bado, Patricia; Tovar-Moll, Fernanda; Moll, Jorge] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio de Janeiro, Brazil.
   [Zahn, Roland] Kings Coll London, Inst Psychiat, Dept Psychol Med, London WC2R 2LS, England.
RP Moll, J (corresponding author), DOr Inst Res & Educ IDOR, Cognit & Behav Neurosci Unit, Rio De Janeiro, Brazil.
EM jorge.moll@idor.org
RI Zahn, Roland/O-8944-2019; Paiva, Fernando F/C-1429-2012; Zahn,
   Roland/C-4665-2008; Moll, Fernanda Tovar/N-3320-2018
OI Zahn, Roland/0000-0002-8447-1453; Paiva, Fernando F/0000-0002-8989-9707;
   Zahn, Roland/0000-0002-8447-1453; Moll, Fernanda
   Tovar/0000-0002-0292-5985
FU FAPERJ Sediadas grant; INNT grant; CAPESCAPES; CNPqNational Council for
   Scientific and Technological Development (CNPq); IDOR; MRC clinician
   scientist awardMedical Research Council UK (MRC) [G0902304]; FAPESP,
   BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/10498-6]; Medical Research CouncilMedical Research Council UK
   (MRC) [G0902304] Funding Source: researchfish
FX This research was supported by FAPERJ Sediadas and INNT grants, CAPES,
   CNPq and by intramural grants from IDOR; RZ was supported by an MRC
   clinician scientist award (G0902304). JRS was supported by FAPESP (grant
   number 2013/10498-6), Brazil. The funder had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Birbaumer N, 2009, INT REV NEUROBIOL, V86, P107, DOI 10.1016/S0074-7742(09)86008-X
   Bishop C.M., 2006, PATTERN RECOGNITION
   Caria A, 2007, NEUROIMAGE, V35, P1238, DOI 10.1016/j.neuroimage.2007.01.018
   Chang C-C, 2012, LIBSVM LIB SUPPORT V
   COX RW, 1995, MAGNET RESON MED, V33, P230, DOI 10.1002/mrm.1910330213
   Decharms RC, 2008, NAT REV NEUROSCI, V9, P720, DOI 10.1038/nrn2414
   deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102
   Evans JR, 2008, INTRO QUANTITATIVE E
   Freire MAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027554
   Green S, 2012, ARCH GEN PSYCHIAT, V69, P1014, DOI 10.1001/archgenpsychiatry.2012.135
   Hammond DC, 2005, J ADULT DEV, V12, P131, DOI 10.1007/s10804-005-7029-5
   Haxby JV, 2012, NEUROIMAGE, V62, P852, DOI 10.1016/j.neuroimage.2012.03.016
   Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072
   Hyman SE, 2007, NAT REV NEUROSCI, V8, P725, DOI 10.1038/nrn2218
   Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132
   Jenkinson M., 1999, MEASURING TRANSFORMA
   Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015
   Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713
   Kotchoubey B, 2001, EPILEPSIA, V42, P406, DOI 10.1046/j.1528-1157.2001.22200.x
   LaConte SM, 2007, HUM BRAIN MAPP, V28, P1033, DOI 10.1002/hbm.20326
   LaConte SM, 2011, NEUROIMAGE, V56, P440, DOI 10.1016/j.neuroimage.2010.06.052
   Linden DEJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038115
   LUBAR JF, 1995, BIOFEEDBACK SELF-REG, V20, P83, DOI 10.1007/BF01712768
   Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004
   MILLER NE, 1978, ANNU REV PSYCHOL, V29, P373, DOI 10.1146/annurev.ps.29.020178.002105
   Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876
   Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070
   Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006
   Phan KL, 2004, NEUROREPORT, V15, P527, DOI 10.1097/00001756-200403010-00029
   Poldrack R. A., 2011, HDB FUNCTIONAL MRI D
   Poldrack RA, 2011, NEURON, V72, P692, DOI 10.1016/j.neuron.2011.11.001
   Posse S, 2003, NEUROIMAGE, V18, P760, DOI 10.1016/S1053-8119(03)00004-1
   Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018
   Ruiz S, 2013, HUM BRAIN MAPP, V34, P200, DOI 10.1002/hbm.21427
   Sato JR, 2008, NEUROIMAGE, V42, P1473, DOI 10.1016/j.neuroimage.2008.06.024
   Sato JR, 2009, NEUROIMAGE, V46, P105, DOI 10.1016/j.neuroimage.2009.01.032
   Sato JR, 2009, HUM BRAIN MAPP, V30, P1068, DOI 10.1002/hbm.20569
   Shibata K, 2011, SCIENCE, V334, P1413, DOI 10.1126/science.1212003
   Sitaram R, 2012, NEUROREHAB NEURAL RE, V26, P256, DOI 10.1177/1545968311418345
   Sitaram R, 2011, NEUROIMAGE, V56, P753, DOI 10.1016/j.neuroimage.2010.08.007
   Sorger B, 2012, CURR BIOL, V22, P1333, DOI 10.1016/j.cub.2012.05.022
   Vapnik V, 1998, STAT LEARNING THEORY
   Weiskopf N, 2003, NEUROIMAGE, V19, P577, DOI 10.1016/S1053-8119(03)00145-9
   Weiskopf N, 2012, NEUROIMAGE, V62, P682, DOI 10.1016/j.neuroimage.2011.10.009
   Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3
   Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931
   Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522
NR 47
TC 16
Z9 16
U1 0
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 2
PY 2013
VL 8
IS 12
AR e81658
DI 10.1371/journal.pone.0081658
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 265IN
UT WOS:000327944500083
PM 24312569
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Ikonomidou, VN
   Richert, ND
   Vortmeyer, A
   Tovar-Moll, F
   Bielekova, B
   Cook, NE
   Duyn, JH
   Bagnato, F
AF Ikonomidou, Vasiliki N.
   Richert, Nancy D.
   Vortmeyer, Alexander
   Tovar-Moll, Fernanda
   Bielekova, Bibiana
   Cook, Natalie E.
   Duyn, Jeff H.
   Bagnato, Francesca
TI Evolution of tumefactive lesions in multiple sclerosis: A 12-year study
   with serial imaging in a single patient
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Article
DE Multiple sclerosis; tumefactive lesion; magnetic resonance imaging;
   recovery; magnetization transfer imaging; tissue-specific imaging
AB We describe the acute presentation and the long-term evolution of recurrent tumefactive lesions (TLs) in a patient with relapsing-remitting multiple sclerosis. Five TLs occurred on three different occasions over a period of 12 years and these were followed by 73 serial magnetic resonance images (MRI). TL evolution was described by means of magnetization transfer imaging (MTI) and cerebrospinal fluid tissue specific imaging (TSI) over the follow-up period. During the study period, the patient had three clinical relapses with only minimal disability progression. MTI demonstrated that only the peripheral portion of each TL reverted to pre-lesional MT ratios within six months' post-enhancement. Recurring TLs may present a similar pattern of evolution that may be associated with a long-term favourable clinical outcome.
C1 [Ikonomidou, Vasiliki N.] George Mason Univ, Volgenau Sch Engn, Dept Bioengn, Fairfax, VA 22030 USA.
   [Ikonomidou, Vasiliki N.; Richert, Nancy D.; Tovar-Moll, Fernanda; Bielekova, Bibiana; Cook, Natalie E.; Bagnato, Francesca] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA.
   [Vortmeyer, Alexander] NINDS, Neurosurg Branch, NIH, Bethesda, MD 20892 USA.
   [Duyn, Jeff H.] NINDS, Adv MRI Sect, LFMI, NIH, Bethesda, MD 20892 USA.
   [Bagnato, Francesca] Univ Maryland, Dept Neurol, Baltimore, MD 21201 USA.
RP Bagnato, F (corresponding author), Univ Maryland, Dept Neurol, 110 Paca St, Baltimore, MD 21201 USA.
EM fbagnato@umm.edu
RI Bielekova, Bibiana/V-1452-2017; Bielekova, Bibiana/AAA-8115-2020; Moll,
   Fernanda Tovar/N-3320-2018
OI Bielekova, Bibiana/0000-0002-0959-9430; Bielekova,
   Bibiana/0000-0002-0959-9430; Moll, Fernanda Tovar/0000-0002-0292-5985
FU Intramural Research Program of the NINDS-NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Neurological Disorders & Stroke (NINDS); NATIONAL
   INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Neurological Disorders & Stroke (NINDS)
   [ZIANS003027, ZIANS003027, ZIANS003055, ZIANS003027, ZIANS003055,
   ZIANS003055, ZIANS003055, ZIANS003055, ZIANS003027, ZIANS003055,
   ZIANS003055, ZIANS003027, ZIANS003027, ZIANS003027, ZIANS003027,
   ZIANS003055, ZIANS003055, ZIANS003027, ZIANS003027, ZIANS003055] Funding
   Source: NIH RePORTER
FX This research was supported by the Intramural Research Program of the
   NINDS-NIH.
CR Altintas A, 2012, MULT SCLER J, V18, P1448, DOI 10.1177/1352458512438237
   Bielekova B, 2000, NAT MED, V6, P1167
   Comi G, 2004, NEUROL SCI, V25, pS374, DOI 10.1007/s10072-004-0345-x
   Davis M, 2010, NEUROLOGY, V74, P851, DOI 10.1212/WNL.0b013e3181d31df5
   Ikonomidou VN, 2005, MAGN RESON MED, V54, P373, DOI 10.1002/mrm.20561
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q
   Lucchinetti CF, 2008, BRAIN, V131, P1759, DOI 10.1093/brain/awn098
   Riva M, 2009, AM J NEURORADIOL, V30, P1394, DOI 10.3174/ajnr.A1573
NR 9
TC 1
Z9 2
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER J
JI Mult. Scler. J.
PD OCT
PY 2013
VL 19
IS 11
BP 1539
EP 1543
DI 10.1177/1352458513498124
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 222QE
UT WOS:000324745400016
PM 24062416
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Barboza, RB
   De Freitas, GR
   Tovar-Moll, F
   Fontenelle, LF
AF Barboza, Raissa B.
   De Freitas, Gabriel R.
   Tovar-Moll, Fernanda
   Fontenelle, Leonardo F.
TI Delayed-onset post-stroke delusional disorder: A case report
SO BEHAVIOURAL NEUROLOGY
LA English
DT Editorial Material
DE Stroke; psychotic symptoms; persistent delusional disorder
ID STROKE; PSYCHOSIS
AB Although the prevalence of neuropsychiatric disorders among patients with cerebrovascular illness is relatively high, there are only few case reports describing post-stroke psychotic symptoms. In general, post-stroke psychoses have been reported to emerge few days after the vascular event and to vanish soon afterwards. In this report, we describe delayed-onset post-stroke delusional disorder, persecutory type. A middle-aged female patient developed a persistent delusional disorder with homicidal behavior about one year after a cerebrovascular accident affecting the right fronto-temporo-parietal region and a long period of chronic post-stroke mixed anxiety and depressive symptoms. Our case suggests that there might be long intervals between stroke and the appearance of psychotic symptoms.
C1 [Barboza, Raissa B.; Fontenelle, Leonardo F.] Univ Fed Rio de Janeiro, Dept Psiquiatria Med Legal, Rio De Janeiro, RJ, Brazil.
   [Barboza, Raissa B.; Fontenelle, Leonardo F.] Univ Fed Rio de Janeiro, Inst Psiquiatria, Programa Ansiedade & Depressao, Rio De Janeiro, RJ, Brazil.
   [Barboza, Raissa B.; Fontenelle, Leonardo F.] Univ Fed Fluminense, Dept Psiquiatria & Saude Mental, Niteroi, RJ, Brazil.
   [De Freitas, Gabriel R.; Tovar-Moll, Fernanda] Inst DOr Pesquisa & Ensino IDOR, Rio De Janeiro, RJ, Brazil.
   [De Freitas, Gabriel R.] Univ Fed Fluminense, Serv Neurol, Niteroi, RJ, Brazil.
   [Tovar-Moll, Fernanda; Fontenelle, Leonardo F.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, RJ, Brazil.
RP Fontenelle, LF (corresponding author), Av Venceslau Bras 71, BR-22290140 Rio De Janeiro, RJ, Brazil.
EM lfontenelle@gmail.com
RI Fontenelle, Leonardo/D-3321-2013; Moll, Fernanda Tovar/N-3320-2018; de
   Freitas, Gabriel R/B-1298-2013
OI Fontenelle, Leonardo/0000-0001-9075-8226; Moll, Fernanda
   Tovar/0000-0002-0292-5985; 
CR Adunsky A, 1997, AGE AGEING, V26, P238, DOI 10.1093/ageing/26.3.238-a
   Almeida OP, 2007, AUST NZ J PSYCHIAT, V41, P274, DOI 10.1080/00048670601172772
   Angelelli P, 2004, ACTA PSYCHIAT SCAND, V110, P55, DOI 10.1111/j.1600-0447.2004.00297.x
   Bonita R, 1997, STROKE, V28, P1898, DOI 10.1161/01.STR.28.10.1898
   Butler C, 2005, J NEUROL NEUROSUR PS, V76, pI31, DOI 10.1136/jnnp.2004.060459
   Carota Antonio, 2005, Psychol Neuropsychiatr Vieil, V3, P235
   FEINBERG TE, 1990, ARCH NEUROL-CHICAGO, V47, P802, DOI 10.1001/archneur.1990.00530070100017
   Goldberg JF, 2002, J CLIN PSYCHIAT, V63, P791, DOI 10.4088/JCP.v63n0907
   Goulart AC, 2010, INT J STROKE, V5, P284, DOI 10.1111/j.1747-4949.2010.00441.x
   Kato Y, 2006, PSYCHIAT RES-NEUROIM, V146, P91, DOI 10.1016/j.pscychresns.2005.10.003
   Kumlien E, 2010, SEIZURE-EUR J EPILEP, V19, P69, DOI 10.1016/j.seizure.2009.11.005
   Kumral E, 2004, NEUROLOGY, V62, P110, DOI 10.1212/WNL.62.1.110
   Leeds L, 2011, BRIT J LEARN DISABIL, V39, P292, DOI 10.1111/j.1468-3156.2010.00666.x
   LEVINE DN, 1982, NEUROLOGY, V32, P267, DOI 10.1212/WNL.32.3.267
   MASSON C, 1992, REV NEUROL, V148, P566
   Metcalf K, 2007, COGN NEUROPSYCHOL, V24, P23, DOI 10.1080/02643290600694901
   Ministeerio da Saude [Internet] Secretaria Executiva Datasus, INF SAUUD INF EP MOR
   Mishra NK, 2008, J NEUROPSYCH CLIN N, V20, P116, DOI 10.1176/jnp.2008.20.1.116
   Peters ER, 2000, J ABNORM PSYCHOL, V109, P386, DOI [10.1037/0021-843X.109.3.386, 10.1037//0021-843X.109.3.386]
   Poetter CE, 2012, J AM GERIATR SOC, V60, P165, DOI 10.1111/j.1532-5415.2011.03709.x
   Santos S, 2009, ACTAS ESP PSIQUIATRI, V37, P240
   SCHENKENBERG T, 1980, NEUROLOGY, V30, P509, DOI 10.1212/WNL.30.5.509
   Strub R.L., 2000, MENTAL STATUS EXAMIN
NR 23
TC 6
Z9 6
U1 0
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 0953-4180
EI 1875-8584
J9 BEHAV NEUROL
JI Behav. Neurol.
PY 2013
VL 27
IS 3
BP 287
EP 291
DI 10.1155/2013/745104
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA 217DM
UT WOS:000324336900007
PM 23619082
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Coutinho, G
   de Oliveira-Souza, R
   Moll, J
   Tovar-Moll, F
   Mattos, P
AF Coutinho, Gabriel
   de Oliveira-Souza, Ricardo
   Moll, Jorge
   Tovar-Moll, Fernanda
   Mattos, Paulo
TI Is it possible to identify individuals with mild cognitive impairment
   and Alzheimer's disease using a 30-minute neuropsychological battery?
SO REVISTA DE PSIQUIATRIA CLINICA
LA English
DT Article
DE Alzheimer's disease; cognitive assessment; dementia; memory; mild
   cognitive impairment
ID MENTAL-STATE-EXAMINATION; OLDER-ADULTS; DEMENTIA; METAANALYSIS;
   PERFORMANCE; PROGRESSION; DIAGNOSIS; MEMORY; TESTS
AB Background: Distinguishing individuals with dementia from those with mild cognitive impairment (MCI) might demand a neuropsychological evaluation. Methods: One hundred and thirty-one consecutive referred elderly patients (37 clinical-controls, 41 with amnestic MCI and 53 with possible/probable AD) were diagnosed with a comprehensive (full) neuropsychological battery, MRI and clinical data. All of the results were blindly coded and evaluated latter with a subset of the tests to reclassify the subjects as MCI, dementia or clinical-control. Agreement rates between both batteries were calculated. We also used ROC curves to establish the sensitivity and specificity of the brief battery for discriminating (i) clinical-control individuals from a group dementia and MCI patients; (ii) individuals with dementia from individuals without dementia; (iii) clinical-control individuals from a group of MCI. We compared performance of the three groups on all full battery tasks. Results: All neuropsychological tests showed differences between clinical-control and dementia groups. The comparison between MCI and the other groups mainly showed memory differences. Agreement between brief and full batteries was substantial (kappa = 0.805). Analyses with ROC curves showed good sensitivity and specificity to discriminate non-demented (clinical control plus MCI groups) and AD group and also to discriminate clinical-control individuals from individuals with cognitive decline (MCI plus AD group). However, sensitivity and specificity significantly decreased when brief battery was tested to discriminate only normal and MCI diagnosis. Discussion: The use of a brief battery might not be indicated to discriminate MCI and clinical-control individuals, but its use might be adequate to discriminate less specific groups (demented versus non-demented and pathological [dementia and MCI] and non-pathological [clinical-control] groups).
C1 [Coutinho, Gabriel; de Oliveira-Souza, Ricardo; Moll, Jorge; Tovar-Moll, Fernanda; Mattos, Paulo] DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.
   [Coutinho, Gabriel; Tovar-Moll, Fernanda; Mattos, Paulo] Fed Univ Rio de Janeiro UFRJ, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil.
   [de Oliveira-Souza, Ricardo] Fed Univ State Rio de Janeiro UNI Rio, Rio De Janeiro, RJ, Brazil.
RP Coutinho, G (corresponding author), Rua Diniz Cordeiro 30,2 Andar, BR-22251040 Rio De Janeiro, RJ, Brazil.
EM gabrielccoutinho@gmail.com
RI Moll, Fernanda Tovar/N-3320-2018; de Mattos, Paulo Eduardo
   Luiz/D-2328-2014
OI Moll, Fernanda Tovar/0000-0002-0292-5985; de Mattos, Paulo Eduardo
   Luiz/0000-0003-0709-3783
CR Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2
   Crook T H 3rd, 1992, Int Psychogeriatr, V4, P165, DOI 10.1017/S1041610292000991
   de Paula JJ, 2012, REV PSIQ CLIN-BRAZIL, V39, P19
   de Paula JJ, 2010, REV PSIQ CLIN-BRAZIL, V37, P246
   Diniz BSO, 2007, INT PSYCHOGERIATR, V19, P647, DOI 10.1017/S104161020700542X
   Diniz BS, 2009, EUR ARCH PSY CLIN N, V259, P248, DOI 10.1007/s00406-008-0864-1
   Diniz BS, 2008, REV BRAS PSIQUIATR, V30, P316, DOI 10.1590/S1516-44462008000400003
   de Abreu I, 2008, REV BRAS PSIQUIATR, V30, P346, DOI 10.1590/S1516-44462008000400008
   Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6
   Huntley JD, 2010, INT J GERIATR PSYCH, V25, P121, DOI 10.1002/gps.2314
   Jalbert JJ, 2008, EPIDEMIOL REV, V30, P15, DOI 10.1093/epirev/mxn008
   Ladeira RB, 2009, CLINICS, V64, P967, DOI 10.1590/S1807-59322009001000006
   Lonie JA, 2009, INT J GERIATR PSYCH, V24, P902, DOI 10.1002/gps.2208
   Lourenco RA, 2008, REV BRAS PSIQUIATR, V30, P309, DOI 10.1590/S1516-44462008000400002
   Malloy-Diniz LF, 2007, REV BRAS PSIQUIATR, V29, P324, DOI 10.1590/S1516-44462006005000053
   MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
   Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x
   Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014
   Nitrini R, 2009, INT PSYCHOGERIATR, V21, P622, DOI 10.1017/S1041610209009430
   Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538
   Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303
   PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x
   Yassuda MS, 2009, ARCH CLIN NEUROPSYCH, V24, P71, DOI 10.1093/arclin/acp009
   YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4
   Zidan M, 2012, REV PSIQ CLIN-BRAZIL, V39, P161
NR 27
TC 2
Z9 2
U1 0
U2 6
PU UNIV SAO PAULO, INST PSIQUIATRIA
PI SAO PAULO
PA RUA OVIDIO PIRES CAMPOS, 785, 1 ANDAR, SAO PAULO, 05403-010, BRAZIL
SN 0101-6083
J9 REV PSIQ CLIN-BRAZIL
JI Rev. Psiquiatr. Clin.
PY 2013
VL 40
IS 4
BP 139
EP 143
DI 10.1590/S0101-60832013000400003
PG 5
WC Psychiatry
SC Psychiatry
GA 220PN
UT WOS:000324597500003
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Kahn, SA
   Biasoli, D
   Garcia, C
   Geraldo, LHM
   Pontes, B
   Sobrinho, M
   Frauches, ACB
   Romao, L
   Soletti, RC
   Assuncao, FD
   Tovar-Moll, F
   de Souza, JM
   Lima, FRS
   Anderluh, G
   Moura-Neto, V
AF Kahn, Suzana Assad
   Biasoli, Deborah
   Garcia, Celina
   Geraldo, Luiz Henrique M.
   Pontes, Bruno
   Sobrinho, Morgana
   Bon Frauches, Ana Carina
   Romao, Luciana
   Soletti, Rossana C.
   Assuncao, Fernando dos Santos
   Tovar-Moll, Fernanda
   de Souza, Jorge Marcondes
   Lima, Flavia R. S.
   Anderluh, Gregor
   Moura-Neto, Vivaldo
TI Equinatoxin II Potentiates Temozolomide- and Etoposide-Induced
   Glioblastoma Cell Death
SO CURRENT TOPICS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE glioblastoma; equinatoxin II; temozolomide; etoposide
ID STEM-CELLS; CHEMOTHERAPY; MECHANISMS; THERAPY; CANCER; CYTOTOXICITY;
   BEVACIZUMAB; EXPRESSION; APOPTOSIS; NEURONS
AB Glioblastoma (GBM) is considered incurable due to its resistance to current cancer treatments. So far, all clinically available alternatives for treating GBM are limited, evoking the development of novel treatment strategies that can more effectively manage these tumors. Extensive effort is being dedicated to characterize the molecular basis of GBM resistance to chemotherapy and to explore novel therapeutic procedures that may improve overall survival. Cytolysins are toxins that form pores in target cell membranes, modifying ion homeostasis and leading to cell death. These pore-forming toxins might be used, therefore, to enhance the efficiency of conventional chemotherapeutic drugs, facilitating their entrance into the cell. In this study, we show that a non-cytotoxic concentration of equinatoxin II (EqTx-II), a pore-forming toxin from the sea anemone Actinia equina, potentiates the cytotoxicity induced by temozolomide (TMZ), a first-line GBM treatment, and by etoposide (VP-16), a second- or third-line GBM treatment. We also suggest that this effect is selective to GBM cells and occurs via PI3K/Akt pathway inhibition. Finally, Magnetic resonance imaging (MRI) revealed that a non-cytotoxic concentration of EqTx-II potentiates the VP-16-induced inhibition of GBM growth in vivo. These combined therapies constitute a new and potentially valuable tool for GBM treatment, leading to the requirement of lower concentrations of chemotherapeutic drugs and possibly reducing, therefore, the adverse effects of chemotherapy.
C1 [Kahn, Suzana Assad; Biasoli, Deborah; Garcia, Celina; Geraldo, Luiz Henrique M.; Pontes, Bruno; Sobrinho, Morgana; Bon Frauches, Ana Carina; Soletti, Rossana C.; Assuncao, Fernando dos Santos; Tovar-Moll, Fernanda; Lima, Flavia R. S.; Moura-Neto, Vivaldo] Univ Fed Rio de Janeiro, CCS, Inst Ciencias Biomed, BR-21949590 Rio De Janeiro, Brazil.
   [Romao, Luciana] Univ Fed Rio de Janeiro Macae, BR-27930560 Macae, Brazil.
   [Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [de Souza, Jorge Marcondes] Hosp Univ Clementino Fraga Filho, Fac Med, Dept Neurocirurgia, Rio De Janeiro, RJ, Brazil.
   [Anderluh, Gregor] Natl Inst Chem, Lab Mol Biol & Nanobiotechnol, Ljubljana 1000, Slovenia.
   [Anderluh, Gregor] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana 1000, Slovenia.
RP Moura-Neto, V (corresponding author), Univ Fed Rio de Janeiro, CCS, Inst Ciencias Biomed, Bloco F, BR-21949590 Rio De Janeiro, Brazil.
EM vivaldo@icb.ufrj.br
RI Pontes, Bruno/L-5121-2015; Anderluh, Gregor/C-6905-2014; Romao,
   Luciana/I-4291-2015; Moll, Fernanda Tovar/N-3320-2018
OI Anderluh, Gregor/0000-0002-9916-8465; Moll, Fernanda
   Tovar/0000-0002-0292-5985; Souza Lima, Flavia
   Regina/0000-0003-0799-9235; Geraldo, Luiz Henrique/0000-0003-3318-4697;
   Bon Frauches Oliveira, Ana Carina/0000-0001-7325-6021; Moura-Neto,
   Vivaldo/0000-0002-6266-043X
FU National Institute for Translational Neuroscience (INNT) from Ministry
   of Science and Technology; Brazilian Federal Agency for the Support and
   Evaluation of Graduate Education (CAPES) from the Ministry of Education;
   National Council for Technological and Scientific Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Rio de Janeiro State Research Foundation (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Ary Frauzino Foundation to Cancer Research; PhD program on
   Morphological Sciences (PCM) from the Federal University of Rio de
   Janeiro (UFRJ)
FX This work was supported by National Institute for Translational
   Neuroscience (INNT) from Ministry of Science and Technology; Brazilian
   Federal Agency for the Support and Evaluation of Graduate Education
   (CAPES) from the Ministry of Education; National Council for
   Technological and Scientific Development (CNPq); Rio de Janeiro State
   Research Foundation (FAPERJ); Ary Frauzino Foundation to Cancer Research
   and PhD program on Morphological Sciences (PCM) from the Federal
   University of Rio de Janeiro (UFRJ). MRIs were acquired at the
   Bioimaging National Center (CENABIO), National Institute for Structural
   Biology and Bioimaging (INBEB), UFRJ.
CR Ahles TA, 2007, NAT REV CANCER, V7, P192, DOI 10.1038/nrc2073
   Altaner C, 2008, NEOPLASMA, V55, P369
   Anderluh G, 1996, BIOCHEM BIOPH RES CO, V220, P437, DOI 10.1006/bbrc.1996.0391
   Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X
   Aoki T, 2007, EXPERT OPIN PHARMACO, V8, P3133, DOI 10.1517/14656566.8.18.3133
   Bakrac B, 2010, J BIOL CHEM, V285, P22186, DOI 10.1074/jbc.M110.105122
   Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236
   BERNSTEIN CN, 1994, GLIA, V12, P108, DOI 10.1002/glia.440120204
   Darmani NA, 2010, PHARMACEUTICALS, V3, P2930, DOI 10.3390/ph3092930
   Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905
   De Raedt T, 2011, CANCER CELL, V20, P400, DOI 10.1016/j.ccr.2011.08.014
   Desjardins A, 2012, CANCER-AM CANCER SOC, V118, P1302, DOI 10.1002/cncr.26381
   Einhorn LH, 2006, SUPPORT CARE CANCER, V14, P1262, DOI 10.1007/s00520-006-0106-x
   Faria J, 2006, DIFFERENTIATION, V74, P562, DOI 10.1111/j.1432-0436.2006.00090.x
   GABELLA G, 1981, NEUROSCIENCE, V6, P425, DOI 10.1016/0306-4522(81)90135-4
   Garcia-Saez AJ, 2011, J BIOL CHEM, V286, P37768, DOI 10.1074/jbc.M111.281592
   GARDNER RS, 1974, ANAL BIOCHEM, V59, P272, DOI 10.1016/0003-2697(74)90033-5
   He H, 2010, J PROTEOME RES, V9, P2098, DOI 10.1021/pr900793a
   Hirose Y, 2001, CANCER RES, V61, P1957
   Jordan K, 2007, CRIT REV ONCOL HEMAT, V61, P162, DOI 10.1016/j.critrevonc.2006.08.003
   Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055
   Kreuzaler P., 2012, NATURE REV CANC
   Lima FRS, 2012, BBA-REV CANCER, V1826, P338, DOI 10.1016/j.bbcan.2012.05.004
   Lima FRS, 2001, J NEUROSCI, V21, P2028, DOI 10.1523/JNEUROSCI.21-06-02028.2001
   Lohr L, 2008, CANCER J, V14, P85, DOI 10.1097/PPO.0b013e31816a0f07
   Lorizate M, 2009, J BIOL CHEM, V284, P22238, DOI 10.1074/jbc.M109.029256
   Ma JG, 2001, CANCER RES, V61, P5491
   Marques-Gallego P, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-43
   Mustafa S, 2008, EUR J NEUROSCI, V28, P323, DOI 10.1111/j.1460-9568.2008.06325.x
   Nam C, 2006, NEUROTOXICOL TERATOL, V28, P664, DOI 10.1016/j.ntt.2006.09.021
   Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010
   Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66
   PLUMB JA, 1989, CANCER RES, V49, P4435
   Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853
   Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167
   Rolle K, 2010, CANCER BIOL THER, V9, P396
   Rooprai HK, 1999, INT J DEV NEUROSCI, V17, P613, DOI 10.1016/S0736-5748(99)00051-9
   Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785
   Rozzi A, 2011, SUPPORT CARE CANCER, V19, P697, DOI 10.1007/s00520-010-0893-y
   Sarkaria JN, 2008, CLIN CANCER RES, V14, P2900, DOI 10.1158/1078-0432.CCR-07-1719
   Sasselli V, 2012, DEV BIOL, V366, P64, DOI 10.1016/j.ydbio.2012.01.012
   Soletti RC, 2008, ANTI-CANCER DRUG, V19, P517, DOI 10.1097/CAD.0b013e3282faa704
   Soletti RC, 2010, ANTICANCER RES, V30, P1209
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202
   Watanabe K, 2002, ACTA NEUROCHIR, V144, P1265, DOI 10.1007/s00701-002-1023-5
   Xiao WH, 2008, PAIN, V135, P262, DOI 10.1016/j.pain.2007.06.001
   Xu JX, 2007, EXP CELL RES, V313, P1877, DOI 10.1016/j.yexcr.2007.03.006
NR 48
TC 15
Z9 15
U1 0
U2 15
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1568-0266
EI 1873-5294
J9 CURR TOP MED CHEM
JI Curr. Top. Med. Chem.
PD OCT
PY 2012
VL 12
IS 19
BP 2082
EP 2093
PG 12
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 074AH
UT WOS:000313783700006
PM 23167797
DA 2020-12-17
ER

PT J
AU Moll, J
   Bado, P
   de Oliveira-Souza, R
   Bramati, IE
   Lima, DO
   Paiva, FF
   Sato, JR
   Tovar-Moll, F
   Zahn, R
AF Moll, Jorge
   Bado, Patricia
   de Oliveira-Souza, Ricardo
   Bramati, Ivanei E.
   Lima, Debora O.
   Paiva, Fernando F.
   Sato, Joao R.
   Tovar-Moll, Fernanda
   Zahn, Roland
TI A Neural Signature of Affiliative Emotion in the Human Septohypothalamic
   Area
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
ID FMRI TIME-SERIES; PREFRONTAL CORTEX; ROMANTIC LOVE; BRAIN; ATTACHMENT;
   STIMULATION; OXYTOCIN; SYSTEMS; REWARD; DAMAGE
AB Comparative studies have established that a number of structures within the rostromedial basal forebrain are critical for affiliative behaviors and social attachment. Lesion and neuroimaging studies concur with the importance of these regions for attachment and the experience of affiliation in humans as well. Yet it remains obscure whether the neural bases of affiliative experiences can be differentiated from the emotional valence with which they are inextricably associated at the experiential level. Here we show, using functional MRI, that kinship-related social scenarios evocative of affiliative emotion induce septal-preoptic-anterior hypothalamic activity that cannot be explained by positive or negative emotional valence alone. Our findings suggest that a phylogenetically conserved ensemble of basal forebrain structures, especially the septohypothalamic area, may play a key role in enabling human affiliative emotion. Our finding of a neural signature of human affiliative experience bears direct implications for the neurobiological mechanisms underpinning impaired affiliative experiences and behaviors in neuropsychiatric conditions.
C1 [Moll, Jorge; Bado, Patricia; de Oliveira-Souza, Ricardo; Bramati, Ivanei E.; Lima, Debora O.; Paiva, Fernando F.; Sato, Joao R.; Tovar-Moll, Fernanda; Zahn, Roland] DOr Inst Res & Educ IDOR, Cognit & Behav Neurosci Unit, BR-22281100 Rio De Janeiro, Brazil.
   [de Oliveira-Souza, Ricardo] Fed Univ State Rio de Janeiro, Gaffreee Guinle Univ Hosp, BR-20520054 Rio De Janeiro, Brazil.
   [Sato, Joao R.] Univ Fed ABC, Ctr Math Computat & Cognit, BR-09020040 Santo Andre, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, Brazil.
   [Zahn, Roland] Univ Manchester, Manchester M13 9PL, Lancs, England.
   [Zahn, Roland] Manchester Acad Hlth Sci Ctr, Sch Psychol Sci, Manchester M13 9PL, Lancs, England.
RP Moll, J (corresponding author), IDOR, Cognit & Behav Neurosci Unit, Rua Diniz Cordeiro 30,3 Andar, BR-22281100 Rio De Janeiro, Brazil.
EM jorge.moll@idor.org
RI Moll, Fernanda Tovar/N-3320-2018; Zahn, Roland/O-8944-2019;
   Neurociencia, Inct/I-1011-2013; Zahn, Roland/C-4665-2008; Moll,
   Jorge/B-2654-2013; Paiva, Fernando F/C-1429-2012
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Zahn,
   Roland/0000-0002-8447-1453; Zahn, Roland/0000-0002-8447-1453; Paiva,
   Fernando F/0000-0002-8989-9707
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Pronex and
   Instituto Nacional de Neurociencia Translacional grants); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq); IDOR, Brazil; Stepping Stones; MRC
   clinician scientist awardMedical Research Council UK (MRC) [G0902304];
   Medical Research CouncilMedical Research Council UK (MRC) [G0902304]
   Funding Source: researchfish
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro (Pronex and Instituto Nacional de Neurociencia
   Translacional grants), Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior, Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico, and by intramural grants from IDOR, Brazil. R.Z. was
   supported by Stepping Stones and an MRC clinician scientist award
   (G0902304). We thank Aniela Improta Franca for her help in developing
   and balancing the written stimuli according to psycholinguistic
   variables.
CR ANDY OJ, 1968, J COMP NEUROL, V133, P383, DOI 10.1002/cne.901330308
   Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004
   Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003
   Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9
   BISHOP MP, 1963, SCIENCE, V140, P394, DOI 10.1126/science.140.3565.394
   Bodurka J, 2007, NEUROIMAGE, V34, P542, DOI 10.1016/j.neuroimage.2006.09.039
   Decety J, 2011, ANN NY ACAD SCI, V1231, P35, DOI 10.1111/j.1749-6632.2011.06027.x
   Depue RA, 2005, BEHAV BRAIN SCI, V28, P313
   Eisthen HL, 2002, BRAIN BEHAV EVOLUT, V59, P273, DOI 10.1159/000063564
   Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007
   FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018
   Gillath O, 2005, NEUROIMAGE, V28, P835, DOI 10.1016/j.neuroimage.2005.06.048
   Goodson JL, 2006, P NATL ACAD SCI USA, V103, P17013, DOI 10.1073/pnas.0606278103
   GORMAN DG, 1992, ARCH NEUROL-CHICAGO, V49, P308, DOI 10.1001/archneur.1992.00530270128029
   Hsu M, 2008, SCIENCE, V320, P1092, DOI 10.1126/science.1153651
   Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148
   Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579
   IRVIN RW, 1990, PHYSIOL BEHAV, V48, P693, DOI 10.1016/0031-9384(90)90213-N
   Koscik TR, 2011, NEUROPSYCHOLOGIA, V49, P602, DOI 10.1016/j.neuropsychologia.2010.09.023
   Krajbich I, 2009, J NEUROSCI, V29, P2188, DOI 10.1523/JNEUROSCI.5086-08.2009
   Krueger F, 2007, P NATL ACAD SCI USA, V104, P20084, DOI 10.1073/pnas.0710103104
   Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012
   Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042
   Mai J. K., 2004, ATLAS HUMAN BRAIN
   Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014
   Moll J, 2007, SOC NEUROSCI-UK, V2, P336, DOI 10.1080/17470910701392024
   Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103
   Moll J, 2011, NEUROIMAGE, V54, P1735, DOI 10.1016/j.neuroimage.2010.08.026
   Morrone-Strupinsky JV, 2007, PERS INDIV DIFFER, V42, P1267, DOI 10.1016/j.paid.2006.10.005
   NAUTA W J H, 1969, P136
   Nelson EE, 1998, NEUROSCI BIOBEHAV R, V22, P437, DOI 10.1016/S0149-7634(97)00052-3
   Rempel-Clower NL, 1998, J COMP NEUROL, V398, P393, DOI 10.1002/(SICI)1096-9861(19980831)398:3<393::AID-CNE7>3.0.CO;2-V
   Stack EC, 2002, BEHAV BRAIN RES, V131, P17, DOI 10.1016/S0166-4328(01)00370-9
   Strathearn L, 2009, NEUROPSYCHOPHARMACOL, V34, P2655, DOI 10.1038/npp.2009.103
   WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023
   Zahn R, 2009, NEUROSCI LETT, V457, P107, DOI 10.1016/j.neulet.2009.03.090
   Zahn R, 2009, CEREB CORTEX, V19, P276, DOI 10.1093/cercor/bhn080
NR 37
TC 32
Z9 32
U1 0
U2 20
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD SEP 5
PY 2012
VL 32
IS 36
BP 12499
EP 12505
DI 10.1523/JNEUROSCI.6508-11.2012
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA 004JG
UT WOS:000308677300020
PM 22956840
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Finger, EC
   Marsh, A
   Blair, KS
   Majestic, C
   Evangelou, I
   Gupta, K
   Schneider, MR
   Sims, C
   Pope, K
   Fowler, K
   Sinclair, S
   Tovar-Moll, F
   Pine, D
   Blair, RJ
AF Finger, Elizabeth Carrie
   Marsh, Abigail
   Blair, Karina Simone
   Majestic, Catherine
   Evangelou, Iordanis
   Gupta, Karan
   Schneider, Marguerite Reid
   Sims, Courtney
   Pope, Kayla
   Fowler, Katherine
   Sinclair, Stephen
   Tovar-Moll, Fernanda
   Pine, Daniel
   Blair, Robert James
TI Impaired functional but preserved structural connectivity in limbic
   white matter tracts in youth with conduct disorder or oppositional
   defiant disorder plus psychopathic traits
SO PSYCHIATRY RESEARCH-NEUROIMAGING
LA English
DT Article
DE Psychopathic traits; Conduct disorder; Oppositional defiant disorder;
   Diffusion tensor imaging; Functional connectivity
ID CALLOUS-UNEMOTIONAL TRAITS; VENTROMEDIAL PREFRONTAL CORTEX; FEARFUL
   EXPRESSIONS; VOXELWISE ANALYSIS; CHILDREN; DIFFUSION; AMYGDALA; BOYS;
   ADOLESCENCE; DIMENSIONS
AB Youths with conduct disorder or oppositional defiant disorder and psychopathic traits (CD/ODD + PT) are at high risk of adult antisocial behavior and psychopathy. Neuroimaging studies demonstrate functional abnormalities in orbitofrontal cortex and the amygdala in both youths and adults with psychopathic traits. Diffusion tensor imaging in psychopathic adults demonstrates disrupted structural connectivity between these regions (uncinate fasiculus). The current study examined whether functional neural abnormalities present in youths with CD/ODD + PT are associated with similar white matter abnormalities. Youths with CD/ODD + PT and comparison participants completed 3.0 T diffusion tensor scans and functional magnetic resonance imaging scans. Diffusion tensor imaging did not reveal disruption in structural connections within the uncinate fasiculus or other white matter tracts in youths with CD/ODD + PT, despite the demonstration of disrupted amygdala-prefrontal functional connectivity in these youths. These results suggest that disrupted amygdala-frontal white matter connectivity as measured by fractional anisotropy is less sensitive than imaging measurements of functional perturbations in youths with psychopathic traits. If white matter tracts are intact in youths with this disorder, childhood may provide a critical window for intervention and treatment, before significant structural brain abnormalities solidify. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
C1 [Finger, Elizabeth Carrie; Gupta, Karan] Univ Western Ontario, Dept Clin Neurol Sci, Schulich Sch Med, London, ON N6A 5A5, Canada.
   [Marsh, Abigail] Georgetown Univ, Dept Psychol, Washington, DC 20057 USA.
   [Blair, Karina Simone; Majestic, Catherine; Schneider, Marguerite Reid; Sims, Courtney; Pope, Kayla; Fowler, Katherine; Sinclair, Stephen; Pine, Daniel; Blair, Robert James] NIMH, Mood & Anxiety Program, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.
   [Evangelou, Iordanis] Natl Inst Neurol Disorders & Stroke, Neuroimmunol Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD USA.
   [Tovar-Moll, Fernanda] LABS DOr Hosp Network, Cognit & Behav Neurosci Unit, Rio De Janeiro, Brazil.
RP Finger, EC (corresponding author), Univ Western Ontario, Dept Clin Neurol Sci, Schulich Sch Med, B10-004,339 Windermere Rd, London, ON N6A 5A5, Canada.
EM Elizabeth.Finger@lhsc.on.ca
RI Moll, Fernanda Tovar/N-3320-2018; Pine, Daniel/Z-1601-2019;
   Neurociencia, Inct/I-1011-2013; Finger, Elizabeth/B-6453-2015
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Finger,
   Elizabeth/0000-0003-4461-7427
FU Intramural Research Program of the National Institute of Mental
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH); NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Mental Health (NIMH) [ZIAMH002860, ZIAMH002860,
   ZIAMH002860, ZIAMH002860, ZIAMH002860, ZIAMH002860, ZIAMH002860,
   ZIAMH002860] Funding Source: NIH RePORTER
FX This research was funded through the Intramural Research Program of the
   National Institute of Mental Health.
CR Andersson J. L. R., 2007, TR07JA1 FMRIB
   Andersson JL, 2007, TR07JA2 FMRIB
   Blair RJR, 2007, TRENDS COGN SCI, V11, P387, DOI 10.1016/j.tics.2007.07.003
   Blair RJR, 2001, J ABNORM CHILD PSYCH, V29, P491, DOI 10.1023/A:1012225108281
   Budhani S, 2005, J CHILD PSYCHOL PSYC, V46, P972, DOI 10.1111/j.1469-7610.2004.00398.x
   Burgund ED, 2002, NEUROIMAGE, V17, P184, DOI 10.1006/nimg.2002.1174
   Burke JD, 2007, J CLIN CHILD ADOLESC, V36, P334, DOI 10.1080/15374410701444223
   Craig MC, 2009, MOL PSYCHIATR, V14, P946, DOI 10.1038/mp.2009.40
   Dadds MR, 2005, J CONSULT CLIN PSYCH, V73, P400, DOI 10.1037/0022-006X.73.3.400
   De Brito SA, 2009, BRAIN, V132, P843, DOI 10.1093/brain/awp011
   Edens JF, 2001, BEHAV SCI LAW, V19, P53, DOI 10.1002/bsl.425
   Finger EC, 2008, ARCH GEN PSYCHIAT, V65, P586, DOI 10.1001/archpsyc.65.5.586
   Finger EC, 2011, AM J PSYCHIAT, V168, P152, DOI 10.1176/appi.ajp.2010.10010129
   FORTH A, 2004, HARE PSYCHOPATHY CHE
   Forth A. E., 2003, HARE PSYCHOPATHY CHE
   Frick P. J., 2001, ANTISOCIAL PROCESS S
   Frick PJ, 2000, PSYCHOL ASSESSMENT, V12, P382, DOI 10.1037//1040-3590.12.4.382
   Frick PJ, 2003, J ABNORM CHILD PSYCH, V31, P457, DOI 10.1023/A:1023899703866
   Frick PJ, 2005, J ABNORM CHILD PSYCH, V33, P471, DOI 10.1007/s10648-005-5728-9
   Frick PJ, 1999, J ABNORM CHILD PSYCH, V27, P383, DOI 10.1023/A:1021928018403
   Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004
   Jones AP, 2009, AM J PSYCHIAT, V166, P95, DOI 10.1176/appi.ajp.2008.07071050
   Kang HC, 2003, NEUROIMAGE, V19, P16, DOI 10.1016/S1053-8119(03)00038-7
   Kolko DJ, 2010, J ABNORM PSYCHOL, V119, P713, DOI 10.1037/a0020910
   Kosson DS, 2006, NEUROIMAGE, V29, P1161, DOI 10.1016/j.neuroimage.2005.07.060
   Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8
   LYKKEN DT, 1957, J ABNORM SOC PSYCH, V55, P6, DOI 10.1037/h0047232
   Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1
   Marsh AA, 2008, AM J PSYCHIAT, V165, P712, DOI 10.1176/appi.ajp.2007.07071145
   McMahon RJ, 2010, J ABNORM PSYCHOL, V119, P752, DOI 10.1037/a0020796
   Morriss MC, 1999, NEURORADIOLOGY, V41, P929, DOI 10.1007/s002340050869
   Mukherjee P, 2001, RADIOLOGY, V221, P349, DOI 10.1148/radiol.2212001702
   Murrie DC, 2002, PSYCHOL ASSESSMENT, V14, P390, DOI 10.1037//1040-3590.14.4.390
   NEWMAN JP, 1986, J ABNORM PSYCHOL, V95, P252, DOI 10.1037/0021-843X.95.3.252
   Pardini DA, 2010, J AM ACAD CHILD PSY, V49, P1134, DOI 10.1016/j.jaac.2010.07.010
   Passamonti L, 2010, ARCH GEN PSYCHIAT, V67, P729, DOI 10.1001/archgenpsychiatry.2010.75
   Rane S, 2010, NMR BIOMED, V23, P459, DOI 10.1002/nbm.1482
   Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719
   Rubia K, 2009, AM J PSYCHIAT, V166, P83, DOI 10.1176/appi.ajp.2008.08020212
   Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284
   Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149
   Schmithorst VJ, 2002, RADIOLOGY, V222, P212, DOI 10.1148/radiol.2221010626
   Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018
   Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051
   Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45
   Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024
   Talairach J. T., 1988, COPLANAR STEREOTAXIC
   Thottakara P, 2006, NEUROIMAGE, V29, P868, DOI 10.1016/j.neuroimage.2005.08.051
   Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978
   Viding E, 2005, J CHILD PSYCHOL PSYC, V46, P592, DOI 10.1111/j.1469-7610.2004.00393.x
   Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027
NR 51
TC 60
Z9 64
U1 0
U2 33
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0925-4927
EI 1872-7506
J9 PSYCHIAT RES-NEUROIM
JI Psychiatry Res. Neuroimaging
PD JUN 30
PY 2012
VL 202
IS 3
BP 239
EP 244
DI 10.1016/j.pscychresns.2011.11.002
PG 6
WC Clinical Neurology; Neuroimaging; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 007NT
UT WOS:000308896100007
PM 22819939
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Simoes, EL
   Bramati, I
   Rodrigues, E
   Franzoi, A
   Moll, J
   Lent, R
   Tovar-Moll, F
AF Simoes, Elington L.
   Bramati, Ivanei
   Rodrigues, Erika
   Franzoi, Ana
   Moll, Jorge
   Lent, Roberto
   Tovar-Moll, Fernanda
TI Functional Expansion of Sensorimotor Representation and Structural
   Reorganization of Callosal Connections in Lower Limb Amputees
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
ID UPPER-EXTREMITY AMPUTEES; PRIMARY MOTOR CORTEX; FMRI TIME-SERIES;
   MASSIVE CORTICAL REORGANIZATION; SOMATOSENSORY CORTEX; ADULT MONKEYS;
   PHANTOM LIMBS; DYNAMIC ORGANIZATION; PUTATIVE MECHANISMS;
   CORPUS-CALLOSUM
AB Previous studies have indicated that amputation or deafferentation of a limb induces functional changes in sensory (S1) and motor (M1) cortices, related to phantom limb pain. However, the extent of cortical reorganization after lower limb amputation in patients with nonpainful phantom phenomena remains uncertain. In this study, we combined functional magnetic resonance (fMRI) and diffusion tensor imaging (DTI) to investigate the existence and extent of cortical and callosal plasticity in these subjects. Nine "painless" patients with lower limb amputation and nine control subjects (sex- and age-matched) underwent a 3-T MRI protocol, including fMRI with somatosensory stimulation. In amputees, we observed an expansion of activation maps of the stump in S1 and M1 of the deafferented hemisphere, spreading to neighboring regions that represent the trunk and upper limbs. We also observed that tactile stimulation of the intact foot in amputees induced a greater activation of ipsilateral S1, when compared with controls. These results demonstrate a functional remapping of S1 in lower limb amputees. However, in contrast to previous studies, these neuroplastic changes do not appear to be dependent on phantom pain but do also occur in those who reported only the presence of phantom sensation without pain. In addition, our findings indicate that amputation of a limb also induces changes in the cortical representation of the intact limb. Finally, DTI analysis showed structural changes in the corpus callosum of amputees, compatible with the hypothesis that phantom sensations may depend on inhibitory release in the sensorimotor cortex.
C1 [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Ctr Ciencias Saude, BR-21941920 Rio De Janeiro, Brazil.
   [Bramati, Ivanei; Rodrigues, Erika; Moll, Jorge; Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, BR-22281100 Rio De Janeiro, Brazil.
   [Rodrigues, Erika] Augusto Motta Univ Ctr UNISUAM, BR-21041010 Rio De Janeiro, Brazil.
   [Franzoi, Ana] Brazilian Assoc Rehabil, BR-22461000 Rio De Janeiro, Brazil.
   [Moll, Jorge; Lent, Roberto; Tovar-Moll, Fernanda] Natl Inst Translat Neurosci, BR-22941920 Rio De Janeiro, Brazil.
RP Tovar-Moll, F (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Ctr Ciencias Saude, Bl F, BR-21941920 Rio De Janeiro, Brazil.
EM fernanda.tovarmoll@idor.org
RI Moll, Jorge/B-2654-2013; Neurociencia, Inct/I-1011-2013; de Carvalho
   Rodrigues, Erika/AAE-9445-2020; Moll, Fernanda Tovar/N-3320-2018;
   Rodrigues, Erika/R-6007-2017
OI de Carvalho Rodrigues, Erika/0000-0001-5464-2963; Moll, Fernanda
   Tovar/0000-0002-0292-5985; Rodrigues, Erika/0000-0001-5464-2963
FU Ministry of Science and Technology (Instituto Nacional de Neurociencia
   Translacional), Brazilian Council for the Development of Science and
   Technology; Foundation for Research Support in the State of Rio de
   Janeiro
FX This work was funded by grants to R. L. from the Ministry of Science and
   Technology (Instituto Nacional de Neurociencia Translacional), Brazilian
   Council for the Development of Science and Technology, and the
   Foundation for Research Support in the State of Rio de Janeiro.
CR ARCADI JA, 1977, J UROLOGY, V118, P354, DOI 10.1016/S0022-5347(17)58015-5
   Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707
   Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022
   Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018
   Benner T, 2006, MAGN RESON MED, V56, P204, DOI 10.1002/mrm.20936
   Birbaumer N, 1997, J NEUROSCI, V17, P5503
   Bjorkman B, 2008, J PAIN, V9, P1018, DOI 10.1016/j.jpain.2008.06.003
   Borsook D, 1998, NEUROREPORT, V9, P1013, DOI 10.1097/00001756-199804200-00011
   Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149
   Carson RG, 2005, BRAIN RES REV, V49, P641, DOI 10.1016/j.brainresrev.2005.03.005
   Casale R, 2009, EUR J PHYS REHAB MED, V45, P559
   Chahine Lama, 2007, Middle East Journal of Anesthesiology, V19, P345
   Chen R, 1998, J NEUROSCI, V18, P3443
   Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8
   Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926
   COHEN LG, 1991, BRAIN, V114, P615, DOI 10.1093/brain/114.1.615
   Condes-Lara M, 2000, EUR J PAIN-LONDON, V4, P239, DOI 10.1053/eujp.2000.0176
   Curt A, 2011, SPINAL CORD, V49, P588, DOI 10.1038/sc.2010.143
   Darian-Smith C, 2000, NAT NEUROSCI, V3, P476, DOI 10.1038/74852
   Dettmers C, 2001, NEUROSCI LETT, V307, P109, DOI 10.1016/S0304-3940(01)01953-X
   Diers M, 2010, PAIN, V149, P296, DOI 10.1016/j.pain.2010.02.020
   Doetsch GS, 1997, SOMATOSENS MOT RES, V14, P6, DOI 10.1080/08990229771178
   DONOGHUE JP, 1990, EXP BRAIN RES, V79, P492
   DORPAT TL, 1971, COMPR PSYCHIAT, V12, P27, DOI 10.1016/0010-440X(71)90053-8
   Elbert T, 2004, NEUROSCIENTIST, V10, P129, DOI 10.1177/1073858403262111
   Flor H, 2000, NEUROREPORT, V11, P1407, DOI 10.1097/00001756-200005150-00011
   Flor H, 2003, J REHABIL MED, V35, P66, DOI 10.1080/16501960310010179
   Flor H, 2002, LANCET NEUROL, V1, P182, DOI 10.1016/S1474-4422(02)00074-1
   Flor H, 1998, EXP BRAIN RES, V119, P205, DOI 10.1007/s002210050334
   FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0
   Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991
   Florence SL, 1995, J NEUROSCI, V15, P8083
   FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007
   GARRAGHTY PE, 1991, SOMATOSENS MOT RES, V8, P347, DOI 10.3109/08990229109144757
   Garraghty PE, 2006, J COMP NEUROL, V497, P636, DOI 10.1002/cne.21018
   Giraux P, 2001, NAT NEUROSCI, V4, P691, DOI 10.1038/89472
   Giummarra MJ, 2008, NEUROSCI BIOBEHAV R, V32, P143, DOI 10.1016/j.neubiorev.2007.07.001
   Giummarra MJ, 2007, BRAIN RES REV, V54, P219, DOI 10.1016/j.brainresrev.2007.01.009
   Grusser SM, 2004, EXP BRAIN RES, V154, P97, DOI 10.1007/s00221-003-1649-4
   Grusser SM, 2001, NEUROSCIENCE, V102, P263, DOI 10.1016/S0306-4522(00)00491-7
   Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510
   Hamzei F, 2001, NEUROREPORT, V12, P957, DOI 10.1097/00001756-200104170-00019
   Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044
   Irlbacher K, 2007, CLIN NEUROPHYSIOL, V118, P308, DOI 10.1016/j.clinph.2006.09.023
   Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004
   JULIANO SL, 1991, P NATL ACAD SCI USA, V88, P780, DOI 10.1073/pnas.88.3.780
   KAAS JH, 1983, PHYSIOL REV, V63, P206
   KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.ne.14.030191.001033
   Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001
   Knecht S, 1998, BRAIN, V121, P717, DOI 10.1093/brain/121.4.717
   Lotze M, 2001, BRAIN, V124, P2268, DOI 10.1093/brain/124.11.2268
   Lotze M, 1999, NAT NEUROSCI, V2, P501, DOI 10.1038/9145
   Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042
   Maclver K, 2008, BRAIN, V131, P2181, DOI 10.1093/brain/awn124
   Marbach J J, 1978, J Endod, V4, P362, DOI 10.1016/S0099-2399(78)80211-8
   Melzack R, 1999, PAIN, pS121
   MELZACK R, 1990, TRENDS NEUROSCI, V13, P88, DOI 10.1016/0166-2236(90)90179-E
   Mercier C, 2006, BRAIN, V129, P2202, DOI 10.1093/brain/awl180
   Merzenich M M, 1993, J Hand Ther, V6, P89
   MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408
   Montoya P, 1998, EUR J NEUROSCI, V10, P1095, DOI 10.1046/j.1460-9568.1998.00122.x
   Montoya P, 1997, PAIN, V72, P87, DOI 10.1016/S0304-3959(97)00004-3
   Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058
   NICOLELIS MAL, 1993, NATURE, V361, P533, DOI 10.1038/361533a0
   OVESEN P, 1991, PAIN, V44, P289, DOI 10.1016/0304-3959(91)90099-J
   Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.3.CO;2-A
   PascualLeone A, 1996, NEUROREPORT, V7, P2068, DOI 10.1097/00001756-199609020-00002
   Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612
   PONS TP, 1988, P NATL ACAD SCI USA, V85, P5279, DOI 10.1073/pnas.85.14.5279
   PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843
   Puhse G, 2010, INT J ANDROL, V33, pE216, DOI 10.1111/j.1365-2605.2009.00994.x
   Qi HX, 2011, J NEUROSCI, V31, P13662, DOI 10.1523/JNEUROSCI.2366-11.2011
   RAMACHANDRAN VS, 1992, SCIENCE, V258, P1159, DOI 10.1126/science.1439826
   RAMACHANDRAN VS, 1993, P NATL ACAD SCI USA, V90, P10413, DOI 10.1073/pnas.90.22.10413
   Ramachandran VS, 2000, ARCH NEUROL-CHICAGO, V57, P317, DOI 10.1001/archneur.57.3.317
   Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603
   Reilly KT, 2008, NEUROSCIENTIST, V14, P195, DOI 10.1177/1073858407309466
   Roricht S, 1999, NEUROLOGY, V53, P106, DOI 10.1212/WNL.53.1.106
   Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284
   SANES JN, 1990, EXP BRAIN RES, V79, P479
   Schwenkreis P, 2003, NEUROSCI LETT, V349, P187, DOI 10.1016/S0304-3940(03)00838-3
   Schwenkreis P, 2001, CLIN NEUROPHYSIOL, V112, P627, DOI 10.1016/S1388-2457(01)00486-2
   Simonyan K, 2008, BRAIN, V131, P447, DOI 10.1093/brain/awm303
   Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062
   Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051
   Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024
   Soros P, 2003, NEUROLOGY, V60, P1542, DOI 10.1212/01.WNL.0000059547.68899.F5
   STAPS T, 1985, CANCER, V56, P2898, DOI 10.1002/1097-0142(19851215)56:12<2898::AID-CNCR2820561229>3.0.CO;2-J
   Tanaka H, 2008, NEUROLOGY, V70, P82, DOI 10.1212/01.wnl.0000265394.80360.b5
   Tovar-Moll F, 2009, AM J NEURORADIOL, V30, P1380, DOI 10.3174/ajnr.A1564
   Vargas CD, 2009, P NATL ACAD SCI USA, V106, P7197, DOI 10.1073/pnas.0809614106
   Wahl M, 2007, J NEUROSCI, V27, P12132, DOI 10.1523/JNEUROSCI.2320-07.2007
   Werhahn KJ, 2002, BRAIN, V125, P1402, DOI 10.1093/brain/awf140
   Werhahn KJ, 2002, NAT NEUROSCI, V5, P936, DOI 10.1038/nn917
   WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023
   Wu CWH, 2000, NEURON, V28, P967, DOI 10.1016/S0896-6273(00)00167-7
   Xerri C, 1999, CEREB CORTEX, V9, P264, DOI 10.1093/cercor/9.3.264
NR 97
TC 68
Z9 69
U1 1
U2 34
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD FEB 29
PY 2012
VL 32
IS 9
BP 3211
EP 3220
DI 10.1523/JNEUROSCI.4592-11.2012
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA 901CA
UT WOS:000300938100027
PM 22378892
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU de Oliveira-Souza, R
   Tovar-Moll, F
AF de Oliveira-Souza, Ricardo
   Tovar-Moll, Fernanda
TI The Unbearable Lightness of the Extrapyramidal System
SO JOURNAL OF THE HISTORY OF THE NEUROSCIENCES
LA English
DT Article
DE extrapyramidal system; basal ganglia; pyramidal syndrome; hemiplegia;
   Babinski sign; history of neurology; movement disorders
ID MOTOR; ANATOMY; ORGANIZATION; INFARCTION; PARALYSIS; MOVEMENTS;
   PATHWAYS; FIBERS; TRACTS; CORD
AB The concept of the extrapyramidal system comprises an amalgam of disparate and often conflicting ideas with a tortuous history. To the theoretical neuroscientist or practicing clinician, it promptly evokes semantic associations that are hardly reminiscent of its original meaning. The purpose of this article is to revisit the sources of the extrapyramidal concept and to examine the transformations that it went through from its inception, in the late 1890s, up to the neuroimaging revolution of the 1980s. Our review shows that the use of "extrapyramidal" as a surrogate for the basal ganglia, disorders of movement, or certain manifestations of spastic hemiplegia does not apply to humans; rather, it represents the historical product of the unwarranted translation of results of animal experimentation into the interpretation of clinical findings on human patients, misguided clinico-anatomic deductions, and fanciful phylogenetic notions. We conclude that the extrapyramidal concept is a valid and robust anatomic concept as long as it strictly refers to the collection of descending fibers originating in a few discrete brainstem tegmental motor nuclei that project to the spinal cord.
C1 [de Oliveira-Souza, Ricardo; Tovar-Moll, Fernanda] DOr Inst Res & Educ, Rio De Janeiro, Brazil.
   [de Oliveira-Souza, Ricardo] Fed Univ State Rio de Janeiro, Rio De Janeiro, Brazil.
RP de Oliveira-Souza, R (corresponding author), Rua Diniz Cordeiro,30-3 Andar, BR-22281100 Rio De Janeiro, Brazil.
EM rdeoliveira@gmail.com
RI Neurociencia, Inct/I-1011-2013; Moll, Fernanda Tovar/N-3320-2018
OI Moll, Fernanda Tovar/0000-0002-0292-5985
CR Anton G, 1893, WIEN KLIN WOCHENSCHR, V6, P859
   BABINSKI J, 1898, SEM MED PARIS, V18, P321
   BARBEAU A, 1958, J NERV MENT DIS, V127, P469, DOI 10.1097/00005053-195812000-00001
   Barbeau A, 1981, J Neurol Sci, V51, P311
   Bouchard C., 1866, ARCH GEN MED, V7, P561
   Bouchard C, 1866, ARCH GEN MED, V7, P272
   Bouchard C., 1866, ARCH GEN MED, V8, P273
   Bouchard C, 1866, ARCH GEN MED, V7, P441
   BRODAL A, 1963, ACTA NEUROL SCAND, V39, P17
   Brodal P, 2010, CENTRAL NERVOUS SYST
   Brown WJ, 1961, NEUROLOGY, V11, P829
   Bucy P C, 1978, J Neurosurg Nurs, V10, P144
   Collier J, 1901, BRAIN, V24, P177, DOI 10.1093/brain/24.2.177
   CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020
   de Oliveira-Souza R, 2011, EMOT REV, V3, P1
   Denny-Brown D., 1966, CEREBRAL CONTROL MOV
   Denny-Brown D, 1967, NEUROPHYSIOLOGICAL B, P415
   Denny-Brown D., 1968, HANDBOOK CLINICAL NE, V6, P133
   Elliott TR, 1925, LANCET, V1, P65
   Finger S., 1994, ORIGINS NEUROSCIENCE
   FISHER CM, 1977, CAN J NEUROL SCI, V4, P251, DOI 10.1017/S0317167100025075
   Foerster O, 1936, BRAIN, V59, P135, DOI 10.1093/brain/59.2.135
   Foix C, 1926, REV NEUROL PARIS, V33, P214
   Forel A., 1877, ARCH PSYCHIAT NERVEN, V7, P393, DOI [10.1007/BF02041873, DOI 10.1007/BF02041873]
   Fulton JF, 1935, J AMER MED ASSOC, V104, P357, DOI 10.1001/jama.1935.02760050003002
   Gee S, 1898, BRAIN, V21, P1
   Heimer L, 2008, ANATOMY OF NEUROPSYCHIATRY: THE NEW ANATOMY OF THE BASAL FOREBRAIN AND ITS IMPLICATIONS FOR NEUROPSYCHIATRIC ILLNESS, P1, DOI 10.1016/B978-012374239-1.50004-X
   HODOS W, 1969, PSYCHOL REV, V76, P337, DOI 10.1037/h0027523
   Hunt JR, 1917, BRAIN, V40, P58
   Hunt JR, 1918, BRAIN, V41, P302, DOI 10.1093/brain/41.3-4.302
   Hunt JR, 1917, J NERV MENT DIS, V6, P211, DOI DOI 10.1097/00005053-191709000-00003
   JACKSON JH, 1987, J MENT SCI, V33, P25, DOI DOI 10.1192/BJP.33.141.25
   Jakob A, 1925, ARCH NEURO PSYCHIATR, V13, P596, DOI 10.1001/archneurpsyc.1925.02200110053005
   Kennedy PR, 1997, NEUROLOGY, V48, P1472, DOI 10.1212/WNL.48.5.1472-b
   Lanska Douglas J, 2010, Handb Clin Neurol, V95, P501, DOI 10.1016/S0072-9752(08)02133-7
   LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1
   Long E, 1908, REV NEUROL-FRANCE, V16, P0757
   LOUIS ED, 1993, J HIST MED ALL SCI, V48, P68, DOI 10.1093/jhmas/48.1.68
   Lyell C., 1830, PRINCIPLES GEOLOGY B
   Lyell Charles, 1847, PRINCIPLES GEOLOGY M
   MAGOUN HW, 1958, CIBA F S, P4
   Marie P, 1904, REV NEUROL-FRANCE, V12, P697
   Marie P, 1903, NOUV ICONOGR SALPETR, V16, P80
   MCLARDY T, 1948, BRAIN, V71, P290, DOI 10.1093/brain/71.3.290
   METTLER FA, 1947, RES PUBL ASSOC RES N, V27, P162
   MEYERS R, 1953, NEUROLOGY, V3, P627, DOI 10.1212/WNL.3.9.627
   Nathan PW, 1996, BRAIN, V119, P1809, DOI 10.1093/brain/119.6.1809
   NATHAN PW, 1982, BRAIN, V105, P223, DOI 10.1093/brain/105.2.223
   NAUTA WJH, 1984, CIBA F SYMP, V107, P3
   NUDO RJ, 1988, J COMP NEUROL, V277, P53, DOI 10.1002/cne.902770105
   PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C
   PAULSON GW, 1986, ARCH NEUROL-CHICAGO, V43, P93, DOI 10.1001/archneur.1986.00520010087030
   ROPPER AH, 1979, NEUROLOGY, V29, P91
   Schmahmann JD, 2007, J HIST NEUROSCI, V16, P362, DOI 10.1080/09647040600620468
   Schmahmann JD, 2007, J HIST NEUROSCI, V16, P237, DOI 10.1080/09647040500495896
   Sie PG, 1956, LOCALIZATION FIBRE S
   Thomas A, 1903, REV NEUROL, V11, P94
   Thomas HM, 1910, B JOHNS HOPKINS HOSP, V21, P304
   Tovar-Moll F, 2007, NEUROREPORT, V18, P1417, DOI 10.1097/WNR.0b013e3282e9a509
   Tower SS, 1940, BRAIN, V63, P36, DOI 10.1093/brain/63.1.36
   Weisscheidel E, 1937, ARCH PSYCHIAT, V107, P443
   Wiesendanger M, 1984, Hum Neurobiol, V2, P227
   Wilson SAK, 1911, BRAIN, V34, P295
   Zulch KJ, 1975, CEREBRAL LOCALIZATIO, P32
NR 64
TC 6
Z9 6
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0964-704X
EI 1744-5213
J9 J HIST NEUROSCI
JI J. Hist. Neurosci.
PY 2012
VL 21
IS 3
BP 280
EP 292
DI 10.1080/0964704X.2011.595652
PG 13
WC History & Philosophy Of Science; Neurosciences
SC History & Philosophy of Science; Neurosciences & Neurology
GA 963PP
UT WOS:000305635300004
PM 22724489
DA 2020-12-17
ER

PT J
AU Iwata, NK
   Kwan, JY
   Danielian, LE
   Butman, JA
   Tovar-Moll, F
   Bayat, E
   Floeter, MK
AF Iwata, Nobue K.
   Kwan, Justin Y.
   Danielian, Laura E.
   Butman, John A.
   Tovar-Moll, Fernanda
   Bayat, Elham
   Floeter, Mary Kay
TI White matter alterations differ in primary lateral sclerosis and
   amyotrophic lateral sclerosis
SO BRAIN
LA English
DT Article
DE diffusion tensor imaging; diffusion tensor tractography; motor neuron
   disorders; primary lateral sclerosis; corpus callosum
ID MILD COGNITIVE IMPAIRMENT; DIFFUSION TENSOR MRI; CORTICOSPINAL TRACT;
   MOTOR CORTEX; TRANSCALLOSAL INHIBITION; SPATIAL STATISTICS; AXONAL
   PROJECTIONS; CLINICAL-FEATURES; ALS; BRAIN
AB Primary lateral sclerosis is a sporadic disorder characterized by slowly progressive corticospinal dysfunction. Primary lateral sclerosis differs from amyotrophic lateral sclerosis by its lack of lower motor neuron signs and long survival. Few pathological studies have been carried out on patients with primary lateral sclerosis, and the relationship between primary lateral sclerosis and amyotrophic lateral sclerosis remains uncertain. To detect in vivo structural differences between the two disorders, diffusion tensor imaging of white matter tracts was carried out in 19 patients with primary lateral sclerosis, 18 patients with amyotrophic lateral sclerosis and 19 age-matched controls. Fibre tracking was used to reconstruct the intracranial portion of the corticospinal tract and three regions of the corpus callosum: the genu, splenium and callosal fibres connecting the motor cortices. Both patient groups had reduced fractional anisotropy, a measure associated with axonal organization, and increased mean diffusivity of the reconstructed corticospinal and callosal motor fibres compared with controls, without changes in the genu or splenium. Voxelwise comparison of the whole brain white matter using tract-based spatial statistics confirmed the differences between patients and controls in the diffusion properties of the corticospinal tracts and motor fibres of the callosum. This analysis further revealed differences in the regional distribution of white matter alterations between the patient groups. In patients with amyotrophic lateral sclerosis, the greatest reduction in fractional anisotropy occurred in the distal portions of the intracranial corticospinal tract, consistent with a distal axonal degeneration. In patients with primary lateral sclerosis, the greatest loss of fractional anisotropy and mean diffusivity occurred in the subcortical white matter underlying the motor cortex, with reduced volume, suggesting tissue loss. Clinical measures of upper motor neuron dysfunction correlated with reductions in fractional anisotropy in the corticospinal tract in patients with amyotrophic lateral sclerosis and increased mean diffusivity and volume loss of the corticospinal tract in patients with primary lateral sclerosis. Changes in the diffusion properties of the motor fibres of the corpus callosum were strongly correlated with changes in corticospinal fibres in patients, but not in controls. These findings indicate that degeneration is not selective for corticospinal neurons, but affects callosal neurons within the motor cortex in motor neuron disorders.
C1 [Iwata, Nobue K.; Kwan, Justin Y.; Danielian, Laura E.; Floeter, Mary Kay] NINDS, EMG Sect, NIH, Bethesda, MD 20892 USA.
   [Iwata, Nobue K.] Int Univ Hlth & Welf, Mita Hosp, Dept Neurol, Tokyo, Japan.
   [Butman, John A.] NIH, Ctr Clin, Bethesda, MD 20892 USA.
   [Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Bayat, Elham] George Washington Univ, Dept Neurol, ALS Clin, Washington, DC 20037 USA.
RP Floeter, MK (corresponding author), NINDS, EMG Sect, NIH, 10 Ctr Dr,Bldg 10,Room 7-5680, Bethesda, MD 20892 USA.
EM floeterm@ninds.nih.gov
RI Neurociencia, Inct/I-1011-2013; Butman, John A/A-2694-2008; Butman,
   John/J-2780-2013; Moll, Fernanda Tovar/N-3320-2018
OI Butman, John/0000-0002-1547-9195; Moll, Fernanda
   Tovar/0000-0002-0292-5985
FU National Institute of Neurological Disorders and StrokeUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [NS 002976]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [ZO1
   NS002976]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Neurological Disorders &
   Stroke (NINDS) [ZIANS002976, ZIANS002976, ZIANS002976, ZIANS002976,
   ZIANS002976, ZIANS002976, ZIANS002976, ZIANS002976, ZIANS002976,
   ZIANS002976] Funding Source: NIH RePORTER
FX Intramural Research Program of the National Institute of Neurological
   Disorders and Stroke (#NS 002976), National Institutes of Health (ZO1
   NS002976).
CR Agosta F, 2010, AM J NEURORADIOL, V31, P1457, DOI 10.3174/ajnr.A2105
   Agosta F, 2010, EUR J NEUROSCI, V32, P1490, DOI 10.1111/j.1460-9568.2010.07445.x
   Andersson J. L. R., 2007, TR07JA1 FMRIB
   Andersson JL, 2007, TR07JA2 FMRIB
   Aoki Shigeki, 2005, Radiat Med, V23, P195
   Avanzino L, 2007, J PHYSIOL-LONDON, V583, P99, DOI 10.1113/jphysiol.2007.134510
   Bartels C, 2008, NEUROMUSCULAR DISORD, V18, P398, DOI 10.1016/j.nmd.2008.02.005
   Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782
   BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206
   BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0
   Butman JA, 2007, AM J NEURORADIOL, V28, P87
   CATSMANBERREVOETS CE, 1980, EXP BRAIN RES, V39, P433
   Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5
   Ciccarelli O, 2009, HUM BRAIN MAPP, V30, P615, DOI 10.1002/hbm.20527
   Cosottini M, 2005, RADIOLOGY, V237, P258, DOI 10.1148/radiol.2371041506
   Danielian LE, 2010, NEUROIMAGE, V49, P1572, DOI 10.1016/j.neuroimage.2009.08.062
   Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051
   Erb W, 1902, LANCET, V2, P969
   ERB W, 1875, BERLINER KLIN WOCHEN, V26, P357
   Filippini N, 2010, NEUROLOGY, V75, P1645, DOI 10.1212/WNL.0b013e3181fb84d1
   Fink JK, 2001, SEMIN NEUROL, V21, P199, DOI 10.1055/s-2001-15265
   Floeter MK, 2009, AMYOTROPH LATERAL SC, V10, P339, DOI 10.3109/17482960903171136
   Gordon PH, 2009, NEUROLOGY, V72, P1948, DOI 10.1212/WNL.0b013e3181a8269b
   Graham JM, 2004, NEUROLOGY, V63, P2111, DOI 10.1212/01.WNL.0000145766.03057.E7
   Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044
   Holodny AI, 2005, ANN NY ACAD SCI, V1064, P88, DOI 10.1196/annals.1340.016
   HUDSON AJ, 1993, BRAIN RES BULL, V30, P359, DOI 10.1016/0361-9230(93)90265-D
   Iwata NK, 2008, NEUROLOGY, V70, P528, DOI 10.1212/01.wnl.0000299186.72374.19
   Jacob S, 2003, NEURORADIOLOGY, V45, P598, DOI 10.1007/s00234-003-1014-0
   Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004
   JONES EG, 1979, J COMP NEUROL, V188, P113, DOI 10.1002/cne.901880110
   KOESTER SE, 1993, DEV BIOL, V160, P1, DOI 10.1006/dbio.1993.1281
   Li G, 2011, NEURON, V69, P585, DOI 10.1016/j.neuron.2011.02.011
   Litvan I, 1996, NEUROLOGY, V47, P969, DOI 10.1212/WNL.47.4.969
   Mitsumoto H, 2007, NEUROLOGY, V68, P1402, DOI 10.1212/01.wnl.0000260065.57832.87
   Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151
   Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009
   Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3
   Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058
   Nickerson JP, 2009, CLIN NEURORADIOL, V19, P129, DOI 10.1007/s00062-009-8040-1
   PRINGLE CE, 1992, BRAIN, V115, P495, DOI 10.1093/brain/115.2.495
   Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd
   Reich DS, 2006, AM J NEURORADIOL, V27, P2168
   Roccatagliata L, 2009, AMYOTROPH LATERAL SC, V10, P47, DOI 10.1080/17482960802267530
   Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284
   Singer MA, 2007, MUSCLE NERVE, V35, P291, DOI 10.1002/mus.20728
   Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062
   Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051
   Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024
   Suh SI, 2006, AM J PHYS MED REHAB, V85, P863, DOI 10.1097/01.phm.0000242651.30244.a4
   Tartaglia MC, 2009, NEUROLOGY, V72, P1236, DOI 10.1212/01.wnl.0000345665.75512.f9
   Turner MR, 2011, LANCET NEUROL, V10, P400, DOI 10.1016/S1474-4422(11)70049-7
   Ulug AM, 2004, J MAGN RESON IMAGING, V19, P34, DOI 10.1002/jmri.10433
   Unrath A, 2010, HUM BRAIN MAPP, V31, P1727, DOI 10.1002/hbm.20971
   Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049
   Wittstock M, 2007, CLIN NEUROPHYSIOL, V118, P301, DOI 10.1016/j.clinph.2006.09.026
   Wong JCT, 2007, J NEUROIMAGING, V17, P234, DOI 10.1111/j.1552-6569.2007.00100.x
   Xue R, 1999, MAGNET RESON MED, V42, P1123, DOI 10.1002/(SICI)1522-2594(199912)42:6<1123::AID-MRM17>3.0.CO;2-H
   Zhai P, 2003, NEUROLOGY, V60, P1258, DOI 10.1212/01.WNL.0000058900.02672.D2
   Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01
   Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068
NR 61
TC 80
Z9 83
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
J9 BRAIN
JI Brain
PD SEP
PY 2011
VL 134
BP 2642
EP 2655
DI 10.1093/brain/awr178
PN 9
PG 14
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 821FH
UT WOS:000294959800020
PM 21798965
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Fontenelle, LF
   Bramati, IE
   Moll, J
   Mendlowicz, MV
   de Oliveira-Souza, R
   Tovar-Moll, F
AF Fontenelle, Leonardo F.
   Bramati, Ivanei E.
   Moll, Jorge
   Mendlowicz, Mauro V.
   de Oliveira-Souza, Ricardo
   Tovar-Moll, Fernanda
TI White Matter Changes in OCD Revealed by Diffusion Tensor Imaging
SO CNS SPECTRUMS
LA English
DT Article
ID OBSESSIVE-COMPULSIVE DISORDER; CEREBRAL-BLOOD-FLOW; EMISSION
   COMPUTED-TOMOGRAPHY; VOXEL-BASED MORPHOMETRY; FUNCTIONAL MRI; SYMPTOM
   IMPROVEMENT; ANTERIOR CINGULATE; BRAIN ACTIVATION; CORPUS-CALLOSUM;
   VOLUMETRIC MRI
AB Introduction: The aim of this study was to investigate white matter (WM) abnormalities in obsessive-compulsive disorder (OCD) and its relationship to severity of obsessive-compulsive symptoms.
   Methods: Conventional and diffusion tensor imaging were acquired in nine patients with OCD and nine gender-and age-matched healthy volunteers. Changes in fractional anisotropy (FA) and mean diffusivity (MD) were investigated using selected regions of interest (ROIs) analyses and whole brain tract-based spatial statistic analyses. A priori ROIs were placed bilaterally in internal capsule (IC), superior longitudinal fascicule (SLF), cingulate bundle (CB), and corpus calosum (CC).
   Results: ROIs analyses showed that, as compared to healthy volunteers, patients with OCD exhibited reduced FA values bilaterally in regions of the posterior limb of the IC and in the SLF and increased MD values bilaterally in the posterior limb of the IC, in the left CB, and in the splenium of CC. Voxelwise analysis showed that, as compared to controls, patients with OCD exhibited reduced FA and increased MD in regions of the cortical spinal tract (genu and posterior limb of internal capsule and corona radiata) and the SLF. Severity of OCD correlated with WM alterations in different brain regions, ie, the left (rho=0.70 [MD]) and right (rho=0.70 [MD]) anterior limb of the IC, the left (rho=0.97 [MD]) and right SLF (rho=0.81 [MD]), and the genu of CC (rho=0.66 [MD]; rho=-0.69 [FA]).
   Conclusion: Our findings support the involvement of different WM tracts in OCD and suggest that greater impairment in WM integrity is associated with increased severity of OCD symptoms.
C1 [Fontenelle, Leonardo F.] Univ Fed Rio de Janeiro, Dept Psychiat & Legal Med, Anxiety & Depress Res Program, Inst Psychiat, BR-22410003 Rio De Janeiro, Brazil.
   [Fontenelle, Leonardo F.; Mendlowicz, Mauro V.] Univ Fed Fluminense, Dept Psychiat & Mental Hlth, Inst Community Hlth, Niteroi, RJ, Brazil.
   [Bramati, Ivanei E.; Moll, Jorge; de Oliveira-Souza, Ricardo; Tovar-Moll, Fernanda] Brain Morphometry & Invest Neuroimaging LABS DOr, Rio De Janeiro, Brazil.
   [de Oliveira-Souza, Ricardo] Univ Fed Estado Rio de Janeiro, Gaffree & Guinle Univ Hosp, Rio De Janeiro, Brazil.
RP Fontenelle, LF (corresponding author), Univ Fed Rio de Janeiro, Dept Psychiat & Legal Med, Anxiety & Depress Res Program, Inst Psychiat, Rua Visconde Piraja 547,Sala 719, BR-22410003 Rio De Janeiro, Brazil.
EM lfontenelle@gmail.com
RI Neurociencia, Inct/I-1011-2013; Fontenelle, Leonardo/D-3321-2013; Moll,
   Jorge/B-2654-2013; Moll, Fernanda Tovar/N-3320-2018
OI Fontenelle, Leonardo/0000-0001-9075-8226; Moll, Fernanda
   Tovar/0000-0002-0292-5985; Moll, Jorge/0000-0002-4297-591X
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX Funding for the manuscript was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq); the CNPq had no further
   role in study design; in the collection, analysis and interpretation of
   data; in the writing of the report; and in the decision to submit the
   paper for publication.
CR American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Atmaca M, 2007, PROG NEURO-PSYCHOPH, V31, P46, DOI 10.1016/j.pnpbp.2006.06.008
   Atmaca M, 2006, PROG NEURO-PSYCHOPH, V30, P1051, DOI 10.1016/j.pnpbp.2006.03.033
   AZARI NP, 1993, BIOL PSYCHIAT, V34, P798, DOI 10.1016/0006-3223(93)90069-P
   Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075
   Busatto GF, 2000, PSYCHIAT RES-NEUROIM, V99, P15, DOI 10.1016/S0925-4927(00)00050-0
   Cannistraro PA, 2007, DEPRESS ANXIETY, V24, P440, DOI 10.1002/da.20246
   Carmona S, 2007, NEUROSCI LETT, V421, P218, DOI 10.1016/j.neulet.2007.05.047
   Castillo ARGL, 2005, J NEURAL TRANSM, V112, P1115, DOI 10.1007/s00702-004-0240-x
   Cunha J. A., 2001, MANUAL VERSAO PORTUG
   Davis KD, 2005, J NEUROSCI, V25, P8402, DOI 10.1523/JNEUROSCI.2315-05.2005
   Duran FLD, 2009, NEUROSCI LETT, V452, P68, DOI 10.1016/j.neulet.2009.01.007
   Del-Ben Cristina Marta, 2001, Revista Brasileira de Psiquiatria, V23, P156, DOI 10.1590/S1516-44462001000300008
   Fontenelle LF, 2006, PROG NEURO-PSYCHOPH, V30, P327, DOI 10.1016/j.pnpbp.2005.11.001
   GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006
   GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1012
   Guy W, 1976, ECDEU ASSESSMENT MAN
   Ha TH, 2009, NEUROREPORT, V20, P735, DOI 10.1097/WNR.0b013e32832ad3da
   HORWITZ B, 1991, PSYCHIAT RES-NEUROIM, V40, P221, DOI 10.1016/0925-4927(91)90014-H
   Isaacs KL, 2004, EPILEPSY BEHAV, V5, P569, DOI 10.1016/j.yebeh.2004.04.009
   Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004
   Kang DH, 2003, ACTA PSYCHIAT SCAND, V107, P291, DOI 10.1034/j.1600-0447.2003.00070.x
   Kitamura H, 2006, ACTA PSYCHIAT SCAND, V114, P101, DOI 10.1111/j.1600-0447.2006.00858.x
   Kwon JS, 2003, PSYCHIAT RES-NEUROIM, V122, P37, DOI 10.1016/S0925-4927(02)00104-X
   Lazaro L, 2008, J PSYCHIATR RES, V42, P1051, DOI 10.1016/j.jpsychires.2007.12.007
   LUCEY JV, 1995, BRIT J PSYCHIAT, V167, P629, DOI 10.1192/bjp.167.5.629
   Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186
   Maltby N, 2005, NEUROIMAGE, V24, P495, DOI 10.1016/j.neuroimage.2004.08.041
   Mataix-Cols D, 2006, PSYCHIAT CLIN N AM, V29, P391, DOI 10.1016/j.psc.2006.02.006
   Menzies L, 2008, AM J PSYCHIAT, V165, P1308, DOI 10.1176/appi.ajp.2008.07101677
   Mori S., 2005, MRI ATLAS HUMAN WHIT
   Nabeyama M, 2008, PSYCHIAT RES-NEUROIM, V163, P236, DOI 10.1016/j.pscychresns.2007.11.001
   Nakamae T, 2008, PROG NEURO-PSYCHOPH, V32, P1221, DOI 10.1016/j.pnpbp.2008.03.010
   Nakao T, 2005, BIOL PSYCHIAT, V57, P901, DOI 10.1016/j.biopsych.2004.12.039
   Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058
   Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.3.CO;2-A
   Pantoni L, 2001, ACTA NEUROL SCAND, V104, P185, DOI 10.1034/j.1600-0404.2001.00370.x
   Price G, 2007, NEUROIMAGE, V35, P458, DOI 10.1016/j.neuroimage.2006.12.019
   Riffkin J, 2005, PSYCHIAT RES-NEUROIM, V138, P99, DOI 10.1016/j.pscychresns.2004.11.007
   Ro LT, 2007, ACTA NEUROL BELG, V107, P94
   Rosso SM, 2001, J NEUROL, V248, P965, DOI 10.1007/s004150170049
   Rotge JY, 2008, J PSYCHIATR NEUROSCI, V33, P405
   Rotge JY, 2009, BIOL PSYCHIAT, V65, P75, DOI 10.1016/j.biopsych.2008.06.019
   RUBIN RT, 1995, BIOL PSYCHIAT, V38, P429, DOI 10.1016/0006-3223(94)00305-M
   RUBIN RT, 1992, ARCH GEN PSYCHIAT, V49, P695
   Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284
   Saito Y, 2008, RADIOLOGY, V246, P536, DOI 10.1148/radiol.2462061469
   Schienle A, 2005, INT J PSYCHOPHYSIOL, V57, P69, DOI 10.1016/j.ijpsycho.2004.12.013
   Shin YW, 2006, ACTA PSYCHIAT SCAND, V113, P420, DOI 10.1111/j.1600-0447.2005.00709.x
   Simonyan K, 2008, BRAIN, V131, P447, DOI 10.1093/brain/awm303
   SIMPSON S, 1995, BRIT J PSYCHIAT, V166, P390, DOI 10.1192/bjp.166.3.390
   Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051
   Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024
   Stewart SE, 2007, ARCH GEN PSYCHIAT, V64, P209, DOI 10.1001/archpsyc.64.2.209
   Szeszko PR, 2005, ARCH GEN PSYCHIAT, V62, P782, DOI 10.1001/archpsyc.62.7.782
   Szeszko PR, 2004, AM J PSYCHIAT, V161, P1049, DOI 10.1176/appi.ajp.161.6.1049
   Tovar-Moll F, 2009, AM J NEURORADIOL, V30, P1380, DOI 10.3174/ajnr.A1564
   Tovar-Moll F, 2007, CEREB CORTEX, V17, P531, DOI 10.1093/cercor/bhj178
   Valente AA, 2005, BIOL PSYCHIAT, V58, P479, DOI 10.1016/j.biopsych.2005.04.021
   van den Heuvel OA, 2009, BRAIN, V132, P853, DOI 10.1093/brain/awn267
   Viard A, 2005, PSYCHOL MED, V35, P1007, DOI 10.1017/S0033291704004295
   Wakana S, RADIOLOGY, V230, P77
   Yoo SY, 2007, ACTA PSYCHIAT SCAND, V116, P211, DOI 10.1111/j.1600-0447.2007.01046.x
   Zalesky A, MAGN RESON IN PRESS
NR 64
TC 19
Z9 20
U1 0
U2 5
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1092-8529
J9 CNS SPECTRUMS
JI CNS Spectr.
PD MAY
PY 2011
VL 16
IS 5
BP 101
EP 109
DI 10.1017/S1092852912000260
PG 9
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 951KF
UT WOS:000304718700001
PM 24725386
DA 2020-12-17
ER

PT J
AU de Souza, AS
   de Oliveira-Souza, R
   Moll, J
   Tovar-Moll, F
   Andreiuolo, PA
   Bottino, CMC
AF de Souza, Andrea Silveira
   de Oliveira-Souza, Ricardo
   Moll, Jorge
   Tovar-Moll, Fernanda
   Andreiuolo, Pedro Angelo
   Bottino, Cassio M. C.
TI Contribution of H-1 Spectroscopy to a Brief Cognitive-Functional Test
   Battery for the Diagnosis of Mild Alzheimer's Disease
SO DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
LA English
DT Article
DE Alzheimer dementia; Alzheimer's disease; Clinical assessment; Diagnostic
   criteria; Mild cognitive impairment; Magnetic resonance spectroscopy;
   Cognitive analysis
ID MAGNETIC-RESONANCE-SPECTROSCOPY; PROTON MR SPECTROSCOPY; VOXEL-BASED
   MORPHOMETRY; NEOCORTICAL NEUROFIBRILLARY TANGLES; NINCDS-ADRDA CRITERIA;
   MEDIAL TEMPORAL-LOBE; N-ACETYL-ASPARTATE; MINI-MENTAL-STATE;
   SENILE-DEMENTIA; DIFFERENTIAL-DIAGNOSIS
AB Background/Aims: The diagnosis of mild or questionable Alzheimer's disease (AD) depends on clinical criteria that often leave a margin for doubt. We aim to verify the diagnostic accuracy of amnestic mild cognitive impairment (aMCI) and AD with proton spectroscopy (H-1-MRS) combined with brief cognitive-functional scales. Methods: The relationship between H-1-MRS of the posterior cingulate cortex and the cognitive performance in Mini Mental State Examination, Blessed-Roth Dementia Rating and Functional Assessment Staging of Alzheimer Disease scales were investigated in 25 AD, 10 aMCI and 33 normal control (NC) individuals. Results: The N-acetylaspartate (NAA)/creatine and myoinositol/NAA ratios distinguished AD patients from NC (p < 0.005), and added value in diagnostic accuracy and specificity by discriminant function analysis when combined to clinical diagnosis and simple neuropsychiatric scales; an increase of 3.7% for aMCI patients) and of 5% (for AD individuals) was observed in diagnostic accuracy, and one of 5.5% (aMCI) and of 11.1% (AD) in specificity. Conclusion: H-1-MRS combined with brief cognitive-functional scales provided maximum diagnostic accuracy of AD patients, and can be useful when subtle cognitive and memory dysfunction is present. Copyright (C) 2012 S. Karger AG, Basel
C1 [de Souza, Andrea Silveira; de Oliveira-Souza, Ricardo; Moll, Jorge; Tovar-Moll, Fernanda; Andreiuolo, Pedro Angelo] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [de Oliveira-Souza, Ricardo] Gaffree & Guinle Univ Hosp, Rio De Janeiro, Brazil.
   [de Oliveira-Souza, Ricardo] Philippe Pinel Inst, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Bottino, Cassio M. C.] Univ Sao Paulo, Sch Med, Old Age Res Grp PROTER, Inst Psychiat, Sao Paulo, Brazil.
   [Bottino, Cassio M. C.] Univ Sao Paulo, Sch Med, Old Age Res Grp PROTER, Dept Psychiat, Sao Paulo, Brazil.
RP de Souza, AS (corresponding author), Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
EM andrea.silveiradesouza@gmail.com
RI de Souza, Andrea Silveira/AAL-1976-2020; Neurociencia, Inct/I-1011-2013;
   Moll, Fernanda Tovar/N-3320-2018
OI de Souza, Andrea Silveira/0000-0002-1553-2312; Moll, Fernanda
   Tovar/0000-0002-0292-5985; Moll, Jorge/0000-0002-4297-591X
FU D'Or Institute for Research and Education (IDOR)
FX This research was supported by intramural grants from the D'Or Institute
   for Research and Education (IDOR). MRS tools were initially provided by
   Philips Medical Systems through a clinical research agreement with
   LABS-D'Or and the Rede D'Or Hospital Network.
CR Adalsteinsson E, 2000, LANCET, V355, P1696, DOI 10.1016/S0140-6736(00)02246-7
   *AM PSYCH ASS, 2000, DIAGN STAT MAN MENT, P147
   ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631
   Baron JC, 2001, NEUROIMAGE, V14, P298, DOI 10.1006/nimg.2001.0848
   BERG L, 1988, MT SINAI J MED, V55, P87
   Bickel H, 2009, DEMENT GERIATR COGN, V27, P548, DOI 10.1159/000227781
   BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81, DOI 10.1001/archneur.1995.00540250089017
   BISQUERRA R, 2004, INTRO ESTATISTICA EN
   Bitsch A, 1999, AM J NEURORADIOL, V20, P1619
   BLACKER D, 1994, ARCH NEUROL-CHICAGO, V51, P1198, DOI 10.1001/archneur.1994.00540240042014
   BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797
   Bonte FJ, 2004, J NUCL MED, V45, P771
   Bottino CMC, 2008, DEMENT GERIATR COGN, V26, P291, DOI 10.1159/000161053
   BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809
   Brambati SM, 2009, DEMENT GERIATR COGN, V28, P541, DOI 10.1159/000255240
   Castillo M, 1996, AM J NEURORADIOL, V17, P1
   Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004
   Chao LL, 2005, NEUROLOGY, V64, P282, DOI 10.1212/01.WNL.0000149638.45635.FF
   Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015
   Chetelat G, 2009, BRAIN, V132, DOI 10.1093/brain/awp253
   Cummings JL, 1996, NEUROLOGY, V47, P876, DOI 10.1212/WNL.47.4.876
   DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502
   DESTEFANO N, 1995, MAGN RESON MED, V34, P721
   Diniz BS, 2009, DEMENT GERIATR COGN, V27, P224, DOI 10.1159/000203346
   Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3
   DUYCKAERTS C, 1985, ACTA NEUROPATHOL, V66, P72, DOI 10.1007/BF00698298
   Engelhardt E, 2005, ARQ NEURO-PSIQUIAT, V63, P195, DOI 10.1590/S0004-282X2005000200001
   Ernst T, 1997, RADIOLOGY, V203, P829, DOI 10.1148/radiology.203.3.9169712
   Firbank MJ, 2002, DEMENT GERIATR COGN, V14, P64, DOI 10.1159/000064927
   Folstein MF, 1997, PSYCHIAT CLIN N AM, V20, P45, DOI 10.1016/S0193-953X(05)70392-0
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   GALASKO D, 1995, NEUROLOGY, V45, P1451, DOI 10.1212/WNL.45.8.1451
   Garden DLF, 2009, BRAIN, V132, P1847, DOI 10.1093/brain/awp090
   Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01
   GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106
   GomezIsla T, 1996, J NEUROSCI, V16, P4491
   Grigoletto F, 1999, NEUROLOGY, V53, P315, DOI 10.1212/WNL.53.2.315
   HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009
   Hirata Y, 2005, NEUROSCI LETT, V382, P269, DOI 10.1016/j.neulet.2005.03.038
   HOF PR, 1992, ARCH NEUROL-CHICAGO, V49, P946, DOI 10.1001/archneur.1992.00530330070019
   Huang W, 2001, NEUROLOGY, V57, P626, DOI 10.1212/WNL.57.4.626
   HUESGEN CT, 1993, NEUROLOGY, V43, P145, DOI 10.1212/WNL.43.1_Part_1.145
   HYMAN BT, 1986, ANN NEUROL, V20, P472, DOI 10.1002/ana.410200406
   Jack CR, 2000, NEUROLOGY, V55, P484, DOI 10.1212/WNL.55.4.484
   Jessen F, 2000, NEUROLOGY, V55, P684, DOI 10.1212/WNL.55.5.684
   Jessen F, 2001, NEUROLOGY, V57, P930, DOI 10.1212/WNL.57.5.930
   Jones BF, 2006, CEREB CORTEX, V16, P1701, DOI 10.1093/cercor/bhj105
   Kachigan S. K., 1991, MULTIVARIATE STAT AN
   Kantarci K, 2000, NEUROLOGY, V55, P210, DOI 10.1212/WNL.55.2.210
   Kantarci K, 2003, AM J NEURORADIOL, V24, P843
   Kantarci K, 2002, DEMENT GERIATR COGN, V14, P198, DOI 10.1159/000066021
   Kornhuber J, 2009, DEMENT GERIATR COGN, V27, P404, DOI 10.1159/000210388
   KWOONYUEN PF, 1994, BRAIN RES, V667, P167, DOI 10.1016/0006-8993(94)91494-X
   MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
   Meguro K, 2001, J NEUROL NEUROSUR PS, V71, P315, DOI 10.1136/jnnp.71.3.315
   MILLER BL, 1991, NMR BIOMED, V4, P47, DOI 10.1002/nbm.1940040203
   MILLER BL, 1993, RADIOLOGY, V187, P433, DOI 10.1148/radiology.187.2.8475286
   Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114
   MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479
   MOATS RA, 1995, AM J NEURORADIOL, V16, P1779
   MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a
   NELSON A, 1986, J NERV MENT DIS, V174, P73, DOI 10.1097/00005053-198602000-00002
   Nitrini R, 2004, ALZ DIS ASSOC DIS, V18, P241
   Parnetti L, 1997, MECH AGEING DEV, V97, P9, DOI 10.1016/S0047-6374(97)01877-0
   PEARSON RCA, 1985, P NATL ACAD SCI USA, V82, P4531, DOI 10.1073/pnas.82.13.4531
   PERRY EK, 1978, BRIT MED J, V2, P1457, DOI 10.1136/bmj.2.6150.1457
   Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133
   Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985
   Petrella JR, 2003, RADIOLOGY, V226, P315, DOI 10.1148/radiol.2262011600
   Pfefferbaum A, 1999, ARCH GEN PSYCHIAT, V56, P185, DOI 10.1001/archpsyc.56.2.185
   RANGO M, 1995, MAGNET RESON MED, V33, P595, DOI 10.1002/mrm.1910330503
   Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202
   REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P653
   REISBERG B, 1992, NEURODEVELOPMENT AGI, P345
   Rivas-Vazquez RA, 2004, ARCH CLIN NEUROPSYCH, V19, P11, DOI 10.1016/S0887-6177(02)00167-1
   Ross BD, 1997, BIOPHYS CHEM, V68, P161, DOI 10.1016/S0301-4622(97)00032-X
   ROSS BD, 1996, CLIN MAGNETIC RESONA, P928
   Schuff N, 1998, RADIOLOGY, V207, P91, DOI 10.1148/radiology.207.1.9530304
   Sclan S G, 1992, Int Psychogeriatr, V4 Suppl 1, P55
   SHONK TK, 1995, RADIOLOGY, V195, P65, DOI 10.1148/radiology.195.1.7892497
   SIMMONS ML, 1991, NEUROSCIENCE, V45, P37, DOI 10.1016/0306-4522(91)90101-S
   Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797
   Soares DP, 2009, CLIN RADIOL, V64, P12, DOI 10.1016/j.crad.2008.07.002
   TERRY RD, 1987, J NEUROPATH EXP NEUR, V46, P262, DOI 10.1097/00005072-198705000-00003
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   TSAI GC, 1995, PROG NEUROBIOL, V46, P531, DOI 10.1016/0301-0082(95)00014-M
   Valenzuela MJ, 2001, NEUROLOGY, V56, P592, DOI 10.1212/WNL.56.5.592
   Villain N, 2008, J NEUROSCI, V28, P6174, DOI 10.1523/JNEUROSCI.1392-08.2008
   Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640
   Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112
   Wimo A, 2006, DEMENT GERIATR COGN, V21, P175, DOI 10.1159/000090733
   Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01
NR 92
TC 6
Z9 6
U1 0
U2 6
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1420-8008
EI 1421-9824
J9 DEMENT GERIATR COGN
JI Dement. Geriatr. Cogn. Disord.
PY 2011
VL 32
IS 5
BP 351
EP 361
DI 10.1159/000334656
PG 11
WC Geriatrics & Gerontology; Clinical Neurology; Psychiatry
SC Geriatrics & Gerontology; Neurosciences & Neurology; Psychiatry
GA 889RN
UT WOS:000300091000007
PM 22311276
DA 2020-12-17
ER

PT J
AU Sato, JR
   de Oliveira-Souza, R
   Thomaz, CE
   Basilio, R
   Bramati, IE
   Amaro, E
   Tovar-Moll, F
   Hare, RD
   Moll, J
AF Sato, Joao R.
   de Oliveira-Souza, Ricardo
   Thomaz, Carlos E.
   Basilio, Rodrigo
   Bramati, Ivanei E.
   Amaro, Edson, Jr.
   Tovar-Moll, Fernanda
   Hare, Robert D.
   Moll, Jorge
TI Identification of psychopathic individuals using pattern classification
   of MRI images
SO SOCIAL NEUROSCIENCE
LA English
DT Article
DE Psychopathy; Antisocial; Voxel-based morphometry; Moral; Machine
   learning
ID VOXEL-BASED MORPHOMETRY; SUPPORT VECTOR MACHINES; STRUCTURAL BRAIN
   ABNORMALITIES; CRIMINAL PSYCHOPATHS; GRAY-MATTER; MORAL SENSITIVITY;
   GREY-MATTER; PERSONALITY; NEUROBIOLOGY; VOLUME
AB Background: Psychopathy is a disorder of personality characterized by severe impairments of social conduct, emotional experience, and interpersonal behavior. Psychopaths consistently violate social norms and bring considerable financial, emotional, or physical harm to others and to society as a whole. Recent developments in analysis methods of magnetic resonance imaging (MRI), such as voxel-based-morphometry (VBM), have become major tools to understand the anatomical correlates of this disorder. Nevertheless, the identification of psychopathy by neuroimaging or other neurobiological tools (e. g., genetic testing) remains elusive.
   Methods/Principal findings: The main aim of this study was to develop an approach to distinguish psychopaths from healthy controls, based on the integration between pattern recognition methods and gray matter quantification. We employed support vector machines (SVM) and maximum uncertainty linear discrimination analysis (MLDA), with a feature-selection algorithm. Imaging data from 15 healthy controls and 15 psychopathic individuals (7 women in each group) were analyzed with SPM2 and the optimized VBM preprocessing routines. Participants were scanned with a 1.5 Tesla MRI system. Both SVM and MLDA achieved an overall leave-one-out accuracy of 80%, but SVM mapping was sparser than using MLDA. The superior temporal sulcus/gyrus (bilaterally) was identified as a region containing the most relevant information to separate the two groups.
   Conclusion/significance: These results indicate that gray matter quantitative measures contain robust information to predict high psychopathy scores in individual subjects. The methods employed herein might prove useful as an adjunct to the established clinical and neuropsychological measures in patient screening and diagnostic accuracy.
C1 [Sato, Joao R.] Univ Fed ABC, Ctr Math Computat & Cognit, BR-09060000 Santo Andre, SP, Brazil.
   [de Oliveira-Souza, Ricardo; Basilio, Rodrigo; Bramati, Ivanei E.; Tovar-Moll, Fernanda; Moll, Jorge] DOr Inst Res & Educ, Cognit & Behav Neurosci Unit, Rio De Janeiro, Brazil.
   [Sato, Joao R.; Amaro, Edson, Jr.] Univ Sao Paulo, Fac Med, Dept Radiol, NIF LIM44, Sao Paulo, Brazil.
   [Thomaz, Carlos E.] Ctr Univ FEI, Dept Elect Engn, Sao Bernardo Do Campo, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Biomed Sci Inst, Rio De Janeiro, Brazil.
   [Hare, Robert D.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.
   [Hare, Robert D.] Darkstone Res Grp, Vancouver, BC, Canada.
RP Sato, JR (corresponding author), Univ Fed ABC, Ctr Math Computat & Cognit, Ave Atlantica 420, BR-09060000 Santo Andre, SP, Brazil.
EM joao.sato@ufabc.edu.br; jorge.moll@idor.org
RI Moll, Fernanda Tovar/N-3320-2018; Neurociencia, Inct/I-1011-2013;
   Thomaz, Carlos/AAF-1878-2019; Hare, Robert D/E-8333-2017; Moll,
   Jorge/B-2654-2013; Amaro, Edson/B-6653-2009
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Thomaz,
   Carlos/0000-0001-5566-1963; Amaro, Edson/0000-0002-5889-1382
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); CAPESCAPES; CNPqNational Council for
   Scientific and Technological Development (CNPq); IDOR, Brazil
FX This research was supported by FAPERJ (Pronex and INNT grants), FAPESP,
   CAPES, and CNPq, as well as by intramural grants from IDOR, Brazil.
CR American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Benetti S, 2010, HUM BRAIN MAPP, V31, P1482, DOI 10.1002/hbm.20954
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bertisch H, 2010, AM J MED GENET B, V153B, P885, DOI 10.1002/ajmg.b.31054
   Bezdjian S, 2011, PSYCHOL MED, V41, P589, DOI 10.1017/S0033291710000966
   Blair RJR, 2006, J CHILD PSYCHOL PSYC, V47, P262, DOI 10.1111/j.1469-7610.2006.01596.x
   Bradley D, 2009, BRAIN, V132, P2327, DOI 10.1093/brain/awp156
   Brunner R, 2010, NEUROIMAGE, V49, P114, DOI 10.1016/j.neuroimage.2009.07.070
   Camchong J, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.035.2009
   Cooke DJ, 1999, PSYCHOL ASSESSMENT, V11, P3, DOI 10.1037/1040-3590.11.1.3
   Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023
   De Brito SA, 2009, BRAIN, V132, P843, DOI 10.1093/brain/awp011
   de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872
   de Oliveira-Souza R, 2008, NEUROIMAGE, V40, P1202, DOI 10.1016/j.neuroimage.2007.12.054
   De Oliveira-Souza R, 2008, CRIM JUSTICE BEHAV, V35, P427, DOI 10.1177/0093854807310853
   Decety J, 2002, NEUROIMAGE, V15, P265, DOI 10.1006/nimg.2001.0938
   DEVIJVER P, 1982, PATTERN CLASSIFICATI
   Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024
   Emblem KE, 2008, MAGN RESON MED, V60, P945, DOI 10.1002/mrm.21736
   Fan Y, 2005, LECT NOTES COMPUT SC, V3749, P1
   Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402
   Fukunaga K., 1990, INTRO STAT PATTERN R
   Fullam RS, 2009, BRIT J PSYCHIAT, V194, P229, DOI 10.1192/bjp.bp.108.053199
   Gao Y, 2010, PSYCHOL MED, V40, P1007, DOI 10.1017/S0033291709991279
   Gao Y, 2009, CAN J PSYCHIAT, V54, P813, DOI 10.1177/070674370905401204
   Georgopoulos AP, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016011
   Gerardin E, 2009, NEUROIMAGE, V47, P1476, DOI 10.1016/j.neuroimage.2009.05.036
   Glenn AL, 2009, MOL PSYCHIATR, V14, P5, DOI 10.1038/mp.2008.104
   Glenn AL, 2008, PSYCHIAT CLIN N AM, V31, P463, DOI 10.1016/j.psc.2008.03.004
   Glenn AL, 2010, BIOL PSYCHIAT, V67, P52, DOI 10.1016/j.biopsych.2009.06.018
   Goldstein KE, 2009, SCHIZOPHR RES, V112, P14, DOI 10.1016/j.schres.2009.04.027
   Golland P, 2002, LECT NOTES COMPUT SC, V2488, P508
   Golland P, 2000, LECT NOTES COMPUT SC, V1935, P72
   Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786
   Grezes J, 2007, NEUROIMAGE, V35, P959, DOI 10.1016/j.neuroimage.2006.11.030
   Guy LS, 2006, PSYCHOL ASSESSMENT, V18, P225, DOI 10.1037/1040-3590.18.2.225
   Hare RD, 2006, PSYCHIAT CLIN N AM, V29, P709, DOI 10.1016/j.psc.2006.04.007
   Hare Robert D, 2005, Curr Psychiatry Rep, V7, P57, DOI 10.1007/s11920-005-0026-3
   Hart SD, 1995, MANUAL PSYCHOPATHY C
   Hastie T, 2001, ELEMENTS STAT LEARNI
   Honea RA, 2008, BIOL PSYCHIAT, V63, P465, DOI 10.1016/j.biopsych.2007.05.027
   Kalbe E, 2010, CORTEX, V46, P769, DOI 10.1016/j.cortex.2009.07.010
   Kiehl KA, 2006, J ABNORM PSYCHOL, V115, P443, DOI 10.1037/0021-843X.115.3.443
   Koutsouleris N, 2010, SCHIZOPHR RES, V123, P175, DOI 10.1016/j.schres.2010.08.032
   Lao ZQ, 2004, NEUROIMAGE, V21, P46, DOI 10.1016/j.neuroimage.2003.09.027
   Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017
   Lukic AS, 2002, ARTIF INTELL MED, V25, P69, DOI 10.1016/S0933-3657(02)00009-X
   Materna S, 2008, NEUROPSYCHOLOGIA, V46, P2759, DOI 10.1016/j.neuropsychologia.2008.05.016
   Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993
   Millon T, 2002, PSYCHOPATHY ANTISOCI
   Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002
   Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768
   Moll J, 2007, SOC NEUROSCI-UK, V2, P336, DOI 10.1080/17470910701392024
   Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070
   Muller JL, 2008, PSYCHIAT RES-NEUROIM, V163, P213, DOI 10.1016/j.pscychresns.2007.08.010
   Nardo D, 2010, J PSYCHIATR RES, V44, P477, DOI 10.1016/j.jpsychires.2009.10.014
   Rilling JK, 2007, BIOL PSYCHIAT, V61, P1260, DOI 10.1016/j.biopsych.2006.07.021
   Sato JR, 2008, NEUROIMAGE, V42, P1473, DOI 10.1016/j.neuroimage.2008.06.024
   Sato JR, 2008, J NEUROSCI METH, V172, P94, DOI 10.1016/j.jneumeth.2008.04.008
   Sato JR, 2009, HUM BRAIN MAPP, V30, P1068, DOI 10.1002/hbm.20569
   Schaufelberger MS, 2007, BRIT J PSYCHIAT, V191, pS117, DOI 10.1192/bjp.191.51.s117
   Schlaepfer TE, 2006, INT J NEUROPSYCHOPH, V9, P147, DOI 10.1017/S1461145705005705
   Soderstrom H, 2002, PSYCHIAT RES-NEUROIM, V114, P81, DOI 10.1016/S0925-4927(02)00006-9
   Soloff P, 2008, PSYCHIAT RES-NEUROIM, V164, P223, DOI 10.1016/j.pscychresns.2008.02.003
   Thomaz CE, 2007, IMAGE VISION COMPUT, V25, P981, DOI 10.1016/j.imavis.2006.07.011
   Thomaz C. E., 2006, J BRAZILIAN COMPUTER, V12, P7, DOI DOI 10.1007/BF03192391
   Thomaz CE, 2007, J MATH IMAGING VIS, V29, P95, DOI 10.1007/s10851-007-0033-6
   Tiihonen J, 2008, PSYCHIAT RES-NEUROIM, V163, P201, DOI 10.1016/j.pscychresns.2007.08.012
   Vapnik V, 1998, STAT LEARNING THEORY
   Veit R, 2010, NEUROIMAGE, V49, P3365, DOI 10.1016/j.neuroimage.2009.11.040
   Weber S, 2008, BEHAV SCI LAW, V26, P7, DOI 10.1002/bsl.802
   Williams KM, 2007, J PERS ASSESS, V88, P205, DOI 10.1080/00223890701268074
   Wilson SM, 2009, NEUROIMAGE, V47, P1558, DOI 10.1016/j.neuroimage.2009.05.085
   WORSLEY KJ, 1995, ANN STAT, V23, P640, DOI 10.1214/aos/1176324540
   Yang YL, 2005, BIOL PSYCHIAT, V57, P1103, DOI 10.1016/j.biopsych.2005.01.021
   Zhu CZ, 2005, LECT NOTES COMPUT SC, V3750, P468
   Zou K, 2010, BIOL PSYCHIAT, V67, P186, DOI 10.1016/j.biopsych.2009.09.014
NR 77
TC 20
Z9 20
U1 1
U2 32
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1747-0919
EI 1747-0927
J9 SOC NEUROSCI-UK
JI Soc. Neurosci.
PY 2011
VL 6
IS 5-6
SI SI
BP 627
EP 639
DI 10.1080/17470919.2011.562687
PG 13
WC Neurosciences; Psychology
SC Neurosciences & Neurology; Psychology
GA 882NL
UT WOS:000299570500016
PM 21590586
DA 2020-12-17
ER

PT J
AU Tovar-Moll, F
   Evangelou, IE
   Chiu, AW
   Richert, ND
   Ostuni, JL
   Ohayon, JM
   Auh, S
   Ehrmantraut, M
   Talagala, SL
   McFarland, HF
   Bagnato, F
AF Tovar-Moll, F.
   Evangelou, I. E.
   Chiu, A. W.
   Richert, N. D.
   Ostuni, J. L.
   Ohayon, J. M.
   Auh, S.
   Ehrmantraut, M.
   Talagala, S. L.
   McFarland, H. F.
   Bagnato, F.
TI Thalamic Involvement and Its Impact on Clinical Disability in Patients
   with Multiple Sclerosis: A Diffusion Tensor Imaging Study at 3T
SO AMERICAN JOURNAL OF NEURORADIOLOGY
LA English
DT Article; Proceedings Paper
CT 92nd Scientific Assembly and Annual Meeting of the
   Radiological-Society-of-North-America
CY NOV 26-DEC 01, 2006
CL Chicago, IL
SP Radiol Soc N Amer
ID GRAY-MATTER INVOLVEMENT; NORMAL-APPEARING WHITE; STATUS SCALE EDSS;
   MAGNETIZATION-TRANSFER; CORTICAL-LESIONS; BASAL GANGLIA; HEAD-INJURY;
   MRI; GREY; MS
AB BACKGROUND AND PURPOSE: Several studies suggest that grey matter involvement may play a role in multiple sclerosis (MS) pathology. Diffusion tensor imaging (DTI) at 3T was used to investigate the presence of damage to the normal-appearing thalamus in MS and its relationship with disability.
   MATERIALS AND METHODS: Twenty-four patients with relapsing-remitting (FIR, n = 13, age = 41.7 +/- 6.1, Expanded Disability Status Scale [EDSSI score = 2.2 +/- 1.2) and secondary-progressive (n = 11, age = 46.9 +/- 9.6, EDSS = 5.9 +/- 1.0) MS and 24 age- and sex-matched healthy volunteers were studied. Fractional anisotropy (FA) and mean diffusivity (MD) were measured in regions of interest of normal-appearing thalamus. We examined group differences in MD and FA and correlations between DTI-derived metrics and clinical or imaging measures of disease.
   RESULTS: Patients with MS had higher thalamic FA (P < .0001) and MID (P = .035) than volunteers. MD values correlated with the Paced Auditory Serial Addition Task V = -0.43, P = .034) and motor EDSS (r = 0.47, P = .021) scores. In patients with RRMS, MID values correlated with global EDSS (r = 0.75, P = .003) and motor EDSS V = 0.68, P = .010). Correlations were found between MID values and T1 and T2 lesion load V = 0.58, P < .05) and brain parenchymal fraction V = -0.46, P < .05).
   CONCLUSIONS: DTI was able to detect abnormalities in normal-appearing thalamus of patients with MS. The strength of association between thalamic DTI measures and functional impairment was in the same range as those seen with standard MR imaging disease measures. The assessment of the integrity of the thalamus with DTI is a promising metric as a marker of disease for future studies.
C1 [Tovar-Moll, F.; Evangelou, I. E.; Chiu, A. W.; Richert, N. D.; Ostuni, J. L.; Ohayon, J. M.; Ehrmantraut, M.; McFarland, H. F.; Bagnato, F.] NINDS, NIH, Neuroimmunol Branch, Bethesda, MD 20892 USA.
   [Auh, S.] NINDS, NIH, Off Clin Director, Bethesda, MD 20892 USA.
   [Talagala, S. L.] NINDS, NIH, NIH MRI Res Facil, Bethesda, MD 20892 USA.
RP Bagnato, F (corresponding author), Bldg 10,Room 5C103,9000 Rockville Pike, Bethesda, MD 20892 USA.
EM bagnatof@ninds.nih.gov
RI Moll, Fernanda Tovar/N-3320-2018; Neurociencia, Inct/I-1011-2013
OI Moll, Fernanda Tovar/0000-0002-0292-5985; 
FU Intramural NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA Funding Source:
   Medline
CR Alexander AL, 2006, NEUROIMAG CLIN N AM, V16, P299, DOI 10.1016/j.nic.2006.02.006
   ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041
   Audoin B, 2004, J MAGN RESON IMAGING, V20, P765, DOI 10.1002/jmri.20178
   Audoin B, 2007, NEUROIMAGE, V36, P1324, DOI 10.1016/j.neuroimage.2007.04.038
   Bagnato F, 2003, BRAIN, V126, P1782, DOI 10.1093/brain/awg182
   Bagnato Francesca, 2003, Curr Neurol Neurosci Rep, V3, P238, DOI 10.1007/s11910-003-0084-z
   Barkhof F, 1999, MULT SCLER J, V5, P283, DOI 10.1177/135245859900500415
   Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022
   Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075
   Bermel RA, 2003, NEUROREPORT, V14, P335, DOI 10.1097/01.wnr.0000059773.23122.ce
   CAO M, 2005, MULT SCLER, V11, P232
   Ceccarelli A, 2007, J NEUROL, V254, P513, DOI 10.1007/s00415-006-0408-4
   Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926
   Cifelli A, 2002, ANN NEUROL, V52, P650, DOI 10.1002/ana.10326
   Codella M, 2002, J NEUROL SCI, V194, P71, DOI 10.1016/S0022-510X(01)00682-7
   Davies GR, 2005, J NEUROL, V252, P1037, DOI 10.1007/s00415-005-0808-x
   Derache N, 2006, J NEUROL SCI, V245, P103, DOI 10.1016/j.jns.2005.09.017
   Fabiano AJ, 2003, J NEUROIMAGING, V13, P307, DOI 10.1177/1051228403257620
   Filippi M, 2001, NEUROL SCI, V22, P195, DOI 10.1007/s100720170023
   Filippi M, 2001, J NEUROL SCI, V183, P69, DOI 10.1016/S0022-510X(00)00471-8
   Fushimi Y, 2007, NMR BIOMED, V20, P743, DOI 10.1002/nbm.1139
   Geurts JJG, 2006, MAGN RESON MED, V55, P478, DOI 10.1002/mrm.20792
   Griffin CM, 2001, MULT SCLER J, V7, P290, DOI 10.1177/135245850100700504
   GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889
   GRONWALL D, 1974, LANCET, V2, P605
   Gupta S, 2005, MULT SCLER J, V11, P658, DOI 10.1191/1352458505ms1229oa
   Hagmann P, 2003, NEUROIMAGE, V19, P545, DOI 10.1016/S1053-8119(03)00142-3
   Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510
   Inglese M, 2004, NEUROLOGY, V63, P170, DOI 10.1212/01.WNL.0000133133.77952.7C
   Inglese M, 2004, NEUROIMAGE, V21, P1825, DOI 10.1016/j.neuroimage.2003.12.008
   JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111
   Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004
   Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105
   Kidd D, 1999, BRAIN, V122, P17, DOI 10.1093/brain/122.1.17
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Kutzelnigg A, 2005, J NEUROL SCI, V233, P55, DOI 10.1016/j.jns.2005.03.027
   Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907
   McFarland HF, 2002, MULT SCLER J, V8, P40, DOI 10.1191/1352458502ms767xx
   O'Sullivan M, 2004, NEUROLOGY, V62, P702, DOI 10.1212/01.WNL.0000113760.72706.D2
   Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765
   POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302
   Richert ND, 1998, AM J NEURORADIOL, V19, P1705
   Rovaris M, 2006, BRAIN, V129, P2628, DOI 10.1093/brain/awl222
   Rovaris M, 2002, ARCH NEUROL-CHICAGO, V59, P1406, DOI 10.1001/archneur.59.9.1406
   Sharma J, 2006, J NEUROIMAGING, V16, P302, DOI 10.1111/j.1552-6569.2006.00054.x
   Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040
   Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027
NR 47
TC 60
Z9 61
U1 0
U2 3
PU AMER SOC NEURORADIOLOGY
PI DENVILLE
PA PO BOX 3000, DENVILLE, NJ 07834-9349 USA
SN 0195-6108
EI 1936-959X
J9 AM J NEURORADIOL
JI Am. J. Neuroradiol.
PD AUG
PY 2009
VL 30
IS 7
BP 1380
EP 1386
DI 10.3174/ajnr.A1564
PG 7
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA 486BE
UT WOS:000269169600022
PM 19369608
OA Green Published, Other Gold
DA 2020-12-17
ER

PT J
AU Riva, M
   Ikonomidou, VN
   Ostuni, JJ
   van Gelderen, P
   Auh, S
   Ohayon, JM
   Tovar-Moll, F
   Richert, ND
   Duyn, JH
   Bagnato, F
AF Riva, M.
   Ikonomidou, V. N.
   Ostuni, J. J.
   van Gelderen, P.
   Auh, S.
   Ohayon, J. M.
   Tovar-Moll, F.
   Richert, N. D.
   Duyn, J. H.
   Bagnato, F.
TI Tissue-Specific Imaging Is a Robust Methodology to Differentiate In Vivo
   T1 Black Holes with Advanced Multiple Sclerosis-Induced Damage
SO AMERICAN JOURNAL OF NEURORADIOLOGY
LA English
DT Article; Proceedings Paper
CT 58th Annual Meeting of the American-Academy-of-Neurology
CY APR 01-08, 2006
CL San Diego, CA
SP Amer Acad Neurol
ID SPIN-ECHO MRI; HYPOINTENSE LESIONS; INTERFERON BETA-1B; ENHANCING
   LESIONS; AXONAL LOSS; BRAIN; MS; DISABILITY; CONTRAST; RECOVERY
AB BACKGROUND AND PURPOSE: Brains of patients with multiple sclerosis (MS) characteristically have "black holes" (BHs), hypointense lesions on T1-weighted (T1W) spin-echo (SE) images. Although conventional MR imaging can disclose chronic BHs (CBHs), it cannot stage the degree of their pathologic condition. Tissue-specific imaging (TSI), a recently introduced MR imaging technique, allows selective visualization of white matter (WM), gray matter (GM), and CSF on the basis of T1 values of classes of tissue. We investigated the ability of TSI-CSF to separate CBHs with longer T1 values, which likely represent lesions containing higher levels of destruction and unbound water.
   MATERIALS AND METHODS: Eighteen patients with MS, who had already undergone MR imaging twice (24 months apart) on a 1.5T scanner, underwent a 3T MR imaging examination. Images acquired at 1.5T included sequences of precontrast and postcontrast T1W SE, T2-weighted (T2W) SE, and magnetization transfer (MT). Sequences obtained at 3T included precontrast and postcontrast T1W SE, T2W SE, T1 inversion recovery prepared fast spoiled gradient recalled-echo (IR-FSPGR) and TSI. A BH on the 3T-IR-FSPGR was defined as a CBH if seen as a hypointense, nonenhancing lesion with a corresponding T2 abnormality for at least 24 months. CBHs were separated into 2 groups: those visible as hyperintensities on TSI-CSF (group A), and those not appearing on the TSI-CSF (group B).
   RESULTS: Mean MT ratios of group-A lesions (0.22 +/- 0.06, 0.13-0.35) were lower (F-1,F- (13) = 60.39; P < .0001) than those of group-B lesions (0.32 +/- 0.03, 0.27-0.36).
   CONCLUSIONS: Group-A lesions had more advanced tissue damage; thus, TSI is a potentially valuable method for qualitative and objective identification.
C1 [Riva, M.; Ikonomidou, V. N.; Ostuni, J. J.; Ohayon, J. M.; Tovar-Moll, F.; Richert, N. D.; Bagnato, F.] NINDS, NIH, Neuroimmunol Branch, Bethesda, MD 20892 USA.
   [Ikonomidou, V. N.; van Gelderen, P.; Duyn, J. H.] NINDS, NIH, Adv MRI Sect, LFMI, Bethesda, MD 20892 USA.
   [Auh, S.] NINDS, NIH, Off Clin Director, Bethesda, MD 20892 USA.
RP Bagnato, F (corresponding author), NINDS, NIH, Neuroimmunol Branch, Bldg 10,Room 5C103,10 Ctr Dr, Bethesda, MD 20892 USA.
EM bagnatof@ninds.nih.gov
RI van Gelderen, Peter/U-4535-2019; Duyn, Jozef/F-2483-2010; Neurociencia,
   Inct/I-1011-2013; Moll, Fernanda Tovar/N-3320-2018; Riva,
   Marco/AAC-1357-2019
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Riva,
   Marco/0000-0003-4643-6451
FU Intramural NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [Z99 NS999999] Funding
   Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND
   STROKEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [ZIANS003027, ZIANS003027, ZIANS003027,
   ZIANS002990, ZIANS003027, ZIANS003027, ZIANS002990, ZIANS003027,
   ZIANS002990, ZIANS002990, ZIANS002990, ZIANS003027, ZIANS002990,
   ZIANS003027, ZIANS002990, ZIANS002990, ZIANS003027, ZIANS003027,
   ZIANS002990, ZIANS002990] Funding Source: NIH RePORTER
CR Bagnato F, 2005, J NEUROVIROL, V11, P525, DOI 10.1080/13550280500385039
   Bagnato F, 2003, BRAIN, V126, P1782, DOI 10.1093/brain/awg182
   Bagnato F, 2007, EXPERT OPIN BIOL TH, V7, P1079, DOI 10.1517/14712598.7.7.1079
   Barkhof F, 2003, ARCH NEUROL-CHICAGO, V60, P1073, DOI 10.1001/archneur.60.8.1073
   Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003
   Barkhof F, 2001, BRAIN, V124, P1396, DOI 10.1093/brain/124.7.1396
   Barkhof F, 2000, NEUROIMAG CLIN N AM, V10, P739
   Bermel RA, 2006, LANCET NEUROL, V5, P158, DOI 10.1016/S1474-4422(06)70349-0
   Bitsch A, 2001, ANN NEUROL, V49, P793, DOI 10.1002/ana.1053
   BOTTOMLEY PA, 1984, MED PHYS, V11, P425, DOI 10.1118/1.595535
   Brex PA, 2001, NEUROLOGY, V57, P2185, DOI 10.1212/WNL.57.12.2185
   Bruck W, 1997, ANN NEUROL, V42, P783, DOI 10.1002/ana.410420515
   Ciccarelli O, 1999, EUR J NEUROL, V6, P455, DOI 10.1046/j.1468-1331.1999.640455.x
   Cohen MS, 2000, HUM BRAIN MAPP, V10, P204, DOI 10.1002/1097-0193(200008)10:4<204::AID-HBM60>3.0.CO;2-2
   Cotton F, 2003, NEUROLOGY, V60, P640, DOI 10.1212/01.WNL.0000046587.83503.1E
   Filippi M, 1998, NEUROLOGY, V50, P238, DOI 10.1212/WNL.50.1.238
   Filippi M, 2001, NEUROLOGY, V57, P731, DOI 10.1212/WNL.57.4.731
   Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409
   FREITAG P, 2001, MULT SCLER
   Giugni E, 1997, MULT SCLER, V3, P221, DOI 10.1177/135245859700300401
   GROSSMAN RI, 1986, RADIOLOGY, V161, P721, DOI 10.1148/radiology.161.3.3786722
   Gupta S, 2005, MULT SCLER J, V11, P658, DOI 10.1191/1352458505ms1229oa
   HARRIS JO, 1991, ANN NEUROL, V29, P548, DOI 10.1002/ana.410290515
   Ikonomidou VN, 2005, MAGN RESON MED, V54, P373, DOI 10.1002/mrm.20561
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Lassmann H, 2008, NEUROIMAG CLIN N AM, V18, P563, DOI 10.1016/j.nic.2008.06.005
   MADELIN G, 2008, J NEUROIMAGING  1106
   Moraal B, 2008, EUR RADIOL, V18, P2311, DOI 10.1007/s00330-008-1009-7
   POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302
   REDPATH TW, 1994, BRIT J RADIOL, V67, P1258, DOI 10.1259/0007-1285-67-804-1258
   Richert ND, 1998, AM J NEURORADIOL, V19, P1705
   Richert ND, 2001, MULT SCLER, V7, P49, DOI 10.1177/135245850100700109
   Sailer M, 2001, EUR J NEUROL, V8, P37, DOI 10.1046/j.1468-1331.2001.00147.x
   Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202
   Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040
   Truyen L, 1996, NEUROLOGY, V47, P1469, DOI 10.1212/WNL.47.6.1469
   van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747
   van Walderveen MAA, 1998, NEUROLOGY, V50, P1282, DOI 10.1212/WNL.50.5.1282
   van Walderveen MAA, 2001, ARCH NEUROL-CHICAGO, V58, P76, DOI 10.1001/archneur.58.1.76
   VANWALDERVEEN MAA, 1995, NEUROLOGY, V45, P1684, DOI 10.1212/WNL.45.9.1684
   Wattjes MP, 2007, AM J NEURORADIOL, V28, P54
   Zivadinov R, 2008, J NEUROL, V255, P61, DOI 10.1007/s00415-008-1009-1
NR 42
TC 21
Z9 21
U1 0
U2 2
PU AMER SOC NEURORADIOLOGY
PI DENVILLE
PA PO BOX 3000, DENVILLE, NJ 07834-9349 USA
SN 0195-6108
EI 1936-959X
J9 AM J NEURORADIOL
JI Am. J. Neuroradiol.
PD AUG
PY 2009
VL 30
IS 7
BP 1394
EP 1401
DI 10.3174/ajnr.A1573
PG 8
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA 486BE
UT WOS:000269169600025
PM 19406765
OA Green Accepted, Other Gold, Green Published
DA 2020-12-17
ER

PT J
AU de Melo, FCM
   Diacoyannis, L
   Moll, A
   Tovar-Moll, F
AF Monteiro de Melo, Fernanda Chagas
   Diacoyannis, Luana
   Moll, Andre
   Tovar-Moll, Fernanda
TI Reduction by 98% in Uterine Myoma Volume Associated with Significant
   Symptom Relief After Peripheral Treatment with Magnetic Resonance
   Imaging-Guided Focused Ultrasound Surgery
SO JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY
LA English
DT Article
DE Fibroid; Focused ultrasound; MRgFUS; Myomas; Shrinkage
ID ARTERY EMBOLIZATION; DIFFUSION; LEIOMYOMAS; FIBROIDS; TISSUES; DAMAGE
AB Magnetic resonance imaging-guided focused ultrasound surgery is a noninvasive treatment for symptomatic uterine myomas. Previous studies have demonstrated a correlation between the treated volume of the myoma, improvement in symptoms, and lesion shrinkage. We report a case in which MRgFUS treatment only at the periphery of the myoma resulted in a 98% reduction in tumor volume at 8 months posttreatment, and at 12-month follow-up, only a small lesion was visible at magnetic resonance imaging. The patient's symptoms, as assessed using the Uterine Fibroids Symptom and Quality of life (UFS-QOL) questionnaire, were substantially improved at both 6 and 12 months posttreatment. We also provide a hypothesis to explain this dramatic reduction in myoma volume after only partial MRgFUS treatment of the lesion. Journal of Minimally Invasive Gynecology (2009) 16, 501-503 (C) 2009 AAGL. All rights reserved.
C1 [Monteiro de Melo, Fernanda Chagas; Tovar-Moll, Fernanda] LABS DOr Hosp Network, Ctr Neurosci, Brain Morphometry & Quantitat Neuroimaging Unit, BR-22281100 Rio De Janeiro, Brazil.
   [Monteiro de Melo, Fernanda Chagas; Diacoyannis, Luana; Moll, Andre] Barra DOr Hosp, Rio De Janeiro, Brazil.
RP de Melo, FCM (corresponding author), LABS DOr Hosp Network, Ctr Neurosci, Brain Morphometry & Quantitat Neuroimaging Unit, Rua Diniz Cordeiro 39, BR-22281100 Rio De Janeiro, Brazil.
EM nandachagas@hotmail.com
RI Neurociencia, Inct/I-1011-2013; Moll, Fernanda Tovar/N-3320-2018
OI Moll, Fernanda Tovar/0000-0002-0292-5985
CR CHENG KH, 1992, CANCER RES, V52, P6066
   FARRER-BROWN G, 1970, Journal of Obstetrics and Gynaecology of the British Commonwealth, V77, P967
   Fennessy FM, 2007, RADIOLOGY, V243, P885, DOI 10.1148/radiol.2433060267
   Funaki K, 2007, AM J OBSTET GYNECOL, V196
   Funaki K, 2007, J MINIM INVAS GYN, V14, P616, DOI 10.1016/j.jmig.2007.04.009
   Graham SJ, 1999, MAGNET RESON MED, V42, P1061, DOI 10.1002/(SICI)1522-2594(199912)42:6<1061::AID-MRM10>3.0.CO;2-T
   KNIGHT RA, 1991, STROKE, V22, P802, DOI 10.1161/01.STR.22.6.802
   LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909
   Lenard ZM, 2008, RADIOLOGY, V249, P187, DOI 10.1148/radiol.2491071600
   Leonhardt H, 2005, ACTA OBSTET GYN SCAN, V84, P303, DOI 10.1111/j.0001-6349.2005.0358d.x
   McDannold N, 2006, RADIOLOGY, V240, P263, DOI 10.1148/radiol.2401050717
   Morita Y, 2008, EUR J OBSTET GYN R B, V139, P199, DOI 10.1016/j.ejogrb.2007.10.018
   MOSELEY ME, 1990, AM J NEURORADIOL, V11, P423
   Pelage JP, 2005, RADIOGRAPHICS, V25, pS99, DOI 10.1148/rg.25si055510
   Rabinovici J, 2007, ULTRASOUND OBST GYN, V30, P771, DOI 10.1002/uog.4099
   Sampson JA, 1912, SURG GYNECOL OBSTET, V14, P215
   Spies JB, 2002, OBSTET GYNECOL, V99, P290, DOI 10.1016/S0029-7844(01)01702-1
   Stewart EA, 2006, FERTIL STERIL, V85, P22, DOI 10.1016/j.fertnstert.2005.04.072
   Stewart EA, 2003, AM J OBSTET GYNECOL, V189, P48, DOI 10.1067/mob.2003.345
   Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9
   Stewart EA, 2007, OBSTET GYNECOL, V110, P279, DOI 10.1097/01.AOG.0000275283.39475.f6
   Tempany CMC, 2003, RADIOLOGY, V226, P897, DOI 10.1148/radiol.2271020395
   Tranquart F, 2002, ULTRASOUND OBST GYN, V19, P81, DOI 10.1046/j.0960-7692.2001.00535.x
   Wei JJ, 2006, FERTIL STERIL, V85, P179, DOI 10.1016/j.fertnstert.2005.07.1294
   Weintraub JL, 2002, J ULTRAS MED, V21, P633, DOI 10.7863/jum.2002.21.6.633
   Zupi E, 2003, FERTIL STERIL, V79, P107, DOI 10.1016/S0015-0282(02)04399-6
NR 26
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1553-4650
EI 1553-4669
J9 J MINIM INVAS GYN
JI J. Minim. Invasive Gynecol.
PD JUL-AUG
PY 2009
VL 16
IS 4
BP 501
EP 503
DI 10.1016/j.jmig.2009.04.007
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 473KD
UT WOS:000268204000025
PM 19573831
DA 2020-12-17
ER

PT J
AU Eslinger, PJ
   Robinson-Long, M
   Realmuto, J
   Moll, J
   deOliveira-Souza, R
   Tovar-Moll, F
   Wang, JL
   Yang, QX
AF Eslinger, Paul J.
   Robinson-Long, Melissa
   Realmuto, Jennifer
   Moll, Jorge
   deOliveira-Souza, Ricardo
   Tovar-Moll, Fernanda
   Wang, Jianli
   Yang, Qing X.
TI Developmental frontal lobe imaging in moral judgment: Arthur Benton's
   enduring influence 60 years later
SO JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
LA English
DT Article
DE Functional magnetic resonance imaging; Moral judgment; Frontal lobe;
   Brain development
ID MEDIAL PREFRONTAL CORTEX; EXECUTIVE FUNCTION; NEURAL BASES; SELF;
   NETWORKS; BEHAVIOR; EMOTION; DAMAGE; CONSEQUENCES; CIRCUITS
AB Early prefrontal cortex damage has been associated with developmental deficits in social adaptation, moral behavior, and empathy that alter the maturation of social cognition and social emotions. The seminal case of Ackerly and Benton (1948) continues to provide the most striking clinical example of prefrontal-related neurodevelopmental impairments, with more recent case reports confirming and elaborating these influential observations. This study investigated the prefrontal hypothesis of moral decision making in healthy, typically developing children and adolescents (10-17 years of age) using functional magnetic resonance imaging (fMRI). Participants judged the actions in age-appropriate moral vignettes as right or wrong, and results were contrasted to a nonsocial/nonmoral baseline condition requiring similar right versus wrong judgments. Results confirmed a predominant cluster of activity in the most rostral-medial (frontal polar) prefrontal region across moral judgment conditions, along with left lateroposterior orbitofrontal/ventrolateral prefrontal, left temporoparietal junction, midline thalamus and globus pallidus, and bilateral inferior occipital clusters. Trials entailing ambiguous moral situations activated considerably more prefrontal and parietal regions than did routine moral situations, suggesting the need for more neurocognitive resources. While age regression analysis identified a few regions of greater or lesser activity with age, the frontal polar activations did not change with age. Findings confirm a significant role for anterior-medial prefrontal cortex in the typical development and maturation of moral decision making, consistent with clinical lesion case descriptions.
C1 [Eslinger, Paul J.; Realmuto, Jennifer] Penn State Coll Med, Dept Neurol, Hershey, PA USA.
   [Eslinger, Paul J.; Robinson-Long, Melissa; Realmuto, Jennifer; Wang, Jianli; Yang, Qing X.] Milton S Hershey Med Ctr, Hershey, PA USA.
   [Eslinger, Paul J.; Robinson-Long, Melissa] Penn State Coll Med, Dept Neural & Behav Sci, Hershey, PA USA.
   [Eslinger, Paul J.] Penn State Coll Med, Dept Pediat, Hershey, PA USA.
   [Eslinger, Paul J.; Wang, Jianli] Penn State Coll Med, Ctr NMR Res, Dept Radiol, Hershey, PA USA.
   [Yang, Qing X.] Penn State Coll Med, Dept Neurosurg, Hershey, PA USA.
   [Moll, Jorge; deOliveira-Souza, Ricardo; Tovar-Moll, Fernanda] LABS DOr Hosp Network, Cognit Neurosci Unit, Rio De Janeiro, Brazil.
   [deOliveira-Souza, Ricardo] Hosp Univ Gaffree & Guinle, Rio De Janeiro, Brazil.
RP Eslinger, PJ (corresponding author), Penn State Hershey Med Ctr, Dept Neurol EC037, POB 850, Hershey, PA 17033 USA.
EM peslinger@psu.edu
RI Neurociencia, Inct/I-1011-2013; sarinopoulos, isidoros/B-5453-2010;
   Moll, Fernanda Tovar/N-3320-2018; Moll, Jorge/B-2654-2013
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Moll,
   Jorge/0000-0002-4297-591X
FU Pennsylvania Department of Health Tobacco Settlement Fund [4100020604];
   Children, Youth, and Family Consortium of Pennsylvania State University
FX This work was supported in part by the Pennsylvania Department of Health
   Tobacco Settlement Fund ( Grant 4100020604) and the Children, Youth, and
   Family Consortium of Pennsylvania State University.
CR ACKERLY SS, 1947, RES PUBL ASSOC RES N, V27, P479
   Anderson SW, 2006, J INT NEUROPSYCH SOC, V12, P224, DOI 10.1017/S1355617706060346
   Anderson SW, 1999, NAT NEUROSCI, V2, P1032
   BARONCOHEN S, 1993, UNDERSTANDING OTHER
   BENTON A, 1991, DEV NEUROPSYCHOL, V7, P275, DOI 10.1080/87565649109540495
   Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#
   Davidson RJ, 2000, PSYCHOL BULL, V126, P890, DOI [10.1037//0033-2909.126.6.890, 10.1037/0033-2909.126.6.890]
   Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004
   Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1
   ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021
   ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731
   ESLINGER PJ, 1997, DEV PREFRONTAL CORTE, P295
   Flavell J. H., 1993, COGNITIVE DEV
   Gibbs J. C., 2003, MORAL DEV REALITY TH
   GRATTAN LM, 1991, DEV NEUROPSYCHOL, V7, P283, DOI 10.1080/87565649109540496
   GRATTAN LM, 1992, BRAIN COGNITION, V20, P185, DOI 10.1016/0278-2626(92)90068-W
   Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027
   Harlow J. M., 1868, PUBLICATIONS MASSACH, V2, P327, DOI DOI 10.1177/0957154X9300401407
   Hebb D. O., 1949, ORG BEHAV A NEUROPSY
   Hoffman M. L., 2000, EMPATHY MORAL DEV IM
   Hongwanishkul D, 2005, DEV NEUROPSYCHOL, V28, P617, DOI 10.1207/s15326942dn2802_4
   Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672
   KOHLBERG L, 1964, REV CHILD DEV RES, V1, P383
   Kohlberg L., 1984, MORALITY MORAL BEHAV, P52
   LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155
   MARLOWE WB, 1992, BRAIN COGNITION, V20, P205, DOI 10.1016/0278-2626(92)90070-3
   MATEER CA, 1991, DEV NEUROPSYCHOL, V7, P359, DOI 10.1080/87565649109540498
   Moll J, 2003, NEUROREPORT, V14, P299, DOI 10.1097/01.wnr.0000057866.05120.28
   Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002
   Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768
   MOLL J, 2001, ARQUIVOS NEUROPSIQUI, V59, P667
   Moll J, 2007, SOC NEUROSCI-UK, V2, P336, DOI 10.1080/17470910701392024
   Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103
   Piaget J., 1968, 6 PSYCHOL STUDIES
   Powell KB, 2004, J CHILD NEUROL, V19, P785, DOI 10.1177/08830738040190100801
   PRICE BH, 1990, BRAIN, V113, P1383, DOI 10.1093/brain/113.5.1383
   Saleem KS, 2008, J COMP NEUROL, V506, P659, DOI 10.1002/cne.21577
   Seger CA, 2004, NEUROPSYCHOLOGIA, V42, P1168, DOI 10.1016/j.neuropsychologia.2004.02.003
   Seitz RJ, 2006, NEUROPSYCHOLOGY, V20, P743, DOI 10.1037/0894-4105.20.6.743
   Stams GJ, 2006, J ABNORM CHILD PSYCH, V34, P697, DOI 10.1007/s10802-006-9056-5
   Young L, 2007, P NATL ACAD SCI USA, V104, P8235, DOI 10.1073/pnas.0701408104
   Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104
NR 42
TC 20
Z9 21
U1 0
U2 18
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1380-3395
EI 1744-411X
J9 J CLIN EXP NEUROPSYC
JI J. Clin. Exp. Neuropsychol.
PY 2009
VL 31
IS 2
BP 158
EP 169
AR PII 906235897
DI 10.1080/13803390802298064
PG 12
WC Psychology, Clinical; Clinical Neurology; Psychology
SC Psychology; Neurosciences & Neurology
GA 397FG
UT WOS:000262647600003
PM 19048446
DA 2020-12-17
ER

PT J
AU de Oliveira-Souza, R
   Hare, RD
   Bramati, IE
   Garrido, GJ
   Ignacio, FA
   Tovar-Moll, F
   Moll, J
AF de Oliveira-Souza, Ricardo
   Hare, Robert D.
   Bramati, Ivanei E.
   Garrido, Griselda J.
   Ignacio, Fatima Azevedo
   Tovar-Moll, Fernanda
   Moll, Jorge
TI Psychopathy as a disorder of the moral brain: Fronto-temporo-limbic grey
   matter reductions demonstrated by voxel-based morphometry
SO NEUROIMAGE
LA English
DT Article
DE moral; limbic; prefrontal cortex; orbitofrontal; psychopathy; community
   psychiatric patients; antisocial behavior; brain morphometry
ID PREFRONTAL GRAY-MATTER; FLUID INTELLIGENCE; RESPONSE REVERSAL; LATENT
   STRUCTURE; DECISION-MAKING; PCL-SV; CORTEX; RISK; DEMENTIA; VOLUME
AB Major advances have been made in the understanding of the neurobiology of psychopathy in the past years, yet the distribution and extent of neuroanatomical abnormalities underlying the disorder are still poorly known. It is also unclear if different dimensions of the construct of psychopathy (e. g., emotional callousness, antisocial behavior) correspond to structural abnormalities in distinct regions of the brain. We tested the following hypotheses: (1) psychopathy is related to grey matter reductions in regions of the brain that underlie moral conduct and (2) the severity of psychopathy is related to the degree of structural abnormalities. Optimized voxel-based morphometry and the screening version of the Psychopathy Checklist (PCL: SV) were employed to investigate a matched sample of 15 community psychiatric patients with high PCL: SV scores, and 15 healthy normal volunteers. The analyses controlled for total grey matter, white matter and cerebrospinal fluid volumes. Grey matter reductions were observed in the frontopolar, orbitofrontal and anterior temporal cortices, superior temporal sulcus region, and insula of the patients. The degree of structural abnormalities was significantly related to the interpersonal/affective dimension of psychopathy. The pattern of grey matter reductions in patients with high psychopathy scores comprised a distributed fronto-temporal network which plays a critical role in moral sensibility and behavior. (C) 2008 Elsevier Inc. All rights reserved.
C1 [de Oliveira-Souza, Ricardo; Bramati, Ivanei E.; Tovar-Moll, Fernanda; Moll, Jorge] LABS Hosp Network, Cognit & Behav Neurosci Unit, BR-22281080 Rio De Janeiro, RJ, Brazil.
   [de Oliveira-Souza, Ricardo] Gaffree & Guinle Univ Hosp, Rio De Janeiro, Brazil.
   [Hare, Robert D.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.
   [Hare, Robert D.] Darkstone Res Grp, Vancouver, BC, Canada.
   [Garrido, Griselda J.] Inst Israelita Ensino & Pesquisa Albert Einstein, Sao Paulo, Brazil.
   [Ignacio, Fatima Azevedo] Inst Philippe Pinel, Rio De Janeiro, Brazil.
RP Moll, J (corresponding author), LABS Hosp Network, Cognit & Behav Neurosci Unit, BR-22281080 Rio De Janeiro, RJ, Brazil.
EM mollj@neuroscience-rio.org
RI Hare, Robert D/E-8333-2017; Neurociencia, Inct/I-1011-2013; Moll,
   Fernanda Tovar/N-3320-2018; Moll, Jorge/B-2654-2013
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Moll,
   Jorge/0000-0002-4297-591X
CR Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189
   Birbaumer N, 2005, ARCH GEN PSYCHIAT, V62, P799, DOI 10.1001/archpsyc.62.7.799
   Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122
   BOOK AS, 2006, FORENSIC USES CLIN A
   Bozeat S, 2000, J NEUROL NEUROSUR PS, V69, P178, DOI 10.1136/jnnp.69.2.178
   Cleckley H., 1976, MASK SANITY
   Colom R, 2006, PSICOTHEMA, V18, P816
   Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048
   Critchley HD, 2003, NEUROIMAGE, V18, P908, DOI 10.1016/S1053-8119(03)00011-9
   Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654
   Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187
   DEOLIVEIRASOUZA R, IN PRESS CRIMINAL JU
   Dolan M, 2004, PSYCHOL MED, V34, P1093, DOI 10.1017/S0033291704002028
   Dolan M, 2002, PSYCHOL MED, V32, P105, DOI 10.1017/S0033291701004688
   Dolan MC, 2002, PSYCHIAT RES-NEUROIM, V116, P133, DOI 10.1016/S0925-4927(02)00085-9
   ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021
   ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731
   Forth AE, 1996, PERS INDIV DIFFER, V20, P531, DOI 10.1016/0191-8869(95)00221-9
   Freedman LJ, 2000, J COMP NEUROL, V421, P172
   Gong QY, 2005, NEUROIMAGE, V25, P1175, DOI 10.1016/j.neuroimage.2004.12.044
   Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786
   Guay JP, 2007, J ABNORM PSYCHOL, V116, P701, DOI 10.1037/0021-843X.116.4.701
   Guy LS, 2006, PSYCHOL ASSESSMENT, V18, P225, DOI 10.1037/1040-3590.18.2.225
   Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025
   Hare R. D., 2003, HARE PSYCHOPATHY CHE
   HARE RD, 1966, J ABNORM PSYCHOL, V71, P25, DOI 10.1037/h0022909
   Hare Robert D, 2005, Curr Psychiatry Rep, V7, P57, DOI 10.1007/s11920-005-0026-3
   Hart S., 1995, HARE PSYCHOPATHY CHE
   Heaton R. K., 1993, WISCONSIN CARD SORTI
   Heekeren HR, 2003, NEUROREPORT, V14, P1215, DOI 10.1097/00001756-200307010-00005
   Heims HC, 2004, NEUROPSYCHOLOGIA, V42, P1979, DOI 10.1016/j.neuropsychologia.2004.06.001
   Howard D., 1992, PYRAMIDS PALM TREES
   Jefferies E, 2006, BRAIN, V129, P2132, DOI 10.1093/brain/awl153
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593
   Kiehl KA, 2004, PSYCHIAT RES-NEUROIM, V130, P295, DOI 10.1016/j.pscychresns.2004.02.001
   Kiehl KA, 2006, PSYCHIAT RES, V142, P107, DOI 10.1016/j.psychres.2005.09.013
   Koechlin E, 1999, NATURE, V399, P148
   Kruesi MJP, 2004, PSYCHIAT RES-NEUROIM, V132, P1, DOI 10.1016/j.pscychresns.2004.07.002
   Laakso MP, 2001, BEHAV BRAIN RES, V118, P187, DOI 10.1016/S0166-4328(00)00324-7
   LAPIERRE D, 1995, NEUROPSYCHOLOGIA, V33, P139, DOI 10.1016/0028-3932(94)00110-B
   Losel F, 2004, J ABNORM PSYCHOL, V113, P522, DOI 10.1037/0021-843X.113.4.522
   MacMillan M, 2000, ODD KIND FAME STORIE
   Mega MS, 1997, J NEUROPSYCH CLIN N, V9, P315
   Mendez MF, 2000, J NEUROPSYCH CLIN N, V12, P71, DOI 10.1176/jnp.12.1.71
   Mitchell DGV, 2002, NEUROPSYCHOLOGIA, V40, P2013, DOI 10.1016/S0028-3932(02)00056-8
   Moll J, 2003, NEUROREPORT, V14, P299, DOI 10.1097/01.wnr.0000057866.05120.28
   Moll J, 2001, ARQ NEURO-PSIQUIAT, V59, P657, DOI 10.1590/S0004-282X2001000500001
   Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768
   Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103
   Monahan J, 2001, RETHINKING RISK ASSE
   MUFSON EJ, 1981, NEUROSCIENCE, V6, P1231, DOI 10.1016/0306-4522(81)90184-6
   Neumann CS, 2006, PSYCHOL ASSESSMENT, V18, P142, DOI 10.1037/1040-3590.18.2.142
   NEWMAN JP, 1987, J ABNORM PSYCHOL, V96, P145, DOI 10.1037/0021-843X.96.2.145
   Nitrini R, 2004, ALZ DIS ASSOC DIS, V18, P241
   Ogloff JRP, 2006, AUST NZ J PSYCHIAT, V40, P519, DOI 10.1111/j.1440-1614.2006.01834.x
   Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4
   Patrick C. J., 2006, HDB PSYCHOPATHY
   Price JL, 1999, ANN NY ACAD SCI, V877, P383, DOI 10.1111/j.1749-6632.1999.tb09278.x
   Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119
   Raine A, 2004, BIOL PSYCHIAT, V55, P185, DOI 10.1016/S0006-3223(03)00727-3
   Raine A, 2003, ARCH GEN PSYCHIAT, V60, P1134, DOI 10.1001/archpsyc.60.11.1134
   RAINE A, 2006, HDB PSYCHOPATHY, P278
   Rogers R. D., 2006, HDB PSYCHOPATHY, P313
   SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9
   Schmitt WA, 1999, J ABNORM PSYCHOL, V108, P538, DOI 10.1037/0021-843X.108.3.538
   Silani G, 2005, BRAIN, V128, P2453, DOI 10.1093/brain/awh579
   Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271
   SPITZER RL, 2000, HDB PSYCHIAT MEASURE, P96
   Steadman HJ, 2000, LAW HUMAN BEHAV, V24, P83, DOI 10.1023/A:1005478820425
   Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8
   Tranel D, 2005, BRAIN, V128, P2872, DOI 10.1093/brain/awh643
   Urbaniok F, 2007, INT J LAW PSYCHIAT, V30, P147, DOI 10.1016/j.ijlp.2006.04.001
   Viding E, 2005, J CHILD PSYCHOL PSYC, V46, P592, DOI 10.1111/j.1469-7610.2004.00393.x
   Walters GD, 2007, ASSESSMENT, V14, P270, DOI 10.1177/1073191107299594
   Yang YL, 2005, BIOL PSYCHIAT, V57, P1103, DOI 10.1016/j.biopsych.2005.01.021
   Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327
   Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104
   Zak PJ, 2004, ANN NY ACAD SCI, V1032, P224, DOI 10.1196/annals.1314.025
NR 78
TC 157
Z9 161
U1 1
U2 43
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1053-8119
EI 1095-9572
J9 NEUROIMAGE
JI Neuroimage
PD APR 15
PY 2008
VL 40
IS 3
BP 1202
EP 1213
DI 10.1016/j.neuroimage.2007.12.054
PG 12
WC Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA 284TH
UT WOS:000254728200019
PM 18289882
DA 2020-12-17
ER

PT J
AU Fontenelle, LF
   Bramati, IE
   Moll, J
   de Oliveira-Souza, R
   Tovar-Moll, F
AF Fontenelle, Leonardo F.
   Bramati, Ivanei E.
   Moll, Jorge
   de Oliveira-Souza, Ricardo
   Tovar-Moll, Fernanda
TI White matter changes in obsessive-compulsive disorder revealed by
   diffusion tensor imaging
SO BIOLOGICAL PSYCHIATRY
LA English
DT Meeting Abstract
CT 63rd Annual Convention of the Society-of-Biological-Psychiatry
CY 2008
CL Washington, DC
SP Soc Biol Psychiat
C1 [Fontenelle, Leonardo F.] Univ Fed Rio de Janeiro, Inst Psychiat, Anxiety & Depress Res Program, Rio De Janeiro, Brazil.
   [Fontenelle, Leonardo F.] Univ Fed Fluminense, Inst Community Hlth, Dept Psychiat & Mental Hlth, Niteroi, RJ, Brazil.
   [Fontenelle, Leonardo F.; Bramati, Ivanei E.; Moll, Jorge; de Oliveira-Souza, Ricardo; Tovar-Moll, Fernanda] LABS Hosp Network, Rio De Janeiro, Brazil.
   [de Oliveira-Souza, Ricardo] Gaffree & Guinle Univ Hosp, Dept Clin Med, Rio De Janeiro, Brazil.
RI Fontenelle, Leonardo/D-3321-2013; Moll, Fernanda Tovar/N-3320-2018
OI Fontenelle, Leonardo/0000-0001-9075-8226; Moll, Fernanda
   Tovar/0000-0002-0292-5985
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0006-3223
J9 BIOL PSYCHIAT
JI Biol. Psychiatry
PD APR 1
PY 2008
VL 63
IS 7
SU S
MA 542
BP 173S
EP 173S
PG 1
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 276SV
UT WOS:000254163700552
DA 2020-12-17
ER

PT J
AU Simonyan, K
   Tovar-Moll, F
   Ostuni, J
   Hallett, M
   Kalasinsky, VF
   Lewin-Smith, MR
   Rushing, EJ
   Vortmeyer, AO
   Ludlow, CL
AF Simonyan, Kristina
   Tovar-Moll, Fernanda
   Ostuni, John
   Hallett, Mark
   Kalasinsky, Victor F.
   Lewin-Smith, Michael R.
   Rushing, Elisabeth J.
   Vortmeyer, Alexander O.
   Ludlow, Christy L.
TI Focal white matter changes in spasmodic dysphonia: a combined diffusion
   tensor imaging and neuropathological study
SO BRAIN
LA English
DT Article
DE laryngeal dystonia; corticobulbar tract; basal ganglia; neuroimaging;
   neuropathology
ID BOTULINUM TOXIN TREATMENT; BASAL GANGLIA; INTERNAL CAPSULE; WRITERS
   CRAMP; HUMAN BRAIN; LANGUAGE LATERALIZATION; COMPUTED-TOMOGRAPHY; WATER
   DIFFUSION; PYRAMIDAL TRACT; RHESUS-MONKEY
AB Spasmodic dysphonia is a neurological disorder characterized by involuntary spasms in the laryngeal muscles during speech production. Although the clinical symptoms are well characterized, the pathophysiology of this voice disorder is unknown. We describe here, for the first time to our knowledge, disorder-specific brain abnormalities in these patients as determined by a combined approach of diffusion tensor imaging ( DTI) and postmortem histopathology. We used DTI to identify brain changes and to target those brain regions for neuropathological examination. DTI showed right-sided decrease of fractional anisotropy in the genu of the internal capsule and bilateral increase of overall water diffusivity in the white matter along the corticobulbar/ corticospinal tract in 20 spasmodic dysphonia patients compared to 20 healthy subjects. In addition, water diffusivity was bilaterally increased in the lentiform nucleus, ventral thalamus and cerebellar white and grey matter in the patients. These brain changes were substantiated with focal histopathological abnormalities presented as a loss of axonal density and myelin content in the right genu of the internal capsule and clusters of mineral depositions, containing calcium, phosphorus and iron, in the parenchyma and vessel walls of the posterior limb of the internal capsule, putamen, globus pallidus and cerebellum in the postmortem brain tissue from one patient compared to three controls. The specificity of these brain abnormalities is confirmed by their localization, limited only to the corticobulbar/ corticospinal tract and its main input/ output structures. We also found positive correlation between the diffusivity changes and clinical symptoms of spasmodic dysphonia ( r= 0.509, P= 0.037). These brain abnormalities may alter the central control of voluntary voice production and, therefore, may underlie the pathophysiology of this disorder.
C1 [Simonyan, Kristina; Ludlow, Christy L.] NINDS, Med Neurol Branch, Laryngeal & Speech Sect, NIH, Bethesda, MD 20892 USA.
   [Tovar-Moll, Fernanda] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD USA.
   [Ostuni, John] NINDS, Clin Neurosci Program, NIH, Bethesda, MD USA.
   [Hallett, Mark] NINDS, Human Motor Control Sect, NIH, Bethesda, MD USA.
   [Kalasinsky, Victor F.; Lewin-Smith, Michael R.] NINDS, Dept Environm & Infect Dis Sci, NIH, Bethesda, MD USA.
   [Rushing, Elisabeth J.] NINDS, Dept Neuropathol & Ophthalm Pathol, Armed Forces Inst Pathol, NIH, Bethesda, MD USA.
   [Vortmeyer, Alexander O.] NINDS, Surg Neurol Branch, NIH, Bethesda, MD USA.
RP Simonyan, K (corresponding author), NINDS, Med Neurol Branch, Laryngeal & Speech Sect, NIH, 10 Canc Dr,Bldg 10,Room 5D38, Bethesda, MD 20892 USA.
EM simonyak@ninds.nih.gov
RI Neurociencia, Inct/I-1011-2013; Moll, Fernanda Tovar/N-3320-2018;
   Simonyan, Kristina/E-2511-2016
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Ludlow,
   Christy/0000-0002-2015-6171; Simonyan, Kristina/0000-0001-7444-0437
FU NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [Z01NS003031, Z01NS002980, Z01NS002980, Z01NS002980, Z01NS003031,
   Z01NS002980, Z01NS002980, Z01NS002980, Z01NS002980, Z01NS002980,
   Z01NS002980, Z01NS002980] Funding Source: NIH RePORTER; Intramural NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [Z01 NS002980-08, Z99 NS999999] Funding
   Source: Medline
CR Ali SO, 2006, J SPEECH LANG HEAR R, V49, P1127, DOI 10.1044/1092-4388(2006/081)
   Aoki Shigeki, 2005, Radiat Med, V23, P195
   Arbib M. A., 1981, HDB PHYSL NERVOUS SY, V2, P1449, DOI DOI 10.1016/J.JPHYSPARIS.2008.03.001
   Barkmeier JM, 2001, J COMMUN DISORD, V34, P21, DOI 10.1016/S0021-9924(00)00039-3
   BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1
   Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782
   Berardelli A, 1998, BRAIN, V121, P1195, DOI 10.1093/brain/121.7.1195
   BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859
   Bielamowicz S, 2000, ANN OTO RHINOL LARYN, V109, P194, DOI 10.1177/000348940010900215
   BINDER JR, 1995, ARCH NEUROL-CHICAGO, V52, P593, DOI 10.1001/archneur.1995.00540300067015
   Black KJ, 1998, NEUROLOGY, V51, P819, DOI 10.1212/WNL.51.3.819
   BLOCH CS, 1985, ANN OTO RHINOL LARYN, V94, P51
   Blood AJ, 2006, NEUROREPORT, V17, P1251, DOI 10.1097/01.wnr.0000230500.03330.01
   BOGOUSSLAVSKY J, 1990, NEUROLOGY, V40, P1499, DOI 10.1212/WNL.40.10.1499
   Bonilha L, 2007, MOVEMENT DISORD, V22, P1110, DOI 10.1002/mds.21295
   Bookheimer SY, 1997, NEUROLOGY, V48, P1056, DOI 10.1212/WNL.48.4.1056
   BROWN LL, 1989, J NEUROSCI, V9, P4033
   Campbell DB, 1999, EXP NEUROL, V160, P268, DOI 10.1006/exnr.1999.7171
   Campbell DB, 1998, NEUROSCIENCE, V85, P773, DOI 10.1016/S0306-4522(97)00672-6
   Carbon M, 2004, ANN NEUROL, V56, P283, DOI 10.1002/ana.20177
   Casanova MF, 2003, PSYCHIAT RES, V121, P59, DOI 10.1016/S0165-1781(03)00202-6
   CeballosBaumann AO, 1997, BRAIN, V120, P571, DOI 10.1093/brain/120.4.571
   Colosimo C, 2005, J NEUROL NEUROSUR PS, V76, P1591, DOI 10.1136/jnnp.2004.056614
   DAVIDOFF RA, 1990, NEUROLOGY, V40, P332
   Desmond JE, 1995, BRAIN, V118, P1411, DOI 10.1093/brain/118.6.1411
   Edgar JD, 2001, J VOICE, V15, P362, DOI 10.1016/S0892-1997(01)00038-8
   Eidelberg D, 1998, CURR OPIN NEUROL, V11, P319, DOI 10.1097/00019052-199808000-00007
   FLETCHER NA, 1988, MOVEMENT DISORD, V3, P336, DOI 10.1002/mds.870030410
   Furutani K, 2005, J MED INVESTIG, V52, P186, DOI 10.2152/jmi.52.186
   Galardi G, 1996, ACTA NEUROL SCAND, V94, P172, DOI 10.1111/j.1600-0404.1996.tb07049.x
   Gass A, 2001, J NEUROL SCI, V186, pS15, DOI 10.1016/S0022-510X(01)00487-7
   Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001
   Hallett M, 1998, ARCH NEUROL-CHICAGO, V55, P601, DOI 10.1001/archneur.55.5.601
   Hallett Mark, 2004, Adv Neurol, V94, P1
   Haslinger B, 2005, NEUROLOGY, V65, P1562, DOI 10.1212/01.wnl.0000184478.59063.db
   Holodny AI, 2005, RADIOLOGY, V234, P649, DOI 10.1148/radiol.2343032087
   Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787
   Hutchinson M, 2000, NEUROLOGY, V55, P673, DOI 10.1212/WNL.55.5.673
   IWATSUBO T, 1990, NEUROLOGY, V40, P309, DOI 10.1212/WNL.40.2.309
   Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004
   Jinnah HA, 2006, NEUROLOGY, V67, P1740, DOI 10.1212/01.wnl.0000246112.19504.61
   Jurgens U, 2007, BRAIN RES, V1148, P90, DOI 10.1016/j.brainres.2007.02.020
   JURGENS U, 1982, BRAIN LANG, V15, P234, DOI 10.1016/0093-934X(82)90058-X
   Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9
   Kantarci K, 2001, RADIOLOGY, V219, P101, DOI 10.1148/radiology.219.1.r01ap14101
   Karnell MP, 2007, J VOICE, V21, P576, DOI 10.1016/j.jvoice.2006.05.001
   KULISEVSKY J, 1988, MOVEMENT DISORD, V3, P170, DOI 10.1002/mds.870030209
   KUYPERS HGJ, 1958, BRAIN, V81, P364, DOI 10.1093/brain/81.3.364
   Le Ber I, 2006, NEUROLOGY, V67, P1769, DOI 10.1212/01.wnl.0000244484.60489.50
   Le Bihan D, 2002, NMR BIOMED, V15, P431, DOI 10.1002/nbm.798
   LEDOUX MS, 1993, EXP NEUROL, V120, P302, DOI 10.1006/exnr.1993.1064
   Levy LM, 2002, ANN NEUROL, V51, P93, DOI 10.1002/ana.10073
   LUDLOW CL, 1995, ANN OTO RHINOL LARYN, V104, P928, DOI 10.1177/000348949510401203
   MANELFE C, 1981, AM J NEURORADIOL, V2, P149
   McNaught KS, 2004, ANN NEUROL, V56, P540, DOI 10.1002/ana.20225
   Meunier S, 2003, NEUROSCIENTIST, V9, P76, DOI 10.1177/1073858402239593
   Mori S., 2005, MRI ATLAS HUMAN WHIT
   Nash EA, 1996, LARYNGOSCOPE, V106, P484, DOI 10.1097/00005537-199604000-00017
   Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058
   Odergren T, 1998, MOVEMENT DISORD, V13, P497, DOI 10.1002/mds.870130321
   Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.3.CO;2-A
   Perlmutter JS, 1997, J NEUROSCI, V17, P843
   Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452
   Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765
   Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209
   Pizoli CE, 2002, J NEUROSCI, V22, P7825
   Preibisch C, 2001, J NEUROL, V248, P10, DOI 10.1007/s004150170263
   Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x
   Richter A, 1998, MOVEMENT DISORD, V13, P718, DOI 10.1002/mds.870130419
   ROSS ED, 1980, NEUROLOGY, V30, P59, DOI 10.1212/WNL.30.1.59
   Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284
   Sapienza CM, 2000, J VOICE, V14, P502, DOI 10.1016/S0892-1997(00)80008-9
   SASTRY S, 1995, NEUROSCIENCE, V67, P649, DOI 10.1016/0306-4522(94)00618-F
   Simonyan K, 2005, NEUROSCIENCE, V130, P133, DOI 10.1016/j.neuroscience.2004.08.031
   Simonyan K, 2002, BRAIN RES, V949, P23, DOI 10.1016/S0006-8993(02)02960-8
   Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062
   Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024
   SOISSON T, 1982, J NEURORADIOLOGY, V9, P304
   Sykova E, 2004, NEUROSCIENCE, V129, P861, DOI 10.1016/j.neuroscience.2004.06.077
   TREDICI G, 1982, J ANAT, V134, P199
   Vernooij MW, 2007, NEUROIMAGE, V35, P1064, DOI 10.1016/j.neuroimage.2006.12.041
   Wildgruber D, 2001, NEUROIMAGE, V13, P101, DOI 10.1006/nimg.2000.0672
   Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027
   Wszolek ZK, 2006, NEUROLOGY, V67, P620, DOI 10.1212/01.wnl.0000230141.40784.09
   ZHANG ZH, 1989, CHINESE MED J-PEKING, V102, P24
   Zweig R M, 1988, Adv Neurol, V49, P395
NR 86
TC 85
Z9 87
U1 0
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
J9 BRAIN
JI Brain
PD FEB
PY 2008
VL 131
BP 447
EP 459
DI 10.1093/brain/awm303
PN 2
PG 13
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 258XO
UT WOS:000252903900016
PM 18083751
OA Bronze, Green Accepted
DA 2020-12-17
ER

PT J
AU Tovar-Moll, F
   Moll, J
   Bramati, IE
   de Souza, AS
AF Tovar-Moll, Fernanda
   Moll, Jorge
   Bramati, Ivanei Edson
   de Souza, Andrea Silveira
TI The human pyramidal syndrome Redux
SO NEUROREPORT
LA English
DT Article
DE medullary pyramid; pyramidal tract; spastic hemiplegia; tractography
ID INFARCTION; HEMIPLEGIA; RECOVERY; SCALE
AB Experimental studies in nonhuman primates have questioned the selectivity of pyramidal tract damage in giving rise to the classical pyramidal syndrome in humans, characterized by permanent spastic hemiplegia (PSH). According to this view, concomitant injury of extrapyramidal pathways is necessary for the development of both hemiplegia and spasticity. In this study we used conventional magnetic resonance imaging and diffusion tensor imaging tractography to characterize the anatomical correlates of PSH in a patient with a rare and discrete unilateral lesion of the medullary pyramid. Our findings support the hypothesis that damage confined to the medullary pyramid/pyramidal tract is sufficient to produce PSH. In contrast to nonhuman primates, the human 'pyramidal' and 'pyramid' syndromes are equivalent clinico-anatomic concepts.
C1 Univ Fed Rio de Janeiro, Inst Biomed Sci, Dept Anat, BR-21941 Rio De Janeiro, Brazil.
   Gaffree Guinle Univ Hosp, Labs DOr Hosp Network, Cognit & Behav Neurosci Unit, Rio De Janeiro, Brazil.
   Gaffree Guinle Univ Hosp, Rio De Janeiro, Brazil.
RP Tovar-Moll, F (corresponding author), Cognit & Behav Neurosci Unit, R Pinheiro Guimaraes 22,4 andar, BR-22281080 Rio De Janeiro, Brazil.
EM tovarmollf@gmail.com; rdeoliveira@gmail.com
RI de Souza, Andrea Silveira/AAL-1976-2020; Moll, Fernanda
   Tovar/N-3320-2018
OI de Souza, Andrea Silveira/0000-0002-1553-2312; Moll, Fernanda
   Tovar/0000-0002-0292-5985
CR AGUILAR MJ, 1969, AMER J PHYSICAL MED, V48, P279
   Bassetti C, 1996, NEUROLOGY, V46, P165, DOI 10.1212/WNL.46.1.165
   Benton A.L., 1994, CONTRIBUTIONS NEUROP
   BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206
   Brown WJ, 1961, NEUROLOGY, V11, P829
   Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014
   CAPLAN LR, 1989, NEUROLOGY, V39, P1246, DOI 10.1212/WNL.39.9.1246
   Crawford JR, 1998, J CLIN EXP NEUROPSYC, V20, P898, DOI 10.1076/jcen.20.6.898.1112
   DEJERINE J, 1914, SEMEIOLOGY NERVOUS S
   Dellon A L, 1978, J Hand Surg Am, V3, P474
   DENNYBROWN D, 1966, CEREBRAL CONTROL MEA
   FISHER CM, 1992, CAN J NEUROL SCI, V19, P57, DOI 10.1017/S0317167100042542
   FISHER CM, 1977, CAN J NEUROL SCI, V4, P251, DOI 10.1017/S0317167100025075
   HALLETT M, 1993, NEUROLOGY, V43, P2723, DOI 10.1212/WNL.43.12.2723
   HANKEY GJ, 1989, J NEUROL NEUROSUR PS, V52, P395, DOI 10.1136/jnnp.52.3.395
   Hirayama K, 1986, CLIN NEUROL TOKYO, V26, P448
   Katoh M, 2000, J CLIN NEUROSCI, V7, P543, DOI 10.1054/jocn.2000.0675
   Manschot S, 1998, J NEUROL NEUROSUR PS, V64, P253, DOI 10.1136/jnnp.64.2.253
   Oliveira-Souza R, 1989, Arq Neuropsiquiatr, V47, P8
   Prus J, 1898, WIEN KLIN WOCHENSCHR, V11, P857
   ROPPER AH, 1979, NEUROLOGY, V29, P91
   ROSS ED, 1980, NEUROLOGY, V30, P59, DOI 10.1212/WNL.30.1.59
   Spreen O, 1998, COMPENDIUM NEUROPSYC
   Thomalla G, 2005, J NEUROL NEUROSUR PS, V76, P266, DOI 10.1136/jnnp.2004.046375
   Wiesendanger M, 1984, Hum Neurobiol, V2, P227
NR 25
TC 4
Z9 4
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0959-4965
EI 1473-558X
J9 NEUROREPORT
JI Neuroreport
PD SEP 17
PY 2007
VL 18
IS 14
BP 1417
EP 1421
DI 10.1097/WNR.0b013e3282e9a509
PG 5
WC Neurosciences
SC Neurosciences & Neurology
GA 210UA
UT WOS:000249479900002
PM 17712266
DA 2020-12-17
ER

PT J
AU Durastanti, V
   Tovar-Moll, F
   Evangelou, I
   Pellegrini, S
   Ohayon, J
   Ehrmantraut, M
   Gaindh, D
   Cantor, F
   McFarland, H
   Bagnato, F
AF Durastanti, V.
   Tovar-Moll, F.
   Evangelou, I.
   Pellegrini, S.
   Ohayon, J.
   Ehrmantraut, M.
   Gaindh, D.
   Cantor, F.
   McFarland, H.
   Bagnato, F.
TI Macroscopic and microscopic changes in deep grey matter structures of
   patients with multiple sclerosis
SO JOURNAL OF NEUROLOGY
LA English
DT Meeting Abstract
CT 17th Meeting of the European-Neurological-Society
CY JUN 16-20, 2007
CL Rhodes, GREECE
SP European Neurolog Soc
C1 Natl Inst Hlth, Bethesda, MD USA.
RI Moll, Fernanda Tovar/N-3320-2018
OI Moll, Fernanda Tovar/0000-0002-0292-5985
NR 0
TC 0
Z9 0
U1 0
U2 0
PU DR DIETRICH STEINKOPFF VERLAG
PI DARMSTADT
PA PO BOX 10 04 62, D-64204 DARMSTADT, GERMANY
SN 0340-5354
J9 J NEUROL
JI J. Neurol.
PD MAY
PY 2007
VL 254
SU 3
BP 14
EP 14
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 175SN
UT WOS:000247034400042
DA 2020-12-17
ER

PT J
AU Tovar-Moll, F
   Moll, J
   de Oliveira-Souza, R
   Bramati, I
   Andreiuolo, PA
   Lent, R
AF Tovar-Moll, Fernanda
   Moll, Jorge
   de Oliveira-Souza, Ricardo
   Bramati, Ivanei
   Andreiuolo, Pedro A.
   Lent, Roberto
TI Neuroplasticity in human callosal dysgenesis: A diffusion tensor imaging
   study
SO CEREBRAL CORTEX
LA English
DT Article
DE callosal agenesis; callosal development; corpus callosum; cortex
   development; cortical commissures; DTI
ID HUMAN CORPUS-CALLOSUM; PROBST LONGITUDINAL BUNDLE; COMMISSURAL FIBERS;
   ACALLOSAL MOUSE; BRAIN REORGANIZATION; SYNAPTIC PLASTICITY; AXONAL
   PROJECTIONS; CONGENITAL ABSENCE; EARLY CALLOSOTOMY; TOPOGRAPHY
AB Callosal dysgenesis (CD) is observed in many neurodevelopmental conditions, but its subjacent mechanisms are unknown, despite extensive research on animals. Here we employ magnetic resonance diffusion tensor imaging and tractography in human CD to reveal the aberrant circuitry of these brains. We searched particularly for evidence of plasticity. Four main findings are described-1) in the presence of a callosal remnant or a hypoplastic corpus callosum (CC), fibers therein largely connect the expected neocortical regions; 2) callosal remnants and hypoplastic CCs display a fiber topography similar to normal; 3) at least 2 long abnormal tracts are formed in patients with defective CC: the well-known Probst bundle (PB) and a so far unknown sigmoid, asymmetrical aberrant bundle connecting the frontal lobe with the contralateral occipitoparietal cortex; and 4) whereas the PB is topographically organized and has an ipsilateral U-connectivity, the sigmoid bundle is a long, heterotopic commissural tract. These observations suggest that when the developing human brain is confronted with factors that hamper CC fibers to cross the midline, some properties of the miswired fibers are maintained (such as side-by-side topography), whereas others are dramatically changed, leading to the formation of grossly abnormal white matter tracts.
C1 Univ Fed Rio de Janeiro, Inst Biomed Sci, Dept Anat, BR-21941 Rio De Janeiro, Brazil.
   Labs Or Hosp Network, Cognit Behav Neurosci Unit, Rio De Janeiro, Brazil.
RP Tovar-Moll, F (corresponding author), Natl Inst Neurol Disorders & Stroke, Neuroimmunol Branch, NIH, 10 Ctr Dr,Bldg 10,Room 5B08, Bethesda, MD 20892 USA.
EM tovarmof@ninds.nih.gov
RI Moll, Jorge/B-2654-2013; Moll, Fernanda Tovar/N-3320-2018
OI Moll, Fernanda Tovar/0000-0002-0292-5985
CR Abe O, 2004, J COMPUT ASSIST TOMO, V28, P533, DOI 10.1097/00004728-200407000-00016
   Albayram S, 2002, RADIOLOGY, V223, P645, DOI 10.1148/radiol.2233011197
   [Anonymous], 2000, JAMA, V284, P3043
   Arnold SE, 2005, PROG BRAIN RES, V147, P319, DOI 10.1016/S0079-6123(04)47023-X
   Bagnard D, 1998, DEVELOPMENT, V125, P5043
   BARBAS H, 1984, EXP BRAIN RES, V55, P187
   Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O
   Bernasconi A, 2000, NEUROREPORT, V11, P3085, DOI 10.1097/00001756-200009280-00010
   Blitz DM, 2004, NAT REV NEUROSCI, V5, P630, DOI 10.1038/nrn1475
   CIPOLLONI PB, 1985, EXP BRAIN RES, V57, P381
   CLARKE S, 1989, J COMP NEUROL, V280, P213, DOI 10.1002/cne.902800205
   Clowry GJ, 2004, EUR J NEUROSCI, V20, P2555, DOI 10.1111/j.1460-9568.2004.03713.x
   DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004
   Elbert T, 2002, J NEUROSCI, V22, P9941
   Feller MB, 2005, CURR OPIN NEUROBIOL, V15, P94, DOI 10.1016/j.conb.2005.01.012
   Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366
   Hedin-Pereira C, 1999, CEREB CORTEX, V9, P50, DOI 10.1093/cercor/9.1.50
   Hori A, 2004, NEUROPATHOLOGY, V24, P56, DOI 10.1111/j.1440-1789.2003.00528.x
   Hu ZL, 2003, J NEUROSCI, V23, P10963
   Huang H, 2004, MAGN RESON MED, V52, P559, DOI 10.1002/mrm.20147
   INNOCENTI GM, 1984, J COMP NEUROL, V230, P287, DOI 10.1002/cne.902300212
   Innocenti GM, 2005, NAT REV NEUROSCI, V6, P955, DOI 10.1038/nrn1790
   Kennard MA, 1942, ARCH NEURO PSYCHIATR, V48, P227, DOI 10.1001/archneurpsyc.1942.02290080073002
   Keshavan MS, 2002, LIFE SCI, V70, P1909, DOI 10.1016/S0024-3205(02)01492-3
   Kier EL, 1997, AM J NEURORADIOL, V18, P715
   Kier EL, 1996, AM J NEURORADIOL, V17, P1631
   KOESTER SE, 1994, J NEUROSCI, V14, P6608
   Kuker W, 2003, EUR RADIOL, V13, P598, DOI 10.1007/s00330-002-1541-9
   LASSONDE M, 1991, NEUROPSYCHOLOGIA, V29, P481, DOI 10.1016/0028-3932(91)90006-T
   LASSONDE M, 1988, BEHAV BRAIN RES, V30, P165, DOI 10.1016/0166-4328(88)90146-5
   Lassonde MC, 2002, IS CL CO NE, P357
   Lazar M, 2003, NEUROIMAGE, V20, P1140, DOI 10.1016/S1053-8119(03)00277-5
   Lee HY, 2004, ELECTROPHORESIS, V25, P28, DOI 10.1002/elps.200305681
   Lee SK, 2005, RADIOGRAPHICS, V25, P53, DOI 10.1148/rg.251045085
   LENT R, 1984, J COMP NEUROL, V223, P548, DOI 10.1002/cne.902230407
   LENT R, 1983, DEV BRAIN RES, V11, P137, DOI 10.1016/0165-3806(83)90210-9
   Lent R, 2005, J COMP NEUROL, V483, P375, DOI 10.1002/cne.20427
   Lessard N, 2002, BRAIN, V125, P1039, DOI 10.1093/brain/awf096
   Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351
   MATSUNAMI K, 1994, NEUROSCI RES, V20, P137, DOI 10.1016/0168-0102(94)90031-0
   Meyer BU, 1998, ANN NEUROL, V43, P360, DOI 10.1002/ana.410430314
   Meyer BU, 1998, J NEUROL, V245, P106, DOI 10.1007/s004150050187
   Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3
   Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781
   NAKAMURA H, 1989, BRAIN RES, V485, P171, DOI 10.1016/0006-8993(89)90679-3
   Nordeen KW, 2004, ANN NY ACAD SCI, V1016, P416, DOI 10.1196/annals.1298.018
   OLAVARRIA J, 1988, J COMP NEUROL, V270, P575, DOI 10.1002/cne.902700411
   OZAKI HS, 1993, J COMP NEUROL, V336, P595, DOI 10.1002/cne.903360411
   OZAKI HS, 1988, BRAIN RES, V441, P5, DOI 10.1016/0006-8993(88)91377-7
   OZAKI HS, 1987, BRAIN RES, V400, P239, DOI 10.1016/0006-8993(87)90623-8
   OZAKI HS, 1989, BRAIN RES, V493, P66, DOI 10.1016/0006-8993(89)91000-7
   Ozaki HS, 1998, J COMP NEUROL, V400, P197, DOI 10.1002/(SICI)1096-9861(19981019)400:2<197::AID-CNE3>3.0.CO;2-4
   Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.3.CO;2-A
   Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765
   Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904
   Probst M, 1901, ARCH PSYCHIAT NERVEN, V34, P709, DOI 10.1007/BF02680175
   RAKIC P, 1968, J COMP NEUROL, V132, P45, DOI 10.1002/cne.901320103
   Rash BG, 2001, J COMP NEUROL, V434, P147, DOI 10.1002/cne.1170
   REIL JC, 1812, ARCH PHYSL, V11, P314
   Richards LJ, 2002, BRAZ J MED BIOL RES, V35, P1431, DOI 10.1590/S0100-879X2002001200004
   Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x
   ROCKLAND KS, 1986, BRAIN RES, V365, P174, DOI 10.1016/0006-8993(86)90736-5
   SAUERWEIN HC, 1994, BEHAV BRAIN RES, V64, P229, DOI 10.1016/0166-4328(94)90135-X
   SCHNEIDER GE, 1979, NEUROPSYCHOLOGIA, V17, P557, DOI 10.1016/0028-3932(79)90033-2
   Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X
   Shrager RI, 1998, MAGNET RESON MED, V40, P160, DOI 10.1002/mrm.1910400121
   Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001
   SPERRY RW, 1970, ASS RES NERVOUS MENT, V48, P123
   Tailby C, 2005, P NATL ACAD SCI USA, V102, P4631, DOI 10.1073/pnas.0402747102
   Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593
   UZIEL D, 2003, SOC NEUR ABSTR
   Villablanca JR, 2000, NEUROSCIENCE, V95, P625
   Xu DR, 2002, NEUROIMAGE, V17, P1131, DOI 10.1006/nimg.2002.1285
   Xue R, 1999, MAGNET RESON MED, V42, P1123, DOI 10.1002/(SICI)1522-2594(199912)42:6<1123::AID-MRM17>3.0.CO;2-H
NR 74
TC 81
Z9 83
U1 0
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1047-3211
EI 1460-2199
J9 CEREB CORTEX
JI Cereb. Cortex
PD MAR
PY 2007
VL 17
IS 3
BP 531
EP 541
DI 10.1093/cercor/bhj178
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 135AD
UT WOS:000244125200004
PM 16627861
OA Bronze
DA 2020-12-17
ER

PT J
AU Bagnato, F
   Butman, JA
   Gupta, S
   Calabrese, M
   Pezawas, L
   Ohayon, JM
   Tovar-Moll, F
   Riva, M
   Cao, MM
   Talagala, SL
   McFarland, HF
AF Bagnato, F.
   Butman, J. A.
   Gupta, S.
   Calabrese, M.
   Pezawas, L.
   Ohayon, J. M.
   Tovar-Moll, F.
   Riva, M.
   Cao, M. M.
   Talagala, S. L.
   McFarland, H. F.
TI In vivo detection of cortical plaques by MR imaging in patients with
   multiple sclerosis
SO AMERICAN JOURNAL OF NEURORADIOLOGY
LA English
DT Article; Proceedings Paper
CT 42nd Annual Meeting of the American-Society-of-Neuroradiology
CY JUN 05-11, 2004
CL Seattle, WA
SP Amer Soc Neuroradiol
ID ATTENUATED INVERSION-RECOVERY; APPEARING WHITE-MATTER; CEREBRAL-CORTEX;
   BRAIN; LESIONS; DEMYELINATION; REGISTRATION; IMPAIRMENT; PATHOLOGY; GREY
AB BACKGROUND AND PURPOSE: In vivo detection of cortical lesions in patients with multiple sclerosis (MS) by MR imaging is hampered by several factors. Among them is the low contrast between small cortical lesions and surrounding cortical gray matter offered by present techniques,
   METHODS: T1-weighted 3D spoiled gradient-recalled-echo (SPGR) volumes and 2D fluid-attenuated inversion recovery (FLAIR) sequences of 22 patients with MS who had 12 monthly brain MR imaging examinations at 1.5T, using a quadrature head coil, were retrospectively analyzed. These serial studies were coregistered and averaged to generate a single high signal-to-noise ratio (SNR) mean image, which was used to identify cortical lesions. The means of 12 FLAIRs and SPGRs from 14 age- and sex-matched healthy volunteers were analyzed as well.
   RESULTS: No cortical lesions were found on images of healthy subjects. Eighty-six cortical lesions were identified in 13 (59.1%) patients, predominantly in the frontal lobe (73.3%); 23.3% of cortical lesions lay entirely in the cortex, whereas the remaining lesions invaded the white matter underneath.
   CONCLUSION: Averaging multiple SPGRs created a single high SNR volume, allowing identification of cortical lesions. Because data were obtained monthly for 1 year, the average image does not account for transient lesion activity. However, for cortical lesions that remained stable during this time, the findings are valid in demonstrating the importance of high SNR images for detecting cortical brain abnormalities in MS.
C1 NINDS, NIB, NIH, Bethesda, MD 20892 USA.
   NIH, Dept Diagnost Radiol, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA.
   New York Med Coll, Valhalla, NY 10595 USA.
   Genes Cognit & Psychosis Program, Bethesda, MD USA.
   NINDS, NIH, MRI Res Facil, Bethesda, MD 20892 USA.
RP Bagnato, F (corresponding author), NINDS, NIB, NIH, 10 Ctr Dr,Bldg 10,Room 5B16, Bethesda, MD 20892 USA.
EM bagnatof@ninds.nih.gov
RI Moll, Fernanda Tovar/N-3320-2018; Riva, Marco/AAC-1357-2019; Pezawas,
   Lukas/A-2367-2011; Butman, John A/A-2694-2008; Butman, John/J-2780-2013
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Riva,
   Marco/0000-0003-4643-6451; Pezawas, Lukas/0000-0002-1329-6352; Butman,
   John/0000-0002-1547-9195
FU NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [Z01NS002853, Z01NS002853, Z01NS002853, Z01NS002853, Z01NS002853,
   Z01NS002853, Z01NS002853, Z01NS002853, Z01NS002853, Z01NS002853,
   Z01NS002853, Z01NS002853, Z01NS002853, Z01NS002853, Z01NS002853,
   Z01NS002853, ZIANS002853, Z01NS002853] Funding Source: NIH RePORTER;
   Intramural NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA Funding Source:
   Medline
CR Bagnato F, 2005, J NEUROVIROL, V11, P525, DOI 10.1080/13550280500385039
   Bagnato F, 2003, BRAIN, V126, P1782, DOI 10.1093/brain/awg182
   Bakshi R, 2001, ARCH NEUROL-CHICAGO, V58, P742, DOI 10.1001/archneur.58.5.742
   Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723
   Boggild MD, 1996, NEURORADIOLOGY, V38, pS10, DOI 10.1007/BF02278111
   Brink BP, 2005, J NEUROPATH EXP NEUR, V64, P147, DOI 10.1093/jnen/64.2.147
   BROWNELL B, 1962, J NEUROL NEUROSUR PS, V25, P315, DOI 10.1136/jnnp.25.4.315
   Chard DT, 2002, BRAIN, V125, P2342, DOI 10.1093/brain/awf240
   Chen JT, 2004, NEUROIMAGE, V23, P1168, DOI 10.1016/j.neuroimage.2004.07.046
   Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F
   Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014
   Filippi M, 1996, BRAIN, V119, P1349, DOI 10.1093/brain/119.4.1349
   Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797
   GawneCain ML, 1997, NEUROLOGY, V49, P364, DOI 10.1212/WNL.49.2.364
   Geurts JJG, 2005, AM J NEURORADIOL, V26, P572
   Geurts JJG, 2005, RADIOLOGY, V236, P254, DOI 10.1148/radiol.2361040450
   Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6
   Kapeller P, 2001, J NEUROL, V248, P131, DOI 10.1007/s004150170248
   Kidd D, 1999, BRAIN, V122, P17, DOI 10.1093/brain/122.1.17
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641
   Pelletier D, 2004, J NEUROIMAGING, V14, p11S, DOI 10.1111/j.1552-6569.2004.tb00274.x
   Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123
   Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004
   Pham DL, 2000, ANNU REV BIOMED ENG, V2, P315, DOI 10.1146/annurev.bioeng.2.1.315
   Rovaris M, 2000, AM J NEURORADIOL, V21, P402
   Rudick RA, 1999, NEUROLOGY, V53, P1698, DOI 10.1212/WNL.53.8.1698
   Sailer M, 2003, BRAIN, V126, P1734, DOI 10.1093/brain/awg175
   Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698
   Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022
   Talairach J. T., 1988, COPLANAR STEREOTAXIC
   YUEN KK, 1971, J ROY STAT SOC C-APP, V20, P297
NR 32
TC 61
Z9 62
U1 0
U2 4
PU AMER SOC NEURORADIOLOGY
PI DENVILLE
PA PO BOX 3000, DENVILLE, NJ 07834-9349 USA
SN 0195-6108
EI 1936-959X
J9 AM J NEURORADIOL
JI Am. J. Neuroradiol.
PD NOV-DEC
PY 2006
VL 27
IS 10
BP 2161
EP 2167
PG 7
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA 109CE
UT WOS:000242284700033
PM 17110688
DA 2020-12-17
ER

EF